1: Bryll A, Skrzypek J, Krzyściak W, Szelągowska M, Śmierciak N, Kozicz T,
Popiela T. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in
Schizophrenia. Biomolecules. 2020 Mar 2;10(3):384. doi: 10.3390/biom10030384.
PMID: 32121669; PMCID: PMC7175146.
2: Morera-Fumero AL, Abreu-Gonzalez P. Role of melatonin in schizophrenia. Int J
Mol Sci. 2013 Apr 25;14(5):9037-50. doi: 10.3390/ijms14059037. PMID: 23698762;
PMCID: PMC3676771.
3: Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory
nutrient status, supplementation, and mechanisms in patients with schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:1-11. doi:
10.1016/j.pnpbp.2017.05.005. Epub 2017 May 9. PMID: 28499901.
4: Das TK, Javadzadeh A, Dey A, Sabesan P, Théberge J, Radua J, Palaniyappan L.
Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of
MRS studies of anterior cingulate glutathione. Prog Neuropsychopharmacol Biol
Psychiatry. 2019 Apr 20;91:94-102. doi: 10.1016/j.pnpbp.2018.08.006. Epub 2018
Aug 17. PMID: 30125624.
5: Wu JQ, Kosten TR, Zhang XY. Free radicals, antioxidant defense systems, and
schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:200-6.
doi: 10.1016/j.pnpbp.2013.02.015. Epub 2013 Mar 5. PMID: 23470289.
6: Raghu G, Berk M, Campochiaro PA, Jaeschke H, Marenzi G, Richeldi L, Wen FQ,
Nicoletti F, Calverley PMA. The Multifaceted Therapeutic Role of
N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr
Neuropharmacol. 2021;19(8):1202-1224. doi: 10.2174/1570159X19666201230144109.
PMID: 33380301; PMCID: PMC8719286.
7: Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. The Potential of
N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs.
2022 May;36(5):451-482. doi: 10.1007/s40263-022-00907-3. Epub 2022 Mar 22.
Erratum in: CNS Drugs. 2022 Apr 28;: PMID: 35316513; PMCID: PMC9095537.
8: Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR,
Smirnova LP. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis
and New Treatment Perspectives. Oxid Med Cell Longev. 2021 Jan 23;2021:8881770.
doi: 10.1155/2021/8881770. PMID: 33552387; PMCID: PMC7847339.
9: Davison J, O'Gorman A, Brennan L, Cotter DR. A systematic review of
metabolite biomarkers of schizophrenia. Schizophr Res. 2018 May;195:32-50. doi:
10.1016/j.schres.2017.09.021. Epub 2017 Sep 22. PMID: 28947341.
10: Lin CH, Chen YM, Lane HY. Novel Treatment for the Most Resistant
Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant. Curr Drug
Targets. 2020;21(6):610-615. doi: 10.2174/1389450120666191011163539. PMID:
31660823.
11: Fraguas D, Díaz-Caneja CM, Ayora M, Hernández-Álvarez F, Rodríguez-Quiroga
A, Recio S, Leza JC, Arango C. Oxidative Stress and Inflammation in FirstEpisode Psychosis: A Systematic Review and Meta-analysis. Schizophr Bull. 2019
Jun 18;45(4):742-751. doi: 10.1093/schbul/sby125. PMID: 30169868; PMCID:
PMC6581144.
12: Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in
schizophrenia: a review. Schizophr Res. 1996 Mar;19(1):1-17. doi:
10.1016/0920-9964(95)00049-6. PMID: 9147491.
13: D'Cruz M, Andrade C. Potential clinical applications of Ashwagandha
(<i>Withania somnifera</i>) in medicine and neuropsychiatry. Expert Rev Clin
Pharmacol. 2022 Sep;15(9):1067-1080. doi: 10.1080/17512433.2022.2121699. Epub
2022 Sep 8. PMID: 36062480.
14: Karagöl G, Songur E, Rakıcıoğlu N. Dietary total antioxidant capacity and
serum 8-OHdG in patients with schizophrenia. Int J Psychiatry Med. 2023
Nov;58(6):544-558. doi: 10.1177/00912174231177638. Epub 2023 May 21. PMID:
37210638.
15: Mandal PK, Gaur S, Roy RG, Samkaria A, Ingole R, Goel A. Schizophrenia,
Bipolar and Major Depressive Disorders: Overview of Clinical Features,
Neurotransmitter Alterations, Pharmacological Interventions, and Impact of
Oxidative Stress in the Disease Process. ACS Chem Neurosci. 2022 Oct
5;13(19):2784-2802. doi: 10.1021/acschemneuro.2c00420. Epub 2022 Sep 20. PMID:
36125113.
16: Chowdari KV, Bamne MN, Nimgaonkar VL. Genetic association studies of
antioxidant pathway genes and schizophrenia. Antioxid Redox Signal. 2011 Oct
1;15(7):2037-45. doi: 10.1089/ars.2010.3508. Epub 2010 Nov 1. PMID: 20673164;
PMCID: PMC3159115.
17: Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and
omega-3 essential fatty acid supplementation in schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):463-93. doi:
10.1016/s0278-5846(00)00181-0. PMID: 11370992.
18: Yang YS, Maddock RJ, Zhang H, Lee J, Hellemann G, Marder SR, Green MF.
N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A
preliminary MRS study. Psychiatry Res Neuroimaging. 2022 Sep;325:111515. doi:
10.1016/j.pscychresns.2022.111515. Epub 2022 Jun 23. PMID: 35839558.
19: Liu H, Yu R, Gao Y, Li X, Guan X, Thomas K, Xiu M, Zhang X. Antioxidant
Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients
Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study. Curr
Neuropharmacol. 2022 Aug 3;20(9):1774-1782. doi:
10.2174/1570159X19666210920090547. PMID: 34544343; PMCID: PMC9881063.
20: Sokolova SV, Sozarukova MM, Khannanova AN, Grishina NK, Portnova GV,
Proskurnina EV. Antioksidantnyi status pri paranoidnoi shizofrenii i bolezni
Al'tsgeimera [Antioxidant status in patients with paranoid schizophrenia and
Alzheimer disease]. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(6):82-87.
Russian. doi: 10.17116/jnevro202012006182. PMID: 32678552.
21: Maas DA, Eijsink VD, van Hulten JA, Panic R, De Weerd P, Homberg JR, Vallès
A, Nait-Oumesmar B, Martens GJM. Antioxidant treatment ameliorates prefrontal
hypomyelination and cognitive deficits in a rat model of schizophrenia.
Neuropsychopharmacology. 2021 May;46(6):1161-1171. doi:
10.1038/s41386-021-00964-0. Epub 2021 Feb 9. PMID: 33564104; PMCID: PMC8115238.
22: Agarwal SM, Stogios N, Ahsan ZA, Lockwood JT, Duncan MJ, Takeuchi H, Cohn T,
Taylor VH, Remington G, Faulkner GEJ, Hahn M. Pharmacological interventions for
prevention of weight gain in people with schizophrenia. Cochrane Database Syst
Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2. PMID:
36190739; PMCID: PMC9528976.
23: Maes M, Sirivichayakul S, Matsumoto AK, Michelin AP, de Oliveira Semeão L,
de Lima Pedrão JV, Moreira EG, Barbosa DS, Carvalho AF, Solmi M, Kanchanatawan
B. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks
of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach. Mol
Neurobiol. 2020 Nov;57(11):4578-4597. doi: 10.1007/s12035-020-02047-5. Epub 2020
Aug 5. PMID: 32754898.
24: Raffa M, Barhoumi S, Atig F, Fendri C, Kerkeni A, Mechri A. Reduced
antioxidant defense systems in schizophrenia and bipolar I disorder. Prog
Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):371-5. doi:
10.1016/j.pnpbp.2012.07.013. Epub 2012 Jul 27. PMID: 22841966.
25: Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in
schizophrenia: are these opportunities for repurposing? Postgrad Med. 2022
Mar;134(2):187-199. doi: 10.1080/00325481.2021.2006514. Epub 2021 Nov 26. PMID:
34766870.
26: Liu H, Liu H, Jiang S, Su L, Lu Y, Chen Z, Li X, Li X, Wang X, Xiu M, Zhang
X. Sex-Specific Association between Antioxidant Defense System and Therapeutic
Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study. Curr
Neuropharmacol. 2022 Aug 3;20(9):1793-1803. doi:
10.2174/1570159X19666211111123918. PMID: 34766896; PMCID: PMC9881066.
27: Zhang XY, Chen DC, Xiu MH, Tang W, Zhang F, Liu L, Chen Y, Liu J, Yao JK,
Kosten TA, Kosten TR. Plasma total antioxidant status and cognitive impairments
in schizophrenia. Schizophr Res. 2012 Aug;139(1-3):66-72. doi:
10.1016/j.schres.2012.04.009. Epub 2012 May 1. PMID: 22555016.
28: Piatoikina AS, Lyakhova AA, Semennov IV, Zhilyaeva TV, Kostina OV, Zhukova
ES, Shcherbatyuk TG, Kasyanov ED, Blagonravova AS, Mazo GE. Association of
antioxidant deficiency and the level of products of protein and lipid
peroxidation in patients with the first episode of schizophrenia. J Mol
Neurosci. 2022 Feb;72(2):217-225. doi: 10.1007/s12031-021-01884-w. Epub 2021 Aug
19. PMID: 34410570.
29: Reddy R, Reddy R. Antioxidant therapeutics for schizophrenia. Antioxid Redox
Signal. 2011 Oct 1;15(7):2047-55. doi: 10.1089/ars.2010.3571. Epub 2011 Apr 20.
PMID: 20977337.
30: Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, Galeazzi
GM. N-acetylcysteine in the treatment of psychiatric disorders: current status
and future prospects. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):279-292.
doi: 10.1080/17425255.2017.1251580. Epub 2016 Nov 2. PMID: 27766914.
31: Rabiee R, Hosseini Hooshiar S, Ghaderi A, Jafarnejad S. Schizophrenia,
Curcumin and Minimizing Side Effects of Antipsychotic Drugs: Possible
Mechanisms. Neurochem Res. 2023 Mar;48(3):713-724. doi:
10.1007/s11064-022-03798-4. Epub 2022 Nov 10. PMID: 36357748.
32: Magalhães PV, Dean O, Andreazza AC, Berk M, Kapczinski F. Antioxidant
treatments for schizophrenia. Cochrane Database Syst Rev. 2016 Feb
5;2(2):CD008919. doi: 10.1002/14651858.CD008919.pub2. PMID: 26848926; PMCID:
PMC10337514.
33: Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B. Nitric oxide
and schizophrenia: present knowledge and emerging concepts of therapy. CNS
Neurol Disord Drug Targets. 2011 Nov;10(7):792-807. doi:
10.2174/187152711798072392. PMID: 21999729.
34: Bastos MAV Jr, Oliveira Bastos PRH, Portella RB, Soares LFG, Conde RB,
Rodrigues PMF Jr, Lucchetti G. Pineal gland and schizophrenia: A systematic
review and meta-analysis. Psychoneuroendocrinology. 2019 Jun;104:100-114. doi:
10.1016/j.psyneuen.2019.02.024. Epub 2019 Feb 25. PMID: 30831343.
35: Albayrak Y, Ünsal C, Beyazyüz M, Ünal A, Kuloğlu M. Reduced total
antioxidant level and increased oxidative stress in patients with deficit
schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry.
2013 Aug 1;45:144-9. doi: 10.1016/j.pnpbp.2013.04.020. Epub 2013 May 6. PMID:
23657077.
36: Regland B. Schizophrenia and single-carbon metabolism. Prog
Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1124-32. doi:
10.1016/j.pnpbp.2005.06.023. PMID: 16095790.
37: Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK,
Dikshit M. Nitrite content and antioxidant enzyme levels in the blood of
schizophrenia patients. Psychopharmacology (Berl). 2001 Nov;158(2):140-5. doi:
10.1007/s002130100860. PMID: 11702087.
38: Goh XX, Tang PY, Tee SF. Effects of antipsychotics on antioxidant defence
system in patients with schizophrenia: A meta-analysis. Psychiatry Res. 2022
Mar;309:114429. doi: 10.1016/j.psychres.2022.114429. Epub 2022 Feb 3. PMID:
35150976.
39: Talukdar PM, Abdul F, Maes M, Binu VS, Venkatasubramanian G, Kutty BM,
Debnath M. Maternal Immune Activation Causes Schizophrenia-like Behaviors in the
Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic
Pathways, and Lowered Antioxidant Defenses and Neuroprotection. Mol Neurobiol.
2020 Oct;57(10):4345-4361. doi: 10.1007/s12035-020-02028-8. Epub 2020 Jul 27.
PMID: 32720073.
40: Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N. Lipid
peroxidation and antioxidant enzyme levels in patients with schizophrenia and
bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5. doi:
10.1002/cbf.940. PMID: 11979513.
41: Anderson G, Maes M. Melatonin: an overlooked factor in schizophrenia and in
the inhibition of anti-psychotic side effects. Metab Brain Dis. 2012
Jun;27(2):113-9. doi: 10.1007/s11011-012-9307-9. Epub 2012 Apr 25. PMID:
22527998.
42: Li HC, Chen QZ, Ma Y, Zhou JF. Imbalanced free radicals and antioxidant
defense systems in schizophrenia: a comparative study. J Zhejiang Univ Sci B.
2006 Dec;7(12):981-6. doi: 10.1631/jzus.2006.B0981. PMID: 17111467; PMCID:
PMC1661668.
43: Uguz AC, Demirci K, Espino J. The Importance of Melatonin and Mitochondria
Interaction in Mood Disorders and Schizophrenia: A Current Assessment. Curr Med
Chem. 2016;23(20):2146-58. doi: 10.2174/0929867323666160428105849. PMID:
27121187.
44: Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali
DP, Brown GM. Sleep and circadian rhythm dysregulation in schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:209-16. doi:
10.1016/j.pnpbp.2012.12.021. Epub 2013 Jan 11. PMID: 23318689.
45: Kouidrat Y, Amad A, Arai M, Miyashita M, Lalau JD, Loas G, Itokawa M.
Advanced glycation end products and schizophrenia: A systematic review. J
Psychiatr Res. 2015 Jul-Aug;66-67:112-7. doi: 10.1016/j.jpsychires.2015.04.023.
Epub 2015 May 8. PMID: 26001588.
46: Pommerening Dornelles E, Gama Marques J, Ouakinin S. Unconjugated bilirubin
and schizophrenia: a systematic review. CNS Spectr. 2019 Dec;24(6):577-588. doi:
10.1017/S109285291800161X. Erratum in: CNS Spectr. 2020 Jun;25(3):448. PMID:
30915934.
47: Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF. Antioxidant enzymes
and lipid peroxidation in different forms of schizophrenia treated with typical
and atypical antipsychotics. Schizophr Res. 2006 Jan 31;81(2-3):291-300. doi:
10.1016/j.schres.2005.10.011. Epub 2005 Nov 23. PMID: 16309894.
48: Skupienski R, Steullet P, Do KQ, Xin L. Developmental changes in cerebral
NAD and neuroenergetics of an antioxidant compromised mouse model of
schizophrenia. Transl Psychiatry. 2023 Aug 5;13(1):275. doi:
10.1038/s41398-023-02568-2. PMID: 37543592; PMCID: PMC10404265.
49: Yao JK, Reddy R. Oxidative stress in schizophrenia: pathogenetic and
therapeutic implications. Antioxid Redox Signal. 2011 Oct 1;15(7):1999-2002.
doi: 10.1089/ars.2010.3646. Epub 2011 May 4. PMID: 21194354; PMCID: PMC3159103.
50: Al-Asmari AK, Khan MW. Inflammation and schizophrenia: alterations in
cytokine levels and perturbation in antioxidative defense systems. Hum Exp
Toxicol. 2014 Feb;33(2):115-22. doi: 10.1177/0960327113493305. Epub 2013 Jul 8.
PMID: 23836841.
51: Tendilla-Beltrán H, Flores G. Due to their anti-inflammatory, antioxidant
and neurotrophic properties, second-generation antipsychotics are suitable in
patients with schizophrenia and COVID-19. Gen Hosp Psychiatry. 2021 JulAug;71:137-139. doi: 10.1016/j.genhosppsych.2021.05.005. Epub 2021 May 23. PMID:
34045093; PMCID: PMC8141345.
52: Kulak A, Steullet P, Cabungcal JH, Werge T, Ingason A, Cuenod M, Do KQ.
Redox dysregulation in the pathophysiology of schizophrenia and bipolar
disorder: insights from animal models. Antioxid Redox Signal. 2013 Apr
20;18(12):1428-43. doi: 10.1089/ars.2012.4858. Epub 2012 Oct 12. PMID: 22938092.
53: Strassnig M, Singh Brar J, Ganguli R. Dietary fatty acid and antioxidant
intake in community-dwelling patients suffering from schizophrenia. Schizophr
Res. 2005 Jul 15;76(2-3):343-51. doi: 10.1016/j.schres.2005.03.002. PMID:
15949667.
54: Morera-Fumero AL, Díaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, CejasMendez MD. Low levels of serum total antioxidant capacity and presence at
admission and absence at discharge of a day/night change as a marker of acute
paranoid schizophrenia relapse. Psychiatry Res. 2017 Mar;249:200-205. doi:
10.1016/j.psychres.2017.01.043. Epub 2017 Jan 19. PMID: 28126575.
55: Kantrowitz J, Citrome L, Javitt D. GABA(B) receptors, schizophrenia and
sleep dysfunction: a review of the relationship and its potential clinical and
therapeutic implications. CNS Drugs. 2009 Aug;23(8):681-91. doi:
10.2165/00023210-200923080-00005. PMID: 19594197; PMCID: PMC4988234.
56: Chen AT, Chibnall JT, Nasrallah HA. Placebo-controlled augmentation trials
of the antioxidant NAC in schizophrenia: A review. Ann Clin Psychiatry. 2016
Aug;28(3):190-6. PMID: 27490835.
57: Ben Othmen L, Mechri A, Fendri C, Bost M, Chazot G, Gaha L, Kerkeni A.
Altered antioxidant defense system in clinically stable patients with
schizophrenia and their unaffected siblings. Prog Neuropsychopharmacol Biol
Psychiatry. 2008 Jan 1;32(1):155-9. doi: 10.1016/j.pnpbp.2007.08.003. Epub 2007
Aug 14. PMID: 17804133.
58: Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in
schizophrenia: an integrative view. Antioxid Redox Signal. 2011 Oct
1;15(7):2011-35. doi: 10.1089/ars.2010.3603. Epub 2011 Apr 21. PMID: 21126177;
PMCID: PMC3159108.
59: Pandurangi AK, Buckley PF. Inflammation, Antipsychotic Drugs, and Evidence
for Effectiveness of Anti-inflammatory Agents in Schizophrenia. Curr Top Behav
Neurosci. 2020;44:227-244. doi: 10.1007/7854_2019_91. PMID: 30993585.
60: Monte AS, de Souza GC, McIntyre RS, Soczynska JK, dos Santos JV, Cordeiro
RC, Ribeiro BM, de Lucena DF, Vasconcelos SM, de Sousa FC, Carvalho AF, Macêdo
DS. Prevention and reversal of ketamine-induced schizophrenia related behavior
by minocycline in mice: Possible involvement of antioxidant and nitrergic
pathways. J Psychopharmacol. 2013 Nov;27(11):1032-43. doi:
10.1177/0269881113503506. Epub 2013 Sep 17. PMID: 24045882.
61: Ruiz-Litago F, Seco J, Echevarría E, Martínez-Cengotitabengoa M, Gil J,
Irazusta J, González-Pinto AM. Adaptive response in the antioxidant defence
system in the course and outcome in first-episode schizophrenia patients: a
12-months follow-up study. Psychiatry Res. 2012 Dec 30;200(2-3):218-22. doi:
10.1016/j.psychres.2012.07.024. Epub 2012 Aug 9. PMID: 22884309.
62: Okubo Eneni AE, Ben-Azu B, Mayowa Ajayi A, Oladele Aderibigbe A. Diosmin
attenuates schizophrenia-like behavior, oxidative stress, and
acetylcholinesterase activity in mice. Drug Metab Pers Ther. 2020 Oct 15;35(4).
doi: 10.1515/dmpt-2020-0119. PMID: 34704698.
63: Samuelsson M, Skogh E, Lundberg K, Vrethem M, Öllinger K. Taurine and
glutathione in plasma and cerebrospinal fluid in olanzapine treated patients
with schizophrenia. Psychiatry Res. 2013 Dec 30;210(3):819-24. doi:
10.1016/j.psychres.2013.09.014. Epub 2013 Oct 7. PMID: 24113127.
64: Phensy A, Driskill C, Lindquist K, Guo L, Jeevakumar V, Fowler B, Du H,
Kroener S. Antioxidant Treatment in Male Mice Prevents Mitochondrial and
Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia. eNeuro.
2017 Aug 17;4(4):ENEURO.0081-17.2017. doi: 10.1523/ENEURO.0081-17.2017. PMID:
28819639; PMCID: PMC5559903.
65: Xuan Y, Yan G, Peng H, Wu R, Xu H. Concurrent changes in ¹H MRS metabolites
and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to
cuprizone: possible implications for schizophrenia. Neurochem Int. 2014
Apr;69:20-7. doi: 10.1016/j.neuint.2014.02.004. Epub 2014 Mar 6. PMID: 24613425.
66: Djordjević VV, Kostić J, Krivokapić Ž, Krtinić D, Ranković M, Petković M,
Ćosić V. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase
in Patients with Schizophrenia. Medicina (Kaunas). 2022 Oct 19;58(10):1491. doi:
10.3390/medicina58101491. PMID: 36295651; PMCID: PMC9609318.
67: Radonjić NV, Knezević ID, Vilimanovich U, Kravić-Stevović T, Marina LV,
Nikolić T, Todorović V, Bumbasirević V, Petronijević ND. Decreased glutathione
levels and altered antioxidant defense in an animal model of schizophrenia:
long-term effects of perinatal phencyclidine administration. Neuropharmacology.
2010 Mar-Apr;58(4-5):739-45. doi: 10.1016/j.neuropharm.2009.12.009. Epub 2009
Dec 27. PMID: 20036264.
68: Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for
antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther.
2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. PMID: 18990082.
69: Sadowska-Bartosz I, Galiniak S, Bartosz G, Zuberek M, Grzelak A, DietrichMuszalska A. Antioxidant properties of atypical antipsychotic drugs used in the
treatment of schizophrenia. Schizophr Res. 2016 Oct;176(2-3):245-251. doi:
10.1016/j.schres.2016.07.010. Epub 2016 Jul 20. PMID: 27449251.
70: Buosi P, Borghi FA, Lopes AM, Facincani IDS, Fernandes-Ferreira R, OliveiraBrancati CIF, do Carmo TS, Souza DRS, da Silva DGH, de Almeida EA, de Araújo
Filho GM. Oxidative stress biomarkers in treatment-responsive and treatmentresistant schizophrenia patients. Trends Psychiatry Psychother. 2021 OctDec;43(4):278-285. doi: 10.47626/2237-6089-2020-0078. Epub 2021 Jan 1. PMID:
34982515; PMCID: PMC8835384.
71: Pitsikas N. The role of nitric oxide donors in schizophrenia: Basic studies
and clinical applications. Eur J Pharmacol. 2015 Nov 5;766:106-13. doi:
10.1016/j.ejphar.2015.09.045. Epub 2015 Oct 3. PMID: 26435027.
72: Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M. A role
for glutathione in the pathophysiology of bipolar disorder and schizophrenia?
Animal models and relevance to clinical practice. Curr Med Chem.
2009;16(23):2965-76. doi: 10.2174/092986709788803060. PMID: 19689277.
73: Benson KL. Sleep in schizophrenia: impairments, correlates, and treatment.
Psychiatr Clin North Am. 2006 Dec;29(4):1033-45; abstract ix-x. doi:
10.1016/j.psc.2006.08.002. PMID: 17118280.
74: Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa
DS, Maes M, Moreira EG. Oxidative and nitrosative stress biomarkers in chronic
schizophrenia. Psychiatry Res. 2017 Jul;253:43-48. doi:
10.1016/j.psychres.2017.03.038. Epub 2017 Mar 21. Erratum in: Psychiatry Res.
2019 Mar;273:809. PMID: 28346888.
75: Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants
in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 1996
Aug;55(1-2):45-54. doi: 10.1016/s0952-3278(96)90144-1. PMID: 8888122.
76: Matsuzawa D, Hashimoto K. Magnetic resonance spectroscopy study of the
antioxidant defense system in schizophrenia. Antioxid Redox Signal. 2011 Oct
1;15(7):2057-65. doi: 10.1089/ars.2010.3453. Epub 2010 Dec 4. PMID: 20712400.
77: Vasconcelos GS, Ximenes NC, de Sousa CN, Oliveira Tde Q, Lima LL, de Lucena
DF, Gama CS, Macêdo D, Vasconcelos SM. Alpha-lipoic acid alone and combined with
clozapine reverses schizophrenia-like symptoms induced by ketamine in mice:
Participation of antioxidant, nitrergic and neurotrophic mechanisms. Schizophr
Res. 2015 Jul;165(2-3):163-70. doi: 10.1016/j.schres.2015.04.017. Epub 2015 Apr
30. PMID: 25937462.
78: Zavodnick AD, Ali R. N-Acetylcysteine and metabotropic glutamate receptors:
implications for the treatment of schizophrenia: a literature review. Psychiatr
Q. 2014 Jun;85(2):177-85. doi: 10.1007/s11126-013-9281-3. PMID: 24390716.
79: Kishi T, Sakuma K, Hatano M, Iwata N. N-acetylcysteine for schizophrenia: A
systematic review and meta-analysis. Psychiatry Clin Neurosci. 2023
Feb;77(2):119-121. doi: 10.1111/pcn.13502. Epub 2022 Nov 19. PMID: 36330886.
80: Moghaddam AH, Parhizgar M, Jelodar SK, Eslami A, Sayrafi R. Nano-hesperetin
attenuates ketamine-induced schizophrenia-like symptoms in mice: participation
of antioxidant parameters. Psychopharmacology (Berl). 2023 May;240(5):1063-1074.
doi: 10.1007/s00213-023-06344-4. Epub 2023 Mar 6. PMID: 36879073.
81: Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A. Decreased
glutathione levels and antioxidant enzyme activities in untreated and treated
schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct
1;33(7):1178-83. doi: 10.1016/j.pnpbp.2009.06.018. Epub 2009 Jul 2. PMID:
19576938.
82: Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E,
Pera J, Filip M. Oxidative stress as an etiological factor and a potential
treatment target of psychiatric disorders. Part 2. Depression, anxiety,
schizophrenia and autism. Pharmacol Rep. 2015 Jun;67(3):569-80. doi:
10.1016/j.pharep.2014.12.015. Epub 2015 Jan 5. PMID: 25933971.
83: Raffa M, Lakhdar R, Ghachem M, Barhoumi S, Safar MT, Bel Hadj Jrad B, Haj
Khelil A, Kerkeni A, Mechri A. Relationship between GSTM1 and GSTT1
polymorphisms and schizophrenia: a case-control study in a Tunisian population.
Gene. 2013 Jan 10;512(2):282-5. doi: 10.1016/j.gene.2012.10.031. Epub 2012 Oct
26. PMID: 23107768.
84: Bahceci B, Kokacya MH, Copoglu US, Bahceci I, Sahin K, Bagcioglu E, Dokuyucu
R. Elevated nucleosome level and oxidative stress in schizophrenia patients.
Bratisl Lek Listy. 2015;116(10):587-90. doi: 10.4149/bll_2015_114. PMID:
26531868.
85: Leza
Bernardo
Biobehav
2015 Jun
JC, García-Bueno B, Bioque M, Arango C, Parellada M, Do K, O'Donnell P,
M. Inflammation in schizophrenia: A question of balance. Neurosci
Rev. 2015 Aug;55:612-26. doi: 10.1016/j.neubiorev.2015.05.014. Epub
16. PMID: 26092265.
86: Pazvantoglu O, Selek S, Okay IT, Sengul C, Karabekiroglu K, Dilbaz N, Erel
O. Oxidative mechanisms in schizophrenia and their relationship with illness
subtype and symptom profile. Psychiatry Clin Neurosci. 2009 Oct;63(5):693-700.
doi: 10.1111/j.1440-1819.2009.02015.x. PMID: 19788631.
87: Pontes-Neto JG, Fontes DAF, de Lyra MAM, Brito MDRM, Chaves LL, Rolim-Neto
PJ, De La Roca Soares MF, Quintans Júnior LJ, de Freitas RM, Soares-Sobrinho JL.
Evaluation of antioxidant potencial of novel CaAl and NiAl layered double
hydroxides loaded with olanzapine. Life Sci. 2018 Aug 15;207:246-252. doi:
10.1016/j.lfs.2018.05.031. Epub 2018 May 17. PMID: 29778806.
88: Patel S, Sharma D, Kalia K, Tiwari V. Crosstalk between endoplasmic
reticulum stress and oxidative stress in schizophrenia: The dawn of new
therapeutic approaches. Neurosci Biobehav Rev. 2017 Dec;83:589-603. doi:
10.1016/j.neubiorev.2017.08.025. Epub 2017 Sep 8. PMID: 28890198.
89: Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A. Decreased glutathione levels
and impaired antioxidant enzyme activities in drug-naive first-episode
schizophrenic patients. BMC Psychiatry. 2011 Aug 2;11:124. doi:
10.1186/1471-244X-11-124. PMID: 21810251; PMCID: PMC3161936.
90: Tharoor H, Maran S, Chandan AK, Pari M, Rao S, Durairaj J. Cognitive and
negative symptoms in schizophrenia with L-Carnosine adjuvant therapy - A
randomized double-blind placebo-controlled study. Pharmacol Res Perspect. 2023
Apr;11(2):e01074. doi: 10.1002/prp2.1074. PMID: 36946070; PMCID: PMC10031293.
91: Andrabi SS, Vishnoi S, Kaushik M, Parveen K, Tabassum H, Akram M, Parvez S.
Reversal of Schizophrenia-like Symptoms and Cholinergic Alterations
by Melatonin. Arch Med Res. 2019 Jul;50(5):295-303. doi:
10.1016/j.arcmed.2019.08.005. Epub 2019 Oct 7. PMID: 31600601.
92: Sertan Copoglu U, Virit O, Hanifi Kokacya M, Orkmez M, Bulbul F, Binnur
Erbagci A, Semiz M, Alpak G, Unal A, Ari M, Savas HA. Increased oxidative stress
and oxidative DNA damage in non-remission schizophrenia patients. Psychiatry
Res. 2015 Sep 30;229(1-2):200-5. doi: 10.1016/j.psychres.2015.07.036. Epub 2015
Jul 15. PMID: 26213375.
93: Brown JS Jr. Effects of bisphenol-A and other endocrine disruptors compared
with abnormalities of schizophrenia: an endocrine-disruption theory of
schizophrenia. Schizophr Bull. 2009 Jan;35(1):256-78. doi:
10.1093/schbul/sbm147. Epub 2008 Jan 31. PMID: 18245062; PMCID: PMC2643957.
94: de Araújo FYR, Chaves Filho AJM, Nunes AM, de Oliveira GV, Gomes PXL,
Vasconcelos GS, Carletti J, de Moraes MO, de Moraes ME, Vasconcelos SMM, de
Sousa FCF, de Lucena DF, Macedo DS. Involvement of anti-inflammatory,
antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect
of the essential oil of Alpinia zerumbet in mice: a comparative study with
olanzapine. Metab Brain Dis. 2021 Dec;36(8):2283-2297. doi:
10.1007/s11011-021-00821-5. Epub 2021 Sep 7. PMID: 34491479.
95: Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen DC, Xiu MH,
Kosten TA, Kosten TR. Effects of risperidone and haloperidol on superoxide
dismutase and nitric oxide in schizophrenia. Neuropharmacology. 2012
Apr;62(5-6):1928-34. doi: 10.1016/j.neuropharm.2011.12.014. Epub 2011 Dec 30.
PMID: 22227558.
96: Wang X, Liu J, Dai Z, Sui Y. Andrographolide improves PCP-induced
schizophrenia-like behaviors through blocking interaction between NRF2 and
KEAP1. J Pharmacol Sci. 2021 Sep;147(1):9-17. doi: 10.1016/j.jphs.2021.05.007.
Epub 2021 May 24. PMID: 34294378.
97: Yolland COB, Phillipou A, Castle DJ, Neill E, Hughes ME, Galletly C, Smith
ZM, Francis PS, Dean OM, Sarris J, Siskind D, Harris AWF, Rossell SL.
Improvement of cognitive function in schizophrenia with <i>N</i>-acetylcysteine:
A theoretical review. Nutr Neurosci. 2020 Feb;23(2):139-148. doi:
10.1080/1028415X.2018.1478766. Epub 2018 May 30. PMID: 29847303.
98: Huo L, Lu X, Wu F, Chang C, Ning Y, Zhang XY. Elevated activity of
superoxide dismutase in male late-life schizophrenia and its correlation with
clinical symptoms and cognitive deficits. BMC Psychiatry. 2021 Dec 4;21(1):606.
doi: 10.1186/s12888-021-03604-5. PMID: 34863137; PMCID: PMC8642951.
99: Tereshkina EB, Savushkina OK, Boksha IS, Prokhorova TA, Vorobyeva EA,
Omel'chenko MA, Pomytkin AN, Kaleda VG, Burbaeva GS. Glutationreduktaza i
glutation-S-transferaza v formennykh élementakh krovi pri shizofrenii i
rasstroĭstvakh shizofrenicheskogo spektra [Glutathione reductase and
glutathione-S-transferase in blood cells in schizophrenia and schizophrenia
spectrum disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2):61-65.
Russian. doi: 10.17116/jnevro201911902161. PMID: 30874529.
100: González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás
L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J.
Oxidative stress biomarkers and clinical dimensions in first 10 years of
schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed). 2018 Jul-Sep;11(3):130-140.
English, Spanish. doi: 10.1016/j.rpsm.2018.03.003. Epub 2018 Apr 22. PMID:
29691142.
101: Maia-de-Oliveira JP, Trzesniak C, Oliveira IR, Kempton MJ, Rezende TM, Iego
S, Baker GB, Dursun SM, Machado-de-Sousa JP, Hallak JE. Nitric oxide
plasma/serum levels in patients with schizophrenia: a systematic review and
meta-analysis. Braz J Psychiatry. 2012 Oct;34 Suppl 2:S149-55. English,
Portuguese. doi: 10.1016/j.rbp.2012.07.001. PMID: 23429845.
102: An H, Du X, Huang X, Qi L, Jia Q, Yin G, Xiao C, Huang XF, Ning Y, Cassidy
RM, Wang L, Soares JC, Zhang XY. Obesity, altered oxidative stress, and clinical
correlates in chronic schizophrenia patients. Transl Psychiatry. 2018 Nov
29;8(1):258. doi: 10.1038/s41398-018-0303-7. PMID: 30498208; PMCID: PMC6265271.
103: Matsumoto AK, Maes M, Supasitthumrong T, Maes A, Michelin AP, de Oliveira
Semeão L, de Lima Pedrão JV, Moreira EG, Kanchanatawan B, Barbosa DS. Deficit
schizophrenia and its features are associated with PON1 Q192R genotypes and
lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial
translocation. CNS Spectr. 2021 Aug;26(4):406-415. doi:
10.1017/S1092852920001388. Epub 2020 Jun 23. PMID: 32638685.
104: Virit O, Altindag A, Yumru M, Dalkilic A, Savas HA, Selek S, Erel O, Herken
H. A defect in the antioxidant defense system in schizophrenia.
Neuropsychobiology. 2009;60(2):87-93. doi: 10.1159/000239684. Epub 2009 Sep 21.
PMID: 19776652.
105: Nedic Erjavec G, Konjevod M, Nikolac Perkovic M, Svob Strac D, Tudor L,
Barbas C, Grune T, Zarkovic N, Pivac N. Short overview on metabolomic approach
and redox changes in psychiatric disorders. Redox Biol. 2018 Apr;14:178-186.
doi: 10.1016/j.redox.2017.09.002. Epub 2017 Sep 6. PMID: 28942195; PMCID:
PMC5609866.
106: Ghaderi A, Banafshe HR, Mirhosseini N, Moradi M, Karimi MA, Mehrzad F,
Bahmani F, Asemi Z. Clinical and metabolic response to vitamin D plus probiotic
in schizophrenia patients. BMC Psychiatry. 2019 Feb 21;19(1):77. doi:
10.1186/s12888-019-2059-x. PMID: 30791895; PMCID: PMC6383260.
107: Wang DM, Du YX, Zhu RR, Tian Y, Chen JJ, Chen DC, Wang L, Zhang XY. The
relationship between cognitive impairment and superoxide dismutase activity in
untreated first-episode patients with schizophrenia. World J Biol Psychiatry.
2022 Sep;23(7):517-524. doi: 10.1080/15622975.2021.2013093. Epub 2021 Dec 17.
PMID: 34918615.
108: Shayganfard M. Berberine: Is it a Promising Agent for Mental Disorders
Treatment? Curr Mol Pharmacol. 2023;16(3):307-320. doi:
10.2174/1874467215666220509213122. PMID: 35538795.
109: Lin CH, Li TM, Huang YJ, Chen SJ, Lane HY. Differential Impacts of
Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and
Chronic Schizophrenia Patients. Int J Neuropsychopharmacol. 2023 Aug
29;26(8):576-583. doi: 10.1093/ijnp/pyad040. PMID: 37422918; PMCID: PMC10464923.
110: Solovyev ND. Importance of selenium and selenoprotein for brain function:
From antioxidant protection to neuronal signalling. J Inorg Biochem. 2015
Dec;153:1-12. doi: 10.1016/j.jinorgbio.2015.09.003. Epub 2015 Sep 15. PMID:
26398431.
111: Bas A, Gultekin G, Incir S, Bas TO, Emul M, Duran A. Level of serum
thioredoxin and correlation with neurocognitive functions in patients with
schizophrenia using clozapine and other atypical antipsychotics. Psychiatry Res.
2017 Jan;247:84-89. doi: 10.1016/j.psychres.2016.11.021. Epub 2016 Nov 15. PMID:
27871032.
112: Bai ZL, Li XS, Chen GY, Du Y, Wei ZX, Chen X, Zheng GE, Deng W, Cheng Y.
Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with
Schizophrenia. J Mol Neurosci. 2018 Nov;66(3):428-436. doi:
10.1007/s12031-018-1165-4. Epub 2018 Oct 9. PMID: 30298298.
113: Bryll A, Krzyściak W, Karcz P, Śmierciak N, Kozicz T, Skrzypek J, Szwajca
M, Pilecki M, Popiela TJ. The Relationship between the Level of Anterior
Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical
State of Patients with Schizophrenia and Personality Disorders. Biomolecules.
2020 Sep 3;10(9):1272. doi: 10.3390/biom10091272. PMID: 32899276; PMCID:
PMC7565827.
114: Do KQ, Cuenod M, Hensch TK. Targeting Oxidative Stress and Aberrant
Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.
Schizophr Bull. 2015 Jul;41(4):835-46. doi: 10.1093/schbul/sbv065. Epub 2015 Jun
1. PMID: 26032508; PMCID: PMC4466197.
115: Chien YL, Hwu HG, Hwang TJ, Hsieh MH, Liu CC, Lin-Shiau SY, Liu CM.
Clinical implications of oxidative stress in schizophrenia: Acute relapse and
chronic stable phase. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr
20;99:109868. doi: 10.1016/j.pnpbp.2020.109868. Epub 2020 Jan 16. PMID:
31954755.
116: Miljević ČD, Nikolić-Kokić A, Blagojević D, Milovanović M, Munjiza A, Jukić
MM, Pešić V, Lečić-Toševski D, Spasić MB. Association between neurological soft
signs and antioxidant enzyme activity in schizophrenic patients. Psychiatry Res.
2018 Nov;269:746-752. doi: 10.1016/j.psychres.2018.09.009. Epub 2018 Sep 5.
PMID: 30273900.
117: Farkhakfar A, Hassanpour S, Zendehdel M. Resveratrol plays neuroprotective
role on ketamine-induced schizophrenia-like behaviors and oxidative damage in
mice. Neurosci Lett. 2023 Sep 14;813:137436. doi: 10.1016/j.neulet.2023.137436.
Epub 2023 Aug 14. PMID: 37586559.
118: Li XR, Xiu MH, Guan XN, Wang YC, Wang J, Leung E, Zhang XY. Altered
Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are
Associated with Poor Treatment Response to Risperidone: 12-Week Results from a
Prospective Longitudinal Study. Neurotherapeutics. 2021 Apr;18(2):1316-1324.
doi: 10.1007/s13311-021-01036-3. Epub 2021 Mar 31. PMID: 33791970; PMCID:
PMC8423973.
119: Mahadik SP, Pillai A, Joshi S, Foster A. Prevention of oxidative stressmediated neuropathology and improved clinical outcome by adjunctive use of a
combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev
Psychiatry. 2006 Apr;18(2):119-31. doi: 10.1080/09540260600581993. PMID:
16777666.
120: Birmann PT, Casaril AM, Abenante L, Penteado F, Brüning CA, Savegnago L,
Lenardão EJ. Neuropharmacology of Organoselenium Compounds in Mental Disorders
and Degenerative Diseases. Curr Med Chem. 2023;30(21):2357-2395. doi:
10.2174/0929867329666220615124412. PMID: 35708081.
121: Gama-Marques J, Tinoco I, Pedro I, Leote F, Silva R, Ouakinin S.
Unconjugated bilirubin and acute schizophrenia: a probable correlation? Actas
Esp Psiquiatr. 2017 Mar;45(2):79-88. Epub 2017 Mar 1. PMID: 28353293.
122: Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA,
Shetty KT, Gangadhar BN. Oxidative stress and neopterin abnormalities in
schizophrenia: a longitudinal study. J Psychiatr Res. 2010 Apr;44(5):310-3. doi:
10.1016/j.jpsychires.2009.09.002. Epub 2009 Oct 21. PMID: 19850302.
123: Gilca M, Piriu G, Gaman L, Delia C, Iosif L, Atanasiu V, Stoian I. A study
of antioxidant activity in patients with schizophrenia taking atypical
antipsychotics. Psychopharmacology (Berl). 2014 Dec;231(24):4703-10. doi:
10.1007/s00213-014-3624-0. Epub 2014 May 29. PMID: 24871701; PMCID: PMC4231214.
124: Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian
rhythm disruption in schizophrenia. Br J Psychiatry. 2012 Apr;200(4):308-16.
doi: 10.1192/bjp.bp.111.096321. Epub 2011 Dec 22. PMID: 22194182; PMCID:
PMC3317037.
125: Kishi T, Sakuma K, Miura G, Ito Y, Yamamoto M, Hirabayashi Y, Iwata N.
Alpha Lipoic Acid for Schizophrenia: A Systematic Review and Meta-analysis. J
Clin Psychopharmacol. 2023 Sep-Oct 01;43(5):477-478. doi:
10.1097/JCP.0000000000001723. PMID: 37683247.
126: Foster HD, Hoffer A. Schizophrenia and cancer: the adrenochrome balanced
morphism. Med Hypotheses. 2004;62(3):415-9. doi: 10.1016/S0306-9877(03)00319-0.
PMID: 14975514.
127: Piatoikina AS, Zhilyaeva TV, Kostina OV, Zhukova ES, Shcherbatyuk TG, Mazo
GE. Gender-related Characteristics of Oxidative Stress Severity and Cognitive
Impairment in Patients With Schizophrenia. J Mol Neurosci. 2023
Aug;73(7-8):628-634. doi: 10.1007/s12031-023-02140-z. Epub 2023 Aug 5. PMID:
37542578.
128: Magaji MG, Iniaghe LO, Abolarin M, Abdullahi OI, Magaji RA.
Neurobehavioural evaluation of resveratrol in murine models of anxiety and
schizophrenia. Metab Brain Dis. 2017 Apr;32(2):437-442. doi:
10.1007/s11011-016-9927-6. Epub 2016 Nov 22. PMID: 27878417.
129: Guler EM, Kurtulmus A, Gul AZ, Kocyigit A, Kirpinar I. Oxidative stress and
schizophrenia: A comparative cross-sectional study of multiple oxidative markers
in patients and their first-degree relatives. Int J Clin Pract. 2021
Nov;75(11):e14711. doi: 10.1111/ijcp.14711. Epub 2021 Aug 16. PMID: 34370389.
130: Ustundag B, Atmaca M, Kirtas O, Selek S, Metin K, Tezcan E. Total
antioxidant response in patients with schizophrenia. Psychiatry Clin Neurosci.
2006 Aug;60(4):458-64. doi: 10.1111/j.1440-1819.2006.01532.x. PMID: 16884448.
131: Zhang XY, Chen DC, Xiu MH, Yang FD, Tan Y, Luo X, Zuo L, Kosten TA, Kosten
TR. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism
in patients with schizophrenia and normal controls. Schizophr Bull. 2014
May;40(3):592-601. doi: 10.1093/schbul/sbt045. Epub 2013 Apr 15. PMID: 23588476;
PMCID: PMC3984504.
132: Zhang XY, Chen DC, Xiu MH, Tan YL, Yang FD, Zhang LY, Zhang LY, Haile CN,
Kosten TR. Clinical symptoms and cognitive impairment associated with male
schizophrenia relate to plasma manganese superoxide dismutase activity: a casecontrol study. J Psychiatr Res. 2013 Aug;47(8):1049-53. doi:
10.1016/j.jpsychires.2013.03.014. Epub 2013 Apr 20. PMID: 23611682.
133: Morales-Medina JC, Aguilar-Alonso P, Di Cerbo A, Iannitti T, Flores G. New
insights on nitric oxide: Focus on animal models of schizophrenia. Behav Brain
Res. 2021 Jul 9;409:113304. doi: 10.1016/j.bbr.2021.113304. Epub 2021 Apr 15.
PMID: 33865887.
134: Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Kirtas O. The
of ginkgo biloba addition to olanzapine on therapeutic effect
enzyme levels in patients with schizophrenia. Psychiatry Clin
Dec;59(6):652-6. doi: 10.1111/j.1440-1819.2005.01432.x. PMID:
effect of extract
and antioxidant
Neurosci. 2005
16401239.
135: Hoffer LJ. Vitamin therapy in schizophrenia. Isr J Psychiatry Relat Sci.
2008;45(1):3-10. PMID: 18587164.
136: Li XF, Zheng YL, Xiu MH, Chen DC, Kosten TR, Zhang XY. Reduced plasma total
antioxidant status in first-episode drug-naive patients with schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1064-7. doi:
10.1016/j.pnpbp.2011.03.001. Epub 2011 Mar 15. PMID: 21392552.
137: Maes M, Supasitthumrong T, Limotai C, Michelin AP, Matsumoto AK, de
Oliveira Semão L, de Lima Pedrão JV, Moreira EG, Carvalho AF, Sirivichayakul S,
Barbosa DS, Kanchanatawan B. Increased Oxidative Stress Toxicity and Lowered
Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis:
Associations with Psychiatric Comorbidities. Mol Neurobiol. 2020
Aug;57(8):3334-3348. doi: 10.1007/s12035-020-01949-8. Epub 2020 Jun 9. PMID:
32514863.
138: Noto C, Ota VK, Gadelha A, Noto MN, Barbosa DS, Bonifácio KL, Nunes SO,
Cordeiro Q, Belangero SI, Bressan RA, Maes M, Brietzke E. Oxidative stress in
drug naïve first episode psychosis and antioxidant effects of risperidone. J
Psychiatr Res. 2015 Sep;68:210-6. doi: 10.1016/j.jpsychires.2015.07.003. Epub
2015 Jul 3. PMID: 26228421.
139: Bitanihirwe BK, Woo TU. Oxidative stress in schizophrenia: an integrated
approach. Neurosci Biobehav Rev. 2011 Jan;35(3):878-93. doi:
10.1016/j.neubiorev.2010.10.008. Epub 2010 Oct 23. PMID: 20974172; PMCID:
PMC3021756.
140: Raffa M, Bel Hadj Youssef I, Ben Othman L, Fendri C, Mechri A.
Concentrations plasmatiques des glutathions et leurs corrélations avec les
caractéristiques cliniques et thérapeutiques des patients atteints de
schizophrénie [Plasmatic glutathione levels and their relationships with
clinical and therapeutic features in patients with schizophrenia]. Encephale.
2021 Feb;47(1):10-14. French. doi: 10.1016/j.encep.2020.01.010. Epub 2021 Jan 6.
PMID: 33358006.
141: Martínez AL, Brea J, Rico S, de Los Frailes MT, Loza MI. Cognitive Deficit
in Schizophrenia: From Etiology to Novel Treatments. Int J Mol Sci. 2021 Sep
14;22(18):9905. doi: 10.3390/ijms22189905. PMID: 34576069; PMCID: PMC8468549.
142: Jamilian H, Ghaderi A. The Effects of Probiotic and Selenium Cosupplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a
Randomized, Double-blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2021
Dec;199(12):4430-4438. doi: 10.1007/s12011-020-02572-3. Epub 2021 Jan 6. PMID:
33409919.
143: Kartalci S, Karabulut AB, Ozcan AC, Porgali E, Unal S. Acute and chronic
effects of electroconvulsive treatment on oxidative parameters in schizophrenia
patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1689-94.
doi: 10.1016/j.pnpbp.2011.05.007. Epub 2011 May 18. PMID: 21620920.
144: Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do
KQ, Deth RC. Decreased Brain Levels of Vitamin B12 in Aging, Autism and
Schizophrenia. PLoS One. 2016 Jan 22;11(1):e0146797. doi:
10.1371/journal.pone.0146797. PMID: 26799654; PMCID: PMC4723262.
145: Maes M. Major neurocognitive psychosis: a novel schizophrenia endophenotype
class that is based on machine learning and resembles Kraepelin's and Bleuler's
conceptions. Acta Neuropsychiatr. 2023 Jun;35(3):123-137. doi:
10.1017/neu.2022.32. Epub 2022 Nov 14. PMID: 36373497.
146: Cecerska-Heryć E, Polikowska A, Serwin N, Roszak M, Grygorcewicz B, Heryć
R, Michalczyk A, Dołęgowska B. Importance of oxidative stress in the
pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric
disorders, a review. Neurochem Int. 2022 Feb;153:105269. doi:
10.1016/j.neuint.2021.105269. Epub 2021 Dec 29. PMID: 34971747.
147: Yao JK, Condray R, Dougherty GG Jr, Keshavan MS, Montrose DM, Matson WR,
McEvoy J, Kaddurah-Daouk R, Reddy RD. Associations between purine metabolites
and clinical symptoms in schizophrenia. PLoS One. 2012;7(8):e42165. doi:
10.1371/journal.pone.0042165. Epub 2012 Aug 14. PMID: 22916123; PMCID:
PMC3419238.
148: Proskurnina EV, Sokolova SV, Ershova ES, Martynov AV, Portnova GV, Kostyuk
SV, Zakharova NV, Kostyuk GP. Antioksidantnyi status plazmy krovi patsientov s
ostrym psikhozom i ego svyaz' s aktivatsiei transkriptsionnogo faktora Nrf2
[Antioxidant status of blood plasma of acutely psychotic patients and its
correlation with Nrf2 activation]. Zh Nevrol Psikhiatr Im S S Korsakova.
2021;121(2):60-66. Russian. doi: 10.17116/jnevro202112102160. PMID: 33728852.
149: Cadet JL, Kahler LA. Free radical mechanisms in schizophrenia and tardive
dyskinesia. Neurosci Biobehav Rev. 1994 Winter;18(4):457-67. doi:
10.1016/0149-7634(94)90001-9. PMID: 7708360.
150: Ermakov EA, Smirnova LP, Bokhan NA, Semke AV, Ivanova SA, Buneva VN,
Nevinsky GA. Catalase activity of IgG antibodies from the sera of healthy donors
and patients with schizophrenia. PLoS One. 2017 Sep 25;12(9):e0183867. doi:
10.1371/journal.pone.0183867. PMID: 28945759; PMCID: PMC5612456.
151: Ciobica A, Padurariu M, Dobrin I, Stefanescu C, Dobrin R. Oxidative stress
in schizophrenia - focusing on the main markers. Psychiatr Danub. 2011
Sep;23(3):237-45. PMID: 21963690.
152: Koola MM. Antipsychotic-minocycline-acetylcysteine combination for
positive, cognitive, and negative symptoms of schizophrenia. Asian J Psychiatr.
2019 Feb;40:100-102. doi: 10.1016/j.ajp.2019.02.007. Epub 2019 Feb 12. PMID:
30776665.
153: Sandyk R. The pineal gland and the mode of onset of schizophrenia. Int J
Neurosci. 1992 Nov-Dec;67(1-4):9-17. doi: 10.3109/00207459208994772. PMID:
1305641.
154: Ben-Azu B, Aderibigbe AO, Ajayi AM, Eneni AO, Umukoro S, Iwalewa EO.
Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and
reversal of ketamine-induced schizophrenia-like behavior by morin in mice. Brain
Res Bull. 2018 May;139:292-306. doi: 10.1016/j.brainresbull.2018.03.006. Epub
2018 Mar 13. PMID: 29548911.
155: Xiu MH, Li Z, Chen DC, Chen S, Curbo ME, Wu HE, Tong YS, Tan SP, Zhang XY.
Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment
in Drug-Naive First-Episode Patients With Schizophrenia. Schizophr Bull. 2020
Dec 1;46(6):1498-1510. doi: 10.1093/schbul/sbaa062. PMID: 32390043; PMCID:
PMC7707068.
156: Chen N, Liu H, Yao J, Chen S, Xiu M, Wu F, Zhang X. Smoke, GPx activity and
symptoms improvement in patients with drug-naive first-episode schizophrenia: A
large-scale 12-week follow-up study. Asian J Psychiatr. 2022 Nov;77:103267. doi:
10.1016/j.ajp.2022.103267. Epub 2022 Sep 27. PMID: 36202003.
157: Gonzalez-Liencres C, Tas C, Brown EC, Erdin S, Onur E, Cubukcoglu Z,
Aydemir O, Esen-Danaci A, Brüne M. Oxidative stress in schizophrenia: a casecontrol study on the effects on social cognition and neurocognition. BMC
Psychiatry. 2014 Sep 24;14:268. doi: 10.1186/s12888-014-0268-x. PMID: 25248376;
PMCID: PMC4180831.
158: Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, Kosten TA, Kosten TR.
Disrupted antioxidant enzyme activity and elevated lipid peroxidation products
in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry. 2007
May;68(5):754-60. doi: 10.4088/jcp.v68n0513. PMID: 17503985.
159: Brown JS Jr. Role of selenium and other trace elements in the geography of
schizophrenia. Schizophr Bull. 1994;20(2):387-98. doi: 10.1093/schbul/20.2.387.
PMID: 8085140.
160: Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W,
Xing Q, He L. Metabolomic profiling to identify potential serum biomarkers for
schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43.
doi: 10.1021/pr2006796. Epub 2011 Nov 8. PMID: 22007635.
161: Mishra A, Mishra AK, Jha S. Effect of traditional medicine brahmi vati and
bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced
seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced
memory loss in laboratory animals. Epilepsy Behav. 2018 Mar;80:144-151. doi:
10.1016/j.yebeh.2017.12.040. Epub 2018 Feb 2. PMID: 29414544.
162: Sofic E, Rustembegovic A, Kroyer G, Cao G. Serum antioxidant capacity in
neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm
(Vienna). 2002 May;109(5-6):711-9. doi: 10.1007/s007020200059. PMID: 12111462.
163: Apam-Castillejos DJ, Tendilla-Beltrán H, Vázquez-Roque RA, VázquezHernández AJ, Fuentes-Medel E, García-Dolores F, Díaz A, Flores G. Secondgeneration antipsychotic olanzapine attenuates behavioral and prefrontal cortex
synaptic plasticity deficits in a neurodevelopmental schizophrenia-related rat
model. J Chem Neuroanat. 2022 Nov;125:102166. doi:
10.1016/j.jchemneu.2022.102166. Epub 2022 Sep 22. PMID: 36156295.
164: Miyake N, Miyamoto S. [Effectiveness of N-acetylcysteine in the treatment
of schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2016
Apr;36(2):29-35. Japanese. PMID: 27333656.
165: Benes FM. Searching for unique endophenotypes for schizophrenia and bipolar
disorder within neural circuits and their molecular regulatory mechanisms.
Schizophr Bull. 2007 Jul;33(4):932-6. doi: 10.1093/schbul/sbm064. Epub 2007 Jun
16. PMID: 17575303; PMCID: PMC2632324.
166: Kathuria A, Lopez-Lengowski K, Watmuff B, McPhie D, Cohen BM, Karmacharya
R. Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are
mediated by NLGN2 and rescued by N-acetylcysteine. Transl Psychiatry. 2019 Nov
28;9(1):321. doi: 10.1038/s41398-019-0660-x. PMID: 31780643; PMCID: PMC6882825.
167: Martínez-Banaclocha M. N-acetyl-cysteine in Schizophrenia: Potential Role
on the Sensitive Cysteine Proteome. Curr Med Chem. 2020;27(37):6424-6439. doi:
10.2174/0929867326666191015091346. PMID: 33115390.
168: Ide M, Ohnishi T, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C,
Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y,
Hara T, Morikawa M, Hashimoto K, Nozaki Y, Toyota T, Wada Y, Tanaka Y, Kato T,
Nishi A, Fujisawa S, Okano H, Itokawa M, Hirokawa N, Kunii Y, Kakita A, Yabe H,
Iwamoto K, Meno K, Katagiri T, Dean B, Uchida K, Kimura H, Yoshikawa T. Excess
hydrogen sulfide and polysulfides production underlies a schizophrenia
pathophysiology. EMBO Mol Med. 2019 Dec;11(12):e10695. doi:
10.15252/emmm.201910695. Epub 2019 Oct 28. PMID: 31657521; PMCID: PMC6895609.
169: Zhang XY, Yao JK. Oxidative stress and therapeutic implications in
psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct
1;46:197-9. doi: 10.1016/j.pnpbp.2013.03.003. Epub 2013 Mar 21. PMID: 23523744.
170: Solberg DK, Refsum H, Andreassen OA, Bentsen H. A five-year follow-up study
of antioxidants, oxidative stress and polyunsaturated fatty acids in
schizophrenia. Acta Neuropsychiatr. 2019 Aug;31(4):202-212. doi:
10.1017/neu.2019.14. Epub 2019 Jun 10. PMID: 31178002.
171: Oh SJ, Fan X. Current understanding on the role of nitric oxide and
therapeutic potential of NO supplementation in schizophrenia. Schizophr Res.
2020 Aug;222:23-30. doi: 10.1016/j.schres.2020.05.050. Epub 2020 May 28. PMID:
32475621.
172: Benitez-King G, Ramírez-Rodríguez G, Ortíz L, Meza I. The neuronal
cytoskeleton as a potential therapeutical target in neurodegenerative diseases
and schizophrenia. Curr Drug Targets CNS Neurol Disord. 2004 Dec;3(6):515-33.
doi: 10.2174/1568007043336761. PMID: 15581421.
173: He Q, You Y, Yu L, Yao L, Lu H, Zhou X, Wu S, Chen L, Chen Y, Zhao X. Uric
acid levels in subjects with schizophrenia: A systematic review and metaanalysis. Psychiatry Res. 2020 Oct;292:113305. doi:
10.1016/j.psychres.2020.113305. Epub 2020 Jul 15. PMID: 32702552.
174: Cabungcal JH, Counotte DS, Lewis E, Tejeda HA, Piantadosi P, Pollock C,
Calhoon GG, Sullivan E, Presgraves E, Kil J, Hong LE, Cuenod M, Do KQ, O'Donnell
P. Juvenile antioxidant treatment prevents adult deficits in a developmental
model of schizophrenia. Neuron. 2014 Sep 3;83(5):1073-1084. doi:
10.1016/j.neuron.2014.07.028. Epub 2014 Aug 14. PMID: 25132466; PMCID:
PMC4418441.
175: Hitzeroth A, Niehaus DJ, Koen L, Botes WC, Deleuze JF, Warnich L.
Association between the MnSOD Ala-9Val polymorphism and development of
schizophrenia and abnormal involuntary movements in the Xhosa population. Prog
Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):664-72. doi:
10.1016/j.pnpbp.2006.12.019. Epub 2007 Jan 12. PMID: 17291655.
176: Porokhovnik LN, Pasekov VP, Egolina NA, Tsvetkova TG, Kosiakova NV,
Gorbachevskaia NL, Sukhotina NK, Kozlovskaia GV, Sorokin AB, Korovina NIu,
Liapunova NA. [Oxidative stress, rRNA genes, and antioxidant enzymes in
pathogenesis of schizophrenia and autism: modeling and clinical advices]. Zh
Obshch Biol. 2013 Sep-Oct;74(5):340-53. Russian. PMID: 25438566.
177: Wu JQ, Chen DC, Tan YL, Tan S, Wang Z, Yang F, Soares JC, Zhang XY.
Association of altered CuZn superoxide dismutase and cognitive impairment in
schizophrenia patients with tardive dyskinesia. J Psychiatr Res. 2014
Nov;58:167-74. doi: 10.1016/j.jpsychires.2014.07.028. Epub 2014 Aug 8. PMID:
25151339.
178: Xiu M, Song X, Yang H, Huang X, Wu F, Zhang X. Smoking Affects the
Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone
in Schizophrenia: A Large-scale Cohort Study. Curr Neuropharmacol.
2023;21(10):2151-2158. doi: 10.2174/1570159X21666230502125800. PMID: 37132112;
PMCID: PMC10556368.
179: Morera-Fumero AL, Díaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L,
Guillen-Pino F. A three-month longitudinal study of changes in day/night serum
total antioxidant capacity in paranoid schizophrenia. PLoS One. 2017 Dec
8;12(12):e0189348. doi: 10.1371/journal.pone.0189348. PMID: 29220388; PMCID:
PMC5722332.
180: Sinichi F, Farid Hosseini F, Fayyazi-Bordbar M, Sinichi M, Jamali J,
Mohammadpour A. Pentoxifylline as adjunctive therapy in cognitive deficits and
symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical
trial. J Psychopharmacol. 2023 Oct;37(10):1003-1010. doi:
10.1177/02698811231186760. Epub 2023 Jul 19. PMID: 37466276.
181: Souza RP, Tampakeras M, Basile V, Shinkai T, Rosa DV, Potkin S, Meltzer HY,
Lieberman JA, Romano-Silva MA, Kennedy JL. Lack of association of GPX1 and MnSOD
genes with symptom severity and response to clozapine treatment in schizophrenia
subjects. Hum Psychopharmacol. 2009 Dec;24(8):676-9. doi: 10.1002/hup.1076.
PMID: 19946932.
182: Padurariu M, Ciobica A, Dobrin I, Stefanescu C. Evaluation of antioxidant
enzymes activities and lipid peroxidation in schizophrenic patients treated with
typical and atypical antipsychotics. Neurosci Lett. 2010 Aug 2;479(3):317-20.
doi: 10.1016/j.neulet.2010.05.088. Epub 2010 Jun 4. PMID: 20561936.
183: Li R, Hei G, Yang Y, Wu R, Zhao J. Research advances in add-on treatment
for negative symptoms and cognitive dysfunction in schizophrenia. Zhong Nan Da
Xue Xue Bao Yi Xue Ban. 2020 Dec 28;45(12):1457-1463. English, Chinese. doi:
10.11817/j.issn.1672-7347.2020.190556. PMID: 33473003.
184: Devanarayanan S, Nandeesha H, Kattimani S, Sarkar S. Relationship between
matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia:
a case control study. Clin Chem Lab Med. 2016 Mar;54(3):447-52. doi:
10.1515/cclm-2015-0212. PMID: 26351924.
185: Bernstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in
schizophrenia. A review. Schizophr Res. 2005 Oct 1;78(1):69-86. doi:
10.1016/j.schres.2005.05.019. PMID: 16005189.
186: Bulbul F, Virit O, Alpak G, Unal A, Bulut M, Kaya MC, Altindag A, Celik H,
Savas HA. Are oxidative stress markers useful to distinguish schizoaffective
disorder from schizophrenia and bipolar disorder? Acta Neuropsychiatr. 2014
Apr;26(2):120-4. doi: 10.1017/neu.2013.44. PMID: 24855890.
187: Porokhovnik LN, Passekov VP, Gorbachevskaya NL, Sorokin AB, Veiko NN,
Lyapunova NA. Active ribosomal genes, translational homeostasis and oxidative
stress in the pathogenesis of schizophrenia and autism. Psychiatr Genet. 2015
Apr;25(2):79-87. doi: 10.1097/YPG.0000000000000076. PMID: 25710845.
188: Wang DF, Cao B, Xu MY, Liu YQ, Yan LL, Liu R, Wang JY, Lu QB. Meta-Analyses
of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the
Risk of Schizophrenia. Medicine (Baltimore). 2015 Sep;94(36):e1507. doi:
10.1097/MD.0000000000001507. PMID: 26356721; PMCID: PMC4616632.
189: Girgis RR, Baker S, Mao X, Gil R, Javitt DC, Kantrowitz JT, Gu M, Spielman
DM, Ojeil N, Xu X, Abi-Dargham A, Shungu DC, Kegeles LS. Effects of acute
N-acetylcysteine challenge on cortical glutathione and glutamate in
schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
Psychiatry Res. 2019 May;275:78-85. doi: 10.1016/j.psychres.2019.03.018. Epub
2019 Mar 12. PMID: 30884334; PMCID: PMC6515541.
190: Pitt B. Letter: Vitamin C and schizophrenia. Lancet. 1974 Nov
9;2(7889):1153-4. doi: 10.1016/s0140-6736(74)90931-3. PMID: 4139465.
191: Mahn A, Castillo A. Potential of Sulforaphane as a Natural Immune System
Enhancer: A Review. Molecules. 2021 Feb 1;26(3):752. doi:
10.3390/molecules26030752. PMID: 33535560; PMCID: PMC7867070.
192: Yadav DK. Potential Therapeutic Strategies of Phytochemicals in
Neurodegenerative Disorders. Curr Top Med Chem. 2021;21(31):2814-2838. doi:
10.2174/1568026621666211201150217. PMID: 34852737.
193: Rao VS, Carvalho AC, Trevisan MT, Andrade GM, Nobre-Júnior HV, Moraes MO,
Magalhães HI, Morais TC, Santos FA. Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia.
Pharmacol Rep. 2012;64(4):848-56. doi: 10.1016/s1734-1140(12)70879-4. PMID:
23087136.
194: Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A.
Oxidative damage and schizophrenia: the potential benefit by atypical
antipsychotics. Neuropsychobiology. 2004;49(4):205-9. doi: 10.1159/000077368.
PMID: 15154399.
195: Bošković M, Vovk T, Koprivšek J, Plesničar BK, Grabnar I. Vitamin E and
essential polyunsaturated fatty acids supplementation in schizophrenia patients
treated with haloperidol. Nutr Neurosci. 2016 May;19(4):156-61. doi:
10.1179/1476830514Y.0000000139. Epub 2016 Mar 2. PMID: 25056532.
196: Johnson S. Micronutrient accumulation and depletion in schizophrenia,
epilepsy, autism and Parkinson's disease? Med Hypotheses. 2001 May;56(5):641-5.
doi: 10.1054/mehy.2000.1302. PMID: 11388783.
197: Nucifora LG, Tanaka T, Hayes LN, Kim M, Lee BJ, Matsuda T, Nucifora FC Jr,
Sedlak T, Mojtabai R, Eaton W, Sawa A. Reduction of plasma glutathione in
psychosis associated with schizophrenia and bipolar disorder in translational
psychiatry. Transl Psychiatry. 2017 Aug 22;7(8):e1215. doi: 10.1038/tp.2017.178.
PMID: 28892069; PMCID: PMC5611744.
198: O'Donnell P. Cortical interneurons, immune factors and oxidative stress as
early targets for schizophrenia. Eur J Neurosci. 2012 Jun;35(12):1866-70. doi:
10.1111/j.1460-9568.2012.08130.x. PMID: 22708597.
199: Burghardt K, Grove T, Ellingrod V. Endothelial nitric oxide synthetase
genetic variants, metabolic syndrome and endothelial function in schizophrenia.
J Psychopharmacol. 2014 Apr;28(4):349-56. doi: 10.1177/0269881113516200. Epub
2013 Dec 17. PMID: 24346810; PMCID: PMC4039171.
200: Akyol O, Yanik M, Elyas H, Namli M, Canatan H, Akin H, Yuce H, Yilmaz HR,
Tutkun H, Sogut S, Herken H, Ozyurt H, Savas HA, Zoroglu SS. Association between
Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):123-31. doi:
10.1016/j.pnpbp.2004.10.014. PMID: 15610954.
201: Vidović B, Milovanović S, Dorđević B, Kotur-Stevuljević J, Stefanović A,
Ivanišević J, Miljković M, Spasić S, Stojanović D, Pantović M. Effect of alphalipoic acid supplementation on oxidative stress markers and antioxidative
defense in patients with schizophrenia. Psychiatr Danub. 2014 Sep;26(3):205-13.
PMID: 25191766.
202: Maldonado MD, Reiter RJ, Pérez-San-Gregorio MA. Melatonin as a potential
therapeutic agent in psychiatric illness. Hum Psychopharmacol. 2009
Jul;24(5):391-400. doi: 10.1002/hup.1032. PMID: 19551767.
203: Onaolapo AY, Aina OA, Onaolapo OJ. Melatonin attenuates behavioural
deficits and reduces brain oxidative stress in a rodent model of schizophrenia.
Biomed Pharmacother. 2017 Aug;92:373-383. doi: 10.1016/j.biopha.2017.05.094.
Epub 2017 May 26. PMID: 28554133.
204: Matsuzawa D, Hashimoto K, Hashimoto T, Shimizu E, Watanabe H, Fujita Y, Iyo
M. Association study between the genetic polymorphisms of glutathione-related
enzymes and schizophrenia in a Japanese population. Am J Med Genet B
Neuropsychiatr Genet. 2009 Jan 5;150B(1):86-94. doi: 10.1002/ajmg.b.30776. PMID:
18449862.
205: Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review.
Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):33-43. doi:
10.1016/s0952-3278(96)90143-x. PMID: 8888121.
206: Kety SS. Dietary factors and schizophrenia. Ciba Found Study Group.
1970;35:76-88. PMID: 4260210.
207: Schmidt AJ, Krieg JC, Vedder H. Antioxidative and steroid systems in
neurological and psychiatric disorders. World J Biol Psychiatry.
2005;6(1):26-35. doi: 10.1080/15622970510029759. PMID: 16097403.
208: Ben-Azu B, Aderibigbe AO, Eneni AO, Ajayi AM, Umukoro S, Iwalewa EO. Morin
Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in
Brains of Mice Exposed to Ketamine: Prevention and Reversal of SchizophreniaLike Symptoms. Neurochem Res. 2018 Sep;43(9):1745-1755. doi:
10.1007/s11064-018-2590-z. Epub 2018 Jun 28. PMID: 29956036.
209: Yao JK, Reddy R, van Kammen DP. Abnormal age-related changes of plasma
antioxidant proteins in schizophrenia. Psychiatry Res. 2000 Dec
27;97(2-3):137-51. doi: 10.1016/s0165-1781(00)00230-4. PMID: 11166086.
210: Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV,
Debsikdar VB, Mahadik SP. Decreased antioxidant enzymes and membrane essential
polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.
Psychiatry Res. 2003 Dec 1;121(2):109-22. doi: 10.1016/s0165-1781(03)00220-8.
PMID: 14656446.
211: Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and
neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate
(DHEAS). Front Neuroendocrinol. 2009 Jan;30(1):65-91. doi:
10.1016/j.yfrne.2008.11.002. Epub 2008 Dec 3. PMID: 19063914; PMCID: PMC2725024.
212: Trebatická J, Ďuračková Z. Psychiatric Disorders and Polyphenols: Can They
Be Helpful in Therapy? Oxid Med Cell Longev. 2015;2015:248529. doi:
10.1155/2015/248529. Epub 2015 Jun 9. PMID: 26180581; PMCID: PMC4477218.
213: Chrétien B, Fedrizzi S, Lelong-Boulouard V, Sassier M, Alexandre J,
Dolladille C. Could N-acetylcysteine improve the safety of clozapine? Hum
Psychopharmacol. 2021 Mar;36(2):e2769. doi: 10.1002/hup.2769. Epub 2020 Nov 18.
PMID: 33206415.
214: Yao JK, Reddy R, McElhinny LG, van Kammen DP. Reduced status of plasma
total antioxidant capacity in schizophrenia. Schizophr Res. 1998 Jun
22;32(1):1-8. doi: 10.1016/s0920-9964(98)00030-9. PMID: 9690328.
215: Pop E. Dexanabinol Pharmos. Curr Opin Investig Drugs. 2000
Dec;1(4):494-503. PMID: 11249704.
216: Rind L, Ahmad M, Khan MI, Badruddeen, Akhtar J, Ahmad U, Yadav C, Owais M.
An insight on safety, efficacy, and molecular docking study reports of
N-acetylcysteine and its compound formulations. J Basic Clin Physiol Pharmacol.
2021 Feb 8;33(3):223-233. doi: 10.1515/jbcpp-2020-0099. PMID: 33638319.
217: Pitsikas N. The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia.
Curr Med Chem. 2016;23(24):2692-2705. doi: 10.2174/0929867323666160812151054.
PMID: 27776474.
218: Altinoz MA, Ozpinar A. Acetylsalicylic acid and its metabolite gentisic
acid may act as adjunctive agents in the treatment of psychiatric disorders.
Behav Pharmacol. 2019 Dec;30(8):627-641. doi: 10.1097/FBP.0000000000000517.
PMID: 31703028.
219: Minutolo G, Petralia A, Dipasquale S, Aguglia E. Nitric oxide in patients
with schizophrenia: the relationship with the severity of illness and the
antipsychotic treatment. Expert Opin Pharmacother. 2012 Oct;13(14):1989-97. doi:
10.1517/14656566.2012.713346. Epub 2012 Aug 28. PMID: 22924902.
220: Hashimoto K. Targeting of NMDA receptors in new treatments for
schizophrenia. Expert Opin Ther Targets. 2014 Sep;18(9):1049-63. doi:
10.1517/14728222.2014.934225. Epub 2014 Jun 26. PMID: 24965576.
221: Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH,
Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS. Metabolomic
analysis of biochemical changes in the plasma and urine of first-episode
neuroleptic-naïve schizophrenia patients after treatment with risperidone. J
Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul
26. PMID: 22800120.
222: Yao JK, Reddy R, van Kammen DP. Reduced level of plasma antioxidant uric
acid in schizophrenia. Psychiatry Res. 1998 Jul 27;80(1):29-39. doi:
10.1016/s0165-1781(98)00051-1. PMID: 9727961.
223: Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandöl E. The impact of
omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and
side effects in schizophrenia patients treated with haloperidol: an open-label
pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1493-9.
doi: 10.1016/j.pnpbp.2007.07.004. Epub 2007 Jul 13. PMID: 17688987.
224: Zoroglu SS, Herken H, Yürekli M, Uz E, Tutkun H, Savaş HA, Bagci C, Ozen
ME, Cengiz B, Cakmak EA, Dogru MI, Akyol O. The possible pathophysiological role
of plasma nitric oxide and adrenomedullin in schizophrenia. J Psychiatr Res.
2002 Sep-Oct;36(5):309-15. doi: 10.1016/s0022-3956(02)00014-6. PMID: 12127598.
225: Ben-Azu B, Aderibigbe AO, Omogbiya IA, Ajayi AM, Owoeye O, Olonode ET,
Iwalewa EO. Probable mechanisms involved in the antipsychotic-like activity of
morin in mice. Biomed Pharmacother. 2018 Sep;105:1079-1090. doi:
10.1016/j.biopha.2018.06.057. Epub 2018 Jun 20. PMID: 30021344.
226: Wood SJ, Yücel M, Pantelis C, Berk M. Neurobiology of schizophrenia
spectrum disorders: the role of oxidative stress. Ann Acad Med Singap. 2009
May;38(5):396-6. PMID: 19521638.
227: Zortea K, Fernandes BS, Guimarães LR, Francesconi LP, Lersch C, Gama CS,
Schroeder R, Zanotto-Filho A, Moreira JC, Lobato MI, Belmonte-de-Abreu PS.
Reduced serum non-enzymatic antioxidant defense and increased lipid peroxidation
in schizophrenic patients on a hypocaloric diet. Neurosci Lett. 2012 Mar
14;512(1):43-7. doi: 10.1016/j.neulet.2012.01.060. Epub 2012 Feb 3. PMID:
22326387.
228: Taneli F, Pirildar S, Akdeniz F, Uyanik BS, Ari Z. Serum nitric oxide
metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch
Med Res. 2004 Sep-Oct;35(5):401-5. doi: 10.1016/j.arcmed.2004.06.002. PMID:
15610909.
229: Smythies J. Redox aspects of signaling by catecholamines and their
metabolites. Antioxid Redox Signal. 2000 Fall;2(3):575-83. doi:
10.1089/15230860050192332. PMID: 11229369.
230: Al-Chalabi BM, Thanoon IA, Ahmed FA. Potential effect of olanzapine on
total antioxidant status and lipid peroxidation in schizophrenic patients.
Neuropsychobiology. 2009;59(1):8-11. doi: 10.1159/000202823. Epub 2009 Feb 17.
PMID: 19221442.
231: De Lima DN Jr, Frota IJ, Macedo DS, Sanders LLO. Alpha Lipoic Acid for
Schizophrenia: Future Investigations With Low Doses and Treatment-Resistant
Patients-Reply to Letter by Kishi and Colleagues. J Clin Psychopharmacol. 2023
Sep-Oct 01;43(5):478-479. doi: 10.1097/JCP.0000000000001753. PMID: 37683248.
232: Smesny S, Milleit B, Schaefer MR, Hipler UC, Milleit C, Wiegand C, Hesse J,
Klier CM, Holub M, Holzer I, Berk M, McGorry PD, Sauer H, Amminger GP. Effects
of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in
individuals at ultra-high risk of psychosis. Prostaglandins Leukot Essent Fatty
Acids. 2015 Oct;101:15-21. doi: 10.1016/j.plefa.2015.07.001. Epub 2015 Jul 21.
PMID: 26260538.
233: Bernstein HG, Heinemann A, Steiner J, Bogerts B. Schizophrenia, sleep
disturbances and the suprachiasmatic nucleus: reduced nitric oxide synthase may
matter. Med Hypotheses. 2010 Feb;74(2):397-8. doi: 10.1016/j.mehy.2009.08.026.
Epub 2009 Sep 9. PMID: 19744797.
234: Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for
neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct
1;46:214-23. doi: 10.1016/j.pnpbp.2012.10.017. Epub 2012 Nov 2. PMID: 23123357;
PMCID: PMC3615047.
235: Gao H, Liu C, Song S, Zhang C, Ma Q, Li X, Xu L. GPX1 Pro198Leu
polymorphism and GSTP1 Ile105Val polymorphisms are not associated with the risk
of schizophrenia in the Chinese Han population. Neuroreport. 2017 Oct
18;28(15):969-972. doi: 10.1097/WNR.0000000000000870. PMID: 28872562.
236: Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative Stress and ADHD: A
Meta-Analysis. J Atten Disord. 2015 Nov;19(11):915-24. doi:
10.1177/1087054713510354. Epub 2013 Nov 14. PMID: 24232168; PMCID: PMC5293138.
237: Wu Z, Liu Q, Zhang Y, Guan X, Xiu M, Zhang X. Superoxide Dismutase, BDNF,
and Cognitive Improvement in Drug-Naive First-Episode Patients With
Schizophrenia: A 12-Week Longitudinal Study. Int J Neuropsychopharmacol. 2022
Feb 11;25(2):128-135. doi: 10.1093/ijnp/pyab065. PMID: 34622272; PMCID:
PMC8832226.
238: Dias KCF, de Almeida JC, Vasconcelos LC, Patrocínio MLV, Barbosa TM,
Ximenes NC, Leitão APA, Louchard BO, Pimenta ATÁ, Pinto FDCL, Leal LKAM, Honório
Junior JER, Vasconcelos SMM. Standardized extract of Erythrina velutina Willd.
attenuates schizophrenia-Like behaviours and oxidative parameters in
experimental animal models. J Pharm Pharmacol. 2019 Mar;71(3):379-389. doi:
10.1111/jphp.13039. Epub 2018 Nov 19. PMID: 30456833.
239: Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y,
Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A,
Matsumoto J, Hino M, Mataga N, Hayashi-Takagi A, Hashimoto K, Kunii Y, Kakita A,
Yabe H, Yoshikawa T. Investigation of betaine as a novel psychotherapeutic for
schizophrenia. EBioMedicine. 2019 Jul;45:432-446. doi:
10.1016/j.ebiom.2019.05.062. Epub 2019 Jun 26. PMID: 31255657; PMCID:
PMC6642071.
240: Emsley R, Chiliza B, Asmal L, du Plessis S, Phahladira L, van Niekerk E,
van Rensburg SJ, Harvey BH. A randomized, controlled trial of omega-3 fatty
acids plus an antioxidant for relapse prevention after antipsychotic
discontinuation in first-episode schizophrenia. Schizophr Res. 2014
Sep;158(1-3):230-5. doi: 10.1016/j.schres.2014.06.004. Epub 2014 Jul 2. PMID:
24996507.
241: Lee BH, Kim YK. Reduced plasma nitric oxide metabolites before and after
antipsychotic treatment in patients with schizophrenia compared to controls.
Schizophr Res. 2008 Sep;104(1-3):36-43. doi: 10.1016/j.schres.2008.06.005. Epub
2008 Jul 18. PMID: 18639442.
242: Pósfai B, Cserép C, Hegedüs P, Szabadits E, Otte DM, Zimmer A, Watanabe M,
Freund TF, Nyiri G. Synaptic and cellular changes induced by the schizophrenia
susceptibility gene G72 are rescued by N-acetylcysteine treatment. Transl
Psychiatry. 2016 May 10;6(5):e807. doi: 10.1038/tp.2016.74. PMID: 27163208;
PMCID: PMC5070069.
243: Stojković T, Radonjić NV, Velimirović M, Jevtić G, Popović V, Doknić M,
Petronijević ND. Risperidone reverses phencyclidine induced decrease in
glutathione levels and alterations of antioxidant defense in rat brain. Prog
Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):192-9. doi:
10.1016/j.pnpbp.2012.06.013. Epub 2012 Jun 24. PMID: 22735395.
244: Medvedev ON, Berk
Sumich A, Krägeloh CU,
schizophrenia symptoms
Mar;51(3):e13398. doi:
PMCID: PMC7988538.
M, Dean OM, Brown E, Sandham MH, Dipnall JF, McNamara RK,
Narayanan A, Siegert RJ. A novel way to quantify
in clinical trials. Eur J Clin Invest. 2021
10.1111/eci.13398. Epub 2020 Sep 19. PMID: 32894576;
245: Sampaio LRL, Cysne Filho FMS, de Almeida JC, Diniz DDS, Patrocínio CFV, de
Sousa CNS, Patrocínio MCA, Macêdo D, Vasconcelos SMM. Advantages of the Alphalipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced
by Ketamine in Rats: Behavioral and Oxidative Stress evidences. Neuroscience.
2018 Mar 1;373:72-81. doi: 10.1016/j.neuroscience.2018.01.008. Epub 2018 Jan 11.
PMID: 29337238.
246: Ventriglio A, Bellomo A, Donato F, Iris B, Giovanna V, Dario DS, Edwige C,
Di Gioia Ilaria, Pettorruso M, Perna G, Valchera A, De Berardis D. Oxidative
Stress in the Early Stage of Psychosis. Curr Top Med Chem. 2021 Oct
25;21(16):1457-1470. doi: 10.2174/1568026621666210701105839. PMID: 34218786.
247: Zugno AI, Chipindo HL, Volpato AM, Budni J, Steckert AV, de Oliveira MB,
Heylmann AS, da Rosa Silveira F, Mastella GA, Maravai SG, Wessler PG, Binatti
AR, Panizzutti B, Schuck PF, Quevedo J, Gama CS. Omega-3 prevents behavior
response and brain oxidative damage in the ketamine model of schizophrenia.
Neuroscience. 2014 Feb 14;259:223-31. doi: 10.1016/j.neuroscience.2013.11.049.
Epub 2013 Dec 4. PMID: 24316471.
248: Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, Nakamura J.
Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to
tardive dyskinesia. Neuropsychopharmacology. 2000 Aug;23(2):170-7. doi:
10.1016/S0893-133X(99)00156-6. PMID: 10882843.
249: Shahzad S, Batool Z, Afzal A, Haider S. Reversal of oxidative stress,
cytokine toxicity and DNA fragmentation by quercetin in dizocilpine-induced
animal model of Schizophrenia. Metab Brain Dis. 2022 Dec;37(8):2793-2805. doi:
10.1007/s11011-022-01090-6. Epub 2022 Sep 24. PMID: 36152087.
250: Akosman MS, Türkmen R, Demirel HH. Investigation of the protective effect
of resveratrol in an MK-801-induced mouse model of schizophrenia. Environ Sci
Pollut Res Int. 2021 Dec;28(46):65872-65884. doi: 10.1007/s11356-021-15664-x.
Epub 2021 Jul 28. PMID: 34322799.
251: Stein L. Neurochemistry of reward and punishment: some implications for the
etiology of schizophrenia. J Psychiatr Res. 1971 Aug;8(3):345-61. doi:
10.1016/0022-3956(71)90030-6. PMID: 4939380.
252: Lerner V, Miodownik C. Motor symptoms of schizophrenia: is tardive
dyskinesia a symptom or side effect? A modern treatment. Curr Psychiatry Rep.
2011 Aug;13(4):295-304. doi: 10.1007/s11920-011-0202-6. PMID: 21519907.
253: Yang Y, Li R, Hei G, Wu R. [Role of sulforaphane in improving negative
symptoms and cognitive symptoms of schizophrenia and the underlying mechanism].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Jun 28;44(6):701-705. Chinese. doi:
10.11817/j.issn.1672-7347.2019.06.014. PMID: 31304933.
254: Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E. Oxidativeantioxidative systems and their relation with serum S100 B levels in patients
with schizophrenia: effects of short term antipsychotic treatment. Prog
Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9. doi:
10.1016/j.pnpbp.2007.03.008. Epub 2007 Mar 21. PMID: 17459548.
255: Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmonte-de-Abreu P.
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances
in schizophrenia: a study of patients treated with haloperidol or clozapine.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):512-5. doi:
10.1016/j.pnpbp.2005.11.009. Epub 2006 Jan 19. PMID: 16426720.
256: Shungu DC. N-acetylcysteine for the treatment of glutathione deficiency and
oxidative stress in schizophrenia. Biol Psychiatry. 2012 Jun 1;71(11):937-8.
doi: 10.1016/j.biopsych.2012.03.025. PMID: 22579304.
257: Jørgensen A. Antioxidanter som tillægsbehandling ved skizofreni
[Antioxidants as adjunctive therapy in schizophrenia]. Ugeskr Laeger. 2016 May
16;178(20):V68238. Danish. PMID: 27189103.
258: Pae CU, Paik IH, Lee C, Lee SJ, Kim JJ, Lee CU. Decreased plasma
antioxidants in schizophrenia. Neuropsychobiology. 2004;50(1):54-6. doi:
10.1159/000077942. PMID: 15179021.
259: Asevedo E, Cunha GR, Zugman A, Mansur RB, Brietzke E. N-acetylcysteine as a
potentially useful medication to prevent conversion to schizophrenia in at-risk
individuals. Rev Neurosci. 2012;23(4):353-62. doi: 10.1515/revneuro-2012-0039.
PMID: 22944654.
260: Pae CU, Kim TS, Patkar AA, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH.
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be
associated with schizophrenia and tardive dyskinesia. Psychiatry Res. 2007 Sep
30;153(1):77-81. doi: 10.1016/j.psychres.2006.04.011. Epub 2007 Jun 19. PMID:
17582511.
261: Wu Z, Zhang XY, Wang H, Tang W, Xia Y, Zhang F, Liu J, Fu Y, Hu J, Chen Y,
Liu L, Chen DC, Xiu MH, Kosten TR, He J. Elevated plasma superoxide dismutase in
first-episode and drug naive patients with schizophrenia: inverse association
with positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan
10;36(1):34-8. doi: 10.1016/j.pnpbp.2011.08.018. Epub 2011 Aug 30. PMID:
21896300.
262: De Lima DN Jr, Costa Filho CWL, Frota IJ, de Oliveira ALB, Menezes CES,
Chaves Filho AJM, Viana GA, Campos EM, Collares M, de Queiroz MGR, da Cruz
Fonseca SG, Vasconcelos SMM, Macêdo DS, Sanders LLO. α-Lipoic Acid as Adjunctive
Treatment for Schizophrenia: A Randomized Double-Blind Study. J Clin
Psychopharmacol. 2023 Jan-Feb 01;43(1):39-45. doi: 10.1097/JCP.0000000000001639.
PMID: 36584248.
263: Marzullo G, Boklage CE. Bimodal rhythms of
birth-month phenomenon in schizophrenia, neural
solstitial hypothesis. Birth Defects Res A Clin
Apr;91(4):249-57. doi: 10.1002/bdra.20806. Epub
general conceptions and the
tube defects, and laterality: a
Mol Teratol. 2011
2011 Apr 6. PMID: 21472844.
264: Pérez-Neri I, Ramírez-Bermúdez J, Montes S, Ríos C. Possible mechanisms of
neurodegeneration in schizophrenia. Neurochem Res. 2006 Oct;31(10):1279-94. doi:
10.1007/s11064-006-9162-3. Epub 2006 Sep 28. PMID: 17006758.
265: Akyol O, Herken H, Uz E, Fadillioğlu E, Unal S, Söğüt S, Ozyurt H, Savaş
HA. The indices of endogenous oxidative and antioxidative processes in plasma
from schizophrenic patients. The possible role of oxidant/antioxidant imbalance.
Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jun;26(5):995-1005. doi:
10.1016/s0278-5846(02)00220-8. PMID: 12369276.
266: Bošković M, Grabnar I, Terzič T, Kores Plesničar B, Vovk T. Oxidative
stress in schizophrenia patients treated with long-acting haloperidol decanoate.
Psychiatry Res. 2013 Dec 30;210(3):761-8. doi: 10.1016/j.psychres.2013.08.035.
Epub 2013 Sep 13. PMID: 24041751.
267: Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation
with a combination of omega-3 fatty acids and antioxidants (vitamins E and C)
improves the outcome of schizophrenia. Schizophr Res. 2003 Aug 1;62(3):195-204.
doi: 10.1016/s0920-9964(02)00284-0. PMID: 12837515.
268: Buie LW, Oertel MD, Cala SO. Allopurinol as adjuvant therapy in poorly
responsive or treatment refractory schizophrenia. Ann Pharmacother. 2006
Dec;40(12):2200-4. doi: 10.1345/aph.1H222. Epub 2006 Nov 21. PMID: 17119103.
269: Nguimfack Mbodie PC. La théorie de l'excitotoxicité du glutamate et
l'implication potentielle des radicaux libres dans l'étiopathogénie de la
schizophrénie apporte-t-elle un éclairage nouveau sur les liens entre:
prédisposition génétique, facteurs environnementaux et biologie dans le
déterminisme de ce trouble? [Do the glutamate excitotoxicity theory and
potential free radicals implication in schizophrenia aetiopathogenesis provide a
new enlightenment to links between: genome, environment and biology in the
determinism of that disorder?]. Encephale. 2002 Mar-Apr;28(2):147-53. French.
PMID: 11972141.
270: Nakano Y, Yoshimura R, Nakano H, Ikenouchi-Sugita A, Hori H, Umene-Nakano
W, Ueda N, Nakamura J. Association between plasma nitric oxide metabolites
levels and negative symptoms of schizophrenia: a pilot study. Hum
Psychopharmacol. 2010 Mar;25(2):139-44. doi: 10.1002/hup.1102. PMID: 20196178.
271: Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan
X, Song X. Changes in metabolism and microbiota after 24-week risperidone
treatment in drug naïve, normal weight patients with first episode
schizophrenia. Schizophr Res. 2018 Nov;201:299-306. doi:
10.1016/j.schres.2018.05.017. Epub 2018 May 30. PMID: 29859859.
272: Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E,
Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K. Negative
correlation between brain glutathione level and negative symptoms in
schizophrenia: a 3T 1H-MRS study. PLoS One. 2008 Apr 9;3(4):e1944. doi:
10.1371/journal.pone.0001944. PMID: 18398470; PMCID: PMC2275307.
273: Paulsen Bda S, da Silveira MS, Galina A, Rehen SK. Pluripotent stem cells
as a model to study oxygen metabolism in neurogenesis and neurodevelopmental
disorders. Arch Biochem Biophys. 2013 Jun;534(1-2):3-10. doi:
10.1016/j.abb.2012.10.009. Epub 2012 Oct 27. PMID: 23111185.
274: Dowling NA, Merkouris SS, Lorains FK. Interventions for comorbid problem
gambling and psychiatric disorders: Advancing a developing field of research.
Addict Behav. 2016 Jul;58:21-30. doi: 10.1016/j.addbeh.2016.02.012. Epub 2016
Feb 10. PMID: 26900888.
275: Seybolt SE. Is it time to reassess alpha lipoic acid and niacinamide
therapy in schizophrenia? Med Hypotheses. 2010 Dec;75(6):572-5. doi:
10.1016/j.mehy.2010.07.034. Epub 2010 Aug 12. PMID: 20708342.
276: Lawther AJ, Zieba J, Fang Z, Furlong TM, Conn I, Govindaraju H, Choong LLY,
Turner N, Siddiqui KS, Bridge W, Merlin S, Hyams TC, Killingsworth M, Eapen V,
Clarke RA, Walker AK. Antioxidant Behavioural Phenotype in the <i>Immp2l</i>
Gene Knock-Out Mouse. Genes (Basel). 2023 Aug 28;14(9):1717. doi:
10.3390/genes14091717. PMID: 37761857; PMCID: PMC10531238.
277: Sawa A, Seidman LJ. Is prophylactic psychiatry around the corner? combating
adolescent oxidative stress for adult psychosis and schizophrenia. Neuron. 2014
Sep 3;83(5):991-3. doi: 10.1016/j.neuron.2014.08.028. PMID: 25189204; PMCID:
PMC8924824.
278: Damazio LS, Silveira FR, Canever L, Castro AA, Estrela JM, Budni J, Zugno
AI. The preventive effects of ascorbic acid supplementation on locomotor and
acetylcholinesterase activity in an animal model of schizophrenia induced by
ketamine. An Acad Bras Cienc. 2017 Apr-Jun;89(2):1133-1141. doi:
10.1590/0001-3765201720160490. Epub 2017 May 15. PMID: 28513779.
279: Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Implication du
stress oxydant dans la physiopathologie de la schizophrénie: revue de la
littérature [Oxidative stress involvement in schizophrenia pathophysiology: a
review]. Encephale. 2006 Mar-Apr;32(2 Pt 1):244-52. French. doi:
10.1016/s0013-7006(06)76151-6. PMID: 16910626.
280: Zhang XY, Zhou DF, Cao LY, Wu GY, Shen YC. The interaction between
superoxide dismutase and prolactin is involved in response to haloperidol and
risperidone treatment in schizophrenia: a double-blind and randomized study. J
Clin Psychopharmacol. 2006 Feb;26(1):103-5. PMID: 16415724.
281: Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in
schizophrenia. Biol Psychiatry. 2013 Sep 15;74(6):400-9. doi:
10.1016/j.biopsych.2013.03.018. Epub 2013 May 15. PMID: 23683390; PMCID:
PMC4018767.
282: Micó JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas
D, Graell M, Gil J, Irazusta J, Castro-Fornieles J, Soutullo C, Arango C, Otero
S, Navarro A, Baeza I, Martínez-Cengotitabengoa M, González-Pinto A. Reduced
antioxidant defense in early onset first-episode psychosis: a case-control
study. BMC Psychiatry. 2011 Feb 14;11:26. doi: 10.1186/1471-244X-11-26. PMID:
21320302; PMCID: PMC3045298.
283: Ozyurt H, Ozyurt B, Sarsilmaz M, Kus I, Songur A, Akyol O. Potential role
of some oxidant/antioxidant status parameters in prefrontal cortex of rat brain
in an experimental psychosis model and the protective effects of melatonin. Eur
Rev Med Pharmacol Sci. 2014;18(15):2137-44. PMID: 25070818.
284: Suboticanec K, Kulcar Z, Turcin R, Sila A, Folnegović-Smalc V, Meştrović B,
Buzina R. Vitamin C and schizophrenia. Acta Med Iugosl. 1984;38(5):299-308.
PMID: 6524440.
285: Potanin SS, Morozova MA. Oksidativnyi stress pri shizofrenii kak
perspektivnaya mishen' dlya psikhofarmakoterapii [Oxidative stress in
schizophrenia as a promising target for psychopharmacotherapy]. Zh Nevrol
Psikhiatr Im S S Korsakova. 2021;121(9):131-138. Russian. doi:
10.17116/jnevro2021121091131. PMID: 34693701.
286: Yolland CO, Hanratty D, Neill E, Rossell SL, Berk M, Dean OM, Castle DJ,
Tan EJ, Phillipou A, Harris AW, Barreiros AR, Hansen A, Siskind D. Meta-analysis
of randomised controlled trials with <i>N</i>-acetylcysteine in the treatment of
schizophrenia. Aust N Z J Psychiatry. 2020 May;54(5):453-466. doi:
10.1177/0004867419893439. Epub 2019 Dec 11. PMID: 31826654.
287: Miljević C, Nikolić-Kokić A, Saicić ZS, Milosavljević M, Blagojević D,
Tosevski DL, Jones DR, Spasić MB. Correlation analysis confirms differences in
antioxidant defence in the blood of types I and II schizophrenic male patients
treated with anti-psychotic medication. Psychiatry Res. 2010 Jun
30;178(1):68-72. doi: 10.1016/j.psychres.2008.10.038. Epub 2010 May 10. PMID:
20452039.
288: Zheng W, Zhang QE, Cai DB, Yang XH, Qiu Y, Ungvari GS, Ng CH, Berk M, Ning
YP, Xiang YT. N-acetylcysteine for major mental disorders: a systematic review
and meta-analysis of randomized controlled trials. Acta Psychiatr Scand. 2018
May;137(5):391-400. doi: 10.1111/acps.12862. Epub 2018 Feb 18. PMID: 29457216.
289: Kim E, Keskey Z, Kang M, Kitchen C, Bentley WE, Chen S, Kelly DL, Payne GF.
Validation of oxidative stress assay for schizophrenia. Schizophr Res. 2019
Oct;212:126-133. doi: 10.1016/j.schres.2019.07.057. Epub 2019 Aug 6. PMID:
31399268.
290: Miyaoka T. [Schizophrenia and idiopathic unconjugated hyperbilirubinemia
(Gilbert's syndrome)]. Seishin Shinkeigaku Zasshi. 2007;109(4):305-12. Japanese.
PMID: 17561669.
291: Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-deAbreu PS. Resveratrol Supplementation in Schizophrenia Patients: A Randomized
Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.
Nutrients. 2016 Jan 29;8(2):73. doi: 10.3390/nu8020073. PMID: 26840331; PMCID:
PMC4772037.
292: Lu Z, Wen T, Wang Y, Kan W, Xun G. Peripheral non-enzymatic antioxidants in
patients with schizophrenia: a case-control study. BMC Psychiatry. 2020 May
15;20(1):241. doi: 10.1186/s12888-020-02635-8. PMID: 32414343; PMCID:
PMC7227358.
293: Supp AD, Avila S Jr, Mastella GA, Damásio L, de Oliveira IH, Godoi AK,
Michels A, Schuck PF, Zugno AI. Ascorbic acid supplementation attenuates
schizophrenia-like symptoms in an animal model induced by ketamine. Int J Dev
Neurosci. 2021 Feb;81(1):26-36. doi: 10.1002/jdn.10058. Epub 2020 Nov 29. PMID:
32780510.
294: Ballesteros A, Jiang P, Summerfelt A, Du X, Chiappelli J, O'Donnell P,
Kochunov P, Hong LE. No evidence of exogenous origin for the abnormal
glutathione redox state in schizophrenia. Schizophr Res. 2013
May;146(1-3):184-9. doi: 10.1016/j.schres.2013.02.001. Epub 2013 Mar 1. PMID:
23466187; PMCID: PMC3622807.
295: Yang YS, Davis MC, Wynn JK, Hellemann G, Green MF, Marder SR.
N-acetylcysteine improves EEG measures of auditory deviance detection and neural
synchronization in schizophrenia: A randomized, controlled pilot study.
Schizophr Res. 2019 Jun;208:479-480. doi: 10.1016/j.schres.2019.01.036. Epub
2019 Jan 31. PMID: 30712814.
296: Seybolt SE. Less is more. Schizophr Res. 2014 Dec;160(1-3):222-3. doi:
10.1016/j.schres.2014.10.022. Epub 2014 Oct 31. PMID: 25458573.
297: Cui G, Qing Y, Hu X, Wang P, Sun L, Yang X, Jiang J, Zhang J, Wang H, Feng
L, Shen Y, Qin S, Wan C. Serum Metabolomic Profiling Based on Fourier TransformIon Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic
Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia? Antioxid
Redox Signal. 2020 Oct 1;33(10):679-688. doi: 10.1089/ars.2020.8141. Epub 2020
Jul 23. PMID: 32578452.
298: Vítek L, Novotná M, Lenícek M, Novotný L, Eberová J, Petrásek J, Jirsa M.
Serum bilirubin levels and UGT1A1 promoter variations in patients with
schizophrenia. Psychiatry Res. 2010 Jul 30;178(2):449-50. doi:
10.1016/j.psychres.2009.12.008. Epub 2010 May 21. PMID: 20483464.
299: Permyakov SE, Kazakov AS, Avkhacheva NV, Permyakov EA. Parvalbumin as a
metal-dependent antioxidant. Cell Calcium. 2014 May;55(5):261-8. doi:
10.1016/j.ceca.2014.03.001. Epub 2014 Mar 11. PMID: 24685310.
300: Butts BD, Houde C, Mehmet H. Maturation-dependent sensitivity of
oligodendrocyte lineage cells to apoptosis: implications for normal development
and disease. Cell Death Differ. 2008 Jul;15(7):1178-86. doi:
10.1038/cdd.2008.70. Epub 2008 May 16. PMID: 18483490.
301: Afonso P, Brissos S, Figueira ML, Paiva T. Discrepant nocturnal melatonin
levels in monozygotic twins discordant for schizophrenia and its impact on
sleep. Schizophr Res. 2010 Jul;120(1-3):227-8. doi:
10.1016/j.schres.2010.03.031. PMID: 20434887.
302: Swanepoel T, Möller M, Harvey BH. N-acetyl cysteine reverses biobehavioural changes induced by prenatal inflammation, adolescent methamphetamine
exposure and combined challenges. Psychopharmacology (Berl). 2018
Jan;235(1):351-368. doi: 10.1007/s00213-017-4776-5. Epub 2017 Nov 8. PMID:
29116368.
303: Palaniyappan L. Adaptive changes to oxidative stress in schizophrenia. Mol
Psychiatry. 2022 Sep;27(9):3565-3566. doi: 10.1038/s41380-022-01550-6. Epub 2022
Apr 8. PMID: 35396349.
304: Alsharif KF, Albrakati A, Al Omairi NE, Almalki AS, Alsanie WF, Elmageed
ZYA, Habotta OA, Lokman MS, Althagafi HA, Alghamdi AAA, Moneim AEA, Alyami H,
Belal SKM, Alnefaie G, Alamri AS, Albezrah NKA, Kassab RB, Albarakati AJA,
Hassan KE, Agil A. Therapeutic antischizophrenic activity of prodigiosin and
selenium co-supplementation against amphetamine hydrochloride-induced
behavioural changes and oxidative, inflammatory, and apoptotic challenges in
rats. Environ Sci Pollut Res Int. 2023 Jan;30(3):7987-8001. doi:
10.1007/s11356-022-22409-x. Epub 2022 Sep 1. PMID: 36048389.
305: Baandrup L, Jennum P, Lublin H, Glenthoj B. Treatment options for residual
insomnia in schizophrenia. Acta Psychiatr Scand. 2013 Jan;127(1):81-2. doi:
10.1111/acps.12016. Epub 2012 Oct 26. PMID: 23106614.
306: Dietrich-Muszalska A, Kontek B. Lipid peroxidation in patients with
schizophrenia. Psychiatry Clin Neurosci. 2010 Oct;64(5):469-75. doi:
10.1111/j.1440-1819.2010.02132.x. PMID: 20923426.
307: Jiang Z, Rompala GR, Zhang S, Cowell RM, Nakazawa K. Social isolation
exacerbates schizophrenia-like phenotypes via oxidative stress in cortical
interneurons. Biol Psychiatry. 2013 May 15;73(10):1024-34. doi:
10.1016/j.biopsych.2012.12.004. Epub 2013 Jan 21. PMID: 23348010; PMCID:
PMC3638045.
308: Rapado-Castro M, Dodd S, Bush AI, Malhi GS, Skvarc DR, On ZX, Berk M, Dean
OM. Cognitive effects of adjunctive N-acetyl cysteine in psychosis. Psychol Med.
2017 Apr;47(5):866-876. doi: 10.1017/S0033291716002932. Epub 2016 Nov 29. PMID:
27894373.
309: Trbovic SM. Schizophrenia as a possible dysfunction of the suprachiasmatic
nucleus. Med Hypotheses. 2010 Jan;74(1):127-31. doi: 10.1016/j.mehy.2009.07.019.
Epub 2009 Aug 5. PMID: 19660876.
310: Michel TM, Sheldrick AJ, Camara S, Grünblatt E, Schneider F, Riederer P.
Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and
occipital cortex of patients with schizophrenia. World J Biol Psychiatry. 2011
Dec;12(8):588-97. doi: 10.3109/15622975.2010.526146. Epub 2010 Nov 15. PMID:
21073395.
311: Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide
spectrum of action. Braz J Psychiatry. 2008 Sep;30(3):271-80. doi:
10.1590/s1516-44462008000300015. PMID: 18833429.
312: Zincir S. Asymmetric dimethylarginine (ADMA) and treatment response
relationship in male patients with first-episode schizophrenia: Author ‫׳‬s reply.
Psychiatry Res. 2015 Jun 30;227(2-3):371. doi: 10.1016/j.psychres.2015.03.039.
PMID: 25965648.
313: Khan NS, Das I. Oxidative stress and superoxide dismutase in schizophrenia.
Biochem Soc Trans. 1997 Aug;25(3):418S. doi: 10.1042/bst025418s. PMID: 9388648.
314: Yang M, Wang C, Zhao G, Kong D, Liu L, Yuan S, Chen W, Feng C, Li Z.
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic
Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with
Schizophrenia: A Meta-Analysis. Curr Neuropharmacol. 2023;21(2):340-352. doi:
10.2174/1570159X20666220706101021. PMID: 35794775; PMCID: PMC10190148.
315: Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, Hensch
TK, LaMantia AS, Lindemann L, Maynard TM, Meyer U, Morishita H, O'Donnell P,
Puhl M, Cuenod M, Do KQ. Oxidative stress-driven parvalbumin interneuron
impairment as a common mechanism in models of schizophrenia. Mol Psychiatry.
2017 Jul;22(7):936-943. doi: 10.1038/mp.2017.47. Epub 2017 Mar 21. PMID:
28322275; PMCID: PMC5491690.
316: Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophr Bull.
1997;23(4):583-609. doi: 10.1093/schbul/23.4.583. PMID: 9365997.
317: Liu F, Zhang B, Xie L, Ruan Y, Xu X, Zeng Y, Messina L, Zhao J, Fan X.
Changes in plasma levels of nitric oxide metabolites and negative symptoms after
16-week minocycline treatment in patients with schizophrenia. Schizophr Res.
2018 Sep;199:390-394. doi: 10.1016/j.schres.2018.03.003. Epub 2018 Mar 9. PMID:
29526457.
318: Altuntas I, Aksoy H, Coskun I, Cayköylü A, Akçay F. Erythrocyte superoxide
dismutase and glutathione peroxidase activities, and malondialdehyde and reduced
glutathione levels in schizophrenic patients. Clin Chem Lab Med. 2000
Dec;38(12):1277-81. doi: 10.1515/CCLM.2000.201. PMID: 11205693.
319: DE SAUVAGE NOLTING WJ. A curious relation between schizophrenia and the
vitamin-C content of blood during pre- and postnatal periods. Folia Psychiatr
Neurol Neurochir Neerl. 1952 Oct;55(4-5):388-409. PMID: 13010324.
320: MacDowell KS, Munarriz-Cuezva E, Caso JR, Madrigal JL, Zabala A, Meana JJ,
García-Bueno B, Leza JC. Paliperidone reverts Toll-like receptor 3 signaling
pathway activation and cognitive deficits in a maternal immune activation mouse
model of schizophrenia. Neuropharmacology. 2017 Apr;116:196-207. doi:
10.1016/j.neuropharm.2016.12.025. Epub 2016 Dec 28. PMID: 28039001.
321: Hoffer A. Megavitamin B-3 therapy for schizophrenia. Can Psychiatr Assoc J.
1971 Dec;16(6):499-504. doi: 10.1177/070674377101600605. PMID: 4947171.
322: Yao JK, Reddy R, McElhinny LG, van Kammen DP. Effects of haloperidol on
antioxidant defense system enzymes in schizophrenia. J Psychiatr Res. 1998 NovDec;32(6):385-91. doi: 10.1016/s0022-3956(98)00028-4. PMID: 9844955.
323: Herken H, Uz E, Ozyurt H, Söğüt S, Virit O, Akyol O. Evidence that the
activities of erythrocyte free radical scavenging enzymes and the products of
lipid peroxidation are increased in different forms of schizophrenia. Mol
Psychiatry. 2001 Jan;6(1):66-73. doi: 10.1038/sj.mp.4000789. PMID: 11244487.
324: Goff DC. Pharmacologic implications of neurobiological models of
schizophrenia. Harv Rev Psychiatry. 2005 Nov-Dec;13(6):352-9. doi:
10.1080/10673220500433262. PMID: 16373329.
325: Pyatoykina AS, Zhilyaeva TV, Semennov IV, Mishanov GA, Blagonravova AS,
Mazo GE. Dvoinoe slepoe randomizirovannoe platsebo-kontroliruemoe issledovanie
primeneniya N-atsetiltsisteina pri shizofrenii: predvaritel'nye rezul'taty [The
double-blind randomized placebo-controlled trial of N-acetylcysteine use in
schizophrenia: preliminary results]. Zh Nevrol Psikhiatr Im S S Korsakova.
2020;120(9):66-71. Russian. doi: 10.17116/jnevro202012009166. PMID: 33081449.
326: Tylec A, Jarzab A, Stryjecka-Zimmer M, Wójcicka A. Stres oksydacyjny w
schizofrenii [Stress oxidative in schizophrenia]. Pol Merkur Lekarski. 2007
Jul;23(133):74-7. Polish. PMID: 18051835.
327: Benton D. Selenium intake, mood and other aspects of psychological
functioning. Nutr Neurosci. 2002 Dec;5(6):363-74. doi:
10.1080/1028415021000055925. PMID: 12509066.
328: Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H. Impaired
antioxidant defense at the onset of psychosis. Schizophr Res. 1996
Mar;19(1):19-26. doi: 10.1016/0920-9964(95)00048-8. PMID: 9147492.
329: Akiibinu MO, Ogundahunsi OA, Ogunyemi EO. Inter-relationship of plasma
markers of oxidative stress and thyroid hormones in schizophrenics. BMC Res
Notes. 2012 Mar 31;5:169. doi: 10.1186/1756-0500-5-169. PMID: 22463715; PMCID:
PMC3337813.
330: Ventriglia M, Scassellati C, Bonvicini C, Squitti R, Bevacqua MG, Foresti
G, Tura GB, Gennarelli M. No association between Ala9Val functional polymorphism
of MnSOD gene and schizophrenia in a representative Italian sample. Neurosci
Lett. 2006 Dec 27;410(3):208-11. doi: 10.1016/j.neulet.2006.10.009. Epub 2006
Oct 18. PMID: 17055157.
331: Becklén M, Orhan F, Piehl F, Cervenka S, Sellgren CM, Flyckt L, Erhardt S,
Fatouros-Bergman H. Plasma bilirubin levels are reduced in first-episode
psychosis patients and associates to working memory and duration of untreated
psychosis. Sci Rep. 2021 Apr 6;11(1):7527. doi: 10.1038/s41598-021-87096-z.
PMID: 33824398; PMCID: PMC8024299.
332: Chen DC, Xiu MH, Liu H, Zhang BS, Wang Y, Kosten TR, Zhang XY. Reduced
status of plasma total antioxidant capacity in schizophrenia with tardive
dyskinesia. J Psychiatr Res. 2010 Nov;44(15):1111-2. doi:
10.1016/j.jpsychires.2010.03.008. Epub 2010 Apr 15. PMID: 20398909.
333: Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C
with atypical antipsychotics reduces oxidative stress and improves the outcome
of schizophrenia. Psychopharmacology (Berl). 2005 Nov;182(4):494-8. doi:
10.1007/s00213-005-0117-1. Epub 2005 Oct 19. PMID: 16133138.
334: Rachkauskas GS. Uroven' perekisnogo okisleniia lipidov i sostoianie
antioksidantnoĭ sistemy pri razlichnykh formakh shizofrenii [The level of lipid
peroxidation and the function of the antioxidant system in different forms of
schizophrenia]. Lik Sprava. 1998 Jul-Aug;(5):92-3. Russian. PMID: 9793317.
335: Berk M, Munib A, Dean O, Malhi GS, Kohlmann K, Schapkaitz I, Jeavons S,
Katz F, Anderson-Hunt M, Conus P, Hanna B, Otmar R, Ng F, Copolov DL, Bush AI.
Qualitative methods in early-phase drug trials: broadening the scope of data and
methods from an RCT of N-acetylcysteine in schizophrenia. J Clin Psychiatry.
2011 Jul;72(7):909-13. doi: 10.4088/JCP.09m05741yel. Epub 2010 Sep 21. PMID:
20868637.
336: Shahzad S, Batool Z, Tabassum S, Ahmad S, Kamil N, Khaliq S, Nawaz A,
Haider S. Spirulina platensis (Blue-green algae): A miracle from sea combats the
oxidative stress and improves behavioral deficits in an animal model of
Schizophrenia. Pak J Pharm Sci. 2020 Jul;33(4(Supplementary)):1847-1853. PMID:
33612469.
337: Baandrup L, Fagerlund B, Glenthoj B. Neurocognitive performance, subjective
well-being, and psychosocial functioning after benzodiazepine withdrawal in
patients with schizophrenia or bipolar disorder: a randomized clinical trial of
add-on melatonin versus placebo. Eur Arch Psychiatry Clin Neurosci. 2017
Mar;267(2):163-171. doi: 10.1007/s00406-016-0711-8. Epub 2016 Jul 11. PMID:
27400927.
338: Tran HQ, Park SJ, Shin EJ, Tran TV, Sharma N, Lee YJ, Jeong JH, Jang CG,
Kim DJ, Nabeshima T, Kim HC. Clozapine attenuates mitochondrial burdens and
abnormal behaviors elicited by phencyclidine in mice via inhibition of p47
^phox; Possible involvements of phosphoinositide 3-kinase/Akt
signaling. J Psychopharmacol. 2018 Nov;32(11):1233-1251. doi:
10.1177/0269881118795244. Epub 2018 Sep 12. PMID: 30207504.
339: Đorđević VV, Lazarević D, Ćosić V, Knežević M, Đorđević VB. Age-related
changes of superoxide dismutase activity in patients with schizophrenia.
Vojnosanit Pregl. 2017 Jan;74(1):31-7. doi: 10.2298/VSP141202142D. PMID:
29350504.
340: da Costa AEM, Gomes NS, Gadelha Filho CVJ, Linhares MGOES, da Costa RO,
Chaves Filho AJM, Cordeiro RC, Vasconcelos GS, da Silva FER, Araujo TDS,
Vasconcelos SMM, Lucena DF, Macêdo DS. Sex influences in the preventive effects
of peripubertal supplementation with N-3 polyunsaturated fatty acids in mice
exposed to the two-hit model of schizophrenia. Eur J Pharmacol. 2021 Apr
15;897:173949. doi: 10.1016/j.ejphar.2021.173949. Epub 2021 Feb 16. PMID:
33607108.
341: Suhas S, Sreeraj VS, Amrutha C, Desai G, Venkatasubramanian G. Is
allopurinol a marvel in the endgame of ultra-resistant schizophrenia? Schizophr
Res. 2022 Mar;241:12-13. doi: 10.1016/j.schres.2022.01.009. Epub 2022 Jan 20.
PMID: 35066431.
342: Casquero-Veiga M, Romero-Miguel D, MacDowell KS, Torres-Sanchez S, GarciaPartida JA, Lamanna-Rama N, Gómez-Rangel V, Romero-Miranda A, Berrocoso E, Leza
JC, Arango C, Desco M, Soto-Montenegro ML. Omega-3 fatty acids during
adolescence prevent schizophrenia-related behavioural deficits:
Neurophysiological evidences from the prenatal viral infection with PolyI:C. Eur
Neuropsychopharmacol. 2021 May;46:14-27. doi: 10.1016/j.euroneuro.2021.02.001.
Epub 2021 Mar 15. PMID: 33735708.
343: Tsai MC, Liou CW, Lin TK, Lin IM, Huang TL. Changes in oxidative stress
markers in patients with schizophrenia: the effect of antipsychotic drugs.
Psychiatry Res. 2013 Oct 30;209(3):284-90. doi: 10.1016/j.psychres.2013.01.023.
Epub 2013 Mar 14. PMID: 23497820.
344: Onaolapo OJ, Ademakinwa OQ, Olalekan TO, Onaolapo AY. Ketamine-induced
behavioural and brain oxidative changes in mice: an assessment of possible
beneficial effects of zinc as mono- or adjunct therapy. Psychopharmacology
(Berl). 2017 Sep;234(18):2707-2725. doi: 10.1007/s00213-017-4666-x. Epub 2017
Jun 14. PMID: 28612134.
345: Gama CS, Salvador M, Andreazza AC, Lobato MI, Berk M, Kapczinski F,
Belmonte-de-Abreu PS. Elevated serum thiobarbituric acid reactive substances in
clinically symptomatic schizophrenic males. Neurosci Lett. 2008 Mar
15;433(3):270-3. doi: 10.1016/j.neulet.2008.01.018. Epub 2008 Jan 16. PMID:
18255229.
346: Widschwendter CG, Rettenbacher MA, Kemmler G, Edlinger M, Baumgartner S,
Fleischhacker WW, Hofer A. Bilirubin concentration correlates with positive
symptoms in patients with schizophrenia. J Clin Psychiatry. 2016
Apr;77(4):512-6. doi: 10.4088/JCP.14m09642. PMID: 27035280.
347: Ben-Azu B, Aderibigbe AO, Ajayi AM, Eneni AO, Omogbiya IA, Owoeye O,
Umukoro S, Iwalewa EO. Morin decreases cortical pyramidal neuron degeneration
via inhibition of neuroinflammation in mouse model of schizophrenia. Int
Immunopharmacol. 2019 May;70:338-353. doi: 10.1016/j.intimp.2019.02.052. Epub
2019 Mar 7. Erratum in: Int Immunopharmacol. 2021 Jan;90:107197. PMID: 30852289.
348: Mishra A, Reeta KH, Sarangi SC, Maiti R, Sood M. Effect of add-on alpha
lipoic acid on psychopathology in patients with treatment-resistant
schizophrenia: a pilot randomized double-blind placebo-controlled trial.
Psychopharmacology (Berl). 2022 Nov;239(11):3525-3535. doi:
10.1007/s00213-022-06225-2. Epub 2022 Sep 7. Erratum in: Psychopharmacology
(Berl). 2022 Sep 14;: PMID: 36069950; PMCID: PMC9449282.
349: Ben-Azu B, Omogbiya IA, Aderibigbe AO, Umukoro S, Ajayi AM, Iwalewa EO.
Doxycycline prevents and reverses schizophrenic-like behaviors induced by
ketamine in mice via modulation of oxidative, nitrergic and cholinergic
pathways. Brain Res Bull. 2018 May;139:114-124. doi:
10.1016/j.brainresbull.2018.02.007. Epub 2018 Feb 6. PMID: 29425796.
350: Feng Y, Yu YH, Wang ST, Ren J, Camer D, Hua YZ, Zhang Q, Huang J, Xue DL,
Zhang XF, Huang XF, Liu Y. Chlorogenic acid protects D-galactose-induced liver
and kidney injury via antioxidation and anti-inflammation effects in mice. Pharm
Biol. 2016;54(6):1027-34. doi: 10.3109/13880209.2015.1093510. Epub 2016 Jan 25.
PMID: 26810301.
351: Maurizi CP. The pathophysiology of enlarged ventricles in normal pressure
communicating hydrocephalus and schizophrenia: a possible therapeutic role for
melatonin. Med Hypotheses. 1987 May;23(1):61-6. doi:
10.1016/0306-9877(87)90182-4. PMID: 3614004.
352: Sanders LLO, de Souza Menezes CE, Chaves Filho AJM, de Almeida Viana G,
Fechine FV, Rodrigues de Queiroz MG, Gonçalvez da Cruz Fonseca S, Mendes
Vasconcelos SM, Amaral de Moraes ME, Gama CS, Seybolt S, de Moura Campos E,
Macêdo D, Freitas de Lucena D. α-Lipoic Acid as Adjunctive Treatment for
Schizophrenia: An Open-Label Trial. J Clin Psychopharmacol. 2017
Dec;37(6):697-701. doi: 10.1097/JCP.0000000000000800. PMID: 29053478.
353: Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis
genes is increased in bipolar disorder, but not in schizophrenia. Mol
Psychiatry. 2006 Mar;11(3):241-51. doi: 10.1038/sj.mp.4001758. PMID: 16288314.
354: Pradhan SC, Swain S. Plasma antioxidants and schizophrenia. Schizophr Res.
2000 Jan 21;41(2):383. PMID: 10708348.
355: Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. The effect of
risperidone treatment on superoxide dismutase in schizophrenia. J Clin
Psychopharmacol. 2003 Apr;23(2):128-31. doi: 10.1097/00004714-200304000-00004.
PMID: 12640213.
356: Emsley R, Chiliza B, Asmal L, du Plessis S, Phahladira L, van Niekerk E,
van Rensburg SJ, Harvey BH. Re: Less is more. Schizophr Res. 2014
Dec;160(1-3):224-5. doi: 10.1016/j.schres.2014.10.014. Epub 2014 Oct 25. PMID:
25458863.
357: Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC,
Ford JM, Krystal JH, Mathalon DH. Glutamatergic modulation of auditory
information processing in the human brain. Biol Psychiatry. 2012 Jun
1;71(11):969-77. doi: 10.1016/j.biopsych.2011.09.031. Epub 2011 Oct 29. PMID:
22036036; PMCID: PMC3290754.
358: Bruno A, Pandolfo G, Crucitti M, Troili GM, Battaglia F, Zoccali RA,
Muscatello MRA. Effect of Red Yeast Rice on Cognitive Functioning in
Schizophrenia: Data From a Pilot Study. J Clin Psychopharmacol. 2019
May/Jun;39(3):210-213. doi: 10.1097/JCP.0000000000001025. PMID: 30921099.
359: Korotkova EI, Misini B, Dorozhko EV, Bukkel MV, Plotnikov EV, Linert W.
Study of OH radicals in human serum blood of healthy individuals and those with
pathological schizophrenia. Int J Mol Sci. 2011 Jan 14;12(1):401-10. doi:
10.3390/ijms12010401. PMID: 21339994; PMCID: PMC3039960.
360: Pinheiro DS, Santos RDS, de Brito RB, Cruz AHDS, Ghedini PC, Reis AAS.
GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant
schizophrenia: A genetic association study in Brazilian patients. PLoS One. 2017
Aug 24;12(8):e0183812. doi: 10.1371/journal.pone.0183812. PMID: 28837637; PMCID:
PMC5570380.
361: Kostyuk SV, Ershova ES, Martynov AV, Artyushin AV, Porokhovnik LN,
Malinovskaya EM, Jestkova EM, Zakharova NV, Kostyuk GP, Izhevskaia VL, Kutsev
SI, Veiko NN. In Vitro Analysis of Biological Activity of Circulating Cell-Free
DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy ControlsPart 2: Adaptive Response. Genes (Basel). 2022 Dec 4;13(12):2283. doi:
10.3390/genes13122283. PMID: 36553550; PMCID: PMC9777734.
362: Michel TM, Thome J, Martin D, Nara K, Zwerina S, Tatschner T, Weijers HG,
Koutsilieri E. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients
with schizophrenic psychosis. J Neural Transm (Vienna). 2004
Sep;111(9):1191-201. doi: 10.1007/s00702-004-0160-9. Epub 2004 Jun 21. PMID:
15338334.
363: Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani MR, Hosseini SM,
Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi SM, Moghadam M, Gharibi F,
Mirshafiee O, Akhondzadeh S. N-acetylcysteine as an adjunct to risperidone for
treatment of negative symptoms in patients with chronic schizophrenia: a
randomized, double-blind, placebo-controlled study. Clin Neuropharmacol. 2013
Nov-Dec;36(6):185-92. doi: 10.1097/WNF.0000000000000001. PMID: 24201233.
364: Wulff K, Joyce E, Middleton B, Dijk DJ, Foster RG. The suitability of
actigraphy, diary data, and urinary melatonin profiles for quantitative
assessment of sleep disturbances in schizophrenia: a case report. Chronobiol
Int. 2006;23(1-2):485-95. doi: 10.1080/07420520500545987. PMID: 16687321.
365: Shamir E, Barak Y, Shalman I, Laudon M, Zisapel N, Tarrasch R, Elizur A,
Weizman R. Melatonin treatment for tardive dyskinesia: a double-blind, placebocontrolled, crossover study. Arch Gen Psychiatry. 2001 Nov;58(11):1049-52. doi:
10.1001/archpsyc.58.11.1049. PMID: 11695951.
366: das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do
KQ. N-acetylcysteine normalizes neurochemical changes in the glutathionedeficient schizophrenia mouse model during development. Biol Psychiatry. 2012
Jun 1;71(11):1006-14. doi: 10.1016/j.biopsych.2011.07.035. Epub 2011 Sep 25.
PMID: 21945305.
367: Chengappa KN, Turkin SR, DeSanti S, Bowie CR, Brar JS, Schlicht PJ, Murphy
SL, Hetrick ML, Bilder R, Fleet D. A preliminary, randomized, double-blind,
placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.
Schizophr Res. 2012 Dec;142(1-3):145-52. doi: 10.1016/j.schres.2012.10.001. Epub
2012 Oct 23. PMID: 23099060.
368: Samaei A, Moradi K, Bagheri S, Ashraf-Ganjouei A, Alikhani R, Mousavi SB,
Rezaei F, Akhondzadeh S. Resveratrol Adjunct Therapy for Negative Symptoms in
Patients With Stable Schizophrenia: A Double-Blind, Randomized PlaceboControlled Trial. Int J Neuropsychopharmacol. 2020 Dec 29;23(12):775-782. doi:
10.1093/ijnp/pyaa006. PMID: 33372679; PMCID: PMC7770519.
369: Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C,
Cousins A, Alameda L, Gholam-Rezaee M, Golay P, Jenni R, Woo TW, Keshavan MS,
Eap CB, Wojcik J, Cuenod M, Buclin T, Gruetter R, Do KQ. N-acetylcysteine in a
Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided
Treatment in Early Psychosis. Schizophr Bull. 2018 Feb 15;44(2):317-327. doi:
10.1093/schbul/sbx093. PMID: 29462456; PMCID: PMC5815074.
370: Lavoie S, Allaman I, Petit JM, Do KQ, Magistretti PJ. Altered glycogen
metabolism in cultured astrocytes from mice with chronic glutathione deficit;
relevance for neuroenergetics in schizophrenia. PLoS One. 2011;6(7):e22875. doi:
10.1371/journal.pone.0022875. Epub 2011 Jul 28. PMID: 21829542; PMCID:
PMC3145770.
371: Oliveira JP, Lobão B, Machado-de-Sousa JP, Baker GB, Dursun S, Hallak JE.
Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop nondopaminergic antipsychotic medications for schizophrenia. Braz J Psychiatry.
2011 Sep;33(3):223-4. doi: 10.1590/s1516-44462011000300003. PMID: 21971773.
372: Cai HL, Jiang P, Tan QY, Dang RL, Tang MM, Xue Y, Deng Y, Zhang BK, Fang
PF, Xu P, Xiang DX, Li HD, Yao JK. Therapeutic efficacy of atypical
antipsychotic drugs by targeting multiple stress-related metabolic pathways.
Transl Psychiatry. 2017 May 16;7(5):e1130. doi: 10.1038/tp.2017.94. PMID:
28509906; PMCID: PMC5534962.
373: Rosenbaum CP. Metabolic, physiological, anatomic and genetic studies in the
schizophrenias: a review and analysis. J Nerv Ment Dis. 1968 Feb;146(2):103-26.
doi: 10.1097/00005053-196802000-00003. PMID: 4871041.
374: Afonso P, Figueira ML, Paiva T. Sleep-promoting action of the endogenous
melatonin in schizophrenia compared to healthy controls. Int J Psychiatry Clin
Pract. 2011 Nov;15(4):311-5. doi: 10.3109/13651501.2011.605954. Epub 2011 Aug
28. PMID: 22122006.
375: Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR,
McEvoy J, Kaddurah-Daouk R. Homeostatic imbalance of purine catabolism in firstepisode neuroleptic-naïve patients with schizophrenia. PLoS One. 2010 Mar
3;5(3):e9508. doi: 10.1371/journal.pone.0009508. PMID: 20209081; PMCID:
PMC2831068.
376: Mahmood D, Khanam R, Pillai KK, Akhtar M. Reversal of oxidative stress by
histamine H₃ receptor-ligands in experimental models of schizophrenia.
Arzneimittelforschung. 2012 May;62(5):222-9. doi: 10.1055/s-0031-1301326. Epub
2012 Feb 13. PMID: 22331799.
377: Zhang XY, Rao WW, Yu Q, Yu Y, Kou C, Tan YL, Chen DC, Zuo L, Luo X, Soares
JC. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism
with age of smoking initiation in male schizophrenia smokers. Am J Med Genet B
Neuropsychiatr Genet. 2016 Mar;171B(2):243-9. doi: 10.1002/ajmg.b.32398. Epub
2015 Nov 6. PMID: 26544677.
378: Sandyk R. Pineal calcification in relation to menopause in schizophrenia.
Int J Neurosci. 1992 Nov-Dec;67(1-4):1-8. doi: 10.3109/00207459208994771. PMID:
1305625.
379: Raffa M, Fendri C, Ben Othmen L, Slama H, Amri M, Kerkeni A, Mechri A. The
reduction of superoxide dismutase activity is associated with the severity of
neurological soft signs in patients with schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):52-6. doi:
10.1016/j.pnpbp.2012.05.005. Epub 2012 May 31. PMID: 22658981.
380: Wu JQ, Chen DC, Tan YL, Soares JC, Zhang XY. Mn-superoxide dismutase
activity is associated with orofacial involuntary movements in schizophrenia
patients with tardive dyskinesia. Hum Psychopharmacol. 2015 Jan;30(1):57-63.
doi: 10.1002/hup.2453. PMID: 25572310.
381: Pae CU. Additive effect between quinine oxidoreductase gene (NQO1:
Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val)
polymorphisms on tardive dyskinesia in patients with schizophrenia. Psychiatry
Res. 2008 Dec 15;161(3):336-8. doi: 10.1016/j.psychres.2006.10.005. Epub 2008
Oct 31. PMID: 18977034.
382: Zhang M, Zhao Z, He L, Wan C. A meta-analysis of oxidative stress markers
in schizophrenia. Sci China Life Sci. 2010 Jan;53(1):112-124. doi:
10.1007/s11427-010-0013-8. Epub 2010 Feb 12. PMID: 20596963.
383: Valvassori SS, Cararo JH, Menegas S, Possamai-Della T, Aguiar-Geraldo JM,
Araujo SL, Mastella GA, Quevedo J, Zugno AI. Haloperidol elicits oxidative
damage in the brain of rats submitted to the ketamine-induced model of
schizophrenia. Brain Res Bull. 2021 May;170:246-253. doi:
10.1016/j.brainresbull.2021.01.021. Epub 2021 Feb 2. PMID: 33545309; PMCID:
PMC10494233.
384: Mas S, Gassó P, Trias G, Bernardo M, Lafuente A. Sulforaphane protects SKN-SH cells against antipsychotic-induced oxidative stress. Fundam Clin
Pharmacol. 2012 Dec;26(6):712-21. doi: 10.1111/j.1472-8206.2011.00988.x. Epub
2011 Sep 19. PMID: 21923690.
385: Gysin R, Riederer IM, Cuénod M, Do KQ, Riederer BM. Skin fibroblast model
to study an impaired glutathione synthesis: consequences of a genetic
polymorphism on the proteome. Brain Res Bull. 2009 Apr 6;79(1):46-52. doi:
10.1016/j.brainresbull.2008.10.015. Epub 2008 Nov 28. PMID: 19041695.
386: Abdallah MS, Mosalam EM, Hassan A, Ramadan AN, Omara-Reda H, Zidan AA,
Samman WA, El-Berri EI. Pentoxifylline as an adjunctive in treatment of negative
symptoms in chronic schizophrenia: A double-blind, randomized, placebo-
controlled trial. CNS Neurosci Ther. 2023 Jan;29(1):354-364. doi:
10.1111/cns.14010. Epub 2022 Nov 7. PMID: 36341700; PMCID: PMC9804082.
387: Romero-Miguel D, Casquero-Veiga M, MacDowell KS, Torres-Sanchez S, GarciaPartida JA, Lamanna-Rama N, Romero-Miranda A, Berrocoso E, Leza JC, Desco M,
Soto-Montenegro ML. A Characterization of the Effects of Minocycline Treatment
During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in
a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders. Int J
Neuropsychopharmacol. 2021 Sep 21;24(9):734-748. doi: 10.1093/ijnp/pyab036.
PMID: 34165516; PMCID: PMC8453277.
388: Jiang J, Peng C, Sun L, Li J, Qing Y, Hu X, Yang X, Li Y, Xu C, Zhang J,
Min J, Li X, Qin S, Lin M, Tan L, Wan C. Leukocyte Proteomic Profiling in FirstEpisode Schizophrenia Patients: Does Oxidative Stress Play Central Roles in the
Pathophysiology Network of Schizophrenia? Antioxid Redox Signal. 2019 Sep
10;31(8):579-588. doi: 10.1089/ars.2019.7805. Epub 2019 Jun 28. PMID: 31126188.
389: Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Pawełczyk A.
Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty
acids in first episode schizophrenia: Secondary outcome analysis of the OFFER
randomized trial. Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:7-13.
doi: 10.1016/j.plefa.2017.05.004. Epub 2017 May 26. PMID: 28651701.
390: Das I, Ramchand CN, Gliddon A, Hirsch SR. Nitric oxide, free radicals and
polyamines may have a role in the membrane pathology of schizophrenia.
Neuropsychobiology. 1998;37(2):65-7. doi: 10.1159/000026478. PMID: 9566267.
391: de Araújo FY, de Oliveira GV, Gomes PX, Soares MA, Silva MI, Carvalho AF,
de Moraes MO, de Moraes ME, Vasconcelos SM, Viana GS, de Sousa FC, Macêdo DS.
Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of
Alpinia zerumbet: possible involvement of an antioxidant effect. J Pharm
Pharmacol. 2011 Aug;63(8):1103-10. doi: 10.1111/j.2042-7158.2011.01312.x. Epub
2011 Jun 11. PMID: 21718294.
392: Reddy R, Keshavan M, Yao JK. Reduced plasma antioxidants in first-episode
patients with schizophrenia. Schizophr Res. 2003 Aug 1;62(3):205-12. doi:
10.1016/s0920-9964(02)00407-3. PMID: 12837516.
393: Uzun Ö, Bolu A, Çelik C. Effect of N-acetylcysteine on clozapine-induced
sialorrhea in schizophrenic patients: a case series. Int Clin Psychopharmacol.
2020 Jul;35(4):229-231. doi: 10.1097/YIC.0000000000000297. PMID: 31743234.
394: Berry T. A selenium transport protein model of a sub-type of schizophrenia.
Med Hypotheses. 1994 Dec;43(6):409-14. doi: 10.1016/0306-9877(94)90017-5. PMID:
7739414.
395: Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M,
Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ,
Bush AI. N-acetyl cysteine as a glutathione precursor for schizophrenia--a
double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008 Sep
1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23. PMID:
18436195.
396: Ershova ES, Savinova EA, Kameneva LV, Porokhovnik LN, Veiko RV, Salimova
TA, Izhevskaya VL, Kutsev SI, N Veiko N, Kostyuk SV. Satellite III (1q12) Copy
Number Variation in Cultured Human Skin Fibroblasts from Schizophrenic Patients
and Healthy Controls. Front Biosci (Landmark Ed). 2023 Aug 31;28(8):191. doi:
10.31083/j.fbl2808191. PMID: 37664948.
397: Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT. Decreased levels of
glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from
patients with psychiatric disorders. Int J Neuropsychopharmacol. 2011
Feb;14(1):123-30. doi: 10.1017/S1461145710000805. Epub 2010 Jul 16. PMID:
20633320.
398: Ozaki T, Mikami K, Toyomaki A, Hashimoto N, Ito YM, Kusumi I. Assessment of
electroencephalography modification by antipsychotic drugs in patients with
schizophrenia spectrum disorders using frontier orbital theory: A preliminary
study. Neuropsychopharmacol Rep. 2023 Jun;43(2):177-187. doi:
10.1002/npr2.12318. Epub 2023 Feb 22. PMID: 36811149; PMCID: PMC10275291.
399: Choy KH, Dean O, Berk M, Bush AI, van den Buuse M. Effects of N-acetylcysteine treatment on glutathione depletion and a short-term spatial memory
deficit in 2-cyclohexene-1-one-treated rats. Eur J Pharmacol. 2010 Dec
15;649(1-3):224-8. doi: 10.1016/j.ejphar.2010.09.035. Epub 2010 Sep 22. PMID:
20868666.
400: de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG,
Dal-Pizzol F, Quevedo J, Zugno AI. Different sub-anesthetic doses of ketamine
increase oxidative stress in the brain of rats. Prog Neuropsychopharmacol Biol
Psychiatry. 2009 Aug 31;33(6):1003-8. doi: 10.1016/j.pnpbp.2009.05.010. Epub
2009 May 18. PMID: 19454299.
401: Kim NW, Song YM, Kim E, Cho HS, Cheon KA, Kim SJ, Park JY. Adjunctive
α-lipoic acid reduces weight gain compared with placebo at 12 weeks in
schizophrenic patients treated with atypical antipsychotics: a double-blind
randomized placebo-controlled study. Int Clin Psychopharmacol. 2016
Sep;31(5):265-74. doi: 10.1097/YIC.0000000000000132. PMID: 27276401.
402: Carmeli C, Knyazeva MG, Cuénod M, Do KQ. Glutathione precursor N-acetylcysteine modulates EEG synchronization in schizophrenia patients: a doubleblind, randomized, placebo-controlled trial. PLoS One. 2012;7(2):e29341. doi:
10.1371/journal.pone.0029341. Epub 2012 Feb 22. PMID: 22383949; PMCID:
PMC3285150.
403: Vaddadi KS, Soosai E, Vaddadi G. Low blood selenium concentrations in
schizophrenic patients on clozapine. Br J Clin Pharmacol. 2003 Mar;55(3):307-9.
doi: 10.1046/j.1365-2125.2003.01773.x. PMID: 12630982; PMCID: PMC1884212.
404: Yao JK, Leonard S, Reddy RD. Increased nitric oxide radicals in postmortem
brain from patients with schizophrenia. Schizophr Bull. 2004;30(4):923-34. doi:
10.1093/oxfordjournals.schbul.a007142. PMID: 15954198.
405: Dickerson FB, Stallings CR, Origoni AE, Sullens A, Khushalani S, Sandson N,
Yolken RH. A double-blind trial of adjunctive allopurinol for schizophrenia.
Schizophr Res. 2009 Apr;109(1-3):66-9. doi: 10.1016/j.schres.2008.12.028. Epub
2009 Feb 4. PMID: 19195842.
406: Shamir E, Barak Y, Plopsky I, Zisapel N, Elizur A, Weizman A. Is melatonin
treatment effective for tardive dyskinesia? J Clin Psychiatry. 2000
Aug;61(8):556-8. doi: 10.4088/jcp.v61n0803. PMID: 10982197.
407: Miljevic C, Nikolic M, Nikolic-Kokic A, Jones DR, Niketic V, Lecic-Tosevski
D, Spasic MB. Lipid status, anti-oxidant enzyme defence and haemoglobin content
in the blood of long-term clozapine-treated schizophrenic patients. Prog
Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):303-7. doi:
10.1016/j.pnpbp.2009.11.024. Epub 2009 Dec 3. PMID: 19962416.
408: Gama CS, Berk M, Andreazza AC, Kapczinski F, Belmonte-de-Abreu P. Serum
levels of brain-derived neurotrophic factor and thiobarbituric acid reactive
substances in chronically medicated schizophrenic patients: a positive
correlation. Braz J Psychiatry. 2008 Dec;30(4):337-40. doi:
10.1590/s1516-44462008000400006. PMID: 19142408.
409: Schwartz DL. Quercetin as an Augmentation Agent in Schizophrenia. J Clin
Psychopharmacol. 2016 Jun;36(3):282-3. doi: 10.1097/JCP.0000000000000498. PMID:
27035495.
410: Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush
AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuénod M, Buclin
T, Do KQ. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity
in schizophrenia patients. Neuropsychopharmacology. 2008 Aug;33(9):2187-99. doi:
10.1038/sj.npp.1301624. Epub 2007 Nov 14. PMID: 18004285.
411: Bulut M, Savas HA, Altindag A, Virit O, Dalkilic A. Beneficial effects of
N-acetylcysteine in treatment resistant schizophrenia. World J Biol Psychiatry.
2009;10(4 Pt 2):626-8. doi: 10.1080/15622970903144004. PMID: 19735056.
412: Zhang XY, Zhou DF, Cao LY, Wu GY. The effects of Ginkgo biloba extract
added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a
double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2006
Sep;188(1):12-7. doi: 10.1007/s00213-006-0476-2. Epub 2006 Aug 12. PMID:
16906395.
413: Kanofsky JD, Sandyk R. Antioxidants in the treatment of schizophrenia. Int
J Neurosci. 1992 Jan;62(1-2):97-100. doi: 10.3109/00207459108999762. PMID:
1342020.
414: Ratliff JC, Palmese LB, Reutenauer EL, Tek C. An open-label pilot trial of
alpha-lipoic acid for weight loss in patients with schizophrenia without
diabetes. Clin Schizophr Relat Psychoses. 2015 Jan;8(4):196-200. doi:
10.3371/CSRP.RAPA.030113. PMID: 23471087.
415: Sampaio LRL, Borges LTN, Barbosa TM, Matos NCB, Lima RF, Oliveira MN,
Gularte VN, Patrocínio MCA, Macêdo D, Vale OCD, Vasconcelos SMM.
Electroencephalographic study of chlorpromazine alone or combined with alphalipoic acid in a model of schizophrenia induced by ketamine in rats. J Psychiatr
Res. 2017 Mar;86:73-82. doi: 10.1016/j.jpsychires.2016.12.003. Epub 2016 Dec 3.
PMID: 27951451.
416: Negrete-Díaz JV, Baltazar-Gaytán E, Bringas ME, Vazquez-Roque RA, Newton S,
Aguilar-Alonso P, León-Chávez BA, Flores G. Neonatal ventral hippocampus lesion
induces increase in nitric oxide [NO] levels which is attenuated by subchronic
haloperidol treatment. Synapse. 2010 Dec;64(12):941-7. doi: 10.1002/syn.20835.
PMID: 20665727.
417: Puzyński S. Badania nad znaczeniem zaburzeń przemiany miedzi,
ceruloplazminy i kwasu askorbinowego w patogenezie schizofrenii [Studies of the
significance of disturbances in the metabolism of copper, ceruloplasmin and
ascorbic acid in the pathogenesis of schizophrenia]. Rocz Akad Med Im Juliana
Marchlewskiego Bialymst. 1969;14:99-162. Polish. PMID: 4989450.
418: Barzilay R, Ganz J, Sadan O, Ben-Zur T, Bren Z, Hinden N, Taler M, Lev N,
Gil-Ad I, Weizman A, Offen D. Mesenchymal stem cells protect from sub-chronic
phencyclidine insult in vivo and counteract changes in astrocyte gene expression
in vitro. Eur Neuropsychopharmacol. 2013 Sep;23(9):1115-23. doi:
10.1016/j.euroneuro.2012.10.002. Epub 2012 Oct 29. PMID: 23116946.
419: Kelleher JP, Centorrino F, Huxley NA, Bates JA, Drake JK, Egli S,
Baldessarini RJ. Pilot randomized, controlled trial of pramipexole to augment
antipsychotic treatment. Eur Neuropsychopharmacol. 2012 Jun;22(6):415-8. doi:
10.1016/j.euroneuro.2011.10.002. Epub 2011 Dec 7. PMID: 22153972.
420: Suzuki E, Nakaki T, Nakamura M, Miyaoka H. Plasma nitrate levels in deficit
versus non-deficit forms of schizophrenia. J Psychiatry Neurosci. 2003
Jul;28(4):288-92. PMID: 12921223; PMCID: PMC165793.
421: Rossell SL, Francis PS, Galletly C, Harris A, Siskind D, Berk M, Bozaoglu
K, Dark F, Dean O, Liu D, Meyer D, Neill E, Phillipou A, Sarris J, Castle DJ.
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind
randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry.
2016 Sep 15;16(1):320. doi: 10.1186/s12888-016-1030-3. PMID: 27629871; PMCID:
PMC5024434.
422: Holecek V, Racek J, Trefil L, Rokyta R. Vysetrování mozkomísního moku z
hlediska volných radikálů a antioxidantů u nĕkterých onemocnĕní CNS [Free
radicals and antioxidants in cerebrospinal fluid in central nervous system
diseases]. Cesk Fysiol. 2002 Aug;51(3):129-32. Czech. PMID: 12402789.
423: Sarsilmaz M, Songur A, Ozyurt H, Kuş I, Ozen OA, Ozyurt B, Söğüt S, Akyol
O. Potential role of dietary omega-3 essential fatty acids on some
oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot
Essent Fatty Acids. 2003 Oct;69(4):253-9. doi: 10.1016/s0952-3278(03)00107-8.
PMID: 12907135.
424: Kut'ko II, Frolov VM, Pustovoĭ IuG, Pavlenko VV, Rachkauskas GS. Vliianie
éndovaskuliarnoĭ lazeroterapii i antioksidantov na immunnyĭ status i
énergeticheskiĭ obmen u bol'nykh s resistentnymi k lecheniiu formami shizofrenii
[The effect of endovascular laser therapy and antioxidants on the immune status
and energy metabolism of patients with treatment-resistant forms of
schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 1996;96(2):34-8. Russian.
PMID: 8754337.
425: Shamir E, Rotenberg VS, Laudon M, Zisapel N, Elizur A. First-night effect
of melatonin treatment in patients with chronic schizophrenia. J Clin
Psychopharmacol. 2000 Dec;20(6):691-4. doi: 10.1097/00004714-200012000-00017.
PMID: 11106143.
426: Nalbandian RM. Nekotorye biokhimicheskie aspekty psikhicheskikh zabolevaniĭ
[Biochemical aspects of psychic disorders]. Vopr Biokhim Mozga.
1972;7(0):221-32. Russian. PMID: 4607707.
427: Dietrich-Muszalska A, Olas B, Rabe-Jablonska J. Oxidative stress in blood
platelets from schizophrenic patients. Platelets. 2005 Nov;16(7):386-91. doi:
10.1080/09537100500128872. PMID: 16236599.
428: Lai CC, Baskaran R, Tsao CY, Tuan LH, Siow PF, Palani M, Lee LJ, Liu CM,
Hwu HG, Lee LJ. Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced
Hyperactivity in Heterozygous <i>Disc1</i> Mutant Mice, a Putative Prodromal
Schizophrenia Animal Model. Int J Mol Sci. 2022 Aug 20;23(16):9419. doi:
10.3390/ijms23169419. PMID: 36012679; PMCID: PMC9408838.
429: Zhang XY, Zhou DF, Su JM, Zhang PY. The effect of extract of ginkgo biloba
added to haloperidol on superoxide dismutase in inpatients with chronic
schizophrenia. J Clin Psychopharmacol. 2001 Feb;21(1):85-8. doi:
10.1097/00004714-200102000-00015. PMID: 11199954.
430: Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of
melatonin in drug-free schizophrenics: no change after subchronic treatment with
antipsychotics. Neuropsychobiology. 1997;36(4):159-63. doi: 10.1159/000119377.
PMID: 9396013.
431: Modabbernia A, Heidari P, Soleimani R, Sobhani A, Roshan ZA, Taslimi S,
Ashrafi M, Modabbernia MJ. Melatonin for prevention of metabolic side-effects of
olanzapine in patients with first-episode schizophrenia: randomized double-blind
placebo-controlled study. J Psychiatr Res. 2014 Jun;53:133-40. doi:
10.1016/j.jpsychires.2014.02.013. Epub 2014 Feb 24. PMID: 24607293.
432: Mishu MP, Uphoff E, Aslam F, Philip S, Wright J, Tirbhowan N, Ajjan RA, Al
Azdi Z, Stubbs B, Churchill R, Siddiqi N. Interventions for preventing type 2
diabetes in adults with mental disorders in low- and middle-income countries.
Cochrane Database Syst Rev. 2021 Feb 16;2(2):CD013281. doi:
10.1002/14651858.CD013281.pub2. PMID: 33591592; PMCID: PMC8092639.
433: Ramirez J, Garnica R, Boll MC, Montes S, Rios C. Low concentration of
nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a
pilot study. Schizophr Res. 2004 Jun 1;68(2-3):357-61. doi:
10.1016/S0920-9964(03)00070-7. PMID: 15099617.
434: Deardorff OG, Burns NA, Hunter DR. Tardive Dyskinesia: Is Vitamin E Singing
the Prostate Blues? Prim Care Companion CNS Disord. 2018 Apr 12;20(2):17l02170.
doi: 10.4088/PCC.17l02170. PMID: 29701932.
435: Hanssen T, Heyden T, Sundberg I, Wetterberg L. Effect of propranolol on
serum-melatonin. Lancet. 1977 Aug 6;2(8032):309-10. doi:
10.1016/s0140-6736(77)91005-4. PMID: 69926.
436: Zhang XY, Zhou DF, Cao LY, Chen DC, Zhu FY, Wu GY. Blood superoxide
dismutase level in schizophrenic patients with tardive dyskinesia: association
with dyskinetic movements. Schizophr Res. 2003 Aug 1;62(3):245-50. doi:
10.1016/s0920-9964(02)00352-3. PMID: 12837521.
437: Baker DA, Madayag A, Kristiansen LV, Meador-Woodruff JH, Haroutunian V,
Raju I. Contribution of cystine-glutamate antiporters to the psychotomimetic
effects of phencyclidine. Neuropsychopharmacology. 2008 Jun;33(7):1760-72. doi:
10.1038/sj.npp.1301532. Epub 2007 Aug 29. PMID: 17728701; PMCID: PMC3907109.
438: Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY. A double-blind, placebocontrolled trial of extract of Ginkgo biloba added to haloperidol in treatmentresistant patients with schizophrenia. J Clin Psychiatry. 2001
Nov;62(11):878-83. doi: 10.4088/jcp.v62n1107. PMID: 11775047.
439: Vítek L. Vztah bilirubinu k nemocem vyvolaným zvýšeným oxidačním stresem
[Relationship of bilirubin to diseases caused by increased oxidative stress].
Vnitr Lek. 2013 Jul;59(7):618-21. Czech. PMID: 23909269.
440: Dean OM, Mancuso SG, Bush AI, Copolov D, Do KQ, Cuénod M, Conus P, Rossell
SL, Castle DJ, Berk M. Benefits of adjunctive N-acetylcysteine in a sub-group of
clozapine-treated individuals diagnosed with schizophrenia. Psychiatry Res. 2015
Dec 30;230(3):982-3. doi: 10.1016/j.psychres.2015.10.037. Epub 2015 Nov 2. PMID:
26626948.
441: Linden N, Onwuanibe A, Sandson N. Rapid resolution of psychotic symptoms in
a patient with schizophrenia using allopurinol as an adjuvant: a case report.
Clin Schizophr Relat Psychoses. 2014 Jan;7(4):231-4. doi:
10.3371/CSRP.LION.020113. PMID: 23395840.
442: Ghisoni K, Latini A. Kuehne LK, Reiber H, Bechter K, Hagberg L, Fuchs D.,
Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF
barrier dysfunction in non-inflammatory affective and schizophrenic spectrum
disorders. Journal of Psychiatric Research, Volume 47, Issue 10, October 2013,
pages 1417-1422. J Psychiatr Res. 2015 Apr;63:141-2. doi:
10.1016/j.jpsychires.2015.02.002. Epub 2015 Feb 25. PMID: 25749244.
443: Kim E, Park DW, Choi SH, Kim JJ, Cho HS. A preliminary investigation of
alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in
patients with schizophrenia. J Clin Psychopharmacol. 2008 Apr;28(2):138-46. doi:
10.1097/JCP.0b013e31816777f7. PMID: 18344723.
444: Reddy R, Sahebarao MP, Mukherjee S, Murthy JN. Enzymes of the antioxidant
defense system in chronic schizophrenic patients. Biol Psychiatry. 1991 Aug
15;30(4):409-12. doi: 10.1016/0006-3223(91)90298-z. PMID: 1912133.
445: Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, Rotrosen J.
Long-term treatment effects of vitamin E for tardive dyskinesia. Biol
Psychiatry. 1998 Jun 15;43(12):868-72. doi: 10.1016/s0006-3223(97)00027-9. PMID:
9627740.
446: Ban TA. Nicotinic acid in the treatment of schizophrenias. Practical and
theoretical considerations. Neuropsychobiology. 1975;1(3):133-45. doi:
10.1159/000117486. PMID: 8743.
447: BRIGGS MH. Possible relations of ascorbic acid, ceruloplasmin and toxic
aromatic metabolites in schizophrenia. N Z Med J. 1962 Apr;61:229-36. PMID:
13873068.
448: Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY. Elevated blood superoxide
dismutase in neuroleptic-free schizophrenia: association with positive symptoms.
Psychiatry Res. 2003 Jan 25;117(1):85-8. doi: 10.1016/s0165-1781(02)00303-7.
PMID: 12581823.
449: Cohen MR, Sailer V, McAmis B, Jenkins P. Superoxide dismutase activity in
fibroblasts from patients with schizophrenia. Biol Psychiatry. 1986
Mar;21(3):322-4. doi: 10.1016/0006-3223(86)90055-7. PMID: 3947714.
450: Sandyk R, Kay SR. "Down regulation" of 5-HT2 receptors: possible role of
melatonin and significance for negative schizophrenia. Int J Neurosci. 1991 JanFeb;56(1-4):209-14. doi: 10.3109/00207459108985419. PMID: 1938138.
451: Vítek L. D. R. Bach et al.: Elevated bilirubin in acute and transient
psychotic disorder. Pharmacopsychiatry 2010; 43: 12-16. Pharmacopsychiatry. 2010
Nov;43(7):285; author reply 285. doi: 10.1055/s-0030-1263170. Epub 2010 Sep 6.
PMID: 20821368.
452: Kalk WW, de Boer J, van der Wouden EJ, Visser A, Vissink A. Een schizofrene
patiënte met verlies van gebitselementen [A schizophrenic patient with loss of
teeth]. Ned Tijdschr Tandheelkd. 2006 May;113(5):202-5. Dutch. PMID: 16729566.
453: Hashimoto K. Regarding "N-acetyl cysteine as a glutathione precursor for
schizophrenia--a double-blind, randomized, placebo-controlled trial". Biol
Psychiatry. 2008 Nov 1;64(9):e1. doi: 10.1016/j.biopsych.2008.06.025. Epub 2008
Aug 21. PMID: 18718574.
454: Das D, De Fonseka N, Das I. Interactions of nitric oxide, free radicals and
polyamines in the membrane pathology of schizophrenia. Biochem Soc Trans. 1998
May;26(2):S143. doi: 10.1042/bst026s143. PMID: 9649818.
455: Glazov VA, Mamtsev VP. Katalaza v krovi i leĭkotsitakh bol'nykh iadernoĭ
shizofrenieĭ [Catalase in the blood and leukocytes of patients with nuclear
schizophrenia]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1976 Apr;76(4):549-52.
Russian. PMID: 936850.
456: Straw GM, Bigelow LB, Kirch DG. Haloperidol and reduced haloperidol
concentrations and psychiatric ratings in schizophrenic patients treated with
ascorbic acid. J Clin Psychopharmacol. 1989 Apr;9(2):130-2. doi:
10.1097/00004714-198904000-00011. PMID: 2566628.
457: Grima G, Benz B, Parpura V, Cuénod M, Do KQ. Dopamine-induced oxidative
stress in neurons with glutathione deficit: implication for schizophrenia.
Schizophr Res. 2003 Aug 1;62(3):213-24. doi: 10.1016/s0920-9964(02)00405-x.
PMID: 12837517.
458: Salmasi FB, Jazayeri M, Ghaeli P, Hashemian F, Akhondzadeh S, Raisi F,
Hosseini SH, Setareh MJ, Khavidaki SD. Comparing the effects of high-dose
vitamin E with those of placebo on insulin resistance in patients with
schizophrenia treated with olanzapine. J Clin Psychopharmacol. 2009
Apr;29(2):182-3. doi: 10.1097/JCP.0b013e31819a6aa2. PMID: 19512983.
459: Chugh TD, Dhingra RK, Gulati RC, Bathla JC. Copper metabolism in
schizophrenia. Indian J Med Res. 1973 Aug;61(8):1147-52. PMID: 4761285.
460: ALTSCHULE MD, GONCZ RM, HOLLIDAY PD. Carbohydrate metabolism in brain
disease. XI. Effects of thioctic (alpha-lipoic) acid in chronic schizophrenia.
AMA Arch Intern Med. 1959 May;103(5):726-9. doi:
10.1001/archinte.1959.00270050048008. PMID: 13636491.
461: Balta S, Kurtoglu E, Bolu A, Aparci M, Ozturk C. Asymmetric
dimethylarginine levels in patients with schizophrenia. Psychiatry Res. 2015 Jun
30;227(2-3):369-70. doi: 10.1016/j.psychres.2015.02.018. PMID: 25965647.
462: DE SAUVAGE NOLTING WJ. Vitamine C en schizophrenie [Vitamin C in
schizophrenia]. Geneeskd Gids. 1953 Oct 1;31(20):424-5. Undetermined Language.
PMID: 13107998.
463: Gałecki P, Pietras T, Szemraj J, Florkowska K, Florkowski A, Zboralski K.
Funkcjonalny polimorfizm genu manganowej dysmutazy ponadtlenkowej (MnSOD) u
chorych na schizofrenie w polskiej populacji [Functional polymorphism of
manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in
Polish population]. Pol Merkur Lekarski. 2006 Mar;20(117):329-32. Polish. PMID:
16780268.
464: Suboticanec K. Vitamin C status in schizophrenia. Bibl Nutr Dieta.
1986;(38):173-81. doi: 10.1159/000412613. PMID: 3516139.
465: Kise Y, Yoshimura S, Akieda K, Umezawa K, Okada K, Yoshitake N, Shiramizu
H, Yamamoto I, Inokuchi S. Acute oral selenium intoxication with ten times the
lethal dose resulting in deep gastric ulcer. J Emerg Med. 2004 Feb;26(2):183-7.
doi: 10.1016/j.jemermed.2003.07.002. PMID: 14980341.
466: Zhou D, Zhang X, Su J, Nan Z, Cui Y, Liu J, Guan Z, Zhang P, Shen Y. The
effects of classic antipsychotic haloperidol plus the extract of ginkgo biloba
on superoxide dismutase in patients with chronic refractory schizophrenia. Chin
Med J (Engl). 1999 Dec;112(12):1093-6. PMID: 11721446.
467: GIAMATTEI L. L'acido tioctico nella terapia della schizofrenia [Thioctic
acid in therapy of schizophrenia]. Osp Psichiatr. 1957 Apr-Jun;25(2):221-8.
Italian. PMID: 13526963.
468: Srám RJ, Binková B, Kocisová J, Topinka J, Fojtíková I, Hanel I, Klaschka
J, Kotĕsovec F, Kubícek V, Gebhart JA. Antioxidants effect on alcohol, drugs and
aging. Prog Clin Biol Res. 1990;340C:327-37. PMID: 2381931.
469: Silver H, Barash I, Odnopozov N, Jahjah N, Mizruhin A. Melatonin secretion
during fluvoxamine treatment in medicated chronic schizophrenic patients:
evidence for the development of tolerance to selective serotonin re-uptake
inhibitor. Biol Psychiatry. 1996 Jul 1;40(1):75-7. doi:
10.1016/0006-3223(95)00431-9. PMID: 8780859.
470: Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An
adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin
Psychopharmacol. 1987 Aug;7(4):282-3. doi: 10.1097/00004714-198708000-00037.
PMID: 3624518.
471: Rachkauskas GS. Effektivnost' énterosorbtsii i kompleksa antioksidantov u
bol'nykh shizofrenieĭ [The efficacy of enterosorption and a combination of
antioxidants in schizophrenics]. Lik Sprava. 1998 Jun;(4):122-4. Russian. PMID:
9784725.
472: Bozhko GKh, Tsaritsinskiĭ VI, Kulabukhov VM, Taranskaia AD. Ekskretsiia
melatonina u bol'nykh depressieĭ pri deĭstvii sveta povyshennoĭ intensivnosti
[Melatonin excretion in patients with depression under the action of light of
increased intensity]. Zh Nevrol Psikhiatr Im S S Korsakova. 1995;95(4):51-3.
Russian. PMID: 8533510.
473: DE SAUVAGE NOLTING WJ. Bestaat er verband tussen psychopathie en het
vitamine C? [Possible relationship between psychopathy and vitamin C]. Geneeskd
Gids. 1954 Jul 8;32(14):269-71. Undetermined Language. PMID: 13183334.
474: Grener AC. Schizophrenia melanosis. Iatrogenic--congenital defect? Dis Nerv
Syst. 1968 Mar;29(3):Suppl:14-5. PMID: 5676976.
475: Prasad C, Hilton CW, Lohr JB, Robertson HJ. Increased cerebrospinal fluid
cyclo(His-Pro) content in schizophrenia. Neuropeptides. 1991 Nov;20(3):187-90.
doi: 10.1016/0143-4179(91)90130-b. PMID: 1762668.
476: Morozov IA. Elektronno-mikroskopicheskoe izuchenie éffekta antioksidantnogo
deĭstviia al'fa-tokoferola [Electron microscopic study of the effect of the
antioxidant action of alpha-tocopherol]. Vopr Pitan. 1985 Jul-Aug;(4):44-8.
Russian. PMID: 4060682.
477: Seybolt SE. In response to re: less is more. Schizophr Res. 2015
Feb;161(2-3):520. doi: 10.1016/j.schres.2014.11.004. Epub 2014 Nov 20. PMID:
25468178.
478: VanderKamp H. A biochemical abnormality in schizophrenia involving ascorbic
acid. Int J Neuropsychiatry. 1966 Jun;2(3):204-6. PMID: 5961958.
479: Hoffer J. Letter: Megavitamin treatment of schizophrenia. Can Psychiatr
Assoc J. 1975 Oct;20(6):492-5. doi: 10.1177/070674377502000621. PMID: 1104135.
480: Grant FW, Cowen MA, Ozerengin MF, Bigelow N. Nutritional requirements in
mental illness. I. Ascorbic acid retention in schizophrenia. A reexamination.
Biol Psychiatry. 1973 Dec;5(3):289-94. PMID: 4708682.
481: CANTE C, CAMPANELLI B. Sul tasso di catalasi eritrocitaria nella
schizofrenia [Erythrocyte catalase in schizophrenia]. Osp Psichiatr. 1956 OctDec;24(4):379-83. Italian. PMID: 13452606.
482: Vanderkamp H. Clinical anomalies in patients with schizophrenia. Exp Med
Surg. 1970;28(3):291-3. PMID: 5525358.
483: Luo HC, Shen YC, Meng FQ. [Therapeutic effect of shuxuening combining
neuroleptics for the treatment of chronic schizophrenia--a double blind study].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Mar;17(3):139-42. Chinese. PMID:
9863076.
484: Ryback RS. Schizophrenics anonymous: a treatment adjunct. Psychiatry Med.
1971 Jul;2(3):247-53. doi: 10.2190/yvw9-xcf3-blew-56we. PMID: 4337250.
485: Gerard RW. The nosology of schizophrenia: a co-operative study. Behav Sci.
1964 Oct;9(4):311-33. doi: 10.1002/bs.3830090403. PMID: 5888786.
486: Pfeiffer CC, Iliev V, Goldstein L, Jenney EH, Schultz R. Blood histamine,
polyamines and the schizophrenias. Computer correlations of the low and high
blood histamine types. Res Commun Chem Pathol Pharmacol. 1970 Mar;1(2):247-65.
PMID: 4400233.
487: Binette Y, Ferron LP, Gravel G, Hamel O, Lamarre G, Legault R, Morin L,
Berthiaume M. Etude de la vitamine C chez les schizophrènes [Study of vitamin C
in schizophrenics]. Union Med Can. 1965 Oct;94(10):1272-5. French. PMID:
5851787.
488: Kut'ko II, Frolov VM, Pustovoĭ IuG, Rachkauskas GS, Pavlenko VV.
Antioksidanty v lechenii shizofrenii (korrektsiia protsessov perekisnogo
okisleniia lipidov) [Antioxidants in the treatment of schizophrenia (the
correction of lipid peroxidation processes)]. Zh Nevrol Psikhiatr Im S S
Korsakova. 1996;96(6):32-4. Russian. PMID: 9072891.
489: Zapletálek M, Komenda S. The effect of thioproperazine on the activity of
serum catalase in schizophrenic psychoses. Act Nerv Super (Praha). 1965
Aug;7(3):265. PMID: 4379825.
490: Zapletálek M, Bĕlicová I, Komenda S. Aktivita katalázy v séru schizofreniků
a zdravých [Catalase activity in the serum of schizophrenic and normal
subjects]. Cesk Psychiatr. 1966 Dec;62(6):401-4. Czech. PMID: 5980802.
491: Vaiva G, Thomas P, Leroux JM, Cottencin O, Dutoit D, Erb F, Goudemand M.
Dosages de la superoxyde dismutase érythrocytaire (SODe) dans les moments
productifs de psychose [Erythrocyte superoxide dismutase (eSOD) determination in
positive moments of psychosis]. Therapie. 1994 Jul-Aug;49(4):343-8. French.
PMID: 7878602.
492: Bindoli A, Rigobello MP, Cavallini L, Dalla Libera A, Galzigna L. Decrease
of serum malondialdehyde in patients treated with chlorpromazine. Clin Chim
Acta. 1987 Nov 16;169(2-3):329-32. doi: 10.1016/0009-8981(87)90334-2. PMID:
3427786.
493: Berry T. Possible involvement of selenium transport protein in a subtype of
schizophrenia. Biol Psychiatry. 1993 Sep 15;34(6):422-3. doi:
10.1016/0006-3223(93)90190-o. PMID: 8218612.
494: Zapletálek M. Der Einfluss von Flupentixol auf die Serumkatalasektivität
[Effect of flupentixol on serum catalase activity]. Act Nerv Super (Praha). 1968
Oct 3;10(3):314-5. German. PMID: 5702543.
495: DELAY J, DENIKER P, FOURMENT J, EURIEULT M, MORDRET M. Essais préliminaires
de l'ascorbate de réserpine en psychiatrie [Preliminary trials with reserpine
ascorbate in psychiatry]. Ann Med Psychol (Paris). 1958 Mar;116 Vol 1(3):535-41.
French. PMID: 13571670.
496: VITOROVIC M. Upotreba askorbinske kisenine u insulinskoj terapiji
shizofrenije [Ascorbic acid requirement in insulin therapy of schizophrenia].
Neuropsihijatrija. 1958;6(1):37-45. Undetermined Language. PMID: 13600584.
497: Slowik S. Badanie poziomu kwasu 1-askorbinowego w płynach ustrojowych u
chorych na przewlekła schizofrenie [Study of the 1-ascorbic acid level in body
fluids of patients with chronic schizophrenia]. Neurol Neurochir Psychiatr Pol.
1965 Nov-Dec;15(6):881-7. Polish. PMID: 5864784.
498: Gulidova GP. Rol' perekiseĭ v izmenenii énergeticheskogo metabolizma v
mitokhondriiakh mozga pri vozdeĭstvii syvorotki krovi bol'nykh shizofrenieĭ
[Role of peroxides in changes in brain mitochondria energy metabolism following
exposure to schizophrenic patients' serum]. Biull Eksp Biol Med. 1981
Jul;92(7):42-4. Russian. PMID: 7295943.
499: DE SAUVAGE NOLTING WJ. Hersengroeistoornissen door vitamine-C gebrek
[Defective brain development caused by vitamin C deficiency]. Geneeskd Gids.
1955 Aug 18;33(17):349-51. Dutch. PMID: 13262537.
500: Wang H. [An investigation on changes in blood CuZn-superoxide dismutase
contents in type I, II schizophrenics]. Zhonghua Shen Jing Jing Shen Ke Za Zhi.
1992 Feb;25(1):6-8, 60. Chinese. PMID: 1591962.
501: Altinkiliç S, Naziroğlu M, Uğuz AC, Ozcankaya R. Fish oil and antipsychotic
drug risperidone modulate oxidative stress in PC12 cell membranes through
regulation of cytosolic calcium ion release and antioxidant system. J Membr
Biol. 2010 Jun;235(3):211-8. doi: 10.1007/s00232-010-9267-0. Epub 2010 Jun 24.
PMID: 20574816.
502: Zapletálek M. Der Einfluss von Thioridazin, Flupentixol und Haloperiodol
auf die Serumkatalase--Aktivität bei den Psychosen des Schizophreniekreises [The
effects of thioridazine, flupenthixol and haloperidol on serum catalase activity
in schizophrenia]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl.
1977;20(2-3):197-204. German. PMID: 305641.
503: Pae CU, Lee C, Paik IH. Therapeutic possibilities of cysteamine in the
treatment of schizophrenia. Med Hypotheses. 2007;69(1):199-202. doi:
10.1016/j.mehy.2006.10.045. Epub 2006 Dec 12. PMID: 17166669.
504: Zincir S, Zincir SB, Doruk A, Erdem M, Celik C, Ak M, Garip B, Yükselir C,
Karaahmetoğlu B. Asymmetric dimethylarginine (ADMA) and treatment response
relationship in male patients with first-episode schizophrenia: a controlled
study. Psychiatry Res. 2014 Dec 15;220(1-2):76-80. doi:
10.1016/j.psychres.2014.07.013. Epub 2014 Jul 23. PMID: 25095755.
505: Miyaoka T, Seno H, Itoga M, Iijima M, Inagaki T, Horiguchi J.
Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's
syndrome). J Clin Psychiatry. 2000 Nov;61(11):868-71. doi: 10.4088/jcp.v61n1110.
PMID: 11105741.
506: Melamed Y, Sirota P, Dicker DR, Fishman P. Superoxide anion production by
neutrophils derived from peripheral blood of schizophrenic patients. Psychiatry
Res. 1998 Jan 16;77(1):29-34. doi: 10.1016/s0165-1781(97)00124-8. PMID:
10710172.
507: Gałecki P, Pietras T, Florkowki A. Procesy pro- i antyoksydacyjne u osób
chorych na schizofrenie z objawami późnych dyskinez [Pro- and antioxidant
processes in schizophrenics with tardive dyskinesia]. Psychiatr Pol. 2005 NovDec;39(6):1131-41. Polish. PMID: 16526180.
508: Liu ML, Zheng P, Liu Z, Xu Y, Mu J, Guo J, Huang T, Meng HQ, Xie P. GC-MS
based metabolomics identification of possible novel biomarkers for schizophrenia
in peripheral blood mononuclear cells. Mol Biosyst. 2014 Jul 29;10(9):2398-406.
doi: 10.1039/c4mb00157e. PMID: 24975926.
509: Gama Marques J, Ouakinin S. Clinical profile in schizophrenia and
schizoaffective spectrum: relation with unconjugated bilirubin in a prospective
and controlled study with psychopathological and psychosocial variables. CNS
Spectr. 2020 Dec;25(6):782-789. doi: 10.1017/S1092852919001639. Epub 2019 Dec
19. PMID: 31852561.
510: Arroll MA, Wilder L, Neil J. Nutritional interventions for the adjunctive
treatment of schizophrenia: a brief review. Nutr J. 2014 Sep 16;13:91. doi:
10.1186/1475-2891-13-91. PMID: 25228271; PMCID: PMC4171568.
511: Hanihara T, Amagai I, Hagimoto H, Makimoto Y. Hypouricemia in chronic
schizophrenic patients with polydipsia and hyponatremia. J Clin Psychiatry. 1997
Jun;58(6):256-60. doi: 10.4088/jcp.v58n0604. PMID: 9228891.
512: Uludag K, Wang DM, Zhang XY. Tardive Dyskinesia Development, Superoxide
Dismutase Levels, and Relevant Genetic Polymorphisms. Oxid Med Cell Longev. 2022
Oct 28;2022:5748924. doi: 10.1155/2022/5748924. PMID: 36338339; PMCID:
PMC9635956.
513: Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A. Glutathione
peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiatry. 1987
Nov;22(11):1349-56. doi: 10.1016/0006-3223(87)90069-2. PMID: 3663787.
514: Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A,
Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de Farias CC,
Moreira EG, Barbosa DS. Lowered paraoxonase 1 (PON1) activity is associated with
increased cytokine levels in drug naïve first episode psychosis. Schizophr Res.
2015 Aug;166(1-3):225-30. doi: 10.1016/j.schres.2015.06.009. Epub 2015 Jun 27.
PMID: 26123170.
515: Mishra A, Maiti R, Mishra BR, Jena M, Nath S, Sahu P. Effect of add-on
ramelteon therapy on sleep and circadian rhythm disruption in patients with
schizophrenia: A randomized controlled trial. Eur Neuropsychopharmacol. 2020
Feb;31:109-118. doi: 10.1016/j.euroneuro.2019.11.008. Epub 2019 Dec 9. PMID:
31831203.
516: McQueen G, Lay A, Lally J, Gabay AS, Collier T, Lythgoe DJ, Barker GJ,
Stone JM, McGuire P, MacCabe JH, Egerton A. Effect of single dose
N-acetylcysteine administration on resting state functional connectivity in
schizophrenia. Psychopharmacology (Berl). 2020 Feb;237(2):443-451. doi:
10.1007/s00213-019-05382-1. Epub 2019 Nov 30. PMID: 31786651; PMCID: PMC7018675.
517: Sirota P, Gavrieli R, Wolach B. Overproduction of neutrophil radical oxygen
species correlates with negative symptoms in schizophrenic patients: parallel
studies on neutrophil chemotaxis, superoxide production and bactericidal
activity. Psychiatry Res. 2003 Dec 1;121(2):123-32. doi:
10.1016/s0165-1781(03)00222-1. PMID: 14656447.
518: Sussulini A, Hauser-Davis RA. Metallomics Applied to the Study of
Neurodegenerative and Mental Diseases. Adv Exp Med Biol. 2018;1055:21-37. doi:
10.1007/978-3-319-90143-5_2. PMID: 29884960.
519: Andrade C. Antipsychotic Augmentation With N-Acetylcysteine for Patients
With Schizophrenia. J Clin Psychiatry. 2022 Sep 26;83(5):22f14664. doi:
10.4088/JCP.22f14664. PMID: 36170201.
520: Reiterer M, Schmidt-Kastner R, Milton SL. Methionine sulfoxide reductase
(Msr) dysfunction in human brain disease. Free Radic Res. 2019
Dec;53(11-12):1144-1154. doi: 10.1080/10715762.2019.1662899. Epub 2019 Nov 27.
PMID: 31775527.
521: Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen DC, Xiu MH, Wang F, Wu GY,
Lu L, Kosten TA, Kosten TR. Superoxide dismutase and cytokines in chronic
patients with schizophrenia: association with psychopathology and response to
antipsychotics. Psychopharmacology (Berl). 2009 May;204(1):177-84. doi:
10.1007/s00213-008-1447-6. Epub 2009 Jan 13. PMID: 19139851.
522: Mahadik SP, Evans DR. Is schizophrenia a metabolic brain disorder? Membrane
phospholipid dysregulation and its therapeutic implications. Psychiatr Clin
North Am. 2003 Mar;26(1):85-102. doi: 10.1016/s0193-953x(02)00033-3. PMID:
12683261.
523: Backon J. How information processing mode could affect prostaglandin E1
metabolism and lung inactivation: relevance of hemispheric specialization,
neurotransmitter asymmetry and brain reactivity. Med Hypotheses. 1984
Jun;14(2):199-206. doi: 10.1016/0306-9877(84)90055-0. PMID: 6146917.
524: Das I, Khan NS, Puri BK, Sooranna SR, de Belleroche J, Hirsch SR. Elevated
platelet calcium mobilization and nitric oxide synthase activity may reflect
abnormalities in schizophrenic brain. Biochem Biophys Res Commun. 1995 Jul
17;212(2):375-80. doi: 10.1006/bbrc.1995.1980. PMID: 7542874.
525: Abbott A. Restless nights, listless days. Nature. 2003 Oct
30;425(6961):896-8. doi: 10.1038/425896a. PMID: 14586438.
526: Wu JQ, Chen DC, Tan YL, Tan SP, Wang ZR, Xiu MH, Yang FD, Zhang XY.
Cognition impairment in schizophrenia patients with tardive dyskinesia:
association with plasma superoxide dismutase activity. Schizophr Res. 2014
Jan;152(1):210-6. doi: 10.1016/j.schres.2013.11.010. Epub 2013 Dec 8. PMID:
24325977.
527: Walker E. Megavitamin research data incomplete but promising. Mod Nurs
Home. 1973 Jun;30(6):4 passim. PMID: 4489239.
528: Zhang XY, Chen DC, Xiu MH, Yang FD, Tan YL, He S, Kosten TA, Kosten TR.
Thioredoxin, a novel oxidative stress marker and cognitive performance in
chronic and medicated schizophrenia versus healthy controls. Schizophr Res. 2013
Feb;143(2-3):301-6. doi: 10.1016/j.schres.2012.11.017. Epub 2012 Dec 11. PMID:
23238053.
529: Zozulia AA, Shchurin MR, Dikaia VI, Bondar' VV, Krym NM, Panteleeva GP.
Vliianie dalargina na opioidnuiu i immunnuiu sistemy bol'nykh s depressivnym
sindromom [The effect of dalargin on the opioid and immune systems in patients
with a depressive syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova.
1994;94(1):61-5. Russian. PMID: 8009937.
530: Coupland N, Nutt O. Successful treatment of tardive oculogyric spasms with
vitamin E. J Clin Psychopharmacol. 1995 Aug;15(4):285-6. doi:
10.1097/00004714-199508000-00009. PMID: 7593713.
531: Anderson G, Maes M. Schizophrenia: linking prenatal infection to cytokines,
the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction,
neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol
Psychiatry. 2013 Apr 5;42:5-19. doi: 10.1016/j.pnpbp.2012.06.014. Epub 2012 Jul
16. PMID: 22800757.
532: Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL. Comparative
proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia.
Mol Psychiatry. 2000 Jan;5(1):85-90. doi: 10.1038/sj.mp.4000580. PMID: 10673773.
533: Zhang XY, Tan YL, Zhou DF, Haile CN, Wu GY, Cao LY, Kosten TA, Kosten TR.
Nicotine dependence, symptoms and oxidative stress in male patients with
schizophrenia. Neuropsychopharmacology. 2007 Sep;32(9):2020-4. doi:
10.1038/sj.npp.1301317. Epub 2007 Jan 17. PMID: 17228336.
534: Breier A, Liffick E, Hummer TA, Vohs JL, Yang Z, Mehdiyoun NF, Visco AC,
Metzler E, Zhang Y, Francis MM. Effects of 12-month, double-blind N-acetyl
cysteine on symptoms, cognition and brain morphology in early phase
schizophrenia spectrum disorders. Schizophr Res. 2018 Sep;199:395-402. doi:
10.1016/j.schres.2018.03.012. Epub 2018 Mar 24. PMID: 29588126.
535: Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X. Relationship
between serum uric acid level and cardiometabolic risks in nondiabetic patients
with schizophrenia. Int Clin Psychopharmacol. 2016 Jan;31(1):51-6. doi:
10.1097/YIC.0000000000000107. PMID: 26550697.
536: Monteleone P, Piccolo A, Martino M, Maj M. Seasonal variation in the
dexamethasone suppression test: a longitudinal study in chronic schizophrenics
and in healthy subjects. Neuropsychobiology. 1994;30(2-3):61-5. doi:
10.1159/000119137. PMID: 7800165.
537: Cai L, Chen T, Yang J, Zhou K, Yan X, Chen W, Sun L, Li L, Qin S, Wang P,
Yang P, Cui D, Burmeister M, He L, Jia W, Wan C. Serum trace element differences
between Schizophrenia patients and controls in the Han Chinese population. Sci
Rep. 2015 Oct 12;5:15013. doi: 10.1038/srep15013. PMID: 26456296; PMCID:
PMC4601041.
538: Brinholi FF, Farias CC, Bonifácio KL, Higachi L, Casagrande R, Moreira EG,
Barbosa DS. Clozapine and olanzapine are better antioxidants than haloperidol,
quetiapine, risperidone and ziprasidone in in vitro models. Biomed Pharmacother.
2016 Jul;81:411-415. doi: 10.1016/j.biopha.2016.02.047. Epub 2016 Apr 27. PMID:
27261620.
539: Rigato I, Ostrow JD, Tiribelli C. Bilirubin and the risk of common nonhepatic diseases. Trends Mol Med. 2005 Jun;11(6):277-83. doi:
10.1016/j.molmed.2005.04.008. PMID: 15949769.
540: Deslauriers J, Racine W, Sarret P, Grignon S. Preventive effect of α-lipoic
acid on prepulse inhibition deficits in a juvenile two-hit model of
schizophrenia. Neuroscience. 2014 Jul 11;272:261-70. doi:
10.1016/j.neuroscience.2014.04.061. Epub 2014 May 9. PMID: 24813434.
541: Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR. The
effects of vitamin and mineral supplementation on symptoms of schizophrenia: a
systematic review and meta-analysis. Psychol Med. 2017 Jul;47(9):1515-1527. doi:
10.1017/S0033291717000022. Epub 2017 Feb 16. Erratum in: Psychol Med. 2018
Feb;48(3):528. PMID: 28202095.
542: Yao JK, Reddy RD, van Kammen DP. Human plasma glutathione peroxidase and
symptom severity in schizophrenia. Biol Psychiatry. 1999 Jun 1;45(11):1512-5.
doi: 10.1016/s0006-3223(98)00184-x. PMID: 10356635.
543: McQueen G, Lally J, Collier T, Zelaya F, Lythgoe DJ, Barker GJ, Stone JM,
McGuire P, MacCabe JH, Egerton A. Effects of N-acetylcysteine on brain glutamate
levels and resting perfusion in schizophrenia. Psychopharmacology (Berl). 2018
Oct;235(10):3045-3054. doi: 10.1007/s00213-018-4997-2. Epub 2018 Aug 23. PMID:
30141055; PMCID: PMC6182588.
544: Brunstein MG, Ghisolfi ES, Ramos FL, Lara DR. A clinical trial of adjuvant
allopurinol therapy for moderately refractory schizophrenia. J Clin Psychiatry.
2005 Feb;66(2):213-9. doi: 10.4088/jcp.v66n0209. PMID: 15705007.
545: Hou Y, Zhang H, Xie G, Cao X, Zhao Y, Liu Y, Mao Z, Yang J, Wu C. Neuronal
injury, but not microglia activation, is associated with ketamine-induced
experimental schizophrenic model in mice. Prog Neuropsychopharmacol Biol
Psychiatry. 2013 Aug 1;45:107-16. doi: 10.1016/j.pnpbp.2013.04.006. Epub 2013
Apr 17. PMID: 23603358.
546: Anderson G, Maes M, Berk M. Schizophrenia is primed for an increased
expression of depression through activation of immuno-inflammatory, oxidative
and nitrosative stress, and tryptophan catabolite pathways. Prog
Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:101-14. doi:
10.1016/j.pnpbp.2012.07.016. Epub 2012 Aug 22. PMID: 22930036.
547: Yang H, Zhang J, Yang M, Xu L, Chen W, Sun Y, Zhang X. Catalase and
interleukin-6 serum elevation in a prediction of treatment-resistance in male
schizophrenia patients. Asian J Psychiatr. 2023 Jan;79:103400. doi:
10.1016/j.ajp.2022.103400. Epub 2022 Dec 12. PMID: 36521406.
548: Rossetti AC, Paladini MS, Riva MA, Molteni R. Oxidation-reduction
mechanisms in psychiatric disorders: A novel target for pharmacological
intervention. Pharmacol Ther. 2020 Jun;210:107520. doi:
10.1016/j.pharmthera.2020.107520. Epub 2020 Mar 9. PMID: 32165136.
549: Herken H, Uz E, Ozyurt H, Akyol O. Red blood cell nitric oxide levels in
patients with schizophrenia. Schizophr Res. 2001 Dec 1;52(3):289-90. doi:
10.1016/s0920-9964(00)00169-9. PMID: 11705722.
550: Giongo FK, Gallas-Lopes M, Benvenutti R, Sachett A, Bastos LM, Rosa AR,
Herrmann AP. Effects of Taurine in Mice and Zebrafish Behavioral Assays With
Translational Relevance to Schizophrenia. Int J Neuropsychopharmacol. 2023 Feb
14;26(2):125-136. doi: 10.1093/ijnp/pyac073. PMID: 36239455; PMCID: PMC9926054.
551: La YJ, Wan CL, Zhu H, Yang YF, Chen YS, Pan YX, Feng GY, He L. Decreased
levels of apolipoprotein A-I in plasma of schizophrenic patients. J Neural
Transm (Vienna). 2007;114(5):657-63. doi: 10.1007/s00702-006-0607-2. Epub 2006
Dec 14. PMID: 17165100.
552: Nunomura A, Tamaoki T, Motohashi N. [Role of oxidative stress in the
pathophysiology of neuropsychiatric disorders]. Seishin Shinkeigaku Zasshi.
2014;116(10):842-58. Japanese. PMID: 25672211.
553: Do KQ. Gènes, environnement et neurodéveloppement: te cas de la
schizophrénie [Schizophrenia: genes, environment and neurodevelopment]. Rev Med
Suisse. 2013 Sep 18;9(398):1672, 1674-7. French. PMID: 24164017.
554: He S, Li Y, Li T, Xu F, Zeng D, Shi Y, Zhao N, Zhang L, Ma YZ, Wang Q, Yu
W, Shen Y, Huang J, Li H. Sex differences between serum total bilirubin levels
and cognition in patients with schizophrenia. BMC Psychiatry. 2021 Aug
10;21(1):396. doi: 10.1186/s12888-021-03407-8. PMID: 34376171; PMCID:
PMC8353745.
555: Pauling L. Vitamin homeostasis in the brain and megavitamin therapy. N Engl
J Med. 1977 Oct 6;297(14):790-1. doi: 10.1056/NEJM197710062971420. PMID: 895817.
556: Gokhale A, Larimore J, Werner E, So L, Moreno-De-Luca A, Lese-Martin C,
Lupashin VV, Smith Y, Faundez V. Quantitative proteomic and genetic analyses of
the schizophrenia susceptibility factor dysbindin identify novel roles of the
biogenesis of lysosome-related organelles complex 1. J Neurosci. 2012 Mar
14;32(11):3697-711. doi: 10.1523/JNEUROSCI.5640-11.2012. PMID: 22423091; PMCID:
PMC3313842.
557: Murphy BC, O'Reilly RL, Singh SM. DNA methylation and mRNA expression of
SYN III, a candidate gene for schizophrenia. BMC Med Genet. 2008 Dec 22;9:115.
doi: 10.1186/1471-2350-9-115. PMID: 19102774; PMCID: PMC2630979.
558: Rogóż Z, Kamińska K, Lech MA, Lorenc-Koci E. N-Acetylcysteine and
Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF
Levels in a Rat Model of Schizophrenia. Int J Mol Sci. 2022 Feb 15;23(4):2125.
doi: 10.3390/ijms23042125. PMID: 35216241; PMCID: PMC8877560.
559: Kadysheva NM, Mokhovikov AN, Mosketi KV, Kryzhanovskiĭ GN. Sravnitel'naia
éffektivnost' kompleksnogo primeneniia fenazepama, galoperidola, litiia i
metabolicheskikh preparatov v lechenii psikhopatologicheskikh rasstroĭstv s
naviazchivostiami pri maloprogredientnoĭ shizofrenii [Comparative effectiveness
of the combined use of fenazepam, haloperidol, lithium and metabolic
preparations in treating the psychopathologic disorders with obsessions in
slowly progressive schizophrenia]. Zh Nevropatol Psikhiatr Im S S Korsakova.
1988;88(10):88-92. Russian. PMID: 2975124.
560: Gu F, Chauhan V, Chauhan A. Glutathione redox imbalance in brain disorders.
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):89-95. doi:
10.1097/MCO.0000000000000134. PMID: 25405315.
561: Sandyk R, Kay SR. Abnormal EEG and calcification of the pineal gland in
schizophrenia. Int J Neurosci. 1992 Jan;62(1-2):107-11. doi:
10.3109/00207459108999764. PMID: 1342008.
562: Hsu MC, Ouyang WC. A Systematic Review of Effectiveness of Omega-3 Fatty
Acid Supplementation on Symptoms, Social Functions, and Neurobiological
Variables in Schizophrenia. Biol Res Nurs. 2021 Oct;23(4):723-737. doi:
10.1177/10998004211020121. Epub 2021 Jul 20. PMID: 34281415.
563: Afonso AC, Pacheco FD, Canever L, Wessler PG, Mastella GA, Godoi AK, Hubbe
I, Bischoff LM, Bialecki AVS, Zugno AI. Schizophrenia-like behavior is not
altered by melatonin supplementation in rodents. An Acad Bras Cienc.
2020;92(4):e20190981. doi: 10.1590/0001-3765202020190981. Epub 2020 Aug 24.
PMID: 32844989.
564: Maia-de-Oliveira JP, Kandratavicius L, Nunes EA, Machado-de-Sousa JP,
Hallak JE, Dursun SM. Nitric Oxide's Involvement in the Spectrum of Psychotic
Disorders. Curr Med Chem. 2016;23(24):2680-2691. doi:
10.2174/0929867323666160721144549. PMID: 27450675.
565: Pae CU. Comments on "Association between Ala-9Val polymorphism of MnSOD
gene and schizophrenia" by O. Akyol et al. Progress in Neuropsychopharmacology
and Biological Psychiatry 29, 2005, 123-131. Prog Neuropsychopharmacol Biol
Psychiatry. 2006 Jun;30(4):762-3; author reply 761. doi:
10.1016/j.pnpbp.2006.01.025. Epub 2006 Mar 6. PMID: 16571366.
566: Neill E, Rossell SL, Yolland C, Meyer D, Galletly C, Harris A, Siskind D,
Berk M, Bozaoglu K, Dark F, Dean OM, Francis PS, Liu D, Phillipou A, Sarris J,
Castle DJ. N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A
Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.
Schizophr Bull. 2022 Nov 18;48(6):1263-1272. doi: 10.1093/schbul/sbac065. PMID:
35857752; PMCID: PMC9673271.
567: Akinladel KS, Fagbomedo FO, Rahamon SK, Makanjuola VA, Ampitan AB. Serum
copeptin and its diagnostic performance in schizophrenia. Afr J Med Med Sci.
2014 Sep;43(3):259-64. PMID: 26223145.
568: Kimura T, Shono M, Yokota S, Ishizuka K, Watanabe M, Takamatsu J, Miyakawa
T. Apolipoprotein E epsilon4 and tardive dyskinesia in a Japanese population. J
Psychiatr Res. 2000 Jul-Oct;34(4-5):329-32. doi: 10.1016/s0022-3956(00)00023-6.
PMID: 11104846.
569: Zhang XY, Chen DC, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY,
Haile CN, Kosten TA, Lu L, Kosten TR. The novel oxidative stress marker
thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res.
2009 Sep;113(2-3):151-7. doi: 10.1016/j.schres.2009.05.016. Epub 2009 Jun 21.
PMID: 19540723.
570: Hendouei N, Farnia S, Mohseni F, Salehi A, Bagheri M, Shadfar F, Barzegar
F, Hoseini SD, Charati JY, Shaki F. Alterations in oxidative stress markers and
its correlation with clinical findings in schizophrenic patients consuming
perphenazine, clozapine and risperidone. Biomed Pharmacother. 2018
Jul;103:965-972. doi: 10.1016/j.biopha.2018.04.109. Epub 2018 Apr 25. PMID:
29710513.
571: BRIGGS MH, ANDREWS D, KITTO GB, SEGAL L, GRAHAM V, BAILLIE WJ. A comparison
of the metabolism of ascorbic acid in schizophrenia, pregnancy and in normal
subjects. N Z Med J. 1962 Nov;61:555-8. PMID: 14015449.
572: Pradeep JR, Acharya MS, Radhakrishnan R, Srinivasan K. Elevated
Unconjugated Bilirubin in Schizophrenia Compared to Bipolar Affective Disorder.
Prim Care Companion CNS Disord. 2019 Jul 25;21(4):19m02448. doi:
10.4088/PCC.19m02448. PMID: 31364826.
573: Schwartz PJ. Can the season of birth risk factor for schizophrenia be
prevented by bright light treatment for the second trimester mother around the
winter solstice? Med Hypotheses. 2014 Dec;83(6):809-15. doi:
10.1016/j.mehy.2014.10.014. Epub 2014 Oct 23. PMID: 25456791.
574: Vilkov GA, Siletskiĭ OIa, Stepanenko EM. Antiokislitel'naia sposobnost'
syvorotki krovi bol'nykh shizofrenieĭ po otnosheniiu k tkani mozga kak
pokazatel' ee neĭrotropnosti [Antioxidant capacity of the blood serum of
schizophrenic patients in relation to brain tissue as an index of its
neurotropic activity]. Zh Nevropatol Psikhiatr Im S S Korsakova.
1987;87(8):1241-3. Russian. PMID: 3673423.
575: Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M.
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic
diseases and aging. Arch Toxicol. 2023 Oct;97(10):2499-2574. doi:
10.1007/s00204-023-03562-9. Epub 2023 Aug 19. PMID: 37597078; PMCID:
PMC10475008.
576: Mullen PE, Silman RE. The pineal and psychiatry: a review. Psychol Med.
1977 Aug;7(3):407-17. doi: 10.1017/s0033291700004372. PMID: 905458.
577: Maas DA, Vallès A, Martens GJM. Oxidative stress, prefrontal cortex
hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry. 2017
Jul 18;7(7):e1171. doi: 10.1038/tp.2017.138. PMID: 28934193; PMCID: PMC5538118.
578: Tsugawa S, Noda Y, Tarumi R, Mimura Y, Yoshida K, Iwata Y, Elsalhy M,
Kuromiya M, Kurose S, Masuda F, Morita S, Ogyu K, Plitman E, Wada M, Miyazaki T,
Graff-Guerrero A, Mimura M, Nakajima S. Glutathione levels and activities of
glutathione metabolism enzymes in patients with schizophrenia: A systematic
review and meta-analysis. J Psychopharmacol. 2019 Oct;33(10):1199-1214. doi:
10.1177/0269881119845820. Epub 2019 Apr 30. PMID: 31039654.
579: Miyaoka T, Yasukawa R, Yasuda H, Shimizu M, Mizuno S, Sukegawa T, Inagaki
T, Horiguchi J. Urinary excretion of biopyrrins, oxidative metabolites of
bilirubin, increases in patients with psychiatric disorders. Eur
Neuropsychopharmacol. 2005 May;15(3):249-52. doi:
10.1016/j.euroneuro.2004.11.002. Epub 2005 Jan 25. PMID: 15820412.
580: Salehi B, Berkay Yılmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally
M, Lobine D, Akram M, Riaz M, Capanoglu E, Sharopov F, Martins N, Cho WC,
Sharifi-Rad J. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.
Biomolecules. 2019 Aug 9;9(8):356. doi: 10.3390/biom9080356. PMID: 31405030;
PMCID: PMC6723188.
581: Schwartz PJ, Erk SD. Regulation of central dopamine-2 receptor sensitivity
by a proportional control thermostat in humans. Psychiatry Res. 2004 Jun
30;127(1-2):19-26. doi: 10.1016/j.psychres.2004.03.004. PMID: 15261701.
582: Hanzawa R, Ohnuma T, Nagai Y, Shibata N, Maeshima H, Baba H, Hatano T,
Takebayashi Y, Hotta Y, Kitazawa M, Arai H. No association between glutathionesynthesis-related genes and Japanese schizophrenia. Psychiatry Clin Neurosci.
2011 Feb;65(1):39-46. doi: 10.1111/j.1440-1819.2010.02157.x. Epub 2010 Nov 24.
PMID: 21105962.
583: Vidović B, Stefanović A, Milovanović S, Ðorđević B, Kotur-Stevuljević J,
Ivanišević J, Miljković M, Spasić S. Associations of oxidative stress status
parameters with traditional cardiovascular disease risk factors in patients with
schizophrenia. Scand J Clin Lab Invest. 2014 Apr;74(3):184-91. doi:
10.3109/00365513.2013.873947. Epub 2014 Jan 21. PMID: 24446766.
584: Bošković M, Vovk T, Saje M, Goričar K, Dolžan V, Kores Plesničar B, Grabnar
I. Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative
stress, neurochemistry, psychopathology, and extrapyramidal symptoms in
schizophrenia. Neurochem Res. 2013 Feb;38(2):433-42. doi:
10.1007/s11064-012-0937-4. Epub 2012 Dec 2. PMID: 23212700.
585: Ahmed HI, Abdel-Sattar SA, Zaky HS. Vinpocetine halts ketamine-induced
schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin
pathway. Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec;391(12):1327-1338. doi:
10.1007/s00210-018-1552-y. Epub 2018 Aug 6. PMID: 30083945.
586: Adams RN. Stein and Wise theory of schizophrenia: a possible mechanism for
6-hydroxydopamine formation in vivo. Behav Biol. 1972 Dec;7(6):861-6. doi:
10.1016/s0091-6773(72)80178-0. PMID: 4655404.
587: Vidović B, Milovanović S, Stefanović A, Kotur-Stevuljević J, Takić M,
Debeljak-Martačić J, Pantović M, Đorđević B. Effects of Alpha-Lipoic Acid
Supplementation on Plasma Adiponectin Levels and Some Metabolic Risk Factors in
Patients with Schizophrenia. J Med Food. 2017 Jan;20(1):79-85. doi:
10.1089/jmf.2016.0070. Epub 2016 Dec 23. PMID: 28009525.
588: Papadopoulos KI, Sutheesophon W, Aw TC. Genetic polymorphisms affecting
nitric oxide and β-cytokine pathways may contribute to increased COVID-19
mortality in schizophrenia. Asian J Psychiatr. 2022 Mar;69:102981. doi:
10.1016/j.ajp.2021.102981. Epub 2021 Dec 25. PMID: 34973636; PMCID: PMC8709722.
589: Gowardman M, Barrer B, Brown RA. Pimozide (R6238) in chronic schizophrenia:
double blind trial. N Z Med J. 1973 Dec 12;78(504):487-91. PMID: 4591853.
590: Anderson G. Prenatal corticosteroids: pretermer outcomes, stress,
schizophrenia, multiple sclerosis and the developmental role of melatonin and
vitamin D3. J Pediatr Adolesc Gynecol. 2010 Oct;23(5):317-20. doi:
10.1016/j.jpag.2010.03.005. PMID: 20836246.
591: Song M, Liu Y, Zhou J, Shi H, Su X, Shao M, Yang Y, Wang X, Zhao J, Guo D,
Liu Q, Zhang L, Zhang Y, Lv L, Li W. Potential plasma biomarker panels
identification for the diagnosis of first-episode schizophrenia and monitoring
antipsychotic monotherapy with the use of metabolomics analyses. Psychiatry Res.
2023 Mar;321:115070. doi: 10.1016/j.psychres.2023.115070. Epub 2023 Jan 24.
PMID: 36706560.
592: Steiner M, Brown GM, Goldman S. Nocturnal melatonin and cortisol secretion
in newly admitted psychiatric inpatients. Implications for affective disorders.
Eur Arch Psychiatry Clin Neurosci. 1990;240(1):21-7. doi: 10.1007/BF02190088.
PMID: 2147898.
593: Zhang XY, Chen DC, Tan YL, Tan SP, Wang ZR, Yang FD, Okusaga OO, ZuntaSoares GB, Soares JC. The interplay between BDNF and oxidative stress in chronic
schizophrenia. Psychoneuroendocrinology. 2015 Jan;51:201-8. doi:
10.1016/j.psyneuen.2014.09.029. Epub 2014 Oct 7. PMID: 25462893.
594: Fraguas D, Díaz-Caneja CM, Rodríguez-Quiroga A, Arango C. Oxidative Stress
and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and
Meta-Analysis. Int J Neuropsychopharmacol. 2017 Jun 1;20(6):435-444. doi:
10.1093/ijnp/pyx015. PMID: 28575316; PMCID: PMC5452799.
595: Zahir F, Rabbani G, Khan RH, Rizvi SJ, Jamal MS, Abuzenadah AM. The
pharmacological features of bilirubin: the question of the century. Cell Mol
Biol Lett. 2015 Sep;20(3):418-47. doi: 10.1515/cmble-2015-0012. PMID: 26208389.
596: Tunçel ÖK, Sarısoy G, Bilgici B, Pazvantoglu O, Çetin E, Ünverdi E, Avcı B,
Böke Ö. Oxidative stress in bipolar and schizophrenia patients. Psychiatry Res.
2015 Aug 30;228(3):688-94. doi: 10.1016/j.psychres.2015.04.046. Epub 2015 Jun
15. PMID: 26117246.
597: Türkez H, Toğar B. The genotoxic and oxidative damage potential of
olanzapine in vitro. Toxicol Ind Health. 2010 Oct;26(9):583-8. doi:
10.1177/0748233710373090. Epub 2010 Jun 11. PMID: 20542924.
598: Wei C, Sun Y, Chen N, Chen S, Xiu M, Zhang X. Interaction of oxidative
stress and BDNF on executive dysfunction in patients with chronic schizophrenia.
Psychoneuroendocrinology. 2020 Jan;111:104473. doi:
10.1016/j.psyneuen.2019.104473. Epub 2019 Oct 8. PMID: 31655452.
599: Kim EJ, Lim SY, Lee HJ, Lee JY, Choi S, Kim SY, Kim JM, Shin IS, Yoon JS,
Yang SJ, Kim SW. Low dietary intake of n-3 fatty acids, niacin, folate, and
vitamin C in Korean patients with schizophrenia and the development of dietary
guidelines for schizophrenia. Nutr Res. 2017 Sep;45:10-18. doi:
10.1016/j.nutres.2017.07.001. Epub 2017 Jul 19. PMID: 29037327.
600: Skvarc DR, Dean OM, Byrne LK, Gray L, Lane S, Lewis M, Fernandes BS, Berk
M, Marriott A. The effect of N-acetylcysteine (NAC) on human cognition - A
systematic review. Neurosci Biobehav Rev. 2017 Jul;78:44-56. doi:
10.1016/j.neubiorev.2017.04.013. Epub 2017 Apr 21. PMID: 28438466.
601: Amador EC, Olabisi JL, Cunningham EA. Schizophrenia With Decompensation on
Clozapine With Pramipexole. Prim Care Companion CNS Disord. 2019 Dec
26;21(6):19l02436. doi: 10.4088/PCC.19l02436. PMID: 31877244.
602: Cuesta MJ, Conde V, Sigüenza A. Melatonina y trastornos mentales. una
revisión de los aspectos neuroendocrinológicos. Parte 1.: Aspectos
anatomofisiológicos. Melatonina y trastornos mentales [Melatonin and mental
disturbances. A review of the neuroendocrine aspects. 1: Anatomophysiologic
aspects. Melatonin and mental disorders]. Actas Luso Esp Neurol Psiquiatr Cienc
Afines. 1988 Sep-Oct;16(5):301-4. Spanish. PMID: 3071093.
603: APRISON MH, GROSZ HJ. Ascorbic acid level and lag time in oxidation of N,N
dimethyl-p-phenylenediamine; correlation in sera of normal controls, psychotic
patients, and animals. AMA Arch Neurol Psychiatry. 1958 May;79(5):575-9. doi:
10.1001/archneurpsyc.1958.02340050103012. PMID: 13519959.
604: Chocron SE, Weisberger BM, Ben-Yoav H, Winkler TE, Kim E, Kelly DL, Payne
GF, Ghodssi R. Multidimensional mapping method using an arrayed sensing system
for cross-reactivity screening. PLoS One. 2015 Mar 19;10(3):e0116310. doi:
10.1371/journal.pone.0116310. PMID: 25789880; PMCID: PMC4366158.
605: Zheng P, Fang Z, Xu XJ, Liu ML, Du X, Zhang X, Wang H, Zhou J, Xie P.
Metabolite signature for diagnosing major depressive disorder in peripheral
blood mononuclear cells. J Affect Disord. 2016 May;195:75-81. doi:
10.1016/j.jad.2016.02.008. Epub 2016 Feb 5. PMID: 26874244.
606: Gałecki P, Pietras T, Szemraj J. Polimorfizm genu manganowej dysmutazy
ponadtlenkowej (MnSOD) u pacjentów z centralnej Polski z objawami późnych
dyskinez w przebiegu schizofrenii [Manganese superoxide dismutase gene (MnSOD)
polimorphism in schizophrenics with tardive dyskinesia from central Poland].
Psychiatr Pol. 2006 Sep-Oct;40(5):937-48. Polish. PMID: 17217237.
607: Pitt B, Pollitt N. Ascorbic acid and chronic schizophrenia. Br J
Psychiatry. 1971 Feb;118(543):227-8. doi: 10.1192/bjp.118.543.227. PMID:
5576286.
608: Sandyk R, Kanofsky JD. Vitamin C in the treatment of schizophrenia. Int J
Neurosci. 1993 Jan;68(1-2):67-71. doi: 10.3109/00207459308994261. PMID: 8063516.
609: Richardson MA, Read LL, Taylor Clelland CL, Reilly MA, Chao HM, Guynn RW,
Suckow RF, Clelland JD. Evidence for a tetrahydrobiopterin deficit in
schizophrenia. Neuropsychobiology. 2005;52(4):190-201. doi: 10.1159/000089002.
Epub 2005 Oct 18. PMID: 16244500.
610: Tsoporis JN, Ektesabi AM, Gupta S, Izhar S, Salpeas V, Rizos IK,
Kympouropoulos SP, Dos Santos CC, Parker TG, Rizos E. A longitudinal study of
alterations of circulating DJ-1 and miR203a-3p in association to olanzapine
medication in a sample of first episode patients with schizophrenia. J Psychiatr
Res. 2022 Feb;146:109-117. doi: 10.1016/j.jpsychires.2021.12.049. Epub 2021 Dec
22. PMID: 34971908.
611: Cesak O, Vostalova J, Vidlar A, Bastlova P, Student V Jr. Carnosine and
Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical
Assessment. Nutrients. 2023 Apr 5;15(7):1770. doi: 10.3390/nu15071770. PMID:
37049610; PMCID: PMC10096773.
612: Shalev A, Hermesh H, Munitz H. The hypouricemic effect of chlorprothixene.
Clin Pharmacol Ther. 1987 Nov;42(5):562-6. doi: 10.1038/clpt.1987.197. PMID:
3315391.
613: Liou YJ, Tsai SJ, Hong CJ, Liao DL. Association analysis for the CA repeat
polymorphism of the neuronal nitric oxide synthase (NOS1) gene and
schizophrenia. Schizophr Res. 2003 Dec 1;65(1):57-9. doi:
10.1016/s0920-9964(02)00532-7. PMID: 14623375.
614: Han QQ, Shen TT, Wang F, Wu PF, Chen JG. Preventive and Therapeutic
Potential of Vitamin C in Mental Disorders. Curr Med Sci. 2018 Feb;38(1):1-10.
doi: 10.1007/s11596-018-1840-2. Epub 2018 Mar 15. PMID: 30074145.
615: FRIEDHOFF AJ, PALMER M, SIMMONS C. An effect of exercise, skin shock, and
ascorbic acid on serum oxidase activity. AMA Arch Neurol Psychiatry. 1959
May;81(5):620-6. doi: 10.1001/archneurpsyc.1959.02340170086009. PMID: 13636529.
616: Dorevitch A, Lerner V, Shalfman M, Kalian M. Lack of effect of vitamin E on
serum creatine phosphokinase in patients with long-term tardive dyskinesia. Int
Clin Psychopharmacol. 1997 May;12(3):171-3. doi:
10.1097/00004850-199705000-00008. PMID: 9248874.
617: Pfeiffer CC, Iliev V, Nichols RE, Sugerman AA. The serum urate level
reflects degree of stress. J Clin Pharmacol J New Drugs. 1969 NovDec;9(6):384-92. PMID: 5260201.
618: Miller CL, Llenos IC, Cwik M, Walkup J, Weis S. Alterations in kynurenine
precursor and product levels in schizophrenia and bipolar disorder. Neurochem
Int. 2008 May;52(6):1297-303. doi: 10.1016/j.neuint.2008.01.013. Epub 2008 Feb
2. PMID: 18328600.
619: Samad N, Haleem DJ. Antioxidant effects of rice bran oil mitigate repeated
haloperidol-induced tardive dyskinesia in male rats. Metab Brain Dis. 2017
Aug;32(4):1099-1107. doi: 10.1007/s11011-017-0002-8. Epub 2017 Apr 3. PMID:
28374238.
620: Nikolić-Kokić A, Tatalović N, Brkljačić J, Mijović M, Nestorović V,
Mijušković A, Oreščanin-Dušić Z, Vidonja Uzelac T, Nikolić M, Spasić S,
Blagojević D, Miljević Č. Antipsychotic Drug-Mediated Adverse Effects on Rat
Testicles May Be Caused by Altered Redox and Hormonal Homeostasis. Int J Mol
Sci. 2022 Nov 8;23(22):13698. doi: 10.3390/ijms232213698. PMID: 36430171; PMCID:
PMC9691120.
621: Ben-Azu B, Aderibigbe AO, Ajayi AM, Iwalewa EO. Neuroprotective effects of
the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced
schizophrenia-like behaviors and oxidative damage in mice. Pharm Biol. 2016
Dec;54(12):2871-2879. doi: 10.1080/13880209.2016.1190382. Epub 2016 Jun 2. PMID:
27250524.
622: Bromundt V, Köster M, Georgiev-Kill A, Opwis K, Wirz-Justice A, Stoppe G,
Cajochen C. Sleep-wake cycles and cognitive functioning in schizophrenia. Br J
Psychiatry. 2011 Apr;198(4):269-76. doi: 10.1192/bjp.bp.110.078022. Epub 2011
Jan 24. PMID: 21263013.
623: Filiou MD, Teplytska L, Otte DM, Zimmer A, Turck CW. Myelination and
oxidative stress alterations in the cerebellum of the G72/G30 transgenic
schizophrenia mouse model. J Psychiatr Res. 2012 Oct;46(10):1359-65. doi:
10.1016/j.jpsychires.2012.07.004. Epub 2012 Aug 9. PMID: 22884423.
624: Smythies JR. The role of ascorbate in brain: therapeutic implications. J R
Soc Med. 1996 May;89(5):241. doi: 10.1177/014107689608900501. PMID: 8778427;
PMCID: PMC1295771.
625: Al-Hakeim HK, Altufaili MF, Almulla AF, Moustafa SR, Maes M. Increased
Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine
Induced Psychosis. Cells. 2022 Nov 21;11(22):3694. doi: 10.3390/cells11223694.
PMID: 36429122; PMCID: PMC9688750.
626: Jiang HK, Wang JY. Diurnal melatonin and cortisol secretion profiles in
medicated schizophrenic patients. J Formos Med Assoc. 1998 Dec;97(12):830-7.
PMID: 9884485.
627: Banazadeh M, Mehrabani M, Banazadeh N, Dabaghzadeh F, Shahabi F. Evaluating
the effect of black myrobalan on cognitive, positive, and negative symptoms in
patients with chronic schizophrenia: A randomized, double-blind, placebocontrolled trial. Phytother Res. 2022 Jan;36(1):543-550. doi: 10.1002/ptr.7340.
Epub 2021 Nov 23. PMID: 34814232.
628: Kato TA, Hyodo F, Yamato M, Utsumi H, Kanba S. [Redox and microglia in the
pathophysiology of schizophrenia]. Yakugaku Zasshi. 2015;135(5):739-43.
Japanese. doi: 10.1248/yakushi.14-00235-4. PMID: 25948311.
629: Song W, Tavitian A, Cressatti M, Galindez C, Liberman A, Schipper HM.
Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the
GFAP.HMOX1 mouse model of schizophrenia. Free Radic Biol Med. 2017
Sep;110:162-175. doi: 10.1016/j.freeradbiomed.2017.05.025. Epub 2017 Jun 8.
PMID: 28603087.
630: Gawryluk JW, Wang JF, Andreazza AC, Shao L, Yatham LN, Young LT. Prefrontal
cortex glutathione S-transferase levels in patients with bipolar disorder, major
depression and schizophrenia. Int J Neuropsychopharmacol. 2011
Sep;14(8):1069-74. doi: 10.1017/S1461145711000617. Epub 2011 May 9. PMID:
21733244.
631: KHAIMOVICH LA. [On the activity of some enzymes in schizophrenic patients].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1962;62:1205-10. Russian. PMID:
14032241.
632: Bumb JM, Enning F, Leweke FM. Drug repurposing and emerging adjunctive
treatments for schizophrenia. Expert Opin Pharmacother. 2015 May;16(7):1049-67.
doi: 10.1517/14656566.2015.1032248. Epub 2015 Apr 12. PMID: 25866122.
633: Qu M, Wang J, Chen DC, Chen S, Xiu MH, Zhang XY. Sex-specific association
between peripheral superoxide dismutase, BDNF and cognitive impairment in drugnaive first episode patients with schizophrenia. Free Radic Biol Med. 2020 Nov
20;160:887-893. doi: 10.1016/j.freeradbiomed.2020.09.014. Epub 2020 Sep 17.
PMID: 32949664.
634: Lee CR. Letter: Clinical trials with vitamin C. Lancet. 1974 Sep
28;2(7883):775-6. doi: 10.1016/s0140-6736(74)90962-3. PMID: 4143031.
635: Chiu CC, Chen CH, Huang MC, Chen PY, Tsai CJ, Lu ML. The relationship
between serum uric acid concentration and metabolic syndrome in patients with
schizophrenia or schizoaffective disorder. J Clin Psychopharmacol. 2012
Oct;32(5):585-92. doi: 10.1097/JCP.0b013e3182664e64. PMID: 22926590.
636: Smythies JR. Biochemical abnormalities associated with schizophrenia. Br J
Psychiatry. 1975;Spec No 9:41-7. PMID: 1102037.
637: Wang LJ, Lin PY, Lee Y, Huang YC, Wu CC, Hsu ST, Chen CC, Chong MY, Lin CH,
Hung CF. Increased serum levels of cysteine in patients with schizophrenia: A
potential marker of cognitive function preservation. Schizophr Res. 2018
Feb;192:391-397. doi: 10.1016/j.schres.2017.03.041. Epub 2017 Mar 28. PMID:
28363347.
638: Kang SG, Choi JE, An H, Park YM, Lee HJ, Han C, Kim YK, Kim SH, Cho SN, Joe
SH, Jung IK, Kim L, Lee MS. Manganese superoxide dismutase gene Ala-9Val
polymorphism might be related to the severity of abnormal involuntary movements
in Korean schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry.
2008 Dec 12;32(8):1844-7. doi: 10.1016/j.pnpbp.2008.08.013. Epub 2008 Aug 28.
PMID: 18790709.
639: REES L, KING GM. Desoxycortone acetate and ascorbic acid in the treatment
of schizophrenia. J Ment Sci. 1951 Apr;97(407):376-80. doi:
10.1192/bjp.97.407.376. PMID: 14824882.
640: Heinze-Martín G. La melatonina en psiquiatría [Melatonin in psychiatry].
Gac Med Mex. 1997 Jan-Feb;133(1):49-51. Spanish. PMID: 9172991.
641: Bentsen H, Solberg DK, Refsum H, Gran JM, Bøhmer T, Torjesen PA, Halvorsen
O, Lingjærde O. Bimodal distribution of polyunsaturated fatty acids in
schizophrenia suggests two endophenotypes of the disorder. Biol Psychiatry. 2011
Jul 1;70(1):97-105. doi: 10.1016/j.biopsych.2011.02.011. Epub 2011 May 5. PMID:
21546001.
642: Pandolfo G, Genovese G, Bruno A, Campolo D, Tigano V, Cristani M, Casciaro
M, Pioggia G, Gangemi S. Advanced glycation end-products and advanced oxidation
protein products in schizophrenia. Psychiatry Res. 2022 May;311:114527. doi:
10.1016/j.psychres.2022.114527. Epub 2022 Mar 22. PMID: 35344686.
643: Ishola IO, Ben-Azu B, Adebayo OA, Ajayi AM, Omorodion IL, Edje KE, Adeyemi
OO. Prevention and reversal of ketamine-induced experimental psychosis in mice
by the neuroactive flavonoid, hesperidin: The role of oxidative and cholinergic
mechanisms. Brain Res Bull. 2021 Dec;177:239-251. doi:
10.1016/j.brainresbull.2021.10.007. Epub 2021 Oct 12. PMID: 34653559.
644: Djordjević VV, Stojanović I, Stanković-Ferlez D, Ristić T, Lazarević D,
Cosić V, Djordjević VB. Plasma nitrite/nitrate concentrations in patients with
schizophrenia. Clin Chem Lab Med. 2010;48(1):89-94. doi: 10.1515/CCLM.2010.014.
PMID: 20047531.
645: Medina-Hernández V, Ramos-Loyo J, Luquin S, Sánchez LF, García-Estrada J,
Navarro-Ruiz A. Increased lipid peroxidation and neuron specific enolase in
treatment refractory schizophrenics. J Psychiatr Res. 2007 Oct;41(8):652-8. doi:
10.1016/j.jpsychires.2006.02.010. Epub 2006 Apr 4. PMID: 16600300.
646: Bentsen H, Osnes K, Refsum H, Solberg DK, Bøhmer T. A randomized placebocontrolled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Transl Psychiatry. 2013 Dec 17;3(12):e335. doi: 10.1038/tp.2013.110. PMID:
24346133; PMCID: PMC3906471.
647: Ustundag MF, Ozcan H, Gencer AG, Yilmaz ED, Uğur K, Oral E, Bilici M.
Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and
L-arginine levels in psychotic exacerbation of schizophrenia and bipolar
disorder manic episode. Saudi Med J. 2020 Jan;41(1):38-45. doi:
10.15537/smj.2020.1.24817. PMID: 31915793; PMCID: PMC7001079.
648: Holden JM, Itil TM. Laboratory changes with chlordiazepoxide and
thioridazine, alone and combined. Can Psychiatr Assoc J. 1969 Jun;14(3):299-301.
doi: 10.1177/070674376901400311. PMID: 4890979.
649: Wesseling H, Want EJ, Guest PC, Rahmoune H, Holmes E, Bahn S. Hippocampal
Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress,
and Apoptotic Pathways in a Chronic Phencyclidine Rat Model. J Proteome Res.
2015 Aug 7;14(8):3174-87. doi: 10.1021/acs.jproteome.5b00105. Epub 2015 Jun 30.
PMID: 26043028.
650: Lister J, Nobrega JN, Fletcher PJ, Remington G. Oxidative stress and the
antipsychotic-induced vacuous chewing movement model of tardive dyskinesia:
evidence for antioxidant-based prevention strategies. Psychopharmacology (Berl).
2014 Jun;231(11):2237-49. doi: 10.1007/s00213-014-3582-6. Epub 2014 Apr 22.
PMID: 24752659.
651: Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, Belmontede-Abreu PS, Berk M, Kapczinski F. Elevated serum superoxide dismutase and
thiobarbituric acid reactive substances in different phases of bipolar disorder
and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct
1;32(7):1677-81. doi: 10.1016/j.pnpbp.2008.07.001. Epub 2008 Jul 6. PMID:
18657586.
652: Yang YS, Maddock RJ, Lee J, Zhang H, Hellemann G, Narr KL, Marder SR, Green
MF. Brain glutathione levels and age at onset of illness in chronic
schizophrenia. Acta Neuropsychiatr. 2019 Dec;31(6):343-347. doi:
10.1017/neu.2019.29. Epub 2019 Aug 27. PMID: 31364526.
653: Vanelle JM. Schizophrénie et rythmes circadiens [Schizophrenia and
circadian rhythms]. Encephale. 2009 Jan;35 Suppl 2:S80-3. French. doi:
10.1016/S0013-7006(09)75540-X. PMID: 19268177.
654: Kolar D, Kleteckova L, Brozka H, Vales K. Mini-review: Brain energy
metabolism and its role in animal models of depression, bipolar disorder,
schizophrenia and autism. Neurosci Lett. 2021 Aug 24;760:136003. doi:
10.1016/j.neulet.2021.136003. Epub 2021 Jun 14. PMID: 34098028.
655: Hanssen T, Heyden T, Sundberg I, Alfredsson G, Nybäck H, Wetterberg L.
Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
Arch Gen Psychiatry. 1980 Jun;37(6):685-90. doi:
10.1001/archpsyc.1980.01780190083010. PMID: 7387339.
656: Liang CS, Yang FW. Allopurinol may prolong seizure duration on
electroconvulsive therapy: a case report. J Neuropsychiatry Clin Neurosci. 2010
Summer;22(3):352m.e19-352.e19. doi: 10.1176/jnp.2010.22.3.352.e19. PMID:
20686157.
657: Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. Specific subcellular
changes in oxidative stress in prefrontal cortex from patients with bipolar
disorder. J Neurochem. 2013 Nov;127(4):552-61. doi: 10.1111/jnc.12316. Epub 2013
Jun 11. PMID: 23692477.
658: Lara DR, Brunstein MG, Ghisolfi ES, Lobato MI, Belmonte-de-Abreu P, Souza
DO. Allopurinol augmentation for poorly responsive schizophrenia. Int Clin
Psychopharmacol. 2001 Jul;16(4):235-7. doi: 10.1097/00004850-200107000-00008.
PMID: 11459338.
659: REZENDE Vde P. Distúrbios de carência hormo-vitamino-mineral na
esquizofrenia [Hormone, vitamin and mineral deficiency diseases in
schizophrenia]. Hospital (Rio J). 1951 Aug;40(2):241-50. Undetermined Language.
PMID: 14860797.
660: Galzigna L. Molecular interactions in the phenomenology of the onset of
mental illness. Chem Biol Interact. 1973 Jul;7(1):1-9. doi:
10.1016/0009-2797(73)90010-0. PMID: 4198597.
661: Smythies J. Redox mechanisms at the glutamate synapse and their
significance: a review. Eur J Pharmacol. 1999 Apr 1;370(1):1-7. doi:
10.1016/s0014-2999(99)00048-5. PMID: 10323273.
662: Liang CS, Yang FW, Chiang KT, Ho PS. Allopurinol for treatment-resistant
schizophrenia and epilepsy: a case report. Pharmacopsychiatry. 2010
Aug;43(6):233-4. doi: 10.1055/s-0030-1254092. Epub 2010 May 18. PMID: 20486042.
663: Scottish Schizophrenia Research Group. Smoking habits and plasma lipid
peroxide and vitamin E levels in never-treated first-episode patients with
schizophrenia. Br J Psychiatry. 2000 Mar;176:290-3. doi: 10.1192/bjp.176.3.290.
PMID: 10755079.
664: WEINER IB. FOLLOW-UP VALIDATION OF RORSCHACH TEMPO AND COLOR USE INDICATORS
OF SCHIZOPHRENIA. J Proj Tech Pers Assess. 1965 Sep;29:387-91. doi:
10.1080/0091651X.1965.10120225. PMID: 14337530.
665: Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N.
Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin
Psychiatry. 2000 May;61(5):373-7. doi: 10.4088/jcp.v61n0509. PMID: 10847313.
666: Luk'ianov LT. Spirtovoĭ metod opredeleniia bilirubina i ego fraktsiĭ v
syvorotke krovi [Alcohol method for determination of bilirubin and its fractions
in blood serum]. Lab Delo. 1967;2:108-10. Russian. PMID: 4182490.
667: Reay WR, Atkins JR, Carr VJ, Green MJ, Cairns MJ. Pharmacological
enrichment of polygenic risk for precision medicine in complex disorders. Sci
Rep. 2020 Jan 21;10(1):879. doi: 10.1038/s41598-020-57795-0. PMID: 31964963;
PMCID: PMC6972917.
668: Wirz-Justice A, Cajochen C, Nussbaum P. A schizophrenic patient with an
arrhythmic circadian rest-activity cycle. Psychiatry Res. 1997 Nov
14;73(1-2):83-90. doi: 10.1016/s0165-1781(97)00117-0. PMID: 9463841.
669: Miodownik C, Lerner V, Kudkaeva N, Lerner PP, Pashinian A, Bersudsky Y,
Eliyahu R, Kreinin A, Bergman J. Curcumin as Add-On to Antipsychotic Treatment
in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, PlaceboControlled Study. Clin Neuropharmacol. 2019 Jul/Aug;42(4):117-122. doi:
10.1097/WNF.0000000000000344. PMID: 31045590.
670: Oshodi TO, Ben-Azu B, Ishola IO, Ajayi AM, Emokpae O, Umukoro S. Molecular
mechanisms involved in the prevention and reversal of ketamine-induced
schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase
isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice. Mol Biol Rep.
2021 Mar;48(3):2335-2350. doi: 10.1007/s11033-021-06264-6. Epub 2021 Apr 3.
PMID: 33811574.
671: Goh XX, Tang PY, Tee SF. Blood-based oxidation markers in medicated and
unmedicated schizophrenia patients: A meta-analysis. Asian J Psychiatr. 2022
Jan;67:102932. doi: 10.1016/j.ajp.2021.102932. Epub 2021 Nov 21. PMID: 34839098.
672: Yao JK, Reddy RD, van Kammen DP. Oxidative damage and schizophrenia: an
overview of the evidence and its therapeutic implications. CNS Drugs.
2001;15(4):287-310. doi: 10.2165/00023210-200115040-00004. PMID: 11463134.
673: Bulnes S, Picó-Gallardo M, Bengoetxea H, Lafuente JV. Effects of curcumin
nanodelivery on schizophrenia and glioblastoma. Int Rev Neurobiol.
2023;171:163-203. doi: 10.1016/bs.irn.2023.05.013. Epub 2023 Jun 5. PMID:
37783555.
674: Kocot J, Luchowska-Kocot D, Kiełczykowska M, Musik I, Kurzepa J. Does
Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?
Nutrients. 2017 Jun 27;9(7):659. doi: 10.3390/nu9070659. PMID: 28654017; PMCID:
PMC5537779.
675: Yoshino Y, Abe M, Numata S, Ochi S, Mori Y, Ishimaru T, Kinoshita M,
Umehara H, Yamazaki K, Mori T, Ohmori T, Ueno S. Missense variants of the
alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese
schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug
4;53:137-41. doi: 10.1016/j.pnpbp.2014.04.002. Epub 2014 Apr 12. PMID: 24727203.
676: MacKinley M, Ford SD, Jeon P, Théberge J, Palaniyappan L. Central Oxidative
Stress and Early Vocational Outcomes in First Episode Psychosis: A 7-Tesla
Magnetic Resonance Spectroscopy Study of Glutathione. Schizophr Bull. 2022 Jun
21;48(4):921-930. doi: 10.1093/schbul/sbac012. PMID: 35307736; PMCID:
PMC9212125.
677: Kramar B, Pirc Marolt T, Monsalve M, Šuput D, Milisav I. Antipsychotic Drug
Aripiprazole Protects Liver Cells from Oxidative Stress. Int J Mol Sci. 2022 Jul
27;23(15):8292. doi: 10.3390/ijms23158292. PMID: 35955425; PMCID: PMC9368927.
678: Gibbard BA, Lehmann HE. Therapy of Phenothiazine-produced skin
pigmentation: a preliminary report. Am J Psychiatry. 1966 Sep;123(3):351-2. doi:
10.1176/ajp.123.3.351. PMID: 5917622.
679: Smith RS. A comprehensive macrophage-T-lymphocyte theory of schizophrenia.
Med Hypotheses. 1992 Nov;39(3):248-57. doi: 10.1016/0306-9877(92)90117-u. PMID:
1361959.
680: Jiawan VC, Arends J, Slooff CJ, Knegtering H. Medicamenteuze interventie
bij negatieve symptomen bij patiënten met schizofrenie [Pharmacological
treatment of negative symptoms in schizophrenia; research and practice].
Tijdschr Psychiatr. 2010;52(9):627-37. Dutch. PMID: 20862645.
681: Canever L, Alves CSV, Mastella G, Damázio L, Polla JV, Citadin S, De Luca
LA, Barcellos AS, Garcez ML, Quevedo J, Budni J, Zugno AI. The Evaluation of
Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of
Female Rats and in Their Adult Offspring Subjected to an Animal Model of
Schizophrenia. Mol Neurobiol. 2018 Mar;55(3):2301-2319. doi:
10.1007/s12035-017-0493-7. Epub 2017 Mar 24. PMID: 28342013.
682: Miyauchi T. Long-Term Improvement of Aggression in a Patient With
Schizophrenia Using Allopurinol as an Adjuvant: A Case Report. J Clin
Psychopharmacol. 2021 Mar-Apr 01;41(2):212-214. doi:
10.1097/JCP.0000000000001360. PMID: 33587393.
683: Ximenes VF, Rodrigues AP, Cabello C, de Menezes ML, Fernandes JR. The cocatalytic effect of chlorpromazine on peroxidase-mediated oxidation of
melatonin: enhanced production of N1-acetyl-N2-formyl-5-methoxykynuramine. J
Pineal Res. 2008 Mar;44(2):115-20. doi: 10.1111/j.1600-079X.2007.00497.x. PMID:
18289161.
684: Zhang Y, Catts VS, Shannon Weickert C. Lower antioxidant capacity in the
prefrontal cortex of individuals with schizophrenia. Aust N Z J Psychiatry. 2018
Jul;52(7):690-698. doi: 10.1177/0004867417728805. Epub 2017 Sep 9. PMID:
28891319.
685: Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M. Reduction of
night/day difference in melatonin blood levels as a possible disease-related
index in schizophrenia. Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):181-4. PMID:
14523354.
686: Marques JG. Unconjugated Bilirubin in Schizophrenia/Schizoaffective
Disorder Spectrum: An Overlooked and Underestimated Biomarker Candidate. Prim
Care Companion CNS Disord. 2020 Apr 23;22(2):19l02525. doi:
10.4088/PCC.19l02525. PMID: 32324974.
687: Monte AS, da Silva FER, Lima CNC, Vasconcelos GS, Gomes NS, Miyajima F,
Vasconcelos SMM, Gama CS, Seeman MV, de Lucena DF, Macedo DS. Sex influences in
the preventive effects of N-acetylcysteine in a two-hit animal model of
schizophrenia. J Psychopharmacol. 2020 Jan;34(1):125-136. doi:
10.1177/0269881119875979. Epub 2019 Sep 26. PMID: 31556775.
688: Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K.
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.
Drug Dev Res. 2016 Mar;77(2):53-72. doi: 10.1002/ddr.21295. Epub 2016 Feb 21.
PMID: 26899191.
689: Al-Musawi AF, Al-Hakeim HK, Al-Khfaji ZA, Al-Haboby IH, Almulla AF,
Stoyanov DS, Maes M. In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis
on Health-Related Quality of Life and Disabilities Are Partly Mediated by
Generalized Cognitive Decline and the Symptomatome. Int J Environ Res Public
Health. 2022 Nov 18;19(22):15281. doi: 10.3390/ijerph192215281. PMID: 36429996;
PMCID: PMC9690590.
690: Schipperijn AJ. Blauwe plelkken, uitvallende tanden en vermoeidheid bij een
patiënte met schizofrenie [Bruises, loose teeth and fatigue in a patient with
schizophrenia]. Ned Tijdschr Geneeskd. 2005 Dec 17;149(51):2889; author reply
2889. Dutch. PMID: 16398174.
691: Benkert O, Müller-Siecheneder F, Wetzel H. Dopamine agonists in
schizophrenia: a review. Eur Neuropsychopharmacol. 1995;5 Suppl:43-53. doi:
10.1016/0924-977x(95)00022-h. PMID: 8775758.
692: Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ. Activities of superoxide
dismutase and glutathione peroxidase in schizophrenic and manic-depressive
patients. Clin Chem. 1986 May;32(5):805-7. PMID: 2870827.
693: Kashani FL, Kordi-Tamandani DM, Sahranavard R, Hashemi M, Kordi-Tamandani
F, Torkamanzehi A. Analysis of glutathione S-transferase genes polymorphisms and
the risk of schizophrenia in a sample of Iranian population. Neuron Glia Biol.
2011 May;7(2-4):199-203. doi: 10.1017/S1740925X12000130. Epub 2012 Jul 6. PMID:
22874804.
694: Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders:
evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008
Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21. PMID:
18205981.
695: Ozyurt B, Parlaktas BS, Ozyurt H, Aslan H, Ekici F, Atis O. A preliminary
study of the levels of testis oxidative stress parameters after MK-801-induced
experimental psychosis model: protective effects of CAPE. Toxicology. 2007 Jan
25;230(1):83-9. doi: 10.1016/j.tox.2006.11.047. Epub 2006 Nov 15. PMID:
17169478.
696: Cabungcal JH, Preissmann D, Delseth C, Cuénod M, Do KQ, Schenk F.
Transitory glutathione deficit during brain development induces cognitive
impairment in juvenile and adult rats: relevance to schizophrenia. Neurobiol
Dis. 2007 Jun;26(3):634-45. doi: 10.1016/j.nbd.2007.03.001. Epub 2007 Mar 14.
PMID: 17459716.
697: Nardin P, Tramontina AC, Quincozes-Santos A, Tortorelli LS, Lunardi P,
Klein PR, Wartchow KM, Bobermin LD, Gottfried C, Elisabetsky E, Gonçalves CA. In
vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and
antioxidants. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul
1;35(5):1291-6. doi: 10.1016/j.pnpbp.2011.04.004. Epub 2011 Apr 13. PMID:
21513766.
698: Jiang L, Lindpaintner K, Li HF, Gu NF, Langen H, He L, Fountoulakis M.
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
Amino Acids. 2003 Jul;25(1):49-57. doi: 10.1007/s00726-003-0356-6. PMID:
12836058.
699: Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, Do
KQ. Perineuronal nets protect fast-spiking interneurons against oxidative
stress. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5. doi:
10.1073/pnas.1300454110. Epub 2013 May 13. PMID: 23671099; PMCID: PMC3670388.
700: da Silva Araújo T, Maia Chaves Filho AJ, Monte AS, Isabelle de Góis Queiroz
A, Cordeiro RC, de Jesus Souza Machado M, de Freitas Lima R, Freitas de Lucena
D, Maes M, Macêdo D. Reversal of schizophrenia-like symptoms and immune
alterations in mice by immunomodulatory drugs. J Psychiatr Res. 2017
Jan;84:49-58. doi: 10.1016/j.jpsychires.2016.09.017. Epub 2016 Sep 21. PMID:
27697587.
701: Shinkai T, Ohmori O, Matsumoto C, Hori H, Kennedy JL, Nakamura J. Genetic
association analysis of neuronal nitric oxide synthase gene polymorphism with
tardive dyskinesia. Neuromolecular Med. 2004;5(2):163-70. doi:
10.1385/NMM:5:2:163. PMID: 15075442.
702: Tendilla-Beltrán H, Sanchez-Islas NDC, Marina-Ramos M, Leza JC, Flores G.
The prefrontal cortex as a target for atypical antipsychotics in schizophrenia,
lessons of neurodevelopmental animal models. Prog Neurobiol. 2021
Apr;199:101967. doi: 10.1016/j.pneurobio.2020.101967. Epub 2020 Nov 30. PMID:
33271238.
703: Horiguchi J. [Symptomatic psychosis--to create new things by taking lessons
from the past]. Seishin Shinkeigaku Zasshi. 2012;114(11):1330-6. Japanese. PMID:
23367845.
704: Wysokiński A, Kłoszewska I. Uric acid levels in patients with schizophrenia
on clozapine monotherapy. Nord J Psychiatry. 2015 Aug;69(6):453-8. doi:
10.3109/08039488.2014.1002420. Epub 2015 Mar 24. PMID: 25801748.
705: Semba J, Watanabe H, Suhara T, Akanuma N. Neonatal treatment with L-name
(NG-nitro-L-arginine methyl ester) attenuates stereotyped behavior induced by
acute methamphetamine but not development of behavioral sensitization to
methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry. 2000
Aug;24(6):1017-23. doi: 10.1016/s0278-5846(00)00121-4. PMID: 11041541.
706: Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Alaca R, Aktaş H. Oxidative
Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents.
Neuropsychobiology. 2016;73(2):92-7. doi: 10.1159/000444488. Epub 2016 Mar 23.
PMID: 27003298.
707: Levi L, Zamora D, Nastas I, Gonen I, Radu P, Matei V, Ciobanu AM, Nacu A,
Boronin L, Karakrah L, Davidson M, Davis JM, Weiser M. Add-On Pramipexole for
the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized
Controlled Trial. J Clin Psychiatry. 2022 Aug 1;83(5):21m14233. doi:
10.4088/JCP.21m14233. PMID: 35921506.
708: MAAS JW, GLESER GC, GOTTSCHALK LA. Schizophrenia, anxiety, and biochemical
factors. The rate of oxidation of N, N-dimethyl-p-phenylenediamine by plasma and
levels of serum copper and plasma ascorbic acid. Arch Gen Psychiatry. 1961
Feb;4:109-18. doi: 10.1001/archpsyc.1961.01710080005002. PMID: 13764653.
709: Chen S, Xia HS, Zhu F, Yin GZ, Qian ZK, Jiang CX, Gu XC, Yin XY, Tang WJ,
Zhang TH, Wang JJ, Jia QF, Hui L. Association between decreased serum albumin
levels and depressive symptoms in patients with schizophrenia in a Chinese Han
population: A pilot study. Psychiatry Res. 2018 Dec;270:438-442. doi:
10.1016/j.psychres.2018.10.012. Epub 2018 Oct 5. PMID: 30316171.
710: Sandyk R, Kay SR. Melatonin as a mediator of atypical antipsychotic drug
effects. Schizophr Res. 1991 Jan-Feb;4(1):59-61. doi:
10.1016/0920-9964(91)90011-f. PMID: 2009255.
711: Andrade C, Suresh Kumar PN. Treating residual insomnia in schizophrenia:
examining the options. Acta Psychiatr Scand. 2013 Jan;127(1):11. doi:
10.1111/acps.12019. PMID: 23240596.
712: Loven DP, James JF, Biggs L, Little KY. Increased manganese-superoxide
dismutase activity in postmortem brain from neuroleptic-treated psychotic
patients. Biol Psychiatry. 1996 Aug 1;40(3):230-2. doi:
10.1016/0006-3223(95)00669-9. PMID: 8830959.
713: Dorfman-Etrog P, Hermesh H, Prilipko L, Weizman A, Munitz H. The effect of
vitamin E addition to acute neuroleptic treatment on the emergence of
extrapyramidal side effects in schizophrenic patients: an open label study. Eur
Neuropsychopharmacol. 1999 Dec;9(6):475-7. doi: 10.1016/s0924-977x(99)00015-2.
PMID: 10625114.
714: Souêtre E, Salvati E, Krebs B, Belugou JL, Darcourt G. Abnormal melatonin
response to 5-methoxypsoralen in dementia. Am J Psychiatry. 1989
Aug;146(8):1037-40. doi: 10.1176/ajp.146.8.1037. PMID: 2750976.
715: Matsumoto C, Ohmori O, Hori H, Shinkai T, Nakamura J. Analysis of
association between the Gln192Arg polymorphism of the paraoxonase gene and
schizophrenia in humans. Neurosci Lett. 2002 Mar 22;321(3):165-8. doi:
10.1016/s0304-3940(02)00049-6. PMID: 11880198.
716: Kumar J, Liddle EB, Fernandes CC, Palaniyappan L, Hall EL, Robson SE,
Simmonite M, Fiesal J, Katshu MZ, Qureshi A, Skelton M, Christodoulou NG,
Brookes MJ, Morris PG, Liddle PF. Glutathione and glutamate in schizophrenia: a
7T MRS study. Mol Psychiatry. 2020 Apr;25(4):873-882. doi:
10.1038/s41380-018-0104-7. Epub 2018 Jun 22. PMID: 29934548; PMCID: PMC7156342.
717: Suboticanec K, Folnegović-Smalc V, Turcin R, Mestrović B, Buzina R. Plasma
levels and urinary vitamin C excretion in schizophrenic patients. Hum Nutr Clin
Nutr. 1986 Nov;40(6):421-8. PMID: 3793523.
718: Ferrier IN, Arendt J, Johnstone EC, Crow TJ. Reduced nocturnal melatonin
secretion in chronic schizophrenia: relationship to body weight. Clin Endocrinol
(Oxf). 1982 Aug;17(2):181-7. doi: 10.1111/j.1365-2265.1982.tb01577.x. PMID:
6889932.
719: Esshili A, Manitz MP, Freund N, Juckel G. Induction of inducible nitric
oxide synthase expression in activated microglia and astrocytes following preand postnatal immune challenge in an animal model of schizophrenia. Eur
Neuropsychopharmacol. 2020 Jun;35:100-110. doi: 10.1016/j.euroneuro.2020.04.002.
Epub 2020 May 18. PMID: 32439226.
720: Reyes RC, Cittolin-Santos GF, Kim JE, Won SJ, Brennan-Minnella AM, Katz M,
Glass GA, Swanson RA. Neuronal Glutathione Content and Antioxidant Capacity can
be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human
Cerebrospinal Fluid. Neurotherapeutics. 2016 Jan;13(1):217-25. doi:
10.1007/s13311-015-0404-4. Erratum in: Neurotherapeutics. 2016 Jan;13(1):239.
PMID: 26572666; PMCID: PMC4720670.
721: De Berardis D, Fornaro M, Ventriglio A, Pettorruso M, Vellante F,
Napoletano C, Di Giannantonio M. Case of aripiprazole long-acting-related
akathisia successfully managed with carvedilol: A case report. Psychiatry Clin
Neurosci. 2021 Mar;75(3):114-115. doi: 10.1111/pcn.13189. Epub 2021 Jan 14.
PMID: 33331019.
722: Doi N, Hoshi Y, Itokawa M, Yoshikawa T, Ichikawa T, Arai M, Usui C,
Tachikawa H. Paradox of schizophrenia genetics: is a paradigm shift occurring?
Behav Brain Funct. 2012 May 31;8:28. doi: 10.1186/1744-9081-8-28. PMID:
22650965; PMCID: PMC3487746.
723: Jordan W, Dobrowolny H, Bahn S, Bernstein HG, Brigadski T, Frodl T,
Isermann B, Lessmann V, Pilz J, Rodenbeck A, Schiltz K, Schwedhelm E, Tumani H,
Wiltfang J, Guest PC, Steiner J. Oxidative stress in drug-naïve first episode
patients with schizophrenia and major depression: effects of disease acuity and
potential confounders. Eur Arch Psychiatry Clin Neurosci. 2018
Mar;268(2):129-143. doi: 10.1007/s00406-016-0749-7. Epub 2016 Dec 2. PMID:
27913877.
724: McCreadie RG, MacDonald E, Wiles D, Campbell G, Paterson JR. The Nithsdale
Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in
patients with and without tardive dyskinesia, and in normal subjects. Br J
Psychiatry. 1995 Nov;167(5):610-7. doi: 10.1192/bjp.167.5.610. PMID: 8564316.
725: Wesołowska A, Jastrzębska-Więsek M, Cios A, Partyka A. The preclinical
discovery and development of paliperidone for the treatment of schizophrenia.
Expert Opin Drug Discov. 2020 Mar;15(3):279-292. doi:
10.1080/17460441.2020.1682994. Epub 2019 Oct 29. PMID: 31661992.
726: Ramírez E, Luza S. Dimethyl sulfoxide in the treatment of mental patients.
Ann N Y Acad Sci. 1967 Mar 15;141(1):655-67. doi:
10.1111/j.1749-6632.1967.tb34937.x. PMID: 5342267.
727: Otręba M, Wrześniok D, Rok J, Beberok A, Buszman E. Prochlorperazine
interaction with melanin and melanocytes. Pharmazie. 2017 Mar 1;72(3):171-176.
doi: 10.1691/ph.2017.6787. PMID: 29442053.
728: Yasukawa R, Miyaoka T, Yasuda H, Hayashida M, Inagaki T, Horiguch J.
Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin,
in patients with schizophrenia. Psychiatry Res. 2007 Oct 31;153(2):203-7. doi:
10.1016/j.psychres.2006.04.009. Epub 2007 Aug 24. PMID: 17719094.
729: Shamrey VK, Kurasov ES, Nechiporenko VV, Kolchev AI, Tsygan NV.
Vozmozhnosti primeneniya Meksidola v kompleksnoi terapii psikhicheskikh
rasstroistv [Possibilities of using Mexidol in the complex therapy of mental
disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(5):160-164. Russian.
doi: 10.17116/jnevro2020120051160. PMID: 32621483.
730: Sandyk R, Kay SR. Pineal melatonin in schizophrenia: a review and
hypothesis. Schizophr Bull. 1990;16(4):653-62. doi: 10.1093/schbul/16.4.653.
PMID: 2077642.
731: Myken AN, Ebdrup BH, Sørensen ME, Broberg BV, Skjerbæk MW, Glenthøj BY,
Lykkesfeldt J, Nielsen MØ. Lower Vitamin C Levels Are Associated With Less
Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With
First-Episode Psychosis. Int J Neuropsychopharmacol. 2022 Aug 16;25(8):613-618.
doi: 10.1093/ijnp/pyac029. PMID: 35532335; PMCID: PMC9380709.
732: Sun XJ, Zhao X, Xie JN, Wan H. Crocin alleviates schizophrenia-like
symptoms in rats by upregulating silent information regulator-1 and brain
derived neurotrophic factor. Compr Psychiatry. 2020 Nov;103:152209. doi:
10.1016/j.comppsych.2020.152209. Epub 2020 Sep 30. PMID: 33045669.
733: Tendilla-Beltrán H, Coatl-Cuaya H, Meneses-Prado S, Vázquez-Roque RA,
Brambila E, Tapia-Rodríguez M, Martín-Hernández D, Garcés-Ramírez L, Madrigal
JLM, Leza JC, Flores G. Neuroplasticity and inflammatory alterations in the
nucleus accumbens are corrected after risperidone treatment in a schizophreniarelated developmental model in rats. Schizophr Res. 2021 Sep;235:17-28. doi:
10.1016/j.schres.2021.07.014. Epub 2021 Jul 20. PMID: 34298239.
734: Fountoulakis M, Kossida S. Proteomics-driven progress in neurodegeneration
research. Electrophoresis. 2006 Apr;27(8):1556-73. doi: 10.1002/elps.200500738.
PMID: 16555340.
735: Rao AV, Balachandran B. Role of oxidative stress and antioxidants in
neurodegenerative diseases. Nutr Neurosci. 2002 Oct;5(5):291-309. doi:
10.1080/1028415021000033767. PMID: 12385592.
736: Shinkai T, De Luca V, Hwang R, Matsumoto C, Hori H, Ohmori O, Remington G,
Meltzer HY, Lieberman JA, Potkin SG, Nakamura J, Kennedy JL. Association study
between a functional glutathione S-transferase (GSTP1) gene polymorphism
(Ile105Val) and tardive dyskinesia. Neurosci Lett. 2005 Nov 11;388(2):116-20.
doi: 10.1016/j.neulet.2005.06.038. PMID: 16039055.
737: Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll
CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F,
Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Adjunctive agents to
antipsychotics in schizophrenia: a systematic umbrella review and
recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. PMID:
37852631; PMCID: PMC10583081.
738: Maes M, Vojdani A, Geffard M, Moreira EG, Barbosa DS, Michelin AP, Semeão
LO, Sirivichayakul S, Kanchanatawan B. Schizophrenia phenomenology comprises a
bifactorial general severity and a single-group factor, which are differently
associated with neurotoxic immune and immune-regulatory pathways. Biomol
Concepts. 2019 Nov 17;10(1):209-225. doi: 10.1515/bmc-2019-0023. PMID: 31734647.
739: Cherniack EP, Troen BR, Florez HJ, Roos BA, Levis S. Some new food for
thought: the role of vitamin D in the mental health of older adults. Curr
Psychiatry Rep. 2009 Feb;11(1):12-9. doi: 10.1007/s11920-009-0003-3. PMID:
19187703.
740: Nousari Y, Wu BC, Tausk F. From the Caravels to the Wards: Scurvy and
Schizophrenia. J Acad Consult Liaison Psychiatry. 2021 Nov-Dec;62(6):665-666.
doi: 10.1016/j.jaclp.2021.05.006. Epub 2021 Jun 8. PMID: 34111621.
741: Brown K, Reid A, White T, Henderson T, Hukin S, Johnstone C, Glen A.
Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol
Psychiatry. 1998 Jun 15;43(12):863-7. doi: 10.1016/s0006-3223(97)00197-2. PMID:
9627739.
742: Beckmann H, Wetterberg L, Gattaz WF. Melatonin immunoreactivity in
cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry
Res. 1984 Feb;11(2):107-10. doi: 10.1016/0165-1781(84)90093-3. PMID: 6143334.
743: HORWITT MK, MEYER BJ, MEYER AC, HARVEY CC, HAFFRON D. Serum copper and
oxidase activity in schizophrenic patients; correlations with erythrocyte
sedimentation rate, C-reactive protein, ascorbic acid, basal metabolic rate, and
sulfobromophthalein (bromsulphalein). AMA Arch Neurol Psychiatry. 1957
Sep;78(3):275-82. PMID: 13457502.
744: Li M, Yang X, Sun L, Qing Y, Hu X, Jiang J, Wang D, Cui G, Gao Y, Zhang E,
Zhang J, Yang Y, Wan C. Decreased serum apolipoprotein A4 as a potential
peripheral biomarker for patients with schizophrenia. J Psychiatr Res. 2021
May;137:14-21. doi: 10.1016/j.jpsychires.2021.02.016. Epub 2021 Feb 18. PMID:
33640722.
745: Zhang ZJ, Zhang XB, Hou G, Yao H, Reynolds GP. Interaction between
polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase
genes in susceptibility to tardive dyskinesia. Psychiatr Genet. 2003
Sep;13(3):187-92. doi: 10.1097/00041444-200309000-00010. PMID: 12960753.
746: Ravula AR, Teegala SB, Kalakotla S, Pasangulapati JP, Perumal V, Boyina HK.
Fisetin, potential flavonoid with multifarious targets for treating neurological
disorders: An updated review. Eur J Pharmacol. 2021 Nov 5;910:174492. doi:
10.1016/j.ejphar.2021.174492. Epub 2021 Sep 10. PMID: 34516952.
747: Issy AC, Dos-Santos-Pereira M, Pedrazzi JFC, Kubrusly RCC, Del-Bel E. The
role of striatum and prefrontal cortex in the prevention of amphetamine-induced
schizophrenia-like effects mediated by nitric oxide compounds. Prog
Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:353-362. doi:
10.1016/j.pnpbp.2018.03.015. Epub 2018 Mar 16. PMID: 29555252.
748: Shinkai T, Müller DJ, De Luca V, Shaikh S, Matsumoto C, Hwang R, King N,
Trakalo J, Potapova N, Zai G, Hori H, Ohmori O, Meltzer HY, Nakamura J, Kennedy
JL. Genetic association analysis of the glutathione peroxidase (GPX1) gene
polymorphism (Pro197Leu) with tardive dyskinesia. Psychiatry Res. 2006 Feb
28;141(2):123-8. doi: 10.1016/j.psychres.2004.06.023. Epub 2006 Jan 18. PMID:
16413612.
749: Singh V, Singh SP, Chan K. Review and meta-analysis of usage of ginkgo as
an adjunct therapy in chronic schizophrenia. Int J Neuropsychopharmacol. 2010
Mar;13(2):257-71. doi: 10.1017/S1461145709990654. Epub 2009 Sep 24. PMID:
19775502.
750: Miles A, Philbrick DR. Melatonin and psychiatry. Biol Psychiatry. 1988 Feb
15;23(4):405-25. doi: 10.1016/0006-3223(88)90291-0. PMID: 3277676.
751: Yao JK, Leonard S, Reddy R. Altered glutathione redox state in
schizophrenia. Dis Markers. 2006;22(1-2):83-93. doi: 10.1155/2006/248387. PMID:
16410648; PMCID: PMC3850558.
752: Phillips TJ, Scott H, Menassa DA, Bignell AL, Sood A, Morton JS, Akagi T,
Azuma K, Rogers MF, Gilmore CE, Inman GJ, Grant S, Chung Y, Aljunaidy MM, Cooke
CL, Steinkraus BR, Pocklington A, Logan A, Collett GP, Kemp H, Holmans PA,
Murphy MP, Fulga TA, Coney AM, Akashi M, Davidge ST, Case CP. Treating the
placenta to prevent adverse effects of gestational hypoxia on fetal brain
development. Sci Rep. 2017 Aug 22;7(1):9079. doi: 10.1038/s41598-017-06300-1.
PMID: 28831049; PMCID: PMC5567270.
753: Sahbaz C, Özer OF, Kurtulmus A, Kırpınar I, Sahin F, Guloksuz S. Evidence
for an association of serum melatonin concentrations with recognition and
circadian preferences in patients with schizophrenia. Metab Brain Dis. 2019
Jun;34(3):865-874. doi: 10.1007/s11011-019-00395-3. Epub 2019 Feb 13. PMID:
30758707.
754: Smith RS, Maes M. The macrophage-T-lymphocyte theory of schizophrenia:
additional evidence. Med Hypotheses. 1995 Aug;45(2):135-41. doi:
10.1016/0306-9877(95)90062-4. PMID: 8531836.
755: García-Bueno B, Pérez-Nievas BG, Leza JC. Is there a role for the nuclear
receptor PPARγ in neuropsychiatric diseases? Int J Neuropsychopharmacol. 2010
Nov;13(10):1411-29. doi: 10.1017/S1461145710000970. Epub 2010 Aug 27. PMID:
20800014.
756: Maire FW, Hixon AC. Behavioral and performance changes in trained rats
following bufotenine injection. Int J Neuropsychiatry. 1966 Apr;2(2):135-42.
PMID: 5297538.
757: Gigante AD, Andreazza AC, Lafer B, Yatham LN, Beasley CL, Young LT.
Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton
transporter, in post-mortem prefrontal cortex from patients with bipolar
disorder and schizophrenia. Neurosci Lett. 2011 Nov 7;505(1):47-51. doi:
10.1016/j.neulet.2011.09.064. Epub 2011 Oct 4. PMID: 22001364.
758: Berk M, Jeavons S, Dean OM, Dodd S, Moss K, Gama CS, Malhi GS. Nail-biting
stuff? The effect of N-acetyl cysteine on nail-biting. CNS Spectr. 2009
Jul;14(7):357-60. doi: 10.1017/s1092852900023002. PMID: 19773711.
759: Gama Marques J, Pedro I, Ouakinin S. Unconjugated bilirubin and acute
psychosis: a five years retrospective observational and controlled study in
patients with schizophrenia, schizoaffective and bipolar disorders. Int J
Psychiatry Clin Pract. 2019 Nov;23(4):281-285. doi:
10.1080/13651501.2019.1638940. Epub 2019 Jul 23. PMID: 31335268.
760: Zugno AI, Canever L, Heylmann AS, Wessler PG, Steckert A, Mastella GA, de
Oliveira MB, Damázio LS, Pacheco FD, Calixto OP, Pereira FP, Macan TP, Pedro TH,
Schuck PF, Quevedo J, Budni J. Effect of folic acid on oxidative stress and
behavioral changes in the animal model of schizophrenia induced by ketamine. J
Psychiatr Res. 2016 Oct;81:23-35. doi: 10.1016/j.jpsychires.2016.06.013. Epub
2016 Jun 16. PMID: 27367209.
761: Weiser M, Gershon AA, Rubinstein K, Petcu C, Ladea M, Sima D, Podea D,
Keefe RS, Davis JM. A randomized controlled trial of allopurinol vs. placebo
added on to antipsychotics in patients with schizophrenia or schizoaffective
disorder. Schizophr Res. 2012 Jun;138(1):35-8. doi:
10.1016/j.schres.2012.02.014. Epub 2012 Apr 4. PMID: 22483162.
762: Ferrier IN, Johnstone EC, Crow TJ, Arendt J. Melatonin/cortisol ratio in
psychiatric illness. Lancet. 1982 May 8;1(8280):1070. doi:
10.1016/s0140-6736(82)92122-5. PMID: 6122871; PMCID: PMC7135103.
763: Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H. Plasma manganese,
selenium, zinc, copper, and iron concentrations in patients with schizophrenia.
Biol Trace Elem Res. 2004 May;98(2):109-17. doi: 10.1385/BTER:98:2:109. PMID:
15073409.
764: Steullet P, Cabungcal JH, Monin A, Dwir D, O'Donnell
Redox dysregulation, neuroinflammation, and NMDA receptor
"central hub" in schizophrenia pathophysiology? Schizophr
Sep;176(1):41-51. doi: 10.1016/j.schres.2014.06.021. Epub
25000913; PMCID: PMC4282982.
P, Cuenod M, Do KQ.
hypofunction: A
Res. 2016
2014 Jul 5. PMID:
765: Bentsen H, Landrø NI. Neurocognitive effects of an omega-3 fatty acid and
vitamins E+C in schizophrenia: A randomised controlled trial. Prostaglandins
Leukot Essent Fatty Acids. 2018 Sep;136:57-66. doi: 10.1016/j.plefa.2017.10.002.
Epub 2017 Oct 16. PMID: 29079039.
766: Boz Z, Hu M, Yu Y, Huang XF. N-acetylcysteine prevents olanzapine-induced
oxidative stress in mHypoA-59 hypothalamic neurons. Sci Rep. 2020 Nov
5;10(1):19185. doi: 10.1038/s41598-020-75356-3. PMID: 33154380; PMCID:
PMC7644715.
767: Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC, Marx W,
Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi M, Turner A, Gray L, Berk
L, Walder K, Berk M, Dean OM. Minocycline as Treatment for Psychiatric and
Neurological Conditions: A Systematic Review and Meta-Analysis. Int J Mol Sci.
2023 Mar 9;24(6):5250. doi: 10.3390/ijms24065250. PMID: 36982324; PMCID:
PMC10049047.
768: Monin A, Baumann PS, Griffa A, Xin L, Mekle R, Fournier M, Butticaz C,
Klaey M, Cabungcal JH, Steullet P, Ferrari C, Cuenod M, Gruetter R, Thiran JP,
Hagmann P, Conus P, Do KQ. Glutathione deficit impairs myelin maturation:
relevance for white matter integrity in schizophrenia patients. Mol Psychiatry.
2015 Jul;20(7):827-38. doi: 10.1038/mp.2014.88. Epub 2014 Aug 26. PMID:
25155877.
769: VASHETKO VM. VPLYV LIKUVANNIA AMINAZYNOM I REZERPINOM NA AKTYVNIST'
FERMENTIV (KATALAZY, TRANSAMINAZY TA AL'DOLAZY) U KROVI KHVORYKH NA SHYZOFRENIIU
[EFFECT OF AMINAZIN AND RESERPINE ADMINISTRATION ON ENZYME ACTIVITY (CATALASE,
TRANSAMINASE AND ALDOLASE) IN THE BLOOD OF SCHIZOPHRENIA PATIENTS]. Fiziol Zh.
1964 Jan-Feb;10:82-8. Russian. PMID: 14175922.
770: Eriksen SA. Har fiskefett og vitaminer effekt ved psykoser? [Do fish fats
and vitamins have any effect in psychoses?]. Tidsskr Nor Laegeforen. 2003 Mar
6;123(5):674. Norwegian. PMID: 12683202.
771: Wetterberg L, Aperia B, Beck-Friis J, Kjellman BF, Ljunggren JG, Nilsonne
A, Petterson U, Tham A, Undén F. Melatonin and cortisol levels in psychiatric
illness. Lancet. 1982 Jul 10;2(8289):100. doi: 10.1016/s0140-6736(82)91720-2.
PMID: 6123788.
772: Ferreira FR, de Moura NSB, Hassib L, Pombo TR. Resveratrol ameliorates the
effect of maternal immune activation associated with schizophrenia in adulthood
offspring. Neurosci Lett. 2020 Aug 24;734:135100. doi:
10.1016/j.neulet.2020.135100. Epub 2020 May 28. PMID: 32473196.
773: Owe-Larsson B, Ekdahl K, Edbom T, Osby U, Karlsson H, Lundberg C, Lundberg
M. Increased plasma levels of thioredoxin-1 in patients with first episode
psychosis and long-term schizophrenia. Prog Neuropsychopharmacol Biol
Psychiatry. 2011 Jun 1;35(4):1117-21. doi: 10.1016/j.pnpbp.2011.03.012. Epub
2011 Mar 30. PMID: 21457743.
774: Wu ZW, Yu HH, Wang X, Guan HY, Xiu MH, Zhang XY. Interrelationships Between
Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in
Patients With Chronic Schizophrenia. Psychosom Med. 2021 Jun 1;83(5):485-491.
doi: 10.1097/PSY.0000000000000931. PMID: 34080586.
775: Liu H, Wang C, Chen PH, Zhang BS, Zheng YL, Zhang CX, Meng HQ, Wang Y, Chen
DC, Xiu MH, Kosten TR, Zhang XY. Association of the manganese superoxide
dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive
dyskinesia in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry.
2010 May 30;34(4):692-6. doi: 10.1016/j.pnpbp.2010.03.026. Epub 2010 Mar 25.
PMID: 20346996.
776: Yin XL, Jia QF, Zhang GY, Zhang JP, Shirao T, Jiang CX, Yin XY, Liu YS,
Chen P, Gu XC, Qian ZK, Yin GZ, Sen Xia H, Hui L. Association between decreased
serum TBIL concentration and immediate memory impairment in schizophrenia
patients. Sci Rep. 2019 Feb 7;9(1):1622. doi: 10.1038/s41598-018-38227-6. PMID:
30733572; PMCID: PMC6367384.
777: BINETTE Y, FERRON LP, GRAVEL G, HAMEL O, LAMARRE G, LEGAULT R, MORIN L,
BERTHIAUME M. SCHIZOPHR'ENIE, SPECTRES, D'ABSORPTION DU LIQUIDE C'EPHALORACHIDIEN ET ACIDE ASCORBIQUE [SCHIZOPHRENIA; ABSORPTION SPECTRA OF THE
CEREBROSPINAL FLUID AND ASCORBIC ACID]. Union Med Can. 1964 Mar;93:270-5.
French. PMID: 14142337.
778: Shilov YE, Baymeeva NV, Brusov OS, Oleichik IV, Sizov SV, Tyurin IA.
Tsinnabarinovaya kislota kak potentsial'nyi prognosticheskii marker shizofrenii
[Cinnabarinic acid as a potential prognostic marker of schizophrenia]. Zh Nevrol
Psikhiatr Im S S Korsakova. 2022;122(12):138-142. Russian. doi:
10.17116/jnevro2022122121138. PMID: 36537644.
779: Mann K, Rossbach W, Müller MJ, Müller-Siecheneder F, Pott T, Linde I,
Dittmann RW, Hiemke C. Nocturnal hormone profiles in patients with schizophrenia
treated with olanzapine. Psychoneuroendocrinology. 2006 Feb;31(2):256-64. doi:
10.1016/j.psyneuen.2005.08.005. Epub 2005 Sep 26. PMID: 16185814.
780: Bharaj BS, Telang BV. A study of ascorbic acid and ceruloplasmin levels in
scorbutic guinea pigs and its possible relation to the pathogenesis of
schizophrenia. East Afr Med J. 1983 Jul;60(7):459-61. PMID: 6641558.
781: Naguy A, Naguy C. N-acetyl-cysteine in schizophrenia-there is more than
meets the eyes! CNS Spectr. 2021 Oct;26(5):446-447. doi:
10.1017/S1092852920001583. Epub 2020 Jul 9. PMID: 32641196.
782: Oliveira P, Coroa M, Madeira N. Treatment Options for Insomnia in
Schizophrenia: A Systematic Review. Pharmacopsychiatry. 2019 Jul;52(4):165-169.
doi: 10.1055/a-0658-1645. Epub 2018 Jul 30. PMID: 30060263.
783: Mullier E, Roine T, Griffa A, Xin L, Baumann PS, Klauser P, Cleusix M,
Jenni R, Alemàn-Gómez Y, Gruetter R, Conus P, Do KQ, Hagmann P. N-AcetylCysteine Supplementation Improves Functional Connectivity Within the Cingulate
Cortex in Early Psychosis: A Pilot Study. Int J Neuropsychopharmacol. 2019 Aug
1;22(8):478-487. doi: 10.1093/ijnp/pyz022. PMID: 31283822; PMCID: PMC6672595.
784: Beeraka NM, Avila-Rodriguez MF, Aliev G. Recent Reports on Redox StressInduced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor
System in Pathophysiology of Schizophrenia. Mol Neurobiol. 2022
Apr;59(4):2472-2496. doi: 10.1007/s12035-021-02703-4. Epub 2022 Jan 27. PMID:
35083660.
785: Moghaddam AH, Maboudi K, Bavaghar B, Sangdehi SRM, Zare M. Neuroprotective
effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like
behaviors and oxidative damage in male mice. Neurosci Lett. 2021 Nov
20;765:136249. doi: 10.1016/j.neulet.2021.136249. Epub 2021 Sep 15. PMID:
34536510.
786: Golse B, Debray Q, Puget K, Michelson AM. Dosage érythrocytaire de la
superoxyde dismutase 1 et de la glutathion peroxydase dans les schizophrénies de
l'adulte [Superoxide dismutase 1 and glutathione peroxidase levels in
erythrocytes of adult schizophrenics]. Nouv Presse Med. 1978 Jun
10;7(23):2070-1. French. PMID: 673775.
787: Galván-Arrieta T, Trueta C, Cercós MG, Valdés-Tovar M, Alarcón S, Oikawa J,
Zamudio-Meza H, Benítez-King G. The role of melatonin in the neurodevelopmental
etiology of schizophrenia: A study in human olfactory neuronal precursors. J
Pineal Res. 2017 Oct;63(3). doi: 10.1111/jpi.12421. Epub 2017 Jun 9. PMID:
28500770.
788: Li Z, Liu Y, Li X, Ju W, Wu G, Yang X, Fu X, Gao X. Association of Elements
with Schizophrenia and Intervention of Selenium Supplements. Biol Trace Elem
Res. 2018 May;183(1):16-21. doi: 10.1007/s12011-017-1105-0. Epub 2017 Aug 15.
PMID: 28812245.
789: Deutsch SI, Rosse RB, Schwartz BL, Fay-McCarthy M, Rosenberg PB, Fearing K.
Methylene blue adjuvant therapy of schizophrenia. Clin Neuropharmacol. 1997
Aug;20(4):357-63. doi: 10.1097/00002826-199708000-00008. PMID: 9260734.
790: Wang JF, Shao L, Sun X, Young LT. Increased oxidative stress in the
anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.
Bipolar Disord. 2009 Aug;11(5):523-9. doi: 10.1111/j.1399-5618.2009.00717.x.
PMID: 19624391.
791: Cuenod M, Steullet P, Cabungcal JH, Dwir D, Khadimallah I, Klauser P, Conus
P, Do KQ. Caught in vicious circles: a perspective on dynamic feed-forward loops
driving oxidative stress in schizophrenia. Mol Psychiatry. 2022
Apr;27(4):1886-1897. doi: 10.1038/s41380-021-01374-w. Epub 2021 Nov 10. PMID:
34759358; PMCID: PMC9126811.
792: Govorin NV, Vasil'eva AI. [Effect of haloperidol and risperidone on
neuromarkers and indices of endothelial dysfunction in patients with acute
schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(3):54-7. Russian.
PMID: 21423116.
793: Ju P, Ding W, Chen J, Cheng Y, Yang B, Huang L, Zhou Q, Zhu C, Li X, Wang
M, Chen J. The protective effects of Mogroside V and its metabolite 11-oxomogrol of intestinal microbiota against MK801-induced neuronal damages.
Psychopharmacology (Berl). 2020 Apr;237(4):1011-1026. doi:
10.1007/s00213-019-05431-9. Epub 2020 Jan 3. PMID: 31900523.
794: Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu SS, Herken H, Savaş HA,
Köylü A, Akyol O. Is the arginine-nitric oxide pathway involved in the
pathogenesis of schizophrenia? Neuropsychobiology. 2003;47(2):61-5. doi:
10.1159/000070010. PMID: 12707486.
795: Morris G, Walder KR, Berk M, Marx W, Walker AJ, Maes M, Puri BK. The
interplay between oxidative stress and bioenergetic failure in neuropsychiatric
illnesses: can we explain it and can we treat it? Mol Biol Rep. 2020
Jul;47(7):5587-5620. doi: 10.1007/s11033-020-05590-5. Epub 2020 Jun 20. PMID:
32564227.
796: Wise CD, Baden MM, Stein L. Post-mortem measurement of enzymes in human
brain: evidence of a central noradrenergic deficit in schizophrenia. J Psychiatr
Res. 1974;11:185-98. doi: 10.1016/0022-3956(74)90092-2. PMID: 4461790.
797: Das I, Khan NS, Puri BK, Hirsch SR. Elevated endogenous nitric oxide
synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain
nitric oxide production. Neurosci Lett. 1996 Sep 13;215(3):209-11. doi:
10.1016/0304-3940(96)12972-4. PMID: 8899750.
798: DE SAUVAGE NOLTING WJ. Considerations regarding a possible relation between
the vitamin-C-content of the blood of pregnant women and schizophrenia,
debilitas mentis and psychopathia. Folia Psychiatr Neurol Neurochir Neerl. 1955
Aug;58(4):285-95. PMID: 13285581.
799: Wang DM, Chen DC, Wang L, Zhang XY. Sex differences in the association
between symptoms and superoxide dismutase in patients with never-treated firstepisode schizophrenia. World J Biol Psychiatry. 2021 Jun;22(5):325-334. doi:
10.1080/15622975.2020.1805510. Epub 2020 Aug 27. PMID: 32772768.
800: Jakaria M, Cho DY, Ezazul Haque M, Karthivashan G, Kim IS, Ganesan P, Choi
DK. Neuropharmacological Potential and Delivery Prospects of Thymoquinone for
Neurological Disorders. Oxid Med Cell Longev. 2018 Mar 20;2018:1209801. doi:
10.1155/2018/1209801. PMID: 29743967; PMCID: PMC5883931.
801: Otter M. Blauwe plekken, uitvallende tanden en vermoeidheid bij een
patiënte met schizofrenie [Bruises, loose teeth and fatigue in a patient with
schizophrenia]. Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2537-8. Dutch. PMID:
16304896.
802: Akhondzadeh S, Safarcherati A, Amini H. Beneficial antipsychotic effects of
allopurinol as add-on therapy for schizophrenia: a double blind, randomized and
placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2005
Feb;29(2):253-9. doi: 10.1016/j.pnpbp.2004.11.008. Epub 2004 Dec 28. PMID:
15694232.
803: TSAUNE MK, IAKSON ZP, PILIPENKO AK. NEKOTORYE ZAMECHANIIA K OTSENKE
AKTIVNOSTI FERMENTOV I POKAZATELE I BILIRUBINA V DIAGNOSTIKE ZABOLEVANI I
PECHENI U BOL'NYKH SHIZOFRENIE I [EVALUATION OF THE ACTIVITY OF ENZYMES AND
BILIRUBIN IN THE DIAGNOSIS OF LIVER DISEASES IN SCHIZOPHRENICS]. Zh Nevropatol
Psikhiatr Im S S Korsakova. 1964;64:1705-11. Russian. PMID: 14339965.
804: Garcia-Unzueta MT, Herran A, Sierra-Biddle D, Amado JA, Vázquez-Barquero
JL, Alvarez C. Alterations of liver function test in patients treated with
antipsychotics. J Clin Lab Anal. 2003;17(6):216-8. doi: 10.1002/jcla.10094.
PMID: 14614743; PMCID: PMC6807977.
805: Kanofsky JD, Kay SR, Lindenmayer JP, Seifter E. Ascorbic acid action in
neuroleptic-associated amenorrhea. J Clin Psychopharmacol. 1989 Oct;9(5):388-9.
PMID: 2571621.
806: Racz R, Sweet BV, Sohoni P. Oral acetylcysteine for neuropsychiatric
disorders. Am J Health Syst Pharm. 2015 Jun 1;72(11):923-6, 928-9. doi:
10.2146/ajhp140732. PMID: 25987686.
807: Xu X, Shao G, Zhang X, Hu Y, Huang J, Su Y, Zhang M, Cai Y, Zhou H. The
efficacy of nutritional supplements for the adjunctive treatment of
schizophrenia in adults: A systematic review and network meta-analysis.
Psychiatry Res. 2022 May;311:114500. doi: 10.1016/j.psychres.2022.114500. Epub
2022 Mar 7. PMID: 35287043.
808: Sepehrmanesh Z, Heidary M, Akasheh N, Akbari H, Heidary M. Therapeutic
effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic
schizophrenia: A double-blind, randomized clinical trial. Prog
Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:289-296. doi:
10.1016/j.pnpbp.2017.11.001. Epub 2017 Nov 7. PMID: 29126981.
809: Walss-Bass C, Soto-Bernardini MC, Johnson-Pais T, Leach RJ, Ontiveros A,
Nicolini H, Mendoza R, Jerez A, Dassori A, Chavarria-Siles I, Escamilla MA,
Raventos H. Methionine sulfoxide reductase: a novel schizophrenia candidate
gene. Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):219-25. doi:
10.1002/ajmg.b.30791. PMID: 18506707; PMCID: PMC3781017.
810: Konagaya M. [Erythrocyte SOD]. Nihon Rinsho. 2004 Dec;62 Suppl 12:768-71.
Japanese. PMID: 15658446.
811: Ershova ES, Shmarina GV, Martynov AV, Zakharova NV, Veiko RV, Umriukhin PE,
Kostyuk GP, Kutsev SI, Veiko NN, Kostyuk SV. NADPH-oxidase 4 gene overexpression in peripheral blood lymphocytes of the schizophrenia patients. PLoS
One. 2022 Jun 13;17(6):e0269130. doi: 10.1371/journal.pone.0269130. PMID:
35696356; PMCID: PMC9191697.
812: Rapado-Castro M, Berk M, Venugopal K, Bush AI, Dodd S, Dean OM. Towards
stage specific treatments: effects of duration of illness on therapeutic
response to adjunctive treatment with N-acetyl cysteine in schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:69-75. doi:
10.1016/j.pnpbp.2014.10.002. Epub 2014 Oct 12. PMID: 25315856.
813: Readhead B, Hartley BJ, Eastwood BJ, Collier DA, Evans D, Farias R, He C,
Hoffman G, Sklar P, Dudley JT, Schadt EE, Savić R, Brennand KJ. Expression-based
drug screening of neural progenitor cells from individuals with schizophrenia.
Nat Commun. 2018 Oct 24;9(1):4412. doi: 10.1038/s41467-018-06515-4. Erratum in:
Nat Commun. 2018 Nov 19;9(1):4926. PMID: 30356048; PMCID: PMC6200740.
814: Terada K, Murata A, Toki E, Goto S, Yamakawa H, Setoguchi S, Watase D, Koga
M, Takata J, Matsunaga K, Karube Y. Atypical Antipsychotic Drug Ziprasidone
Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study. Molecules.
2020 Sep 14;25(18):4206. doi: 10.3390/molecules25184206. PMID: 32937854; PMCID:
PMC7570562.
815: Zhu X, Cabungcal JH, Cuenod M, Uliana DL, Do KQ, Grace AA. Thalamic
reticular nucleus impairments and abnormal prefrontal control of dopamine system
in a developmental model of schizophrenia: prevention by N-acetylcysteine. Mol
Psychiatry. 2021 Dec;26(12):7679-7689. doi: 10.1038/s41380-021-01198-8. Epub
2021 Jun 30. PMID: 34193975; PMCID: PMC8716611.
816: Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ,
Volkert J, Kopf J, Heupel J, Herterich S, Adolfsson R, Alttoa A, Post A,
Grußendorf H, Kramer A, Gessner A, Schmidt B, Hempel S, Jacob CP, Sanjuán J,
Moltó MD, Lesch KP, Freitag CM, Kent L, Reif A. The genetic contribution of the
NO system at the glutamatergic post-synapse to schizophrenia: further evidence
and meta-analysis. Eur Neuropsychopharmacol. 2014 Jan;24(1):65-85. doi:
10.1016/j.euroneuro.2013.09.005. Epub 2013 Sep 27. PMID: 24220657.
817: Govorin NV, Govorin AV, Skazhutin SA. Znachenie narusheniĭ protsessov
perekisnogo okisleniia lipidov u bol'nykh nepreryvnoĭ paranoidnoĭ shizofrenieĭ s
terapevticheskoĭ rezistentnost'iu [Significance of disorders of the processes of
lipid peroxidation in patients with persistent paranoid schizophrenia resistant
to the treatment]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(7):121-4.
Russian. PMID: 1684458.
818: Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced
erythrocyte membrane essential fatty acids and increased lipid peroxides in
schizophrenia at the never-medicated first-episode of psychosis and after years
of treatment with antipsychotics. Schizophr Res. 2002 Nov 1;58(1):1-10. doi:
10.1016/s0920-9964(01)00334-6. PMID: 12363384.
819: Cieślik P, Kalinowski L, Wierońska JM. Procognitive activity of nitric
oxide inhibitors and donors in animal models. Nitric Oxide. 2022 Feb
1;119:29-40. doi: 10.1016/j.niox.2021.12.003. Epub 2021 Dec 10. PMID: 34896554.
820: Cabungcal JH, Steullet P, Kraftsik R, Cuenod M, Do KQ. Early-life insults
impair parvalbumin interneurons via oxidative stress: reversal by
N-acetylcysteine. Biol Psychiatry. 2013 Mar 15;73(6):574-82. doi:
10.1016/j.biopsych.2012.09.020. Epub 2012 Nov 7. PMID: 23140664.
821: Bernstein HG, Krell D, Braunewell KH, Baumann B, Gundelfinger ED, Diekmann
S, Danos P, Bogerts B. Increased number of nitric oxide synthase immunoreactive
Purkinje cells and dentate nucleus neurons in schizophrenia. J Neurocytol. 2001
Aug;30(8):661-70. doi: 10.1023/a:1016520932139. PMID: 12118154.
822: Ahmed SSSJ, Akram Husain RS, Suresh Kumar, Ramakrishnan V. Association
Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian
Populations: A Meta-Analysis. Neuromolecular Med. 2017 Sep;19(2-3):452-461. doi:
10.1007/s12017-017-8460-z. Epub 2017 Aug 9. PMID: 28795310.
823: Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF. Extract of Ginkgo
biloba treatment for tardive dyskinesia in schizophrenia: a randomized, doubleblind, placebo-controlled trial. J Clin Psychiatry. 2011 May;72(5):615-21. doi:
10.4088/JCP.09m05125yel. Epub 2010 Sep 21. PMID: 20868638.
824: Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal
plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res.
1992 Apr;7(1):77-84. doi: 10.1016/0920-9964(92)90077-i. PMID: 1591200.
825: Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, Whatley SA. A
mitochondrial DNA sequence variant associated with schizophrenia and oxidative
stress. Schizophr Res. 2003 Dec 1;65(1):33-8. doi:
10.1016/s0920-9964(03)00011-2. PMID: 14623372.
826: Ibrahim KS, El-Sayed EM. Proposed remedies for some developmental
disorders. Toxicol Ind Health. 2013 May;29(4):367-84. doi:
10.1177/0748233711433937. Epub 2012 Feb 2. PMID: 22301819.
827: ALLEGRANZA A, BOZZI R, BRUNO A. ELIMINAZIONE URINARIA DEGLI ACIDI
5-IDROSSINDOLACETICO, OMOVANILLICO E VANILMANDELICO IN SOGGETTI SCHIZOFRENICI
SOTTO RESERPINA E CLOROPROMAZINA [URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC
ACID, HOMOVANILLIC AND VANILLYLMANDELIC ACIDS IN SCHIZOPHRENIC SUBJECTS WITH
RESERPINE AND CHLORPROMAZINE]. Riv Patol Nerv Ment. 1963 Jun;84:181-200.
Italian. PMID: 14088041.
828: Gu HS, Chen X, Zhang JW, Zhang L, Li L. Synthesis and biological evaluation
of novel flavanone derivatives as potential antipsychotic agents. Chem Biol Drug
Des. 2017 Mar;89(3):353-364. doi: 10.1111/cbdd.12843. Epub 2016 Sep 26. PMID:
27543496.
829: Mattioli Foggia C. Sindromi catatoniche e disfunzione epatica [Catatonic
syndromes and liver dysfunction]. Epatologia. 1970 Jan-Feb;16(1):57-62. Italian.
PMID: 5525567.
830: Xu H, Yang F. The interplay of dopamine metabolism abnormalities and
mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry.
2022 Nov 7;12(1):464. doi: 10.1038/s41398-022-02233-0. PMID: 36344514; PMCID:
PMC9640700.
831: Coughlin JM, Ishizuka K, Kano SI, Edwards JA, Seifuddin FT, Shimano MA,
Daley EL, Zandi PP, Leweke FM, Cascella NG, Pomper MG, Yolken RH, Sawa A. Marked
reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of
patients with recent-onset schizophrenia. Mol Psychiatry. 2013 Jan;18(1):10-1.
doi: 10.1038/mp.2012.6. Epub 2012 Feb 21. PMID: 22349781; PMCID: PMC4113962.
832: Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z.
Sex difference in the interrelationship between TNF-α and oxidative stress
status in first-episode drug-naïve schizophrenia. J Neuroinflammation. 2021 Sep
15;18(1):202. doi: 10.1186/s12974-021-02261-5. PMID: 34526062; PMCID:
PMC8444364.
833: Soares KV, McGrath JJ. Vitamin E for neuroleptic-induced tardive
dyskinesia. Cochrane Database Syst Rev. 2000;(2):CD000209. doi:
10.1002/14651858.CD000209. Update in: Cochrane Database Syst Rev.
2001;(4):CD000209. PMID: 10796508.
834: Wang M, Chen HJ, Zhang J, Li W, Xie X, Chang HT. Identification of
pLG72-Induced Oxidative Stress Using Systemic Approaches. Biomed Res Int.
2015;2015:429253. doi: 10.1155/2015/429253. Epub 2015 Oct 11. PMID: 26539492;
PMCID: PMC4619840.
835: Akyol O, Chowdhury I, Akyol HR, Tessier K, Vural H, Akyol S. Why are
cardiovascular diseases more common among patients with severe mental illness?
The potential involvement of electronegative low-density lipoprotein (LDL) L5.
Med Hypotheses. 2020 Sep;142:109821. doi: 10.1016/j.mehy.2020.109821. Epub 2020
May 6. PMID: 32417641.
836: Goff DC, Renshaw PF, Sarid-Segal O, Dreyfuss DA, Amico ET, Ciraulo DA. A
placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive
dyskinesia. Biol Psychiatry. 1993 May 15;33(10):700-6. doi:
10.1016/0006-3223(93)90119-x. PMID: 8102552.
837: Radhakrishnan R, Kanigere M, Menon J, Calvin S, Janish A, Srinivasan K.
Association between unconjugated bilirubin and schizophrenia. Psychiatry Res.
2011 Oct 30;189(3):480-2. doi: 10.1016/j.psychres.2011.03.003. Epub 2011 Apr 5.
PMID: 21470692.
838: Oh HK, Jeon SJ, Lee S, Lee HE, Kim E, Park SJ, Kim HN, Jung WY, Cheong JH,
Jang DS, Ryu JH. Swertisin ameliorates pre-pulse inhibition deficits and
cognitive impairment induced by MK-801 in mice. J Psychopharmacol. 2017
Feb;31(2):250-259. doi: 10.1177/0269881116672098. Epub 2016 Oct 11. PMID:
27729563.
839: HOFFER A. TREATMENT OF ORGANIC PSYCHOSIS WITH NICOTINIC ACID. (A SINGLE
CASE). Dis Nerv Syst. 1965 Jun;26:358-61. PMID: 14315070.
840: Waugh DT. The Contribution of Fluoride to the Pathogenesis of Eye Diseases:
Molecular Mechanisms and Implications for Public Health. Int J Environ Res
Public Health. 2019 Mar 8;16(5):856. doi: 10.3390/ijerph16050856. PMID:
30857240; PMCID: PMC6427526.
841: Borkent J, Ioannou M, Folkertsma TS, Wardenaar KJ, Haarman BCM, van Goor H,
Sommer IEC, Bourgonje AR. Serum free thiols in recently diagnosed patients with
schizophrenia spectrum disorder: A potentially useful biomarker of oxidative
stress. Psychiatry Res. 2023 Mar;321:115075. doi:
10.1016/j.psychres.2023.115075. Epub 2023 Jan 26. PMID: 36764120.
842: Maes M, Sirivichayakul S, Matsumoto AK, Maes A, Michelin AP, de Oliveira
Semeão L, de Lima Pedrão JV, Moreira EG, Barbosa DS, Geffard M, Carvalho AF,
Kanchanatawan B. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate
Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are
Inversely Associated with Natural IgM Directed to Malondialdehyde and
Paraoxonase 1 Activity. Mol Neurobiol. 2020 May;57(5):2333-2345. doi:
10.1007/s12035-020-01882-w. Epub 2020 Feb 10. Erratum in: Mol Neurobiol. 2022
Feb;59(2):1350. PMID: 32040834.
843: McGlashan TH, Cleary PA. Clinical laboratory test standards for a sample of
schizophrenics. Psychopharmacologia. 1975 Nov 21;44(3):281-5. doi:
10.1007/BF00428907. PMID: 1208763.
844: Do KQ. Bridging the gaps towards precision psychiatry: Mechanistic
biomarkers for early detection and intervention. Psychiatry Res. 2023
Mar;321:115064. doi: 10.1016/j.psychres.2023.115064. Epub 2023 Jan 18. PMID:
36716550.
845: Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR,
Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R. Altered interactions of
tryptophan metabolites in first-episode neuroleptic-naive patients with
schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33.
Epub 2009 Apr 28. PMID: 19401681; PMCID: PMC2953575.
846: Pardhi VP, Flora S. Stable solid dispersion of lurasidone hydrochloride
with augmented physicochemical properties for the treatment of schizophrenia and
bipolar disorder. Biopharm Drug Dispos. 2020 Nov;41(8-9):334-351. doi:
10.1002/bdd.2252. Epub 2020 Nov 5. PMID: 33080060.
847: Buckman TD, Kling A, Sutphin MS, Steinberg A, Eiduson S. Platelet
glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT
scan abnormalities: relation to psychosocial variables. Psychiatry Res. 1990
Jan;31(1):1-14. doi: 10.1016/0165-1781(90)90103-c. PMID: 1969170.
848: Zoupa E, Pitsikas N. The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP)
and Its Potential for the Schizophrenia Therapy: Lights and Shadows. Molecules.
2021 May 26;26(11):3196. doi: 10.3390/molecules26113196. PMID: 34073534; PMCID:
PMC8199342.
849: Coughlin JM, Hayes LN, Tanaka T, Xiao M, Yolken RH, Worley P, Leweke FM,
Sawa A. Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients
with early psychosis in association with clinical features. Schizophr Res. 2017
May;183:64-69. doi: 10.1016/j.schres.2016.10.040. Epub 2016 Nov 23. PMID:
27889384.
850: Romo-Nava F, Alvarez-Icaza González D, Fresán-Orellana A, Saracco Alvarez
R, Becerra-Palars C, Moreno J, Ontiveros Uribe MP, Berlanga C, Heinze G, Buijs
RM. Melatonin attenuates antipsychotic metabolic effects: an eight-week
randomized, double-blind, parallel-group, placebo-controlled clinical trial.
Bipolar Disord. 2014 Jun;16(4):410-21. doi: 10.1111/bdi.12196. Epub 2014 Mar 17.
PMID: 24636483.
851: Cutando A, Silvestre FJ. Melatonin: implications at the oral level. Bull
Group Int Rech Sci Stomatol Odontol. 1995 Sep-Oct;38(3-4):81-6. PMID: 7492898.
852: Busanello A, Leal CQ, Peroza LR, Röpke J, de Moraes Reis E, de Freitas CM,
Libardoni M, de Vargas Barbosa NB, Fachinetto R. Resveratrol Protects Against
Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.
Neurochem Res. 2017 Nov;42(11):3033-3040. doi: 10.1007/s11064-017-2335-4. Epub
2017 Jul 25. PMID: 28744755.
853: Fanget F, Claustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat
J. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry.
1989 Feb 15;25(4):499-501. doi: 10.1016/0006-3223(89)90205-9. PMID: 2930814.
854: Alias AG, Vijayan N, Nair DS, Sukumaran M. Serum ceruloplasmin in
schizophrenia: significant increase in acute cases especially in catatonia. Biol
Psychiatry. 1972 Jun;4(3):231-8. PMID: 5041917.
855: Cohen SA, Paeglow RJ. Scurvy: an unusual cause of anemia. J Am Board Fam
Pract. 2001 Jul-Aug;14(4):314-6. PMID: 11458974.
856: DE SAUVAGE NOLTING WJ. Vitamin C and the schizophrenic syndrome. Folia
Psychiatr Neurol Neurochir Neerl. 1954 Jun;57(3):347-55. PMID: 13200609.
857: Monpays C, Deslauriers J, Sarret P, Grignon S. Mitochondrial Dysfunction in
Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit
Mouse Model. J Mol Neurosci. 2016 Aug;59(4):440-51. doi:
10.1007/s12031-016-0746-3. Epub 2016 Mar 31. PMID: 27034067.
858: Camacho-Abrego I, González-Cano SI, Aguilar-Alonso P, Brambila E, la Cruz
F, Flores G. Changes in nitric oxide, zinc and metallothionein levels in limbic
regions at pre-pubertal and post-pubertal ages presented in an animal model of
schizophrenia. J Chem Neuroanat. 2021 Jan;111:101889. doi:
10.1016/j.jchemneu.2020.101889. Epub 2020 Nov 14. PMID: 33197552.
859: Mohammed A, El-Bakly WM, Ali A, El-Demerdash E. Rosuvastatin improves
olanzapine's effects on behavioral impairment and hippocampal, hepatic and
metabolic damages in isolated reared male rats. Behav Brain Res. 2020 Jan
27;378:112305. doi: 10.1016/j.bbr.2019.112305. Epub 2019 Oct 18. PMID: 31634496.
860: Viganò D, Lissoni P, Rovelli F, Roselli MG, Malugani F, Gavazzeni C, Conti
A, Maestroni G. A study of light/dark rhythm of melatonin in relation to
cortisol and prolactin secretion in schizophrenia. Neuro Endocrinol Lett. 2001
Apr;22(2):137-41. PMID: 11335890.
861: Chmielewska K, Dzierzbicka K, Inkielewicz-Stępniak I, Przybyłowska M.
Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human
Diseases. Chem Res Toxicol. 2020 Jul 20;33(7):1561-1578. doi:
10.1021/acs.chemrestox.0c00010. Epub 2020 Apr 17. PMID: 32202758.
862: Abd Elkader HAE, Abdou HM, Khamiss OA, Essawy AE. Anti-anxiety and
antidepressant-like effects of astragaloside IV and saponins extracted from
Astragalus spinosus against the bisphenol A-induced motor and cognitive
impairments in a postnatal rat model of schizophrenia. Environ Sci Pollut Res
Int. 2021 Jul;28(26):35171-35187. doi: 10.1007/s11356-021-12927-5. Epub 2021 Mar
5. PMID: 33666843.
863: Machado AK, Andreazza AC, da Silva TM, Boligon AA, do Nascimento V, Scola
G, Duong A, Cadoná FC, Ribeiro EE, da Cruz IB. Neuroprotective Effects of Açaí
(<i>Euterpe oleracea</i> Mart.) against Rotenone <i>In Vitro</i> Exposure. Oxid
Med Cell Longev. 2016;2016:8940850. doi: 10.1155/2016/8940850. Epub 2016 Oct 3.
PMID: 27781077; PMCID: PMC5066013.
864: Pal A, Fontanilla D, Gopalakrishnan A, Chae YK, Markley JL, Ruoho AE. The
sigma-1 receptor protects against cellular oxidative stress and activates
antioxidant response elements. Eur J Pharmacol. 2012 May 5;682(1-3):12-20. doi:
10.1016/j.ejphar.2012.01.030. Epub 2012 Feb 22. PMID: 22381068; PMCID:
PMC3314091.
865: Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of
glutamatergic neurotransmission and oxidative stress associated with tardive
dyskinesia. Am J Psychiatry. 1998 Sep;155(9):1207-13. doi:
10.1176/ajp.155.9.1207. PMID: 9734544.
866: Soares KV, McGrath JJ. Vitamin E for neuroleptic-induced tardive
dyskinesia. Cochrane Database Syst Rev. 2001;(4):CD000209. doi:
10.1002/14651858.CD000209. Update in: Cochrane Database Syst Rev.
2011;(2):CD000209. PMID: 11687073.
867: Hashimoto K, Iyo M. [Glutamate hypothesis of schizophrenia and targets for
new antipsychotic drugs]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2002
Feb;22(1):3-13. Japanese. PMID: 11917507.
868: Miles A, Philbrick D. Melatonin: perspectives in laboratory medicine and
clinical research. Crit Rev Clin Lab Sci. 1987;25(3):231-53. doi:
10.3109/10408368709105884. PMID: 3315465.
869: Vidović B, Dorđević B, Milovanović S, Škrivanj S, Pavlović Z, Stefanović A,
Kotur-Stevuljević J. Selenium, zinc, and copper plasma levels in patients with
schizophrenia: relationship with metabolic risk factors. Biol Trace Elem Res.
2013 Dec;156(1-3):22-8. doi: 10.1007/s12011-013-9842-1. Epub 2013 Oct 24. PMID:
24150923.
870: Kotsirilos V. Psychotic illness--does complementary medicine have a role in
management? Aust Fam Physician. 2006 Mar;35(3):115-6. PMID: 16525522.
871: Ashton MM, Berk M, Ng CH, Hopwood M, Dodd S, Turner A, Brown E, Jacka FN,
Cotton SM, Khoo JP, Chatterton ML, Kavanagh BE, Nadjidai SE, Lo Monaco SL,
Harvey BH, Sarris J, Malhi GS, Dowling NL, Dean OM. Efficacy of adjunctive
Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study
protocol for a proof-of-concept trial. Braz J Psychiatry. 2019 MayJun;41(3):245-253. doi: 10.1590/1516-4446-2018-0114. Epub 2018 Oct 11. PMID:
30328970; PMCID: PMC6794139.
872: Atmaca M, Tezcan E, Ustundag B. Plasma nitric oxide and leptin values in
patients with olanzapine-induced weight gain. J Psychiatr Res. 2007 JanFeb;41(1-2):74-9. doi: 10.1016/j.jpsychires.2005.12.003. Epub 2006 Jan 19. PMID:
16426639.
873: Dorevitch A, Kalian M, Shlafman M, Lerner V. Treatment of long-term tardive
dyskinesia with vitamin E. Biol Psychiatry. 1997 Jan 1;41(1):114-6. doi:
10.1016/s0006-3223(96)00367-8. PMID: 8988802.
874: Lang X, Wang DM, Du XD, Jia QF, Chen DC, Xiu M, Wang L, Zhang X. Elevated
activity of plasma superoxide dismutase in never-treated first-episode
schizophrenia patients: Associated with depressive symptoms. Schizophr Res. 2020
Aug;222:291-296. doi: 10.1016/j.schres.2020.05.032. Epub 2020 May 22. PMID:
32451132.
875: Lamont EW, Coutu DL, Cermakian N, Boivin DB. Circadian rhythms and clock
genes in psychotic disorders. Isr J Psychiatry Relat Sci. 2010;47(1):27-35.
PMID: 20686197.
876: Lehtinen EK, Ucar E, Glenthøj BY, Oranje B. Effects of melatonin on
prepulse inhibition, habituation and sensitization of the human startle reflex
in healthy volunteers. Psychiatry Res. 2014 May 30;216(3):418-23. doi:
10.1016/j.psychres.2014.02.030. Epub 2014 Feb 28. PMID: 24613047.
877: Rovný R, Marko M, Katina S, Murínová J, Roháriková V, Cimrová B, Repiská G,
Minárik G, Riečanský I. Association between genetic variability of neuronal
nitric oxide synthase and sensorimotor gating in humans. Nitric Oxide. 2018 Nov
1;80:32-36. doi: 10.1016/j.niox.2018.08.002. Epub 2018 Aug 8. PMID: 30096361.
878: de Boer J, Kalk WW, van Assen S, van der Wouden EJ. Blauwe plekken,
uitvallende tanden en vermoeidheid bij een patiënte met schizofrenie [Bruises,
loose teeth and fatigue in a patient with schizophrenia]. Ned Tijdschr Geneeskd.
2005 Aug 6;149(32):1769-72. Dutch. PMID: 16121659.
879: Hayashida M, Hashioka S, Hayashida K, Miura S, Tsuchie K, Araki T, Izuhara
M, Kanayama M, Otsuki K, Nagahama M, Jaya MA, Arauchi R, Wake R, Oh-Nishi A,
Horiguchi J, Miyaoka T, Inagaki M, Morita E. Low Serum Levels of Fibroblast
Growth Factor 2 in Gunn Rats: A Hyperbilirubinemia Animal Model of Schizophrenic
Symptoms. CNS Neurol Disord Drug Targets. 2020;19(7):503-508. doi:
10.2174/1871527319999200729153907. PMID: 32729434.
880: Kanig K, Oesterle W. Biochemische Behandlungsmöglichkeiten von Pyschosen
[Biochemical treatment possibilities in psychoses]. Med Welt. 1969 Sep
6;36:1938-45. German. PMID: 4241466.
881: Ganzinelli S, Borda E, Sterin-Borda L. Autoantibodies from schizophrenia
patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3
production. Int J Neuropsychopharmacol. 2010 Apr;13(3):293-303. doi:
10.1017/S1461145709990770. Epub 2009 Oct 19. PMID: 19835666.
882: Alameda L, Fournier M, Khadimallah I, Griffa A, Cleusix M, Jenni R, Ferrari
C, Klauser P, Baumann PS, Cuenod M, Hagmann P, Conus P, Do KQ. Redox
dysregulation as a link between childhood trauma and psychopathological and
neurocognitive profile in patients with early psychosis. Proc Natl Acad Sci U S
A. 2018 Dec 4;115(49):12495-12500. doi: 10.1073/pnas.1812821115. Epub 2018 Nov
19. PMID: 30455310; PMCID: PMC6298080.
883: Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood
cell membrane essential fatty acid metabolism in early psychotic patients
following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty
Acids. 2003 Dec;69(6):393-9. doi: 10.1016/j.plefa.2003.08.010. PMID: 14623492.
884: Li XM, Juorio AV, Chlan-Fourney J, Shrikhande S, Bennett VL, Keegan DL. A
new mechanism for the actions of olanzapine. Can J Psychiatry. 1999
Aug;44(6):605-6. PMID: 10497706.
885: Lane HY, Wang SH, Lin CH. Endogenous antioxidants predicted outcome and
increased after treatment: A benzoate dose-finding, randomized, double-blind,
placebo-controlled trial for Alzheimer's disease. Psychiatry Clin Neurosci. 2023
Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24. PMID: 36335573;
PMCID: PMC10099492.
886: Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM. Melatonin in schizophrenic
outpatients with insomnia: a double-blind, placebo-controlled study. J Clin
Psychiatry. 2007 Feb;68(2):237-41. doi: 10.4088/jcp.v68n0208. PMID: 17335321.
887: Song X, Li W, Yang Y, Zhao J, Jiang C, Li W, Lv L. The nuclear factor-κB
inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acidinduced immune response in pregnant rats and the behavioral defects of their
adult offspring. Behav Brain Funct. 2011 Dec 31;7:50. doi:
10.1186/1744-9081-7-50. PMID: 22208616; PMCID: PMC3286402.
888: Okumura T, Okochi T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita
Y, Kawashima K, Tsunoka T, Ujike H, Inada T, Ozaki N, Iwata N. No association
between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia
in a Japanese population. Neuromolecular Med. 2009;11(2):123-7. doi:
10.1007/s12017-009-8068-z. Epub 2009 Jun 10. PMID: 19513863.
889: Vaziri N, Marques D, Greenway SC, Bousman CA. The cellular mechanism of
antipsychotic-induced myocarditis: A systematic review. Schizophr Res. 2023
Nov;261:206-215. doi: 10.1016/j.schres.2023.09.039. Epub 2023 Oct 3. PMID:
37797362.
890: Ostrovskaia RU. Evoliutsiia problemy neĭroprotektsii [Evolution of the
neuroprotection concept]. Eksp Klin Farmakol. 2003 Mar-Apr;66(2):32-7. Russian.
PMID: 12962045.
891: Otręba M, Beberok A, Wrześniok D, Rok J, Buszman E. Effect of thioridazine
on antioxidant status of HEMn-DP melanocytes. Naunyn Schmiedebergs Arch
Pharmacol. 2015 Oct;388(10):1097-104. doi: 10.1007/s00210-015-1144-z. Epub 2015
Jun 24. PMID: 26105001; PMCID: PMC4561062.
892: Baldessarini RJ. Biological transmethylation involving
S-adenosylmethionine: development of assay methods and implications for
neuropsychiatry. Int Rev Neurobiol. 1975;18:41-67. doi:
10.1016/s0074-7742(08)60033-1. PMID: 1107247.
893: Baandrup L, Lindschou J, Winkel P, Gluud C, Glenthoj BY. Prolonged-release
melatonin versus placebo for benzodiazepine discontinuation in patients with
schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded
trial. World J Biol Psychiatry. 2016 Oct;17(7):514-24. doi:
10.3109/15622975.2015.1048725. Epub 2015 Jun 18. PMID: 26086792.
894: Śmierciak N, Krzyściak W, Szwajca M, Szczęsny-Malysiak E, Kij A, Chłopicki
S, Pilecki M. Improvement in clinical symptoms in patients with the first
episode of psychosis is associated with a decrease in systemic nitric oxide
availability. A pilot study. Psychiatr Pol. 2021 Jun 30;55(3):541-554. English,
Polish. doi: 10.12740/PP/131531. Epub 2021 Jun 30. PMID: 34460880.
895: Suboticanec K, Folnegović-Smalc V, Korbar M, Mestrović B, Buzina R. Vitamin
C status in chronic schizophrenia. Biol Psychiatry. 1990 Dec 1;28(11):959-66.
doi: 10.1016/0006-3223(90)90061-6. PMID: 2275953.
896: Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, Angrist B.
Vitamin E treatment of tardive dyskinesia. Am J Psychiatry. 1993
Sep;150(9):1405-7. doi: 10.1176/ajp.150.9.1405. PMID: 8102511.
897: LEITNER ZA, MOORE T, SHARMAN IM. VITAMIN A AND VITAMIN E IN HUMAN BLOOD. 3.
LEVELS IN PATIENTS IN PSYCHIATRIC HOSPITALS. Br J Nutr. 1964;18:115-27. doi:
10.1079/bjn19640011. PMID: 14112960.
898: Isaacson RH, Beier JI, Khoo NK, Freeman BA, Freyberg Z, Arteel GE.
Olanzapine-induced liver injury in mice: aggravation by high-fat diet and
protection with sulforaphane. J Nutr Biochem. 2020 Jul;81:108399. doi:
10.1016/j.jnutbio.2020.108399. Epub 2020 Apr 8. PMID: 32388251; PMCID:
PMC7263947.
899: Herrmann AP, Andrejew R, Benvenutti R, Gama CS, Elisabetsky E. Effects of
N-acetylcysteine on amphetamine-induced sensitization in mice. Braz J
Psychiatry. 2017 Dec 11;40(2):169-173. doi: 10.1590/1516-4446-2017-2337. PMID:
29236922; PMCID: PMC6900759.
900: Gomberg R. Possible case of allopurinol causing relapse of psychosis.
Schizophr Res. 2007 Jul;93(1-3):409. doi: 10.1016/j.schres.2007.02.015. Epub
2007 Mar 27. PMID: 17389149.
901: George MY, Menze ET, Esmat A, Tadros MG, El-Demerdash E. Potential
therapeutic antipsychotic effects of Naringin against ketamine-induced deficits
in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways. Life
Sci. 2020 May 15;249:117535. doi: 10.1016/j.lfs.2020.117535. Epub 2020 Mar 7.
PMID: 32151688.
902: Ivanova SA, Geers LM, Al Hadithy AF, Pechlivanoglou P, Semke AV, Vyalova
NM, Rudikov EV, Fedorenko OY, Wilffert B, Bokhan NA, Brouwers JR, Loonen AJ.
Dehydroepiandrosterone sulphate as a putative protective factor against tardive
dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:172-7. doi:
10.1016/j.pnpbp.2013.12.015. Epub 2014 Jan 3. PMID: 24389397.
903: Neĭkoya M. Lechenie ostroĭ shizofrenii antibiotikami, gamma-globulinom i
vitaminami [Treatment of acute schizophrenia with antibiotics, gamma-globulin
and vitamins]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1966;66(6):912-7.
Russian. PMID: 4174770.
904: Mosher LR. Nicotinic acid side effects and toxicity: a review. Am J
Psychiatry. 1970 Mar;126(9):1290-6. doi: 10.1176/ajp.126.9.1290. PMID: 4905018.
905: Miola A, Fornaro M, Sambataro F, Solmi M. Melatonin and melatonin-agonists
for metabolic syndrome components in patients treated with antipsychotics: A
systematic review and meta-analysis. Hum Psychopharmacol. 2022 Mar;37(2):e2821.
doi: 10.1002/hup.2821. Epub 2021 Oct 22. PMID: 34687076.
906: Shin JH, Park SJ, Kim ES, Jo YK, Hong J, Cho DH. Sertindole, a potent
antagonist at dopamine D₂ receptors, induces autophagy by increasing reactive
oxygen species in SH-SY5Y neuroblastoma cells. Biol Pharm Bull.
2012;35(7):1069-75. doi: 10.1248/bpb.b12-00009. PMID: 22791154.
907: Klauser P, Xin L, Fournier M, Griffa A, Cleusix M, Jenni R, Cuenod M,
Gruetter R, Hagmann P, Conus P, Baumann PS, Do KQ. N-acetylcysteine add-on
treatment leads to an improvement of fornix white matter integrity in early
psychosis: a double-blind randomized placebo-controlled trial. Transl
Psychiatry. 2018 Oct 12;8(1):220. doi: 10.1038/s41398-018-0266-8. PMID:
30315150; PMCID: PMC6185923.
908: Ravikumar A, Arun P, Devi KV, Augustine J, Kurup PA. Isoprenoid pathway and
free radical generation and damage in neuropsychiatric disorders. Indian J Exp
Biol. 2000 May;38(5):438-46. PMID: 11272406.
909: Tsilioni I, Panagiotidou S, Theoharides TC. Exosomes in neurologic and
psychiatric disorders. Clin Ther. 2014 Jun 1;36(6):882-8. doi:
10.1016/j.clinthera.2014.05.005. Epub 2014 Jun 7. PMID: 24913029.
910: Trivedi MS, Shah JS, Al-Mughairy S, Hodgson NW, Simms B, Trooskens GA, Van
Criekinge W, Deth RC. Food-derived opioid peptides inhibit cysteine uptake with
redox and epigenetic consequences. J Nutr Biochem. 2014 Oct;25(10):1011-8. doi:
10.1016/j.jnutbio.2014.05.004. Epub 2014 Jun 6. PMID: 25018147; PMCID:
PMC4157943.
911: Singh E, Devasahayam G. Neurodegeneration by oxidative stress: a review on
prospective use of small molecules for neuroprotection. Mol Biol Rep. 2020
Apr;47(4):3133-3140. doi: 10.1007/s11033-020-05354-1. Epub 2020 Mar 11. PMID:
32162127.
912: Flemenbaum A, Flemenbaum E. Field dependence, blood uric acid and
cholesterol. Percept Mot Skills. 1975 Aug;41(1):135-41. doi:
10.2466/pms.1975.41.1.135. PMID: 1178395.
913: Altman H, Mehta D, Evenson RC, Sletten IW. Behavioral effects of drug
therapy on psychogeriatric inpatients. II. Multivitamin supplement. J Am Geriatr
Soc. 1973 Jun;21(6):249-52. doi: 10.1111/j.1532-5415.1973.tb01684.x. PMID:
4145685.
914: Huang MW, Lin YJ, Chang CW, Lei FJ, Ho EP, Liu RS, Shyu WC, Hsieh CH.
<i>RGS4</i> deficit in prefrontal cortex contributes to the behaviors related to
schizophrenia via system x_c^--mediated glutamatergic
dysfunction in mice. Theranostics. 2018 Sep 9;8(17):4781-4794. doi:
10.7150/thno.25189. PMID: 30279737; PMCID: PMC6160762.
915: Wei Q, Ji Y, Gao H, Yi W, Pan R, Cheng J, He Y, Tang C, Liu X, Song S, Song
J, Su H. Oxidative stress-mediated particulate matter affects the risk of
relapse in schizophrenia patients: Air purification intervention-based panel
study. Environ Pollut. 2022 Jan 1;292(Pt B):118348. doi:
10.1016/j.envpol.2021.118348. Epub 2021 Oct 9. PMID: 34637828.
916: Sirén AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of
erythropoietin and its structural or functional variants in the nervous system.
Neurotherapeutics. 2009 Jan;6(1):108-27. doi: 10.1016/j.nurt.2008.10.041. PMID:
19110203; PMCID: PMC5084260.
917: Huh L, Lee BJ. Şizofreni Hastalarında Klozapin ile İlişkili Tardif Distoni
Tedavisinde Düşük Doz Aripiprazolün Etkililiği [Efficacy of low-Dose
Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with
Schizophrenia]. Turk Psikiyatri Derg. 2017 Fall;28(3):208-211. Turkish. PMID:
28936820.
918: Dwir D, Giangreco B, Xin L, Tenenbaum L, Cabungcal JH, Steullet P, Goupil
A, Cleusix M, Jenni R, Chtarto A, Baumann PS, Klauser P, Conus P, Tirouvanziam
R, Cuenod M, Do KQ. MMP9/RAGE pathway overactivation mediates redox
dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance:
a reverse translation study in schizophrenia patients. Mol Psychiatry. 2020
Nov;25(11):2889-2904. doi: 10.1038/s41380-019-0393-5. Epub 2019 Mar 25. Erratum
in: Mol Psychiatry. 2020 Mar 26;: PMID: 30911107; PMCID: PMC7577857.
919: Finnerty NJ, Bolger FB, Pålsson E, Lowry JP. An investigation of
hypofrontality in an animal model of schizophrenia using real-time
microelectrochemical sensors for glucose, oxygen, and nitric oxide. ACS Chem
Neurosci. 2013 May 15;4(5):825-31. doi: 10.1021/cn4000567. Epub 2013 Apr 25.
PMID: 23578219; PMCID: PMC3656748.
920: Kristofiková Z, Kozmiková I, Hovorková P, Rícný J, Zach P, Majer E,
Klaschka J, Rípová D. Lateralization of hippocampal nitric oxide mediator system
in people with Alzheimer disease, multi-infarct dementia and schizophrenia.
Neurochem Int. 2008 Nov;53(5):118-25. doi: 10.1016/j.neuint.2008.06.009. Epub
2008 Jul 3. PMID: 18647632.
921: Carlsson C, Dencker SJ. Cerebrospinal uric acid in alcoholics. Acta Neurol
Scand. 1973;49(1):39-46. doi: 10.1111/j.1600-0404.1973.tb01277.x. PMID: 4684592.
922: Bortolasci CC, Marx W, Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi
M, Turner A, Gray L, Berk L, Walder K, Berk M, Dean OM. Minocycline for the
treatment of mental health and neurological conditions: study protocol of a
systematic review and meta-analysis. BMJ Open. 2020 Mar 19;10(3):e035080. doi:
10.1136/bmjopen-2019-035080. PMID: 32198305; PMCID: PMC7103827.
923: Soares-Weiser K, Maayan N, McGrath J. Vitamin E for neuroleptic-induced
tardive dyskinesia. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD000209. doi:
10.1002/14651858.CD000209.pub2. Update in: Cochrane Database Syst Rev. 2018 Jan
17;1:CD000209. PMID: 21328246.
924: Goumeniouk AD, Ancill RJ, MacEwan GW, Koczapski AB. A case of drug-drug
interaction involving clozapine. Can J Psychiatry. 1991 Apr;36(3):234-5. doi:
10.1177/070674379103600324. PMID: 1829392.
925: Thakur KS, Prakash A, Bisht R, Bansal PK. Beneficial effect of candesartan
and lisinopril against haloperidol-induced tardive dyskinesia in rat. J Renin
Angiotensin Aldosterone Syst. 2015 Dec;16(4):917-29. doi:
10.1177/1470320313515038. Epub 2014 Jan 24. PMID: 24464858.
926: Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE,
Moreira JC, Teixeira AL, Lobato MI, Walz JC, Belmonte-de-Abreu PS, KauerSant'Anna M, Kapczinski F, Gama CS. Similarities in serum oxidative stress
markers and inflammatory cytokines in patients with overt schizophrenia at early
and late stages of chronicity. J Psychiatr Res. 2012 Jun;46(6):819-24. doi:
10.1016/j.jpsychires.2012.03.019. Epub 2012 Apr 20. PMID: 22520512.
927: Ebstein R, Belmaker RH, Benbenisty D, Rimon R. Electrophoretic pattern of
red blood cell catechol-o-methyltransferase in schizophrenia and manicdepressive illness. Biol Psychiatry. 1976 Oct;11(5):613-23. PMID: 971452.
928: Pitsikas N, Tarantilis PA. Crocins, the active constituents of Crocus
sativus L., counteracted apomorphine-induced performance deficits in the novel
object recognition task, but not novel object location task, in rats. Neurosci
Lett. 2017 Mar 22;644:37-42. doi: 10.1016/j.neulet.2017.02.042. Epub 2017 Feb
17. PMID: 28216334.
929: Rao ML, Gross G, Strebel B, Halaris A, Huber G, Bräunig P, Marler M.
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in
schizophrenia. Biol Psychiatry. 1994 Feb 1;35(3):151-63. doi:
10.1016/0006-3223(94)91147-9. PMID: 7909693.
930: Yamada K, Kanba S, Anamizu S, Ohnishi K, Ashikari I, Yagi G, Asai M. Low
superoxide dismutase activity in schizophrenic patients with tardive dyskinesia.
Psychol Med. 1997 Sep;27(5):1223-5. doi: 10.1017/s0033291797005114. PMID:
9300527.
931: Markey SP, Boni RL, Yergey JA, Heyes MP. Mass spectrometric determinations
of tryptophan and its metabolites. Adv Exp Med Biol. 1991;294:41-50. doi:
10.1007/978-1-4684-5952-4_4. PMID: 1837685.
932: Monte AS, Mello BSF, Borella VCM, da Silva Araujo T, da Silva FER, Sousa
FCF, de Oliveira ACP, Gama CS, Seeman MV, Vasconcelos SMM, Lucena DF, Macêdo D.
Two-hit model of schizophrenia induced by neonatal immune activation and
peripubertal stress in rats: Study of sex differences and brain oxidative
alterations. Behav Brain Res. 2017 Jul 28;331:30-37. doi:
10.1016/j.bbr.2017.04.057. Epub 2017 May 17. PMID: 28527693.
933: Yuan T, Wang S, Le J, Li Y. Effects of Atypical Antipsychotics on
Neuroactive Vitamins in Patients With Schizophrenia. J Clin Pharmacol. 2020
Oct;60(10):1355-1361. doi: 10.1002/jcph.1625. Epub 2020 May 19. PMID: 32428979.
934: Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPHoxidase in the ketamine model of schizophrenia. J Neurosci. 2008 Dec
17;28(51):13957-66. doi: 10.1523/JNEUROSCI.4457-08.2008. PMID: 19091984; PMCID:
PMC2752712.
935: Fadai F, Mousavi B, Ashtari Z, Ali beigi N, Farhang S, Hashempour S,
Shahhamzei N, Bathaie SZ. Saffron aqueous extract prevents metabolic syndrome in
patients with schizophrenia on olanzapine treatment: a randomized triple blind
placebo controlled study. Pharmacopsychiatry. 2014 Jul;47(4-5):156-61. doi:
10.1055/s-0034-1382001. Epub 2014 Jun 23. PMID: 24955550.
936: Brooks SC, Linn JJ, Disney N. Serotonin, folic acid, and uric acid
metabolism in the diagnosis of neuropsychiatric disorders. Biol Psychiatry. 1978
Dec;13(6):671-84. PMID: 737255.
937: Giangreco B, Dwir D, Klauser P, Jenni R, Golay P, Cleusix M, Baumann PS,
Cuénod M, Conus P, Toni N, Do KQ. Characterization of early psychosis patients
carrying a genetic vulnerability to redox dysregulation: a computational
analysis of mechanism-based gene expression profile in fibroblasts. Mol
Psychiatry. 2023 May;28(5):1983-1994. doi: 10.1038/s41380-023-02034-x. Epub 2023
Mar 31. PMID: 37002404; PMCID: PMC10575782.
938: Chakŭrski I, Stefanov G, Belovezhdov N. Ostro otraviane s alopurinol
(milurit) [Acute allopurinol (milurit) poisoning]. Vutr Boles. 1985;24(1):136-9.
Bulgarian. PMID: 4024604.
939: Robinson S, Rosca P, Durst R, Shai U, Ghinea C, Schmidt U, Nir I. Serum
melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Acta Psychiatr Scand. 1991 Sep;84(3):221-4. doi:
10.1111/j.1600-0447.1991.tb03133.x. PMID: 1950621.
940: Ishitobi M, Kosaka H, Shukunami K, Murata T, Wada Y. Adjunctive treatment
with low-dosage pramipexole for risperidone-associated hyperprolactinemia and
sexual dysfunction in a male patient with schizophrenia. J Clin Psychopharmacol.
2011 Apr;31(2):243-5. doi: 10.1097/JCP.0b013e31820f4fbd. PMID: 21364336.
941: BRUNO A, BOZZI R, ALLEGRANZA A, DEVITO C. L'ELIMINAZIONE DEI PRINCIPALI
METABOLITI URINARI DELLA SEROTONINA, DOPAMINA, NORADRENALINA, ADRENALINA DURANTE
TRATTAMENTO CON RESERPINA E CON CLOROPROMAZINA IN SOGGETTI SCHIZOFRENICI.
CORRELAZIONI CLINICO-BIOLOGICHE [ELIMINATION OF THE PRINCIPAL URINARY
METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING
TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS.
CLINICO-BIOLOGICAL CORRELATIONS]. Riv Patol Nerv Ment. 1963 Sep;84:451-92.
Italian. PMID: 14153094.
942: Hui CW, Bhardwaj SK, Sharma K, Joseph AT, Bisht K, Picard K, Tremblay MÈ,
Srivastava LK. Microglia in the developing prefrontal cortex of rats show
dynamic changes following neonatal disconnection of the ventral hippocampus.
Neuropharmacology. 2019 Mar 1;146:264-275. doi:
10.1016/j.neuropharm.2018.12.007. Epub 2018 Dec 8. PMID: 30537477.
943: Hensley K, Christov A, Kamat S, Zhang XC, Jackson KW, Snow S, Post J.
Proteomic identification of binding partners for the brain metabolite
lanthionine ketimine (LK) and documentation of LK effects on microglia and
motoneuron cell cultures. J Neurosci. 2010 Feb 24;30(8):2979-88. doi:
10.1523/JNEUROSCI.5247-09.2010. PMID: 20181595; PMCID: PMC2836831.
944: Iranpour N, Zandifar A, Farokhnia M, Goguol A, Yekehtaz H, Khodaie-Ardakani
MR, Salehi B, Esalatmanesh S, Zeionoddini A, Mohammadinejad P, Zeinoddini A,
Akhondzadeh S. The effects of pioglitazone adjuvant therapy on negative symptoms
of patients with chronic schizophrenia: a double-blind and placebo-controlled
trial. Hum Psychopharmacol. 2016 Mar;31(2):103-12. doi: 10.1002/hup.2517. Epub
2016 Feb 8. PMID: 26856695.
945: Miyaoka T, Ieda M, Hashioka S, Wake R, Furuya M, Liaury K, Hayashida M,
Tsuchie K, Arauchi R, Araki T, Shioji I, Ezoe S, Inoue K, Yamaguchi T, Horiguchi
J. Analysis of oxidative stress expressed by urinary level of biopyrrins and
8-hydroxydeoxyguanosine in patients with chronic schizophrenia. Psychiatry Clin
Neurosci. 2015 Nov;69(11):693-8. doi: 10.1111/pcn.12319. Epub 2015 Jul 14. PMID:
25975810.
946: Sagara Y. Induction of reactive oxygen species in neurons by haloperidol. J
Neurochem. 1998 Sep;71(3):1002-12. doi: 10.1046/j.1471-4159.1998.71031002.x.
PMID: 9721725.
947: Park SJ, Lee Y, Oh HK, Lee HE, Lee Y, Ko SY, Kim B, Cheong JH, Shin CY, Ryu
JH. Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in
mice. Neuropharmacology. 2014 Nov;86:49-56. doi:
10.1016/j.neuropharm.2014.06.025. Epub 2014 Jul 2. PMID: 24997455.
948: Jones RL, McGeer PL, Greiner AC. Metabolism of exogenous melatonin in
schizophrenic and non-schizophrenic volunteers. Clin Chim Acta. 1969
Nov;26(2):281-5. doi: 10.1016/0009-8981(69)90379-9. PMID: 4242832.
949: Benítez-King G, Ortíz-López L, Jiménez-Rubio G, Ramírez-Rodríguez G.
Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau
hyperphosphorylation induced by oxidative stress: Implications for
neurodevelopment. Eur J Pharmacol. 2010 Oct 10;644(1-3):24-31. doi:
10.1016/j.ejphar.2010.06.057. Epub 2010 Jul 13. PMID: 20621083.
950: Lin CH, Lin CH, Chang YC, Huang YJ, Chen PW, Yang HT, Lane HY. Sodium
Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment
of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial. Biol
Psychiatry. 2018 Sep 15;84(6):422-432. doi: 10.1016/j.biopsych.2017.12.006. Epub
2017 Dec 26. PMID: 29397899.
951: Herrmann AP, Benvenutti R, Pilz LK, Elisabetsky E. N-acetylcysteine
prevents increased amphetamine sensitivity in social isolation-reared mice.
Schizophr Res. 2014 May;155(1-3):109-11. doi: 10.1016/j.schres.2014.03.012. Epub
2014 Apr 13. PMID: 24725851.
952: Fanget F, Claustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat
J. Mélatonine et schizophrénie [Melatonin and schizophrenia]. Encephale. 1989
Nov-Dec;15(6):505-10. French. PMID: 2575517.
953: Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan
P, Houle S, Wilson AA, Kapur S. The effect of antipsychotics on the highaffinity state of D2 and D3 receptors: a positron emission tomography study With
[11C]-(+)-PHNO. Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi:
10.1001/archgenpsychiatry.2009.43. PMID: 19487625.
954: Kulak A, Cuenod M, Do KQ. Behavioral phenotyping of glutathione-deficient
mice: relevance to schizophrenia and bipolar disorder. Behav Brain Res. 2012 Jan
15;226(2):563-70. doi: 10.1016/j.bbr.2011.10.020. Epub 2011 Oct 20. PMID:
22033334.
955: Cyr M, Calon F, Morissette M, Grandbois M, Di Paolo T, Callier S. Drugs
with estrogen-like potency and brain activity: potential therapeutic application
for the CNS. Curr Pharm Des. 2000 Aug;6(12):1287-312. doi:
10.2174/1381612003399725. PMID: 10903393.
956: Shriqui CL, Bradwejn J, Annable L, Jones BD. Vitamin E in the treatment of
tardive dyskinesia: a double-blind placebo-controlled study. Am J Psychiatry.
1992 Mar;149(3):391-3. doi: 10.1176/ajp.149.3.391. PMID: 1346951.
957: Schorah CJ, Morgan DB, Hullin RP. Plasma vitamin C concentrations in
patients in a psychiatric hospital. Hum Nutr Clin Nutr. 1983 Dec;37(6):447-52.
PMID: 6668228.
958: Al-Amin MM, Sultana R, Sultana S, Rahman MM, Reza HM. Astaxanthin
ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in
adult offspring. BMC Neurosci. 2016 Feb 8;17:11. doi: 10.1186/s12868-016-0245-z.
PMID: 26856812; PMCID: PMC4746928.
959: Uzbay T, Parlakpinar H, Akdag E, Celik T, Yararbas G, Ulusoy G, Acet A,
Kose A, Kayir H. Chronic melatonin treatment reverses disruption of prepulse
inhibition in pinealectomized and pinealectomized-plus-ovariectomized rats.
Behav Brain Res. 2013 Feb 15;239:1-7. doi: 10.1016/j.bbr.2012.10.008. Epub 2012
Oct 16. PMID: 23078952.
960: Coleman M. A crossover study of allopurinol administration to a
schizophrenic child. J Autism Child Schizophr. 1974 Sep;4(3):231-40. doi:
10.1007/BF02115229. PMID: 4613729.
961: Alertsen AR, Aukrust A, Skaug OE. Selenium concentrations in blood and
serum from patients with mental diseases. Acta Psychiatr Scand. 1986
Aug;74(2):217-9. doi: 10.1111/j.1600-0447.1986.tb10608.x. PMID: 3776668.
962: Barchas JD, Evans C, Elliott GR, Berger PA. Peptide neuroregulators: the
opioid system as a model. Yale J Biol Med. 1985 Nov-Dec;58(6):579-96. PMID:
2938344; PMCID: PMC2589971.
963: Horrobin DF. Schizophrenia: Reconciliation of the dopamine, prostaglandin,
and opioid concepts and the role of the pineal. Lancet. 1979 Mar
10;1(8115):529-31. doi: 10.1016/s0140-6736(79)90948-6. PMID: 85110.
964: Mielke DH, Gallant DM, Bishop MP. Milipertine: an early evaluation in
severely ill schizophrenics. Curr Ther Res Clin Exp. 1973 Jun;15(6):324-6. PMID:
4197256.
965: Crupi R, Marino A, Cuzzocrea S. n-3 fatty acids: role in neurogenesis and
neuroplasticity. Curr Med Chem. 2013;20(24):2953-63. doi:
10.2174/09298673113209990140. PMID: 23746276.
966: Pillai A, Parikh V, Terry AV Jr, Mahadik SP. Long-term antipsychotic
treatments and crossover studies in rats: differential effects of typical and
atypical agents on the expression of antioxidant enzymes and membrane lipid
peroxidation in rat brain. J Psychiatr Res. 2007 Aug;41(5):372-86. doi:
10.1016/j.jpsychires.2006.01.011. Epub 2006 Mar 27. PMID: 16564057.
967: Dubé M. Scurvy in a man with schizophrenia. CMAJ. 2011 Aug 9;183(11):E760.
doi: 10.1503/cmaj.080505. Epub 2011 May 9. PMID: 21555385; PMCID: PMC3153552.
968: Pålsson E, Lowry J, Klamer D. Information processing deficits and nitric
oxide signalling in the phencyclidine model of schizophrenia. Psychopharmacology
(Berl). 2010 Dec;212(4):643-51. doi: 10.1007/s00213-010-1992-7. Epub 2010 Aug
28. PMID: 20802999.
969: Islam A, Kagawa Y, Miyazaki H, Shil SK, Umaru BA, Yasumoto Y, Yamamoto Y,
Owada Y. FABP7 Protects Astrocytes Against ROS Toxicity via Lipid Droplet
Formation. Mol Neurobiol. 2019 Aug;56(8):5763-5779. doi:
10.1007/s12035-019-1489-2. Epub 2019 Jan 24. PMID: 30680690.
970: Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C,
Jeste DV, Wyatt RJ. Vitamin E in the treatment of tardive dyskinesia: the
possible involvement of free radical mechanisms. Schizophr Bull.
1988;14(2):291-6. doi: 10.1093/schbul/14.2.291. PMID: 2904696.
971: El Khoueiry C, Cabungcal JH, Rovó Z, Fournier M, Do KQ, Steullet P.
Developmental oxidative stress leads to T-type Ca²⁺ channel
hypofunction in thalamic reticular nucleus of mouse models pertinent to
schizophrenia. Mol Psychiatry. 2022 Apr;27(4):2042-2051. doi:
10.1038/s41380-021-01425-2. Epub 2022 Jan 25. PMID: 35079122; PMCID: PMC9126813.
972: Puzyński S. Investigations on ceruloplasmin in chronic schizophrenia. Pol
Med J. 1966;5(6):1484-91. PMID: 4166118.
973: Bishnoi M, Chopra K, Kulkarni SK. Protective effect of rutin, a
polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and
associated behavioural, biochemical and neurochemical changes. Fundam Clin
Pharmacol. 2007 Oct;21(5):521-9. doi: 10.1111/j.1472-8206.2007.00512.x. PMID:
17868205.
974: Lis AW, Bijan R, Lis EW, De Hackbeil KF. Ultraviolet-absorbing urinary
components of mentally retarded children and schizophrenic adults. Clin Chem.
1968 May;14(5):391-402. PMID: 4231276.
975: Yilmaz N, Herken H, Cicek HK, Celik A, Yürekli M, Akyol O. Increased levels
of nitric oxide, cortisol and adrenomedullin in patients with chronic
schizophrenia. Med Princ Pract. 2007;16(2):137-41. doi: 10.1159/000098367. PMID:
17303950.
976: Maes M, Vojdani A, Sirivichayakul S, Barbosa DS, Kanchanatawan B.
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode
Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are
Additional Drug Targets in First Episode Schizophrenia. Mol Neurobiol. 2021
Jul;58(7):3319-3334. doi: 10.1007/s12035-021-02343-8. Epub 2021 Mar 6. PMID:
33675500.
977: Lutgen V, Qualmann K, Resch J, Kong L, Choi S, Baker DA. Reduction in
phencyclidine induced sensorimotor gating deficits in the rat following
increased system xc⁻ activity in the medial prefrontal cortex.
Psychopharmacology (Berl). 2013 Apr;226(3):531-40. doi:
10.1007/s00213-012-2926-3. Epub 2012 Nov 29. PMID: 23192314; PMCID: PMC3595356.
978: Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B.
Glutathione transferases catalyse the detoxication of oxidized metabolites
(o-quinones) of catecholamines and may serve as an antioxidant system preventing
degenerative cellular processes. Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):25-8.
doi: 10.1042/bj3240025. PMID: 9164836; PMCID: PMC1218396.
979: Yi W, Cheng J, Song J, Pan R, Liang Y, Sun X, Li Y, Wu Y, Yan S, Jin X, Mei
L, Cheng J, Zhang X, Su H. Associations of polycyclic aromatic hydrocarbons,
water-soluble ions and metals in PM_2.5 with liver function: Evidence
from schizophrenia cohort. Sci Total Environ. 2023 Apr 10;868:161624. doi:
10.1016/j.scitotenv.2023.161624. Epub 2023 Jan 20. PMID: 36681036.
980: Dassati S, Waldner A, Schweigreiter R. Apolipoprotein D takes center stage
in the stress response of the aging and degenerative brain. Neurobiol Aging.
2014 Jul;35(7):1632-42. doi: 10.1016/j.neurobiolaging.2014.01.148. Epub 2014 Feb
5. PMID: 24612673; PMCID: PMC3988949.
981: Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS. Elevated
plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry.
1998 May 1;43(9):674-9. doi: 10.1016/s0006-3223(97)00282-5. PMID: 9583001.
982: Dietrich-Muszalska A, Olas B. Inhibitory effects of polyphenol compounds on
lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in
human plasma in vitro. World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):276-81. doi:
10.1080/15622970902718790. PMID: 19225991.
983: Pitsikas N. <i>Crocus sativus</i> L. Extracts and Its Constituents Crocins
and Safranal; Potential Candidates for Schizophrenia Treatment? Molecules. 2021
Feb 25;26(5):1237. doi: 10.3390/molecules26051237. PMID: 33669124; PMCID:
PMC7956290.
984: Vilkov GA, Stepanenko EM, Khoruzhaia TA. Vliianie protivomozgovykh antitel
na protsess perekisnogo okisleniia lipidov v mozge [Effect of brain antibodies
on the lipid peroxidation process in the brain]. Biull Eksp Biol Med. 1985
Jan;99(1):48-50. Russian. PMID: 3967070.
985: Rosse RB, Theut SK, Banay-Schwartz M, Leighton M, Scarcella E, Cohen CG,
Deutsch SI. Glycine adjuvant therapy to conventional neuroleptic treatment in
schizophrenia: an open-label, pilot study. Clin Neuropharmacol. 1989
Oct;12(5):416-24. doi: 10.1097/00002826-198910000-00006. PMID: 2611765.
986: Canever L, Freire TG, Mastella GA, Damázio L, Gomes S, Fachim I, Michels C,
Carvalho G, Godói AK, Peterle BR, Gava FF, Valvassori SS, Budni J, Quevedo J,
Zugno AI. Changes in behavioural parameters, oxidative stress and neurotrophins
in the brain of adult offspring induced to an animal model of schizophrenia: The
effects of FA deficient or FA supplemented diet during the neurodevelopmental
phase. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:52-64. doi:
10.1016/j.pnpbp.2018.05.014. Epub 2018 May 18. PMID: 29782958.
987: Shopsin B, Kim SS, Gershon S. A controlled study of lithium vs.
chlorpromazine in acute schizophrenics. Br J Psychiatry. 1971
Oct;119(551):435-40. doi: 10.1192/bjp.119.551.435. PMID: 4942959.
988: Megavitamin and orthomolecular therapy in psychiatry. Nutr Rev. 1974
Jul;32(0):suppl 1:44-7. doi: 10.1111/j.1753-4887.1974.tb05190.x. PMID: 4367658.
989: Flemenbaum A, Anderson RP. Field dependence and blood cholesterol: an
expansion. Percept Mot Skills. 1978 Jun;46(3 Pt 1):867-74. doi:
10.2466/pms.1978.46.3.867. PMID: 673646.
990: Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI. N-acetyl
cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and
d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
Neurosci Lett. 2011 Jul 25;499(3):149-53. doi: 10.1016/j.neulet.2011.05.027.
Epub 2011 May 20. PMID: 21621586.
991: Spring KR, Billy EJ, Ruskin PF. Stimulated parotid fluid of schizophrenics.
J Dent Res. 1968 Nov-Dec;47(6):1199. doi: 10.1177/00220345680470064501. PMID:
5249066.
992: Cercós MG, Galván-Arrieta T, Valdés-Tovar M, Solís-Chagoyán H, Argueta J,
Benítez-King G, Trueta C. Abnormally Increased Secretion in Olfactory Neuronal
Precursors from a Case of Schizophrenia Is Modulated by Melatonin: A Pilot
Study. Int J Mol Sci. 2017 Jul 13;18(7):1439. doi: 10.3390/ijms18071439. PMID:
28703738; PMCID: PMC5535930.
993: Cunnane SC, Manku MS, Horrobin DF. The pineal and regulation of fibrosis:
pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and
prostaglandins in fibrosis and regulation of T lymphocytes. Med Hypotheses. 1979
Apr;5(4):403-14. doi: 10.1016/0306-9877(79)90107-5. PMID: 313500.
994: Heiser P, Sommer O, Schmidt AJ, Clement HW, Hoinkes A, Hopt UT, Schulz E,
Krieg JC, Dobschütz E. Effects of antipsychotics and vitamin C on the formation
of reactive oxygen species. J Psychopharmacol. 2010 Oct;24(10):1499-504. doi:
10.1177/0269881109102538. Epub 2009 Mar 12. PMID: 19282419.
995: Matsuura A, Ishima T, Fujita Y, Iwayama Y, Hasegawa S, Kawahara-Miki R,
Maekawa M, Toyoshima M, Ushida Y, Suganuma H, Kida S, Yoshikawa T, Iyo M,
Hashimoto K. Dietary glucoraphanin prevents the onset of psychosis in the adult
offspring after maternal immune activation. Sci Rep. 2018 Feb 1;8(1):2158. doi:
10.1038/s41598-018-20538-3. PMID: 29391571; PMCID: PMC5794794.
996: Degrell I, Nagy E. Concentration gradients for HVA, 5-HIAA, ascorbic acid,
and uric acid in cerebrospinal fluid. Biol Psychiatry. 1990 Apr 15;27(8):891-6.
doi: 10.1016/0006-3223(90)90470-m. PMID: 1691925.
997: Hoes MJ. Biological markers in psychiatry. Acta Psychiatr Belg. 1986 MayJun;86(3):220-41. PMID: 2428209.
998: Gulidova GP, Khzardzhian VG, Mikhaĭlova NM. Vliianie litiia na
énergeticheskiĭ metabolizm nervnoi tkani [Effect of lithium on the energy
metabolism of nervous tissue]. Zh Nevropatol Psikhiatr Im S S Korsakova.
1977;77(8):1179-86. Russian. PMID: 143178.
999: Kasper S, Barnas C, Heiden A, Volz HP, Laakmann G, Zeit H, Pfolz H.
Pramipexole as adjunct to haloperidol in schizophrenia. Safety and efficacy. Eur
Neuropsychopharmacol. 1997 Feb;7(1):65-70. doi: 10.1016/s0924-977x(96)00393-8.
PMID: 9088887.
1000: Asada S, Ishimaru T, Kubo S, Kodama H, Masuda K. Etude des effets
cliniques du sulpiride et de la perphénazine chez 82 schizophrènes par la
méthode du double aveugle [Study of the clinical effects of sulpiride and
perphenazine in 82 schizophrenic patients by the double blind method].
Encephale. 1976;2(1):73-83. French. PMID: 770152.
1001: Soares-Weiser K, Maayan N, Bergman H. Vitamin E for antipsychotic-induced
tardive dyskinesia. Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000209. doi:
10.1002/14651858.CD000209.pub3. PMID: 29341067; PMCID: PMC6491331.
1002: Hofmann G, Kryspin-Exner K. Stoffwechseluntersuchungen bei Alkoholkranken
[Metabolic investigations in alcoholics]. Wien Z Nervenheilkd Grenzgeb.
1966;23(4):275-87. German. PMID: 4226901.
1003: Johnston VS, Bradley RJ. Molecular pharmacology of hallucinogens. Recent
Adv Biol Psychiatry. 1968;10:74-99. doi: 10.1007/978-1-4684-9072-5_8. PMID:
4872761.
1004: Young J, Wahle KW, Boyle SP. Cytoprotective effects of phenolic
antioxidants and essential fatty acids in human blood monocyte and neuroblastoma
cell lines: surrogates for neurological damage in vivo. Prostaglandins Leukot
Essent Fatty Acids. 2008 Jan;78(1):45-59. doi: 10.1016/j.plefa.2007.10.005. Epub
2007 Nov 26. PMID: 18036798.
1005: Khadimallah I, Jenni R, Cabungcal JH, Cleusix M, Fournier M, Beard E,
Klauser P, Knebel JF, Murray MM, Retsa C, Siciliano M, Spencer KM, Steullet P,
Cuenod M, Conus P, Do KQ. Mitochondrial, exosomal miR137-COX6A2 and gamma
synchrony as biomarkers of parvalbumin interneurons, psychopathology, and
neurocognition in schizophrenia. Mol Psychiatry. 2022 Feb;27(2):1192-1204. doi:
10.1038/s41380-021-01313-9. Epub 2021 Oct 22. PMID: 34686767; PMCID: PMC9054672.
1006: Baandrup L, Fagerlund B, Jennum P, Lublin H, Hansen JL, Winkel P, Gluud C,
Oranje B, Glenthoj BY. Prolonged-release melatonin versus placebo for
benzodiazepine discontinuation in patients with schizophrenia: a randomized
clinical trial - the SMART trial protocol. BMC Psychiatry. 2011 Oct 5;11:160.
doi: 10.1186/1471-244X-11-160. PMID: 21975110; PMCID: PMC3213077.
1007: Baandrup L, Glenthøj BY, Jennum PJ. Objective and subjective sleep
quality: Melatonin versus placebo add-on treatment in patients with
schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.
Psychiatry Res. 2016 Jun 30;240:163-169. doi: 10.1016/j.psychres.2016.04.031.
Epub 2016 Apr 15. PMID: 27107670.
1008: Song W, Zukor H, Lin SH, Hascalovici J, Liberman A, Tavitian A, Mui J,
Vali H, Tong XK, Bhardwaj SK, Srivastava LK, Hamel E, Schipper HM.
Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the
astrocytic compartment. J Neurosci. 2012 Aug 8;32(32):10841-53. doi:
10.1523/JNEUROSCI.6469-11.2012. PMID: 22875919; PMCID: PMC6621004.
1009: Sandyk R, Kay SR. The relationship of pineal calcification and melatonin
secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome.
Int J Neurosci. 1991 Jun;58(3-4):215-47. doi: 10.3109/00207459108985437. PMID:
1365044.
1010: Weng R, Shen S, Tian Y, Burton C, Xu X, Liu Y, Chang C, Bai Y, Liu H.
Metabolomics Approach Reveals Integrated Metabolic Network Associated with
Serotonin Deficiency. Sci Rep. 2015 Jul 8;5:11864. doi: 10.1038/srep11864. PMID:
26154191; PMCID: PMC4495385.
1011: Bennett DR, Baird CJ, Chan KM, Crookes PF, Bremner CG, Gottlieb MM,
Naritoku WY. Zinc toxicity following massive coin ingestion. Am J Forensic Med
Pathol. 1997 Jun;18(2):148-53. doi: 10.1097/00000433-199706000-00008. PMID:
9185931.
1012: Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin
E treatment of tardive dyskinesia. J Clin Psychiatry. 1996 Apr;57(4):167-73.
PMID: 8601552.
1013: Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM. Evidence for
involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release
of glutamate in rat prefrontal cortex. Neuropharmacology. 2012 Sep;63(4):575-81.
doi: 10.1016/j.neuropharm.2012.04.032. Epub 2012 May 9. PMID: 22579658; PMCID:
PMC3392446.
1014: Zhang Z, Zhang X, Hou G, Sha W, Reynolds GP. The increased activity of
plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the
Ala-9Val polymorphism. J Psychiatr Res. 2002 Sep-Oct;36(5):317-24. doi:
10.1016/s0022-3956(02)00007-9. PMID: 12127599.
1015: Camacho-Ochoa M, Walker EL, Evans DL, Piercey MF. Rat brain binding sites
for pramipexole, a clinically useful D3-preferring dopamine agonist. Neurosci
Lett. 1995 Aug 18;196(1-2):97-100. doi: 10.1016/0304-3940(95)11857-s. PMID:
7501268.
1016: Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, Beiram
R, Stark H, Łażewska D, Kieć-Kononowicz K, Sadek B. The Dual-Active Histamine
H₃ Receptor Antagonist and Acetylcholine Esterase Inhibitor E100
Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced
Autism in Mice. Int J Mol Sci. 2020 Jun 3;21(11):3996. doi:
10.3390/ijms21113996. PMID: 32503208; PMCID: PMC7312782.
1017: Lavoie S, Chen Y, Dalton TP, Gysin R, Cuénod M, Steullet P, Do KQ.
Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and
neurons: importance of the glutamate cysteine ligase modifier subunit. J
Neurochem. 2009 Mar;108(6):1410-22. doi: 10.1111/j.1471-4159.2009.05908.x. Epub
2009 Jan 22. PMID: 19183254.
1018: Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of
metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol
Pharmacol. 2000 Jul;58(1):207-16. doi: 10.1124/mol.58.1.207. PMID: 10860943.
1019: Zhang Z, Hou G, Zhang X, Yao H, Sha W, Zhang X. [Pharmacogenetic
assessment of antipsychotic-induced tardive dyskinesia: contribution of
5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant
allele (Gly) and MnSOD wild allele (Val)]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
2003 Apr;20(2):98-102. Chinese. PMID: 12673575.
1020: Dutta A, Karanth SS, Bhattacharya M, Liput M, Augustyniak J, Cheung M,
Stachowiak EK, Stachowiak MK. A proof of concept 'phase zero' study of
neurodevelopment using brain organoid models with Vis/near-infrared spectroscopy
and electrophysiology. Sci Rep. 2020 Dec 2;10(1):20987. doi:
10.1038/s41598-020-77929-8. PMID: 33268815; PMCID: PMC7710726.
1021: Lockwood JT, Remington G. Emerging drugs for antipsychotic-induced tardive
dyskinesia: investigational drugs in Phase II and Phase III clinical trials.
Expert Opin Emerg Drugs. 2015 Sep;20(3):407-21. doi:
10.1517/14728214.2015.1050376. Epub 2015 Jul 15. PMID: 26166007.
1022: Kamińska T, Szuster-Ciesielska A, Wysocka A, Marmurowska-Michałowska H,
Dubas-Slemp H, Kandefer-Szerszeń M. Serum cytokine level and production of
reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient
with hypersensitivity to neuroleptics. Med Sci Monit. 2003 Jul;9(7):CS71-5.
PMID: 12883457.
1023: Siva Sankar DV. Plasma levels of folates, riboflavin, vitamin B6, and
ascorbate in severely disturbed children. J Autism Dev Disord. 1979
Mar;9(1):73-82. doi: 10.1007/BF01531294. PMID: 438115.
1024: Libov I, Miodownik C, Bersudsky Y, Dwolatzky T, Lerner V. Efficacy of
piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a
randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry.
2007 Jul;68(7):1031-7. doi: 10.4088/jcp.v68n0709. PMID: 17685739.
1025: Torrey EF, Davis JM. Adjunct treatments for schizophrenia and bipolar
disorder: what to try when you are out of ideas. Clin Schizophr Relat Psychoses.
2012 Jan;5(4):208-216. doi: 10.3371/CSRP.5.4.5. PMID: 22182458.
1026: Möller M, Du Preez JL, Harvey BH. Development and validation of a single
analytical method for the determination of tryptophan, and its kynurenine
metabolites in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2012
Jun 1;898:121-9. doi: 10.1016/j.jchromb.2012.04.030. Epub 2012 May 4. PMID:
22608808.
1027: van Praag HM. Indoleamines and the central nervous system; a sounding of
their clinical significance. Psychiatr Neurol Neurochir. 1970 JanFeb;73(1):9-36. PMID: 4313906.
1028: Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci
CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of
Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol
Neurobiol. 2022 Jun;59(6):3485-3503. doi: 10.1007/s12035-022-02800-y. Epub 2022
Mar 26. PMID: 35347586.
1029: Goodman AB. A family history study of schizophrenia spectrum disorders
suggests new candidate genes in schizophrenia and autism. Psychiatr Q. 1994
Winter;65(4):287-97. doi: 10.1007/BF02354305. PMID: 7831415.
1030: Roser P, Vollenweider FX, Kawohl W. Potential antipsychotic properties of
central cannabinoid (CB1) receptor antagonists. World J Biol Psychiatry. 2010
Mar;11(2 Pt 2):208-19. doi: 10.3109/15622970801908047. PMID: 20218784.
1031: Eftekhari A, Azarmi Y, Parvizpur A, Eghbal MA. Involvement of oxidative
stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in
freshly isolated rat hepatocytes. Xenobiotica. 2016;46(4):369-78. doi:
10.3109/00498254.2015.1078522. Epub 2015 Sep 12. PMID: 26364812.
1032: Zhang XY, Zhang WF, Zhou DF, Chen DC, Xiu MH, Wu HR, Haile CN, Kosten TA,
Kosten TR. Brain-derived neurotrophic factor levels and its Val66Met gene
polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
Biol Psychiatry. 2012 Oct 15;72(8):700-6. doi: 10.1016/j.biopsych.2012.04.032.
Epub 2012 Jun 12. PMID: 22695185.
1033: Ye Y, Mastwal S, Cao VY, Ren M, Liu Q, Zhang W, Elkahloun AG, Wang KH.
Dopamine is Required for Activity-Dependent Amplification of Arc mRNA in
Developing Postnatal Frontal Cortex. Cereb Cortex. 2017 Jul 1;27(7):3600-3608.
doi: 10.1093/cercor/bhw181. PMID: 27365296; PMCID: PMC6059174.
1034: Bienfait KL, Menza M, Mark MH, Dobkin RD. Impulsive smoking in a patient
with Parkinson's disease treated with dopamine agonists. J Clin Neurosci. 2010
Apr;17(4):539-40. doi: 10.1016/j.jocn.2009.09.001. Epub 2010 Feb 19. PMID:
20171891; PMCID: PMC2834808.
1035: Dietrich-Muszalska A, Olas B, Kontek B, Rabe-Jabłońska J. Beta-glucan from
Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by
haloperidol. Int J Biol Macromol. 2011 Jul 1;49(1):113-6. doi:
10.1016/j.ijbiomac.2011.03.007. Epub 2011 Mar 21. PMID: 21421004.
1036: Hadjiconstantinou M, Neff NH. Catecholamine systems of retina: a model for
studying synaptic mechanisms. Life Sci. 1984 Sep 10;35(11):1135-47. doi:
10.1016/0024-3205(84)90184-x. PMID: 6147740.
1037: McCulloch CE, Lin H, Slate EH, Turnbull BW. Discovering subpopulation
structure with latent class mixed models. Stat Med. 2002 Feb 15;21(3):417-29.
doi: 10.1002/sim.1027. PMID: 11813228.
1038: Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD. Olanzapine-induced
weight gain and increased visceral adiposity is blocked by melatonin replacement
therapy in rats. Neuropsychopharmacology. 2007 Feb;32(2):284-8. doi:
10.1038/sj.npp.1301093. Epub 2006 May 10. PMID: 16710316.
1039: Möller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH. Social
isolation rearing induces mitochondrial, immunological, neurochemical and
behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
Brain Behav Immun. 2013 May;30:156-67. doi: 10.1016/j.bbi.2012.12.011. Epub 2012
Dec 25. PMID: 23270677.
1040: Tran TV, Shin EJ, Jeong JH, Lee JW, Lee Y, Jang CG, Nah SY, Lei XG,
Toriumi K, Yamada K, Nabeshima T, Kim HC. Protective Potential of the
Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in
Mice. Mol Neurobiol. 2017 Nov;54(9):7042-7062. doi: 10.1007/s12035-016-0239-y.
Epub 2016 Oct 28. PMID: 27796745.
1041: Woodrow KM. Gilles de la Tourette's disease--a review. Am J Psychiatry.
1974 Sep;131(9):1000-3. doi: 10.1176/ajp.131.9.1000. PMID: 4606588.
1042: Xu Q, Jia YB, Zhang BY, Zou K, Tao YB, Wang YP, Qiang BQ, Wu GY, Shen Y,
Ji HK, Huang Y, Sun XQ, Ji L, Li YD, Yuan YB, Shu L, Yu X, Shen YC, Yu YQ, Ju
GZ; Chinese Schizophrenia Consortium. Association study of an SNP combination
pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy
for complex disorders. Mol Psychiatry. 2004 May;9(5):510-21. doi:
10.1038/sj.mp.4001472. PMID: 14745454.
1043: Lerner PP, Miodownik C, Lerner V. Tardive dyskinesia (syndrome): Current
concept and modern approaches to its management. Psychiatry Clin Neurosci. 2015
Jun;69(6):321-34. doi: 10.1111/pcn.12270. Epub 2015 Feb 9. PMID: 25556809.
1044: Kato T, Monji A, Hashioka S, Kanba S. Risperidone significantly inhibits
interferon-gamma-induced microglial activation in vitro. Schizophr Res. 2007
May;92(1-3):108-15. doi: 10.1016/j.schres.2007.01.019. Epub 2007 Mar 23. PMID:
17363222.
1045: Lerner V, Miodownik C, Kaptsan A, Bersudsky Y, Libov I, Sela BA, Witztum
E. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind,
placebo-controlled, crossover study. J Clin Psychiatry. 2007 Nov;68(11):1648-54.
doi: 10.4088/jcp.v68n1103. PMID: 18052557.
1046: Delay J, Boissier JR, Deniker P, Simon P, Ginestet D, Wirz-Justice A.
Troubles biochimiques cérébraux et maladies mentales. A propos de la "pink spot"
[Cerebral biochemical disorders and mental diseases. A propos of the "pink
spot"]. Encephale. 1969 Jul-Aug;58(4):360-76. French. PMID: 5378191.
1047: Stefanis N, Bozi M, Christodoulou C, Douzenis A, Gasparinatos G,
Stamboulis E, Stefanis C, Stefanis L. Isolated delusional syndrome in
Parkinson's Disease. Parkinsonism Relat Disord. 2010 Sep;16(8):550-2. doi:
10.1016/j.parkreldis.2010.06.010. PMID: 20620094.
1048: Serafetinides EA, Collins S, Clark ML. Haloperidol, clopenthixol, and
chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as
therapeutic alternatives. J Nerv Ment Dis. 1972 Jan;154(1):31-42. doi:
10.1097/00005053-197201000-00005. PMID: 4550211.
1049: Ben-Shachar D, Zuk R, Gazawi H, Ljubuncic P. Dopamine toxicity involves
mitochondrial complex I inhibition: implications to dopamine-related
neuropsychiatric disorders. Biochem Pharmacol. 2004 May 15;67(10):1965-74. doi:
10.1016/j.bcp.2004.02.015. PMID: 15130772.
1050: Ikeda Y, Inagi R, Miyata T, Nagai R, Arai M, Miyashita M, Itokawa M,
Fujita T, Nangaku M. Glyoxalase I retards renal senescence. Am J Pathol. 2011
Dec;179(6):2810-21. doi: 10.1016/j.ajpath.2011.08.023. Epub 2011 Oct 12. PMID:
22001178; PMCID: PMC3260855.
1051: Barnes AJ, Gutteridge JM, Stocks J, Dormandy TL. Haemolytic syndrome
associated with a red cell lipid abnormality. Br Med J. 1973 May
26;2(5864):462-3. doi: 10.1136/bmj.2.5864.462. PMID: 4712487; PMCID: PMC1589455.
1052: Simpson GM. The treatment of tardive dyskinesia and tardive dystonia. J
Clin Psychiatry. 2000;61 Suppl 4:39-44. PMID: 10739330.
1053: Brandy-García AM, Cabezas-Rodríguez I, Caravia-Durán D, Caminal-Montero L.
Hemarthrosis and scurvy. Reumatol Clin. 2017 Nov-Dec;13(6):364-365. English,
Spanish. doi: 10.1016/j.reuma.2017.03.001. Epub 2017 Apr 19. PMID: 28433625.
1054: Cha HY, Yang SJ, Kim SW. Higher Dietary Inflammation in Patients with
Schizophrenia: A Case-Control Study in Korea. Nutrients. 2021 Jun 13;13(6):2033.
doi: 10.3390/nu13062033. PMID: 34199231; PMCID: PMC8231973.
1055: Vu M, Tortorice K, Zacher J, Dong D, Hur K, Zhang R, Good CB, Glassman PA,
Cunningham FE. Assessment of Use and Safety of Edaravone for Amyotrophic Lateral
Sclerosis in the Veterans Affairs Health Care System. JAMA Netw Open. 2020 Oct
1;3(10):e2014645. doi: 10.1001/jamanetworkopen.2020.14645. PMID: 33017028;
PMCID: PMC7536587.
1056: Reyazuddin M, Azmi SA, Islam N, Rizvi A. Oxidative stress and level of
antioxidant enzymes in drug-naive schizophrenics. Indian J Psychiatry. 2014
Oct;56(4):344-9. doi: 10.4103/0019-5545.146516. PMID: 25568474; PMCID:
PMC4279291.
1057: Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction.
Int J Neurosci. 1991 Mar;57(1-2):1-17. doi: 10.3109/00207459109150342. PMID:
1938149.
1058: Sarandol A, Sarandol E, Acikgoz HE, Eker SS, Akkaya C, Dirican M. Firstepisode psychosis is associated with oxidative stress: Effects of short-term
antipsychotic treatment. Psychiatry Clin Neurosci. 2015 Nov;69(11):699-707. doi:
10.1111/pcn.12333. Epub 2015 Aug 18. PMID: 26172069.
1059: Pålsson E, Fejgin K, Wass C, Engel JA, Svensson L, Klamer D. The amino
acid L-lysine blocks the disruptive effect of phencyclidine on prepulse
inhibition in mice. Psychopharmacology (Berl). 2007 May;192(1):9-15. doi:
10.1007/s00213-006-0683-x. Epub 2007 Jan 19. PMID: 17235609.
1060: Wang C, McInnis J, West JB, Bao J, Anastasio N, Guidry JA, Ye Y, Salvemini
D, Johnson KM. Blockade of phencyclidine-induced cortical apoptosis and deficits
in prepulse inhibition by M40403, a superoxide dismutase mimetic. J Pharmacol
Exp Ther. 2003 Jan;304(1):266-71. doi: 10.1124/jpet.102.041798. PMID: 12490600.
1061: Rao KN, Sentir AM, Engleman EA, Bell RL, Hulvershorn LA, Breier A,
Chambers RA. Toward early estimation and treatment of addiction vulnerability:
radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine
self-administration in neonatal ventral hippocampal lesion rats.
Psychopharmacology (Berl). 2016 Dec;233(23-24):3933-3945. doi:
10.1007/s00213-016-4421-8. Epub 2016 Sep 17. PMID: 27640177; PMCID: PMC5102951.
1062: Lee MY, Chiang CC, Chiu HY, Chan MH, Chen HH. N-acetylcysteine modulates
hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral,
molecular, and electrophysiological studies. Neuropharmacology. 2014
Jun;81:215-23. doi: 10.1016/j.neuropharm.2014.02.006. Epub 2014 Feb 15. PMID:
24534112.
1063: Shen X, Sun Y, Wang M, Shu H, Zhu LJ, Yan PY, Zhang JF, Jin X. Chronic
N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working
memory deficit through upregulating caveolin-1 and synaptophysin in mice.
Psychopharmacology (Berl). 2018 Jan;235(1):179-191. doi:
10.1007/s00213-017-4762-y. Epub 2017 Oct 23. PMID: 29058042.
1064: Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR.
Beneficial action of resveratrol: How and why? Nutrition. 2016 Feb;32(2):174-8.
doi: 10.1016/j.nut.2015.08.017. Epub 2015 Sep 25. PMID: 26706021.
1065: Xu H, Yang HJ, Li XM. Differential effects of antipsychotics on the
development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur
Arch Psychiatry Clin Neurosci. 2014 Mar;264(2):121-9. doi:
10.1007/s00406-013-0414-3. Epub 2013 Jun 1. PMID: 23728937.
1066: Mickley GA, Hoxha Z, DiSorbo A, Wilson GN, Remus JL, Biesan O, Ketchesin
KD, Ramos L, Luchsinger JR, Prodan S, Rogers M, Wiles NR, Hoxha N. Latent
inhibition of a conditioned taste aversion in fetal rats. Dev Psychobiol. 2014
Apr;56(3):435-47. doi: 10.1002/dev.21110. Epub 2013 Mar 26. PMID: 23532964.
1067: Dietrich-Muszalska A, Kolodziejczyk-Czepas J, Nowak P. Comparative Study
of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of
Oxidative Stress in Schizophrenic Patients. Neuropsychiatr Dis Treat. 2021 Feb
17;17:555-565. doi: 10.2147/NDT.S283395. PMID: 33628026; PMCID: PMC7898201.
1068: Berrady R, Baybay H, Khammar Z, Lahlou M, Lamchachti L, Gallouj S, El
Hatimi A, Mernissi FZ, Bono W. Ichtyose acquise et hémopathie maligne : cinq
observations [Acquired ichthyosis and haematological malignancies: five cases].
Ann Dermatol Venereol. 2012 Jan;139(1):9-14. French. doi:
10.1016/j.annder.2011.10.394. Epub 2011 Dec 3. PMID: 22225737.
1069: Khushboo, Gupta VK, Sharma B. Hepatoprotective Effect of Ethanolic Extract
of Garlic Against Reserpine Induced Toxicity in Wistar Rats. Indian J Clin
Biochem. 2023 Apr;38(2):251-261. doi: 10.1007/s12291-022-01045-9. Epub 2022 Jun
14. PMID: 37025430; PMCID: PMC10070574.
1070: Madireddy S, Madireddy S. Regulation of Reactive Oxygen Species-Mediated
Damage in the Pathogenesis of Schizophrenia. Brain Sci. 2020 Oct 16;10(10):742.
doi: 10.3390/brainsci10100742. PMID: 33081261; PMCID: PMC7603028.
1071: Dadheech G, Sharma P, Gautam S. Oxidative Stress-Induced Response of Some
Endogenous Antioxidants in Schizophrenia. Indian J Clin Biochem. 2012
Jul;27(3):278-83. doi: 10.1007/s12291-012-0193-z. Epub 2012 Mar 23. PMID:
26405388; PMCID: PMC4577514.
1072: Caruso G, Grasso M, Fidilio A, Tascedda F, Drago F, Caraci F. Antioxidant
Properties of Second-Generation Antipsychotics: Focus on Microglia.
Pharmaceuticals (Basel). 2020 Dec 12;13(12):457. doi: 10.3390/ph13120457. PMID:
33322693; PMCID: PMC7764768.
1073: D'Souza B, D'Souza V. Oxidative injury and antioxidant vitamins E and C in
Schizophrenia. Indian J Clin Biochem. 2003 Jan;18(1):87-90. doi:
10.1007/BF02867671. PMID: 23105377; PMCID: PMC3453727.
1074: Ceprnja M, Derek L, Unić A, Blazev M, Fistonić M, Kozarić-Kovacić D,
Franić M, Romić Z. Oxidative stress markers in patients with post-traumatic
stress disorder. Coll Antropol. 2011 Dec;35(4):1155-60. PMID: 22397253.
1075: Arinola O, Idonije O. Status of plasma nitric oxide and non-enzymatic
antioxidants before and after antipsychotic treatment in Nigerian patients with
schizophrenia. J Res Med Sci. 2009 Jan;14(1):37-42. PMID: 21772859; PMCID:
PMC3129067.
1076: Otreba M, Wrześniok D, Beberok A, Rok J, Buszman E. FLUPHENAZINE AND
PERPHENAZINE IMPACT ON MELANOGENESIS AND ANTIOXIDANT ENZYMES ACTIVITY IN NORMAL
HUMAN MELANOCYTES. Acta Pol Pharm. 2016 Jul;73(4):903-911. PMID: 29648716.
1077: Koola MM, Praharaj SK, Pillai A. Galantamine-Memantine Combination as an
Antioxidant Treatment for Schizophrenia. Curr Behav Neurosci Rep. 2019
Jun;6(2):37-50. doi: 10.1007/s40473-019-00174-5. Epub 2019 May 17. PMID:
32601581; PMCID: PMC7323923.
1078: Bushana PN, Schmidt MA, Chang KM, Vuong T, Sorg BA, Wisor JP. Effect of
N-Acetylcysteine on Sleep: Impacts of Sex and Time of Day. Antioxidants (Basel).
2023 May 19;12(5):1124. doi: 10.3390/antiox12051124. PMID: 37237990; PMCID:
PMC10215863.
1079: Langbein K, Hesse J, Gussew A, Milleit B, Lavoie S, Amminger GP, Gaser C,
Wagner G, Reichenbach JR, Hipler UC, Winter D, Smesny S. Disturbed glutathione
antioxidative defense is associated with structural brain changes in
neuroleptic-naïve first-episode psychosis patients. Prostaglandins Leukot Essent
Fatty Acids. 2018 Sep;136:103-110. doi: 10.1016/j.plefa.2017.10.005. Epub 2017
Oct 18. PMID: 29111383.
1080: Dadheech G, Mishra S, Gautam S, Sharma P. Evaluation of antioxidant
deficit in schizophrenia. Indian J Psychiatry. 2008 Jan;50(1):16-20. doi:
10.4103/0019-5545.39753. PMID: 19771301; PMCID: PMC2745854.
1081: Kato TA, Monji A, Yasukawa K, Mizoguchi Y, Horikawa H, Seki Y, Hashioka S,
Han YH, Kasai M, Sonoda N, Hirata E, Maeda Y, Inoguchi T, Utsumi H, Kanba S.
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate
(PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic
actions via microglia. Schizophr Res. 2011 Jul;129(2-3):172-82. doi:
10.1016/j.schres.2011.03.019. Epub 2011 Apr 15. PMID: 21497059.
1082: Rambaud V, Marzo A, Chaumette B. Oxidative Stress and Emergence of
Psychosis. Antioxidants (Basel). 2022 Sep 21;11(10):1870. doi:
10.3390/antiox11101870. PMID: 36290593; PMCID: PMC9598314.
1083: Shirai Y, Fujita Y, Hashimoto K. Effects of the antioxidant sulforaphane
on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine
administration. Clin Psychopharmacol Neurosci. 2012 Aug;10(2):94-8. doi:
10.9758/cpn.2012.10.2.94. Epub 2012 Aug 31. PMID: 23430731; PMCID: PMC3569145.
1084: Chow TJ, Loh HC, Tee SF, Tang PY. Evaluation of carotenoid level in
schizophrenic patients using non-invasive measurement. Asian J Psychiatr. 2010
Dec;3(4):190-3. doi: 10.1016/j.ajp.2010.09.006. Epub 2010 Oct 23. PMID:
23050886.
1085: Bošković M, Vovk T, Kores Plesničar B, Grabnar I. Oxidative stress in
schizophrenia. Curr Neuropharmacol. 2011 Jun;9(2):301-12. doi:
10.2174/157015911795596595. PMID: 22131939; PMCID: PMC3131721.
1086: Demirci K, Özçankaya R, Yilmaz
A, Akpınar A. Paliperidone regulates
Role of purine mechanism. Redox Rep.
10.1179/1351000214Y.0000000122. Epub
PMC6837464.
HR, Yiğit A, Uğuz AC, Karakuş K, Demirdaş
intracellular redox system in rat brain:
2015 Jul;20(4):170-6. doi:
2014 Dec 29. PMID: 25545018; PMCID:
1087: Poladian N, Navasardyan I, Narinyan W, Orujyan D, Venketaraman V.
Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and
Adjunct Treatment of Psychiatric Disorders. Clin Pract. 2023 Jul
5;13(4):768-779. doi: 10.3390/clinpract13040070. PMID: 37489419; PMCID:
PMC10366746.
1088: Otreba M, Wrześniok D, Beberok A, Rok J, Buszman E. Melanogenesis and
antioxidant defense system in normal human melanocytes cultured in the presence
of chlorpromazine. Toxicol In Vitro. 2015 Feb;29(1):221-7. doi:
10.1016/j.tiv.2014.10.016. PMID: 25449126.
1089: Berk M, Malhi GS, Gray LJ, Dean OM. The promise of N-acetylcysteine in
neuropsychiatry. Trends Pharmacol Sci. 2013 Mar;34(3):167-77. doi:
10.1016/j.tips.2013.01.001. Epub 2013 Jan 29. PMID: 23369637.
1090: Singh OP, Chakraborty I, Dasgupta A, Datta S. A comparative study of
oxidative stress and interrelationship of important antioxidants in haloperidol
and olanzapine treated patients suffering from schizophrenia. Indian J
Psychiatry. 2008 Jul;50(3):171-6. doi: 10.4103/0019-5545.43627. PMID: 19742187;
PMCID: PMC2738368.
1091: Nandi A, Yan LJ, Jana CK, Das N. Role of Catalase in Oxidative Stress- and
Age-Associated Degenerative Diseases. Oxid Med Cell Longev. 2019 Nov
11;2019:9613090. doi: 10.1155/2019/9613090. PMID: 31827713; PMCID: PMC6885225.
1092: Yui K, Kawasaki Y, Yamada H, Ogawa S. Oxidative Stress and Nitric Oxide in
Autism Spectrum Disorder and Other Neuropsychiatric Disorders. CNS Neurol Disord
Drug Targets. 2016;15(5):587-96. doi: 10.2174/1871527315666160413121751. PMID:
27071787.
1093: Lakkab I, Ouakil A, El Hajaji H, Lachkar N, Lefter R, Ciobica A, El Bali
B, Dobrin R, Hritcu LD, Lachkar M. Carob Seed Peels Effect on Cognitive
Impairment and Oxidative Stress Status in Methionine-Induced Mice Models of
Schizophrenia. Brain Sci. 2022 Dec 3;12(12):1660. doi: 10.3390/brainsci12121660.
PMID: 36552121; PMCID: PMC9775430.
1094: Parikh V, Khan MM, Mahadik SP. Differential effects of antipsychotics on
expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
J Psychiatr Res. 2003 Jan-Feb;37(1):43-51. doi: 10.1016/s0022-3956(02)00048-1.
PMID: 12482469.
1095: Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Zalewska A, Maciejczyk M,
Karakuła-Juchnowicz H. Oxidative Stress Biomarkers as a Predictor of Stage
Illness and Clinical Course of Schizophrenia. Front Psychiatry. 2021 Nov
15;12:728986. doi: 10.3389/fpsyt.2021.728986. PMID: 34867519; PMCID: PMC8636114.
1096: Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current
therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci.
2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. PMID: 21118657; PMCID:
PMC3044191.
1097: Gao Z, Xiu M, Liu J, Wu F, Zhang XY. Obesity, antioxidants and negative
symptom improvement in first-episode schizophrenia patients treated with
risperidone. Schizophrenia (Heidelb). 2023 Mar 23;9(1):17. doi:
10.1038/s41537-023-00346-z. PMID: 36949120; PMCID: PMC10033648.
1098: De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis
A. Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework
of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the
Clinics and Treatment. Antioxidants (Basel). 2023 Apr 21;12(4):975. doi:
10.3390/antiox12040975. PMID: 37107350; PMCID: PMC10135787.
1099: Lambert B, Semmler A, Beer C, Voisey J. Pyrroles as a Potential Biomarker
for Oxidative Stress Disorders. Int J Mol Sci. 2023 Feb 1;24(3):2712. doi:
10.3390/ijms24032712. PMID: 36769035; PMCID: PMC9917263.
1100: Maes M, Barbosa DS, Almulla AF, Kanchanatawan B. A Novel Pathway Phenotype
of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of
Precision Nomothetic Medicine. Antioxidants (Basel). 2022 Apr 20;11(5):803. doi:
10.3390/antiox11050803. PMID: 35624666; PMCID: PMC9137678.
1101: Gao Z, Xiu M, Liu J, Wu F, Zhang X. Smoking, Symptoms Improvement, and
Total Antioxidant Capacity in Patients with Drug-naive First-episode
Schizophrenia: A Prospective Cohort Study. Curr Neuropharmacol. 2023 Oct 19.
doi: 10.2174/1570159X22666231019105328. Epub ahead of print. PMID: 37859307.
1102: Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress, α-tocopherol,
ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin
Biochem. 2006 Sep;21(2):34-8. doi: 10.1007/BF02912908. PMID: 23105610; PMCID:
PMC3453982.
1103: Möller M, Du Preez JL, Viljoen FP, Berk M, Harvey BH. N-Acetyl cysteine
reverses social isolation rearing induced changes in cortico-striatal monoamines
in rats. Metab Brain Dis. 2013 Dec;28(4):687-96. doi: 10.1007/s11011-013-9433-z.
Epub 2013 Sep 3. PMID: 24000072.
1104: Kotzaeroglou A, Tsamesidis I. The Role of Equilibrium between Free
Radicals and Antioxidants in Depression and Bipolar Disorder. Medicines (Basel).
2022 Nov 14;9(11):57. doi: 10.3390/medicines9110057. PMID: 36422118; PMCID:
PMC9694953.
1105: Okubo Eneni AE, Ben-Azu B, Mayowa Ajayi A, Oladele Aderibigbe A. Diosmin
attenuates schizophrenia-like behavior, oxidative stress, and
acetylcholinesterase activity in mice. Drug Metab Pers Ther. 2020 Oct
15:/j/dmdi.ahead-of-print/dmdi-2020-0119/dmdi-2020-0119.xml. doi:
10.1515/dmdi-2020-0119. Epub ahead of print. PMID: 33055311.
1106: Cardis R, Cabungcal JH, Dwir D, Do KQ, Steullet P. A lack of
GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation:
Consequences on parvalbumin interneurons, and their perineuronal nets. Neurobiol
Dis. 2018 Jan;109(Pt A):64-75. doi: 10.1016/j.nbd.2017.10.006. Epub 2017 Oct 10.
PMID: 29024713.
1107: Uddin SMN, Sultana F, Uddin MG, Dewan SMR, Hossain MK, Islam MS. Effect of
antioxidant, malondialdehyde, macro-mineral, and trace element serum
concentrations in Bangladeshi patients with schizophrenia: A case-control study.
Health Sci Rep. 2021 May 11;4(2):e291. doi: 10.1002/hsr2.291. PMID: 34013069;
PMCID: PMC8112814.
1108: Ince S, Ozer M, Kadioglu BG, Kuzucu M, Ozkaraca M, Gezer A, Suleyman H,
Cetin N. The effect of taxifolin on oxidative ovarian damage and reproductive
dysfunctions induced by antipsychotic drugs in female rats. J Obstet Gynaecol
Res. 2021 Jun;47(6):2140-2148. doi: 10.1111/jog.14769. Epub 2021 Mar 23. PMID:
33754437.
1109: Wang K, Xiu M, Su X, Wu F, Zhang X. Association between Changes in Total
Antioxidant Levels and Clinical Symptom Improvement in Patients with
Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone
Monotherapy. Antioxidants (Basel). 2022 Mar 28;11(4):646. doi:
10.3390/antiox11040646. PMID: 35453331; PMCID: PMC9029332.
1110: Lohr JB, Browning JA. Free radical involvement in neuropsychiatric
illnesses. Psychopharmacol Bull. 1995;31(1):159-65. PMID: 7675980.
1111: Zeni-Graiff M, Rios AC, Maurya PK, Rizzo LB, Sethi S, Yamagata AS, Mansur
RB, Pan PM, Asevedo E, Cunha GR, Zugman A, Bressan RA, Gadelha A, Brietzke E.
Peripheral levels of superoxide dismutase and glutathione peroxidase in youths
in ultra-high risk for psychosis: a pilot study. CNS Spectr. 2019
Jun;24(3):333-337. doi: 10.1017/S1092852917000803. Epub 2017 Dec 17. PMID:
29248027.
1112: Wang H, Xu H, Dyck LE, Li XM. Olanzapine and quetiapine protect PC12 cells
from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing
apoptosis. J Neurosci Res. 2005 Aug 15;81(4):572-80. doi: 10.1002/jnr.20570.
PMID: 15948179.
1113: Klomparens EA, Ding Y. The neuroprotective mechanisms and effects of
sulforaphane. Brain Circ. 2019 Apr-Jun;5(2):74-83. doi: 10.4103/bc.bc_7_19. Epub
2019 Jun 27. PMID: 31334360; PMCID: PMC6611193.
1114: Usui N, Matsumoto-Miyai K, Koyama Y, Kobayashi Y, Nakamura Y, Kobayashi H,
Shimada S. Social Communication of Maternal Immune Activation-Affected Offspring
Is Improved by Si-Based Hydrogen-Producing Agent. Front Psychiatry. 2022 Apr
13;13:872302. doi: 10.3389/fpsyt.2022.872302. PMID: 35492705; PMCID: PMC9043691.
1115: Smythies J. The neurotoxicity of glutamate, dopamine, iron and reactive
oxygen species: functional interrelationships in health and disease: a reviewdiscussion. Neurotox Res. 1999 Sep;1(1):27-39. doi: 10.1007/BF03033337. PMID:
12835112.
1116: Moretti M, Fraga DB, Rodrigues ALS. Ascorbic Acid to Manage Psychiatric
Disorders. CNS Drugs. 2017 Jul;31(7):571-583. doi: 10.1007/s40263-017-0446-8.
PMID: 28600627.
1117: Ooi SL, Green R, Pak SC. N-Acetylcysteine for the Treatment of Psychiatric
Disorders: A Review of Current Evidence. Biomed Res Int. 2018 Oct
22;2018:2469486. doi: 10.1155/2018/2469486. PMID: 30426004; PMCID: PMC6217900.
1118: Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK. Physiological
antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate
receptors in prefrontal cortex. J Pharmacol Exp Ther. 2000 Jan;292(1):76-87.
PMID: 10604933.
1119: Dietrich-Muszalska A, Kontek B, Olas B, Rabe-Jabłońska J. Epicatechin
inhibits human plasma lipid peroxidation caused by haloperidol in vitro.
Neurochem Res. 2012 Mar;37(3):557-62. doi: 10.1007/s11064-011-0642-8. Epub 2011
Nov 12. PMID: 22076501.
1120: Ben-Azu B, Aderibigbe AO, Omogbiya IA, Ajayi AM, Iwalewa EO. Morin
Pretreatment Attenuates Schizophrenia-Like Behaviors in Experimental Animal
Models. Drug Res (Stuttg). 2018 Mar;68(3):159-167. doi: 10.1055/s-0043-119127.
Epub 2017 Sep 29. PMID: 28962045.
1121: Llido JP, Jayanti S, Tiribelli C, Gazzin S. Bilirubin and Redox Stress in
Age-Related Brain Diseases. Antioxidants (Basel). 2023 Jul 29;12(8):1525. doi:
10.3390/antiox12081525. PMID: 37627520; PMCID: PMC10451892.
1122: Palaniyappan L, Park MTM, Jeon P, Limongi R, Yang K, Sawa A, Théberge J.
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Antioxidants (Basel). 2021 Oct 27;10(11):1703. doi: 10.3390/antiox10111703.
PMID: 34829575; PMCID: PMC8615159.
1123: Zhang L, Xu S, Huang Q, Xu H. N-acetylcysteine attenuates the cuprizoneinduced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its
anti-inflammation actions. J Neurosci Res. 2018 May;96(5):803-816. doi:
10.1002/jnr.24189. Epub 2017 Nov 8. PMID: 29114910.
1124: Maldonado MD, Pérez-San-Gregorio MA, Reiter RJ. The role of melatonin in
the immuno-neuro-psychology of mental disorders. Recent Pat CNS Drug Discov.
2009 Jan;4(1):61-9. doi: 10.2174/157488909787002564. PMID: 19149715.
1125: Li J, Li D, Guo J, Wang D, Zhang X. Age of Onset Moderates the Association
between Total Antioxidant Capacity and Cognitive Deficits in Patients with DrugNaïve Schizophrenia. Antioxidants (Basel). 2023 Jun 12;12(6):1259. doi:
10.3390/antiox12061259. PMID: 37371989; PMCID: PMC10295646.
1126: Metodiewa D, Kośka C. Reactive oxygen species and reactive nitrogen
species: relevance to cyto(neuro)toxic events and neurologic disorders. An
overview. Neurotox Res. 2000 Feb;1(3):197-233. doi: 10.1007/BF03033290. PMID:
12835102.
1127: Zhao H, Han X, Zhang X, Li L, Li Y, Wang W, McIntyre RS, Teopiz KM, Guo L,
Lu C. Dissecting Causal Associations of Diet-Derived Circulating Antioxidants
with Six Major Mental Disorders: A Mendelian Randomization Study. Antioxidants
(Basel). 2023 Jan 10;12(1):162. doi: 10.3390/antiox12010162. PMID: 36671024;
PMCID: PMC9855039.
1128: Rasool M, Malik A, Saleem S, Ashraf MAB, Khan AQ, Waquar S, Zahid A,
Shaheen S, Abu-Elmagd M, Gauthaman K, Pushparaj PN. Role of Oxidative Stress and
the Identification of Biomarkers Associated With Thyroid Dysfunction in
Schizophrenics. Front Pharmacol. 2021 Apr 29;12:646287. doi:
10.3389/fphar.2021.646287. PMID: 33995058; PMCID: PMC8118265.
1129: Eneni AO, Ben-Azu B, Ajayi AM, Aderibibge AO. Lipopolysaccharide
Exacerbates Ketamine-Induced Psychotic-Like Behavior, Oxidative Stress, and
Neuroinflammation in Mice: Ameliorative Effect of Diosmin. J Mol Neurosci. 2023
Mar;73(2-3):129-142. doi: 10.1007/s12031-022-02077-9. Epub 2023 Jan 18. PMID:
36652038.
1130: Bishnoi M, Chopra K, Kulkarni SK. Protective effect of Curcumin, the
active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial
dyskinesia and associated behavioural, biochemical and neurochemical changes in
rat brain. Pharmacol Biochem Behav. 2008 Feb;88(4):511-22. doi:
10.1016/j.pbb.2007.10.009. Epub 2007 Oct 25. PMID: 18022680.
1131: Songur A, Sarsilmaz M, Sogut S, Ozyurt B, Ozyurt H, Zararsiz I, Turkoglu
AO. Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and
malondialdehyde in rats fed with fish omega-3 fatty acids. Prog
Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):693-8. doi:
10.1016/j.pnpbp.2004.05.006. PMID: 15276695.
1132: Ghanizadeh A, Berk M. Molecular hydrogen: an overview of its
neurobiological effects and therapeutic potential for bipolar disorder and
schizophrenia. Med Gas Res. 2013 Jun 6;3(1):11. doi: 10.1186/2045-9912-3-11.
PMID: 23742229; PMCID: PMC3680337.
1133: Yang K, Jin G, Wu J. The neuropharmacology of (-)-stepholidine and its
potential applications. Curr Neuropharmacol. 2007 Dec;5(4):289-94. doi:
10.2174/157015907782793649. PMID: 19305745; PMCID: PMC2644490.
1134: Edemann-Callesen H, Bernhardt N, Hlusicka EB, Hintz F, Habelt B, Winter R,
Neubert I, Pelz M, Filla A, Soto-Montenegro ML, Winter C, Hadar R. Supplement
Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy
Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model.
Antioxidants (Basel). 2023 May 9;12(5):1068. doi: 10.3390/antiox12051068. PMID:
37237933; PMCID: PMC10215079.
1135: Wang DM, Zhu RR, Tian Y, Uludag K, Chen JJ, Zhou HX, Wang L, Kosten TR,
Zhang XY. Association between MnSOD Activity and Cognitive Impairment in
Unmedicated First-Episode Schizophrenia: Regulated by <i>MnSOD</i> Ala-9Val Gene
Polymorphism. Antioxidants (Basel). 2022 Oct 4;11(10):1981. doi:
10.3390/antiox11101981. PMID: 36290704; PMCID: PMC9598731.
1136: Zahedi Avval F, Mahmoudi N, Nosrati Tirkani A, Jarahi L, Hamidi Alamdari
D, Sadjadi SA. Determining Pro-Oxidant Antioxidant Balance (PAB) and Total
Antioxidant Capacity (TAC) in Patients with Schizophrenia. Iran J Psychiatry.
2018 Jul;13(3):222-226. PMID: 30319706; PMCID: PMC6178326.
1137: Hoffer A. A neurological form of schizophrenia. Can Med Assoc J. 1973 Jan
20;108(2):186 passim. PMID: 4684627; PMCID: PMC1941147.
1138: de Sousa CNS, da Silva Leite CMG, da Silva Medeiros I, Vasconcelos LC,
Cabral LM, Patrocínio CFV, Patrocínio MLV, Mouaffak F, Kebir O, Macedo D,
Patrocínio MCA, Vasconcelos SMM. Alpha-lipoic acid in the treatment of
psychiatric and neurological disorders: a systematic review. Metab Brain Dis.
2019 Feb;34(1):39-52. doi: 10.1007/s11011-018-0344-x. Epub 2018 Nov 22. PMID:
30467770.
1139: Dwir D, Cabungcal JH, Xin L, Giangreco B, Parietti E, Cleusix M, Jenni R,
Klauser P, Conus P, Cuénod M, Steullet P, Do KQ. Timely N-Acetyl-Cysteine and
Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron
Impairments via MMP9/RAGE Pathway: A Translational Approach for Early
Intervention in Psychosis. Schizophr Bull. 2021 Oct 21;47(6):1782-1794. doi:
10.1093/schbul/sbab066. PMID: 34080015; PMCID: PMC8530393.
1140: Blanco-Ayala T, Sathyasaikumar KV, Uys JD, Pérez-de-la-Cruz V, Pidugu LS,
Schwarcz R. N-Acetylcysteine Inhibits Kynurenine Aminotransferase II.
Neuroscience. 2020 Sep 15;444:160-169. doi: 10.1016/j.neuroscience.2020.07.049.
Epub 2020 Aug 5. PMID: 32768617; PMCID: PMC7484245.
1141: Górny M, Bilska-Wilkosz A, Iciek M, Hereta M, Kamińska K, Kamińska A,
Chwatko G, Rogóż Z, Lorenc-Koci E. Alterations in the Antioxidant Enzyme
Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by
Glutathione Deficiency during Early Postnatal Life. Antioxidants (Basel). 2020
Jun 19;9(6):538. doi: 10.3390/antiox9060538. PMID: 32575563; PMCID: PMC7346228.
1142: Firth J, Rosenbaum S, Ward PB, Curtis J, Teasdale SB, Yung AR, Sarris J.
Adjunctive nutrients in first-episode psychosis: A systematic review of
efficacy, tolerability and neurobiological mechanisms. Early Interv Psychiatry.
2018 Oct;12(5):774-783. doi: 10.1111/eip.12544. Epub 2018 Mar 21. PMID:
29561067; PMCID: PMC6175456.
1143: Hou Y, Wu CF, Yang JY, He X, Bi XL, Yu L, Guo T. Effects of clozapine,
olanzapine and haloperidol on nitric oxide production by lipopolysaccharideactivated N9 cells. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec
30;30(8):1523-8. doi: 10.1016/j.pnpbp.2006.05.006. Epub 2006 Jun 27. PMID:
16806626.
1144: Fournier M, Monin A, Ferrari C, Baumann PS, Conus P, Do K. Implication of
the glutamate-cystine antiporter xCT in schizophrenia cases linked to impaired
GSH synthesis. NPJ Schizophr. 2017 Sep 18;3(1):31. doi:
10.1038/s41537-017-0035-3. PMID: 28924227; PMCID: PMC5603608.
1145: Limongi R, Jeon P, Théberge J, Palaniyappan L. Counteracting Effects of
Glutathione on the Glutamate-Driven Excitation/Inhibition Imbalance in FirstEpisode Schizophrenia: A 7T MRS and Dynamic Causal Modeling Study. Antioxidants
(Basel). 2021 Jan 8;10(1):75. doi: 10.3390/antiox10010075. PMID: 33430154;
PMCID: PMC7828075.
1146: Sansone RA, Sansone LA. Getting a Knack for NAC: N-Acetyl-Cysteine. Innov
Clin Neurosci. 2011 Jan;8(1):10-4. PMID: 21311702; PMCID: PMC3036554.
1147: Yılmaz S, Kılıç N, Kaya Ş, Taşcı G. A Potential Biomarker for Predicting
Schizophrenia: Metallothionein-1. Biomedicines. 2023 Feb 16;11(2):590. doi:
10.3390/biomedicines11020590. PMID: 36831126; PMCID: PMC9952915.
1148: Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K. Molecular mechanisms
underlying protective role of quercetin in attenuating Alzheimer's disease. Life
Sci. 2019 May 1;224:109-119. doi: 10.1016/j.lfs.2019.03.055. Epub 2019 Mar 23.
Erratum in: Life Sci. 2019 Aug 15;231:116616. PMID: 30914316.
1149: Sharma G, Shin EJ, Sharma N, Nah SY, Mai HN, Nguyen BT, Jeong JH, Lei XG,
Kim HC. Glutathione peroxidase-1 and neuromodulation: Novel potentials of an old
enzyme. Food Chem Toxicol. 2021 Feb;148:111945. doi: 10.1016/j.fct.2020.111945.
Epub 2020 Dec 29. PMID: 33359022.
1150: Rukmini MS, D'Souza B, D'Souza V. Superoxide dismutase and catalase
activities and their correlation with malondialdehyde in schizophrenic patients.
Indian J Clin Biochem. 2004 Jul;19(2):114-8. doi: 10.1007/BF02894268. PMID:
23105467; PMCID: PMC3454217.
1151: Morris G, Walker AJ, Walder K, Berk M, Marx W, Carvalho AF, Maes M, Puri
BK. Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry. Mol
Neurobiol. 2021 May;58(5):2158-2182. doi: 10.1007/s12035-020-02212-w. Epub 2021
Jan 7. PMID: 33411248.
1152: Bentivegna A, Santambrogio J, Clerici M. <i>UGT1A1</i> mutations and
psychoses: towards understanding the relationship with unconjugated bilirubin.
CNS Spectr. 2021 Jun;26(3):188-190. doi: 10.1017/S1092852919001251. Epub 2019
Jul 24. PMID: 31339084.
1153: Bernstein HG, Becker A, Keilhoff G, Grecksch G, Bogerts B. Schizophrenia
and the nitric oxide controversy: do all things fall into place now? Synapse.
2011 Jun;65(6):545-6; author reply 547. doi: 10.1002/syn.20871. Epub 2010 Dec 3.
PMID: 20939054.
1154: Pawelczyk T, Szymanska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawelczyk
A. Telomere length in blood cells is related to the chronicity, severity, and
recurrence rate of schizophrenia. Neuropsychiatr Dis Treat. 2015 Jun
22;11:1493-503. doi: 10.2147/NDT.S82468. PMID: 26150720; PMCID: PMC4484660.
1155: Xie T, Li Q, Luo X, Tian L, Wang Z, Tan S, Chen S, Yang G, An H, Yang F,
Tan Y. Plasma total antioxidant status and cognitive impairments in firstepisode drug-naïve patients with schizophrenia. Cogn Neurodyn. 2019
Aug;13(4):357-365. doi: 10.1007/s11571-019-09530-3. Epub 2019 Apr 9. PMID:
31354881; PMCID: PMC6624222.
1156: Ribaudo G, Bortoli M, Pavan C, Zagotto G, Orian L. Antioxidant Potential
of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment
and toward a New Challenge for in Silico Molecular Design. Antioxidants (Basel).
2020 Aug 6;9(8):714. doi: 10.3390/antiox9080714. PMID: 32781750; PMCID:
PMC7465375.
1157: Chen P, Wang D, Xiu M, Chen D, Lackey B, Wu HE, Zhou J, Zhang X.
Polymorphism of Transferrin Gene Impacts the Mediating Effects of Psychotic
Symptoms on the Relationship between Oxidative Stress and Cognition in Patients
with Chronic Schizophrenia. Antioxidants (Basel). 2022 Jan 6;11(1):125. doi:
10.3390/antiox11010125. PMID: 35052629; PMCID: PMC8772796.
1158: Sommer O, Aug RL, Schmidt AJ, Heiser P, Schulz E, Vedder H, Clement HW.
Hydrogen Sulfide Affects Radical Formation in the Hippocampus of LPS Treated
Rats and the Effect of Antipsychotics on Hydrogen Sulfide Forming Enzymes in
Human Cell Lines. Front Psychiatry. 2018 Oct 16;9:501. doi:
10.3389/fpsyt.2018.00501. PMID: 30386265; PMCID: PMC6198150.
1159: Cotton SM, Berk M, Watson A, Wood S, Allott K, Bartholomeusz CF,
Bortolasci CC, Walder K, O'Donoghue B, Dean OM, Chanen A, Amminger GP, McGorry
PD, Burnside A, Uren J, Ratheesh A, Dodd S. ENACT: a protocol for a randomised
placebo-controlled trial investigating the efficacy and mechanisms of action of
adjunctive N-acetylcysteine for first-episode psychosis. Trials. 2019 Nov
28;20(1):658. doi: 10.1186/s13063-019-3786-5. PMID: 31779696; PMCID: PMC6883553.
1160: Zinellu A, Sedda S, Mangoni AA. Paraoxonase/Arylesterase Activity of Serum
Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis.
Antioxidants (Basel). 2023 Jul 25;12(8):1484. doi: 10.3390/antiox12081484. PMID:
37627479; PMCID: PMC10451270.
1161: Spain RI, Andeen NK, Gibson PC, Samuels MH, Morris CD, Solomon AJ, Solomon
R, Waslo C, Avasare RS. Lipoic acid supplementation associated with neural
epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy. Kidney
Int. 2021 Dec;100(6):1208-1213. doi: 10.1016/j.kint.2021.10.010. Epub 2021 Oct
16. PMID: 34662650; PMCID: PMC8628858.
1162: Şenyurt M, Aybek H, Herken H, Kaptanoglu B, Korkmaz A. Evaluation of
Oxidative Status in Patients Treated with Electroconvulsive Therapy. Clin
Psychopharmacol Neurosci. 2017 Feb 28;15(1):40-46. doi:
10.9758/cpn.2017.15.1.40. PMID: 28138109; PMCID: PMC5290719.
1163: Kulaksizoglu B, Kulaksizoglu S. Relationship between neutrophil/lymphocyte
ratio with oxidative stress and psychopathology in patients with schizophrenia.
Neuropsychiatr Dis Treat. 2016 Aug 12;12:1999-2005. doi: 10.2147/NDT.S110484.
PMID: 27574431; PMCID: PMC4991539.
1164: Shayganfard M. Molecular and biological functions of resveratrol in
psychiatric disorders: a review of recent evidence. Cell Biosci. 2020 Nov
7;10(1):128. doi: 10.1186/s13578-020-00491-3. PMID: 33292508; PMCID: PMC7648996.
1165: Schölzel-Dorenbos CJ. Blauwe plekken, uitvallende tanden en vermoeidheid
bij een patiënte met schizofrenie [Bruises, loose teeth and fatigue in a patient
with schizophrenia]. Ned Tijdschr Geneeskd. 2005 Dec 31;149(53):3005-6. Dutch.
PMID: 16425857.
1166: Takahashi S, Sonehara K, Takagi K, Miwa T, Horikomi K, Mita N, Nagase H,
Iizuka K, Sakai K. Pharmacological profile of MS-377, a novel antipsychotic
agent with selective affinity for sigma receptors. Psychopharmacology (Berl).
1999 Aug;145(3):295-302. doi: 10.1007/s002130051061. PMID: 10494578.
1167: Wei Z, Bai O, Richardson JS, Mousseau DD, Li XM. Olanzapine protects PC12
cells from oxidative stress induced by hydrogen peroxide. J Neurosci Res. 2003
Aug 1;73(3):364-8. doi: 10.1002/jnr.10668. PMID: 12868070.
1168: Bashkatova V, Mathieu-Kia AM, Durand C, Penit-Soria J. Neurochemical
changes and neurotoxic effects of an acute treatment with sydnocarb, a novel
psychostimulant: comparison with D-amphetamine. Ann N Y Acad Sci. 2002
Jun;965:180-92. doi: 10.1111/j.1749-6632.2002.tb04160.x. PMID: 12105094.
1169: KÖŞger F, YİĞİtaslan S, EŞsİzoĞlu A, GÜleÇ G, KarataŞ RD, DeĞİrmencİ SS.
Inflammation and Oxidative Stress in Deficit Schizophrenia. Noro Psikiyatr Ars.
2020 Sep 21;57(4):303-307. doi: 10.29399/npa.24966. PMID: 33354123; PMCID:
PMC7735140.
1170: Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K,
Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara
A, Mihara S, Ogata Y, Kaneko S, Nakagawa K. Possible associations between
antioxidant enzyme polymorphisms and metabolic abnormalities in patients with
schizophrenia. Neuropsychiatr Dis Treat. 2013;9:1683-98. doi:
10.2147/NDT.S52585. Epub 2013 Nov 1. PMID: 24204153; PMCID: PMC3818100.
1171: Huang L, Tang Y, Sperlagh B. Glial Purinergic Signaling-Mediated Oxidative
Stress (GPOS) in Neuropsychiatric Disorders. Oxid Med Cell Longev. 2022 Mar
4;2022:1075440. doi: 10.1155/2022/1075440. PMID: 35281471; PMCID: PMC8916856.
1172: Garcia-Partida JA, Torres-Sanchez S, MacDowell K, Fernández-Ponce MT,
Casas L, Mantell C, Soto-Montenegro ML, Romero-Miguel D, Lamanna-Rama N, Leza
JC, Desco M, Berrocoso E. The effects of mango leaf extract during adolescence
and adulthood in a rat model of schizophrenia. Front Pharmacol. 2022 Jul
26;13:886514. doi: 10.3389/fphar.2022.886514. PMID: 35959428; PMCID: PMC9360613.
1173: Phensy A, Duzdabanian HE, Brewer S, Panjabi A, Driskill C, Berz A, Peng G,
Kroener S. Antioxidant Treatment with N-acetyl Cysteine Prevents the Development
of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine
Treatment. Front Behav Neurosci. 2017 Jun 6;11:106. doi:
10.3389/fnbeh.2017.00106. PMID: 28634445; PMCID: PMC5459895.
1174: Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. Nitric oxide as a
physiopathological factor in neuropsychiatric disorders. In Vivo. 2004 MayJun;18(3):377-90. PMID: 15341194.
1175: Shayganfard M. Are Essential Trace Elements Effective in Modulation of
Mental Disorders? Update and Perspectives. Biol Trace Elem Res. 2022
Mar;200(3):1032-1059. doi: 10.1007/s12011-021-02733-y. Epub 2021 Apr 27. PMID:
33904124.
1176: Lopes-Rocha A, Bezerra TO, Zanotto R, Lages Nascimento I, Rodrigues A,
Salum C. The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in
a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves
Nitric Oxide. Front Pharmacol. 2022 Jul 12;13:924955. doi:
10.3389/fphar.2022.924955. PMID: 35903343; PMCID: PMC9315304.
1177: Dietrich-Muszalska A, Kolińska-Łukaszuk J. Comparative effects of
aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Psychiatry Clin Neurosci. 2018 May;72(5):329-336. doi: 10.1111/pcn.12631. Epub
2018 Feb 8. PMID: 29280533.
1178: Dietrich-Muszalska A, Kwiatkowska A. Generation of superoxide anion
radicals and platelet glutathione peroxidase activity in patients with
schizophrenia. Neuropsychiatr Dis Treat. 2014 May 5;10:703-9. doi:
10.2147/NDT.S60034. PMID: 24833903; PMCID: PMC4015795.
1179: Pitts MW, Kremer PM, Hashimoto AC, Torres DJ, Byrns CN, Williams CS, Berry
MJ. Competition between the Brain and Testes under Selenium-Compromised
Conditions: Insight into Sex Differences in Selenium Metabolism and Risk of
Neurodevelopmental Disease. J Neurosci. 2015 Nov 18;35(46):15326-38. doi:
10.1523/JNEUROSCI.2724-15.2015. PMID: 26586820; PMCID: PMC4649005.
1180: Tenback DE, van Harten PN. Epidemiology and risk factors for (tardive)
dyskinesia. Int Rev Neurobiol. 2011;98:211-30. doi:
10.1016/B978-0-12-381328-2.00009-2. PMID: 21907089.
1181: Brandies R, Yehuda S. The possible role of retinal dopaminergic system in
visual performance. Neurosci Biobehav Rev. 2008;32(4):611-56. doi:
10.1016/j.neubiorev.2007.09.004. Epub 2007 Oct 10. PMID: 18061262.
1182: Palaniyappan L, Sabesan P, Li X, Luo Q. Schizophrenia Increases
Variability of the Central Antioxidant System: A Meta-Analysis of Variance From
MRS Studies of Glutathione. Front Psychiatry. 2021 Nov 30;12:796466. doi:
10.3389/fpsyt.2021.796466. PMID: 34916980; PMCID: PMC8669304.
1183: Morguenstern EA. Aspectos neuroendócrinos y psicofarmacológicos de la
función pineal. Melatonina y desórdenes psiquiátricos [Neuroendocrine and
psychopharmacologic aspects of the pineal function. Melatonin and psychiatric
disorders]. Acta Psiquiatr Psicol Am Lat. 1989 Jan-Jun;35(1-2):71-9. Spanish.
PMID: 2699386.
1184: Riegel RE, Valvassori SS, Moretti M, Ferreira CL, Steckert AV, de Souza B,
Dal-Pizzol F, Quevedo J. Intracerebroventricular ouabain administration induces
oxidative stress in the rat brain. Int J Dev Neurosci. 2010 May;28(3):233-7.
doi: 10.1016/j.ijdevneu.2010.02.002. Epub 2010 Feb 12. PMID: 20153819.
1185: Bartels C, Späte K, Krampe H, Ehrenreich H. Recombinant Human
Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative
Treatment of Multiple Sclerosis. Ther Adv Neurol Disord. 2008 Nov;1(3):193-206.
doi: 10.1177/1756285608098422. PMID: 21180577; PMCID: PMC3002551.
1186: Carr CN, Straley CM, Baugh TB. Allopurinol for the Treatment of Refractory
Aggression: A Case Series. Pharmacotherapy. 2017 Jun;37(6):748-754. doi:
10.1002/phar.1943. PMID: 28488770.
1187: Waldhauser F, Ehrhart B, Förster E. Clinical aspects of the melatonin
action: impact of development, aging, and puberty, involvement of melatonin in
psychiatric disease and importance of neuroimmunoendocrine interactions.
Experientia. 1993 Aug 15;49(8):671-81. doi: 10.1007/BF01923949. PMID: 8359273.
1188: Jiang Z, Cowell RM, Nakazawa K. Convergence of genetic and environmental
factors on parvalbumin-positive interneurons in schizophrenia. Front Behav
Neurosci. 2013 Sep 3;7:116. doi: 10.3389/fnbeh.2013.00116. PMID: 24027504;
PMCID: PMC3759852.
1189: Zhang L, Zhao J. Profile of minocycline and its potential in the treatment
of schizophrenia. Neuropsychiatr Dis Treat. 2014 Jun 17;10:1103-11. doi:
10.2147/NDT.S64236. PMID: 24971013; PMCID: PMC4069141.
1190: Bach DR, Kindler J, Strik WK. Elevated bilirubin in acute and transient
psychotic disorder. Pharmacopsychiatry. 2010 Jan;43(1):12-6. doi:
10.1055/s-0029-1237376. Epub 2009 Dec 10. PMID: 20178091.
1191: Sandyk R, Kay SR, Gillman MA. The role of melatonin in the antipsychotic
and motor-side effects of neuroleptics: a hypothesis. Int J Neurosci. 1992 MayJun;64(1-4):203-7. doi: 10.3109/00207459209000546. PMID: 1364141.
1192: Vartzoka F, Ozenoglu E, Pitsikas N. The Nitric Oxide (NO) Donor
Molsidomine Attenuates Memory Impairments Induced by the D1/D2 Dopaminergic
Receptor Agonist Apomorphine in the Rat. Molecules. 2023 Sep 28;28(19):6861.
doi: 10.3390/molecules28196861. PMID: 37836704; PMCID: PMC10574075.
1193: Gama Marques J. Mitsuda psychosis and holodysphrenia revisited: An
atypical psychosis in a patient with parieto-occipital paroxysmal
electroencephalographic activity and high unconjugated bilirubin. Psychiatry
Clin Neurosci. 2017 Feb;71(2):148-149. doi: 10.1111/pcn.12487. Epub 2017 Jan 3.
PMID: 27873471.
1194: Katsanou L, Fragkiadaki E, Kampouris S, Konstanta A, Vontzou A, Pitsikas
N. The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and
Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat. Int J
Mol Sci. 2023 Apr 6;24(7):6866. doi: 10.3390/ijms24076866. PMID: 37047839;
PMCID: PMC10095209.
1195: Yoshida H, Kaiya H, Kondo T, Sanpei F, Takeda N, Takeuchi K. [Effects of
zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a
psychiatric hospital]. Yakubutsu Seishin Kodo. 1982 Dec;2(2):69-76. Japanese.
PMID: 6141682.
1196: Ebrahimi M, Ahangar N, Zamani E, Shaki F. L-Carnitine Prevents Behavioural
Alterations in Ketamine-Induced Schizophrenia in Mice: Possible Involvement of
Oxidative Stress and Inflammation Pathways. J Toxicol. 2023 Jun 16;2023:9093231.
doi: 10.1155/2023/9093231. PMID: 37363159; PMCID: PMC10289879.
1197: Ucar E, Lehtinen EK, Glenthøj BY, Oranje B. The effect of acute exogenous
melatonin on P50 suppression in healthy male volunteers stratified for low and
high gating levels. J Psychopharmacol. 2012 Aug;26(8):1113-8. doi:
10.1177/0269881111430752. Epub 2012 Feb 13. PMID: 22331175.
1198: Murray AJ, Rogers JC, Katshu MZUH, Liddle PF, Upthegrove R. Oxidative
Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum
Disorders. Front Psychiatry. 2021 Jul 22;12:703452. doi:
10.3389/fpsyt.2021.703452. PMID: 34366935; PMCID: PMC8339376.
1199: Michael N, Sourgens H, Arolt V, Erfurth A. Severe tardive dyskinesia in
affective disorders: treatment with vitamin E and C. Neuropsychobiology. 2002;46
Suppl 1:28-30. doi: 10.1159/000068019. PMID: 12571430.
1200: Kelly MP, Stein JM, Vecsey CG, Favilla C, Yang X, Bizily SF, Esposito MF,
Wand G, Kanes SJ, Abel T. Developmental etiology for neuroanatomical and
cognitive deficits in mice overexpressing Galphas, a G-protein subunit
genetically linked to schizophrenia. Mol Psychiatry. 2009 Apr;14(4):398-415,
347. doi: 10.1038/mp.2008.124. Epub 2008 Nov 25. Erratum in: Mol Psychiatry.
2009 Dec;14(12):1145. PMID: 19030002; PMCID: PMC3312743.
1201: Yan C, Duan L, Fu C, Tian C, Zhang B, Shao X, Zhu G. Association Between
Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han
Population. Neuropsychiatr Dis Treat. 2020 Feb 18;16:479-487. doi:
10.2147/NDT.S235043. PMID: 32110022; PMCID: PMC7038391.
1202: Pålsson E, Finnerty N, Fejgin K, Klamer D, Wass C, Svensson L, Lowry J.
Increased cortical nitric oxide release after phencyclidine administration.
Synapse. 2009 Dec;63(12):1083-8. doi: 10.1002/syn.20690. PMID: 19642219.
1203: Wiley JL, Golden KM, Bowen SE. Effects of modulation of nitric oxide on
acoustic startle responding and prepulse inhibition in rats. Eur J Pharmacol.
1997 Jun 11;328(2-3):125-30. doi: 10.1016/s0014-2999(97)83038-5. PMID: 9218693.
1204: Dinakaran D, Sreeraj VS, Venkatasubramanian G. Role of Curcumin in the
Management of Schizophrenia: A Narrative Review. Indian J Psychol Med. 2022
Mar;44(2):107-113. doi: 10.1177/02537176211033331. Epub 2021 Sep 13. PMID:
35655971; PMCID: PMC9120991.
1205: Pacchierotti C, Iapichino S, Bossini L, Pieraccini F, Castrogiovanni P.
Melatonin in psychiatric disorders: a review on the melatonin involvement in
psychiatry. Front Neuroendocrinol. 2001 Jan;22(1):18-32. doi:
10.1006/frne.2000.0202. PMID: 11141317.
1206: Gerbaldo H, Muller T, Osuna A, Visciano O, Jorge Benenti E, Carlos Orlando
J. Conducta fotomaníaca y esquizofrenia [Photomaniac behavior and
schizophrenia]. Acta Psiquiatr Psicol Am Lat. 1988 Dec;34(4):321-3. Spanish.
PMID: 3255229.
1207: Wass C, Klamer D, Fejgin K, Pålsson E. The importance of nitric oxide in
social dysfunction. Behav Brain Res. 2009 Jun 8;200(1):113-6. doi:
10.1016/j.bbr.2009.01.002. Epub 2009 Jan 8. PMID: 19166879.
1208: Ponizovsky AM, Barshtein G, Bergelson LD. Biochemical alterations of
erythrocytes as an indicator of mental disorders: an overview. Harv Rev
Psychiatry. 2003 Nov-Dec;11(6):317-32. PMID: 14713568.
1209: Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Karakuła KH, Zalewska A,
Maciejczyk M, Karakula-Juchnowicz H. Pro/Antioxidant State as a Potential
Biomarker of Schizophrenia. J Clin Med. 2021 Sep 15;10(18):4156. doi:
10.3390/jcm10184156. PMID: 34575267; PMCID: PMC8466193.
1210: Yuan Z, Liu H, Zhang X, He Y, Gu S, Mo D, Wang S, Huang Z, Wu K, Zhou R,
Zhong Q, Huang Y, Cao B, Chen H, Wu X. Role of uric acid as a biomarker of
cognitive function in schizophrenia during maintenance period. Front Psychiatry.
2023 Mar 22;14:1123127. doi: 10.3389/fpsyt.2023.1123127. PMID: 37032942; PMCID:
PMC10073439.
1211: Wass C, Svensson L, Fejgin K, Pålsson E, Archer T, Engel JA, Klamer D.
Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of
cognitive flexibility. Pharmacol Biochem Behav. 2008 May;89(3):352-9. doi:
10.1016/j.pbb.2008.01.011. Epub 2008 Jan 26. PMID: 18321564.
1212: Liu C, Song S, Zhang J, Li X, Gao H. Effects of <i>GSTA1</i> and
<i>GPX3</i> Polymorphisms on the Risk of Schizophrenia in Chinese Han
Population. Neuropsychiatr Dis Treat. 2020 Jan 9;16:113-118. doi:
10.2147/NDT.S236298. PMID: 32021204; PMCID: PMC6957098.
1213: Baandrup L, Fasmer OB, Glenthøj BY, Jennum PJ. Circadian rest-activity
rhythms during benzodiazepine tapering covered by melatonin versus placebo addon: data derived from a randomized clinical trial. BMC Psychiatry. 2016 Oct
13;16(1):348. doi: 10.1186/s12888-016-1062-8. PMID: 27737649; PMCID: PMC5064925.
1214: Martorell M, Lucas X, Alarcón-Zapata P, Capó X, Quetglas-Llabrés MM,
Tejada S, Sureda A. Targeting Xanthine Oxidase by Natural Products as a
Therapeutic Approach for Mental Disorders. Curr Pharm Des. 2021;27(3):367-382.
doi: 10.2174/1381612826666200621165839. PMID: 32564744.
1215: Brites D, Fernandes A, Falcão AS, Gordo AC, Silva RF, Brito MA. Biological
risks for neurological abnormalities associated with hyperbilirubinemia. J
Perinatol. 2009 Feb;29 Suppl 1:S8-13. doi: 10.1038/jp.2008.214. PMID: 19177063.
1216: Rolland B, Marche K, Cottencin O, Bordet R. The PPARα Agonist Fenofibrate
Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of
Schizophrenia. Schizophr Res Treatment. 2012;2012:839853. doi:
10.1155/2012/839853. Epub 2012 May 15. PMID: 22966448; PMCID: PMC3420697.
1217: Smaga I, Frankowska M, Filip M. N-acetylcysteine as a new prominent
approach for treating psychiatric disorders. Br J Pharmacol. 2021
Jul;178(13):2569-2594. doi: 10.1111/bph.15456. Epub 2021 May 5. PMID: 33760228.
1218: Lashgari NA, Roudsari NM, Shamsnia HS,
AH. TLR/mTOR inflammatory signaling pathway:
schizophrenia. Can J Physiol Pharmacol. 2023
10.1139/cjpp-2023-0107. Epub ahead of print.
Shayan M, Momtaz S, Abdolghaffari
novel insight for the treatment of
Nov 13. doi:
PMID: 37955633.
1219: Kim SW, Kang HJ, Jhon M, Kim JW, Lee JY, Walker AJ, Agustini B, Kim JM,
Berk M. Statins and Inflammation: New Therapeutic Opportunities in Psychiatry.
Front Psychiatry. 2019 Mar 5;10:103. doi: 10.3389/fpsyt.2019.00103. PMID:
30890971; PMCID: PMC6413672.
1220: Geoffroy PA, Micoulaud Franchi JA, Lopez R, Schroder CM; membres du
consensus Mélatonine SFRMS. The use of melatonin in adult psychiatric disorders:
Expert recommendations by the French institute of medical research on sleep
(SFRMS). Encephale. 2019 Nov;45(5):413-423. doi: 10.1016/j.encep.2019.04.068.
Epub 2019 Jun 24. PMID: 31248601.
1221: Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C.
Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular,
and molecular aspects. Biochem Pharmacol. 2003 Apr 1;65(7):1035-41. doi:
10.1016/s0006-2952(03)00002-9. PMID: 12663039.
1222: Potes Y, Cachán-Vega C, Antuña E, García-González C, Menéndez-Coto N, Boga
JA, Gutiérrez-Rodríguez J, Bermúdez M, Sierra V, Vega-Naredo I, Coto-Montes A,
Caballero B. Benefits of the Neurogenic Potential of Melatonin for Treating
Neurological and Neuropsychiatric Disorders. Int J Mol Sci. 2023 Mar
2;24(5):4803. doi: 10.3390/ijms24054803. PMID: 36902233; PMCID: PMC10002978.
1223: Hurşitoğlu O, Orhan FÖ, Kurutaş EB, Doğaner A, Durmuş HT, Kopar H.
Diagnostic Performance of Increased Malondialdehyde Level and Oxidative Stress
in Patients with Schizophrenia. Noro Psikiyatr Ars. 2021 May 17;58(3):184-188.
doi: 10.29399/npa.27372. PMID: 34526839; PMCID: PMC8419726.
1224: Retsa C, Knebel JF, Geiser E, Ferrari C, Jenni R, Fournier M, Alameda L,
Baumann PS, Clarke S, Conus P, Do KQ, Murray MM. Treatment in early psychosis
with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot
study. Schizophr Res. 2018 Jan;191:80-86. doi: 10.1016/j.schres.2017.07.008.
Epub 2017 Jul 12. PMID: 28711476.
1225: Shiina A, Kanahara N, Sasaki T, Oda Y, Hashimoto T, Hasegawa T, Yoshida T,
Iyo M, Hashimoto K. An Open Study of Sulforaphane-rich Broccoli Sprout Extract
in Patients with Schizophrenia. Clin Psychopharmacol Neurosci. 2015 Apr
30;13(1):62-7. doi: 10.9758/cpn.2015.13.1.62. PMID: 25912539; PMCID: PMC4423155.
1226: Na IS, Nguyen K, Potenzi B, Cheah M. Now you C me: a case of scurvy
presenting as depression and anaemia. BMJ Case Rep. 2020 Mar 4;13(3):e233645.
doi: 10.1136/bcr-2019-233645. PMID: 32139451; PMCID: PMC7059414.
1227: Andreazza AC, Barakauskas VE, Fazeli S, Feresten A, Shao L, Wei V, Wu CH,
Barr AM, Beasley CL. Effects of haloperidol and clozapine administration on
oxidative stress in rat brain, liver and serum. Neurosci Lett. 2015 Mar
30;591:36-40. doi: 10.1016/j.neulet.2015.02.028. Epub 2015 Feb 13. PMID:
25684243.
1228: Del Castillo RM, Ramos E, Martínez A. Interaction of graphene with
antipsychotic drugs: Is there any charge transfer process? J Comput Chem. 2021
Jan 5;42(1):60-65. doi: 10.1002/jcc.26433. Epub 2020 Oct 13. PMID: 33048373.
1229: Kozlova AA, Vaganova AN, Rodionov RN, Gainetdinov RR, Bernhardt N.
Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In
Silico Methods. Int J Mol Sci. 2022 Oct 7;23(19):11902. doi:
10.3390/ijms231911902. PMID: 36233204; PMCID: PMC9569903.
1230: Duan C, Jenkins ZM, Castle D. Therapeutic use of melatonin in
schizophrenia: A systematic review. World J Psychiatry. 2021 Aug
19;11(8):463-476. doi: 10.5498/wjp.v11.i8.463. PMID: 34513608; PMCID:
PMC8394692.
1231: Bókkon I, Antal I. Schizophrenia: redox regulation and volume
neurotransmission. Curr Neuropharmacol. 2011 Jun;9(2):289-300. doi:
10.2174/157015911795596504. PMID: 22131938; PMCID: PMC3131720.
1232: Bringas ME, Morales-Medina JC, Flores-Vivaldo Y, Negrete-Diaz JV, AguilarAlonso P, León-Chávez BA, Lazcano-Ortiz Z, Monroy E, Rodríguez-Moreno A, Quirion
R, Flores G. Clozapine administration reverses behavioral, neuronal, and nitric
oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology.
2012 Mar;62(4):1848-57. doi: 10.1016/j.neuropharm.2011.12.008. Epub 2011 Dec 17.
PMID: 22207157.
1233: Young J, McKinney SB, Ross BM, Wahle KW, Boyle SP. Biomarkers of oxidative
stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty
Acids. 2007 Feb;76(2):73-85. doi: 10.1016/j.plefa.2006.11.003. Epub 2007 Jan 2.
PMID: 17197163.
1234: Scott H, Phillips TJ, Stuart GC, Rogers MF, Steinkraus BR, Grant S, Case
CP. Preeclamptic placentae release factors that damage neurons: implications for
foetal programming of disease. Neuronal Signal. 2018 Oct 12;2(4):NS20180139.
doi: 10.1042/NS20180139. PMID: 32714596; PMCID: PMC7363326.
1235: Gouvêa-Junqueira D, Falvella ACB, Antunes ASLM, Seabra G, Brandão-Teles C,
Martins-de-Souza D, Crunfli F. Novel Treatment Strategies Targeting Myelin and
Oligodendrocyte Dysfunction in Schizophrenia. Front Psychiatry. 2020 Apr
30;11:379. doi: 10.3389/fpsyt.2020.00379. PMID: 32425837; PMCID: PMC7203658.
1236: Moretti M, Rodrigues ALS. Functional role of ascorbic acid in the central
nervous system: a focus on neurogenic and synaptogenic processes. Nutr Neurosci.
2022 Nov;25(11):2431-2441. doi: 10.1080/1028415X.2021.1956848. Epub 2021 Sep 8.
PMID: 34493165.
1237: Hroudová J, Fišar Z. Control mechanisms in mitochondrial oxidative
phosphorylation. Neural Regen Res. 2013 Feb 5;8(4):363-75. doi:
10.3969/j.issn.1673-5374.2013.04.009. PMID: 25206677; PMCID: PMC4107533.
1238: Hassanein EHM, Althagafy HS, Baraka MA, Abd-Alhameed EK, Ibrahim IM.
Pharmacological update of mirtazapine: a narrative literature review. Naunyn
Schmiedebergs Arch Pharmacol. 2023 Nov 9. doi: 10.1007/s00210-023-02818-6. Epub
ahead of print. PMID: 37943296.
1239: Maes M, Kanchanatawan B. In (deficit) schizophrenia, a general cognitive
decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity
on the symptomatome and quality of life. CNS Spectr. 2021 Apr 12:1-10. doi:
10.1017/S1092852921000419. Epub ahead of print. PMID: 33843548.
1240: Salim S. Oxidative stress and psychological disorders. Curr
Neuropharmacol. 2014 Mar;12(2):140-7. doi: 10.2174/1570159X11666131120230309.
PMID: 24669208; PMCID: PMC3964745.
1241: Karahalil B, Elkama A, Ak M, Nemutlu E. Metabolomics mapping changed after
olanzapine therapy in drug-naive schizophrenia patients-the significant impact
of gene polymorphisms. Toxicol Res (Camb). 2022 Jun 1;11(3):547-556. doi:
10.1093/toxres/tfac034. PMID: 35782649; PMCID: PMC9244978.
1242: Moskaleva PV, Shnayder NA, Nasyrova RF. Assotsiatsiya polimorfizmov genov
DDC (AADC), AANAT i ASMT, kodiruyushchikh fermenty sinteza melatonina, s riskom
razvitiya psikhonevrologicheskikh rasstroistv [Association of polymorphic
variants of DDC (AADC), AANAT and ASMT genes encoding enzymes for melatonin
synthesis with the higher risk of neuropsychiatric disorders]. Zh Nevrol
Psikhiatr Im S S Korsakova. 2021;121(5):151-157. Russian. doi:
10.17116/jnevro2021121041151. PMID: 34184492.
1243: Jayanti S, Dalla Verde C, Tiribelli C, Gazzin S. Inflammation,
Dopaminergic Brain and Bilirubin. Int J Mol Sci. 2023 Jul 14;24(14):11478. doi:
10.3390/ijms241411478. PMID: 37511235; PMCID: PMC10380707.
1244: Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai
M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A,
Sumiyoshi T. Identification of N-substituted 8-azatetrahydroquinolone
derivatives as selective and orally active M(1) and M(4) muscarinic
acetylcholine receptors agonists. Bioorg Med Chem Lett. 2013 Aug
15;23(16):4644-7. doi: 10.1016/j.bmcl.2013.06.013. Epub 2013 Jun 13. PMID:
23816371.
1245: Tellez-Merlo G, Morales-Medina JC, Camacho-Ábrego I, Juárez-Díaz I,
Aguilar-Alonso P, de la Cruz F, Iannitti T, Flores G. Prenatal immune challenge
induces behavioral deficits, neuronal remodeling, and increases brain nitric
oxide and zinc levels in the male rat offspring. Neuroscience. 2019 May
15;406:594-605. doi: 10.1016/j.neuroscience.2019.02.018. Epub 2019 Feb 21. PMID:
30797024.
1246: Xu H, Wei Y, Zheng L, Zhang H, Luo T, Li H, Ma J, Chen J. Relation Between
Unconjugated Bilirubin and Peripheral Biomarkers of Inflammation Derived From
Complete Blood Counts in Patients With Acute Stage of Schizophrenia. Front
Psychiatry. 2022 Apr 7;13:843985. doi: 10.3389/fpsyt.2022.843985. PMID:
35463529; PMCID: PMC9022903.
1247: Rostagno C, Di Norscia G, Placidi GF, Gensini GF. Beta-blocker and
angiotensin-converting enzyme inhibitor may limit certain cardiac adverse
effects of clozapine. Gen Hosp Psychiatry. 2008 May-Jun;30(3):280-3. doi:
10.1016/j.genhosppsych.2007.09.003. PMID: 18433662.
1248: Yee BK, Russig H, Feldon J. Apomorphine-induced prepulse inhibition
disruption is associated with a paradoxical enhancement of prepulse stimulus
reactivity. Neuropsychopharmacology. 2004 Feb;29(2):240-8. doi:
10.1038/sj.npp.1300323. PMID: 14666120.
1249: Tarragó T, Kichik N, Claasen B, Prades R, Teixidó M, Giralt E. Baicalin, a
prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorg Med
Chem. 2008 Aug 1;16(15):7516-24. doi: 10.1016/j.bmc.2008.04.067. Epub 2008 Apr
29. PMID: 18650094.
1250: Zhilyaeva TV, Piatoikina AS, Bavrina AP, Kostina OV, Zhukova ES,
Shcherbatyuk TG, Blagonravova AS, Dubinina EE, Mazo GE. Homocysteine in
Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or
Integral Marker of Other Biochemical Disturbances? Schizophr Res Treatment. 2021
Oct 13;2021:7721760. doi: 10.1155/2021/7721760. PMID: 34707909; PMCID:
PMC8545596.
1251: Kawohl W, Giegling I, Mavrogiorgou P, Pogarell O, Mulert C, Möller HJ,
Hegerl U, Rujescu D, Juckel G. Association of functional polymorphisms in NOS1
and NOS3 with loudness dependence of auditory evoked potentials. Int J
Neuropsychopharmacol. 2008 Jun;11(4):477-83. doi: 10.1017/S1461145708008420.
Epub 2008 Feb 8. PMID: 18257968.
1252: Kim J, Park H, Ryu J, Jeon O, Paeng IR. Competitive enzyme-linked
immunosorbent assay for a selective and sensitive determination of dopamine in
the presence of ascorbic acid and uric acid. J Immunoassay Immunochem.
2010;31(1):33-44. doi: 10.1080/15321810903404988. PMID: 20391016.
1253: Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Ng CH, Hopwood M, Harvey BH,
Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo JP, Walder K,
Sarris J, Berk M. The Therapeutic Potential of Mangosteen Pericarp as an
Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Front Psychiatry.
2019 Mar 13;10:115. doi: 10.3389/fpsyt.2019.00115. PMID: 30918489; PMCID:
PMC6424889.
1254: Chen MY, Zhang Q, Liu YF, Zheng WY, Si TL, Su Z, Cheung T, Jackson T, Li
XH, Xiang YT. Schizophrenia and oxidative stress from the perspective of
bibliometric analysis. Front Psychiatry. 2023 Feb 27;14:1145409. doi:
10.3389/fpsyt.2023.1145409. PMID: 36923522; PMCID: PMC10008861.
1255: Fernandez A, Meechan DW, Karpinski BA, Paronett EM, Bryan CA, Rutz HL,
Radin EA, Lubin N, Bonner ER, Popratiloff A, Rothblat LA, Maynard TM, LaMantia
AS. Mitochondrial Dysfunction Leads to Cortical Under-Connectivity and Cognitive
Impairment. Neuron. 2019 Jun 19;102(6):1127-1142.e3. doi:
10.1016/j.neuron.2019.04.013. Epub 2019 May 9. PMID: 31079872; PMCID:
PMC6668992.
1256: Więdłocha M, Zborowska N,
A, Maciejczyk M, Waszkiewicz N,
Schizophrenia Inpatients. Brain
10.3390/brainsci13030490. PMID:
Marcinowicz P, Dębowska W, Dębowska M, Zalewska
Szulc A. Oxidative Stress Biomarkers among
Sci. 2023 Mar 14;13(3):490. doi:
36979300; PMCID: PMC10046541.
1257: Kurachi M, Takahashi T, Sumiyoshi T, Uehara T, Suzuki M. Early
Intervention and a Direction of Novel Therapeutics for the Improvement of
Functional Outcomes in Schizophrenia: A Selective Review. Front Psychiatry. 2018
Feb 19;9:39. doi: 10.3389/fpsyt.2018.00039. PMID: 29515467; PMCID: PMC5826072.
1258: Dogan HO, Ersan EE, Aydin H, Erdoğan S, Erşan S, Alişik M, Bakir S, Erel
Ö, Koç D. Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical
Antipsychotic Drugs. Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):39-45.
doi: 10.9758/cpn.2018.16.1.39. PMID: 29397665; PMCID: PMC5810441.
1259: Zai CC, Tiwari AK, Basile V, de Luca V, Müller DJ, Voineskos AN, Remington
G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. Oxidative stress in tardive
dyskinesia: genetic association study and meta-analysis of NADPH quinine
oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes. Prog
Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):50-6. doi:
10.1016/j.pnpbp.2009.09.020. Epub 2009 Sep 22. PMID: 19778569.
1260: Georgiadou G, Grivas V, Tarantilis PA, Pitsikas N. Crocins, the active
constituents of Crocus Sativus L., counteracted ketamine-induced behavioural
deficits in rats. Psychopharmacology (Berl). 2014 Feb;231(4):717-26. doi:
10.1007/s00213-013-3293-4. Epub 2013 Oct 6. PMID: 24096536.
1261: Iwata Y, Nakajima S, Plitman E, Truong P, Bani-Fatemi A, Caravaggio F, Kim
J, Shah P, Mar W, Chavez S, Remington G, Gerretsen P, De Luca V, Sailasuta N,
Graff-Guerrero A. Glutathione Levels and Glutathione-Glutamate Correlation in
Patients With Treatment-Resistant Schizophrenia. Schizophr Bull Open. 2021 Mar
8;2(1):sgab006. doi: 10.1093/schizbullopen/sgab006. PMID: 33969302; PMCID:
PMC8086698.
1262: Atama CI, Nnaji EC, Christian Ezeoyili I, Udeani FO, Onovo CJ, Ike Ossai
N, Oscar Aguzie I, Nwani CD. Neuromodulatory and oxidative stress evaluations in
African catfish <i>Clarias gariepinus</i> exposed to antipsychotic drug
chlorpromazine. Drug Chem Toxicol. 2022 May;45(3):1318-1324. doi:
10.1080/01480545.2020.1822391. Epub 2020 Sep 22. PMID: 32957809.
1263: Ovesen L. Vitamin therapy in the absence of obvious deficiency. What is
the evidence? Drugs. 1984 Feb;27(2):148-70. doi:
10.2165/00003495-198427020-00003. PMID: 6230219.
1264: Wadhwa R, Gupta R, Maurya PK. Oxidative Stress and Accelerated Aging in
Neurodegenerative and Neuropsychiatric Disorder. Curr Pharm Des.
2018;24(40):4711-4725. doi: 10.2174/1381612825666190115121018. PMID: 30644343.
1265: Güneş M, Camkurt MA, Bulut M, Demir S, İbiloğlu AO, Kaya MC, Atlı A,
Kaplan İ, Sir A. Evaluation of Paraoxonase, Arylesterase and Malondialdehyde
Levels in Schizophrenia Patients Taking Typical, Atypical and Combined
Antipsychotic Treatment. Clin Psychopharmacol Neurosci. 2016 Nov
30;14(4):345-350. doi: 10.9758/cpn.2016.14.4.345. PMID: 27776386; PMCID:
PMC5083945.
1266: Uehara T, Kurachi M, Kondo T, Abe H, Itoh H, Sumiyoshi T, Suzuki M.
Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced
Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine. J Pers Med. 2022
Feb 27;12(3):366. doi: 10.3390/jpm12030366. PMID: 35330366; PMCID: PMC8951253.
1267: Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Interaction of
glutathione depletion and psychotropic drug treatment in prepulse inhibition in
rats and mice. Pharmacol Biochem Behav. 2010 Dec;97(2):293-300. doi:
10.1016/j.pbb.2010.08.013. Epub 2010 Sep 9. PMID: 20816888.
1268: Li XM, Chlan-Fourney J, Juorio AV, Bennett VL, Shrikhande S, Keegan DL, Qi
J, Boulton AA. Differential effects of olanzapine on the gene expression of
superoxide dismutase and the low affinity nerve growth factor receptor. J
Neurosci Res. 1999 Apr 1;56(1):72-5. doi:
10.1002/(SICI)1097-4547(19990401)56:1<72::AID-JNR9>3.0.CO;2-0. PMID: 10213477.
1269: Brondino N, De Silvestri A, Re S, Lanati N, Thiemann P, Verna A, Emanuele
E, Politi P. A Systematic Review and Meta-Analysis of Ginkgo biloba in
Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Evid
Based Complement Alternat Med. 2013;2013:915691. doi: 10.1155/2013/915691. Epub
2013 May 28. PMID: 23781271; PMCID: PMC3679686.
1270: Xue T, Wang X, Hu Y, Cheng Y, Li H, Shi Y, Wang L, Yin D, Cui D. Embryonic
Deletion of TXNIP in GABAergic Neurons Enhanced Oxidative Stress in PV+
Interneurons in Primary Somatosensory Cortex of Aging Mice: Relevance to
Schizophrenia. Brain Sci. 2022 Oct 15;12(10):1395. doi:
10.3390/brainsci12101395. PMID: 36291328; PMCID: PMC9599691.
1271: Kolar D, Krajcovic B, Kleteckova L, Kuncicka D, Vales K, Brozka H. Review:
Genes Involved in Mitochondrial Physiology Within 22q11.2 Deleted Region and
Their Relevance to Schizophrenia. Schizophr Bull. 2023 Jun 28:sbad066. doi:
10.1093/schbul/sbad066. Epub ahead of print. PMID: 37379469.
1272: de Souza DF, Wartchow K, Hansen F, Lunardi P, Guerra MC, Nardin P,
Gonçalves CA. Interleukin-6-induced S100B secretion is inhibited by haloperidol
and risperidone. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:14-22.
doi: 10.1016/j.pnpbp.2012.12.001. Epub 2012 Dec 13. PMID: 23246638.
1273: Fernández MJF, Valero-Cases E, Rincon-Frutos L. Food Components with the
Potential to be Used in the Therapeutic Approach of Mental Diseases. Curr Pharm
Biotechnol. 2019;20(2):100-113. doi: 10.2174/1389201019666180925120657. PMID:
30255749.
1274: Hermann D, Schneider M. Potential protective effects of cannabidiol on
neuroanatomical alterations in cannabis users and psychosis: a critical review.
Curr Pharm Des. 2012;18(32):4897-905. doi: 10.2174/138161212802884825. PMID:
22716143.
1275: Flores-Gómez GD, Apam-Castillejos DJ, Juárez-Díaz I, Fuentes-Medel E, Díaz
A, Tendilla-Beltrán H, Flores G. Aripiprazole attenuates the medial prefrontal
cortex morphological and biochemical alterations in rats with neonatal ventral
hippocampus lesion. J Chem Neuroanat. 2023 Oct;132:102316. doi:
10.1016/j.jchemneu.2023.102316. Epub 2023 Jul 20. PMID: 37481172.
1276: Stoyanov D, Maes MH. How to construct neuroscience-informed psychiatric
classification? Towards nomothetic networks psychiatry. World J Psychiatry. 2021
Jan 19;11(1):1-12. doi: 10.5498/wjp.v11.i1.1. PMID: 33511042; PMCID: PMC7805251.
1277: Parvizi M, Fadai F, Khodaei-Ardakani MR, Amin G, Abdi L, Noroozi M, Ansari
I. Effect of <i>Cuscuta epithymum</i> Acquainted with Risperidone on the
Improvement of Clinical Symptoms and Cognitive Impairment in Patients with
Schizophrenia: A Triple-Blind Randomized Placebo-Controlled Trial. Galen Med J.
2019 Dec 29;8:e1334. doi: 10.31661/gmj.v8i0.1334. PMID: 34466495; PMCID:
PMC8343989.
1278: Dean OM, Data-Franco J, Giorlando F, Berk M. Minocycline: therapeutic
potential in psychiatry. CNS Drugs. 2012 May 1;26(5):391-401. doi:
10.2165/11632000-000000000-00000. PMID: 22486246.
1279: Bygrave AM, Kilonzo K, Kullmann DM, Bannerman DM, Kätzel D. Can N-MethylD-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual
Cell Type? Front Psychiatry. 2019 Nov 21;10:835. doi: 10.3389/fpsyt.2019.00835.
PMID: 31824347; PMCID: PMC6881463.
1280: Zhang Q, Liu Z, Wang T, Yu M, Li X. Efficacy and acceptability of
adjunctive n-acetylcysteine for psychotic disorders: Systematic review and metaanalysis. Hum Psychopharmacol. 2023 Sep 15:e2880. doi: 10.1002/hup.2880. Epub
ahead of print. PMID: 37712506.
1281: Stein A, Zhu C, Du F, Öngür D. Magnetic Resonance Spectroscopy Studies of
Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic
Psychosis. Curr Psychiatry Rep. 2023 Oct 9. doi: 10.1007/s11920-023-01457-1.
Epub ahead of print. PMID: 37812338.
1282: Park SK, Hyun SH, In G, Park CK, Kwak YS, Jang YJ, Kim B, Kim JH, Han CK.
The antioxidant activities of Korean Red Ginseng (<i>Panax ginseng</i>) and
ginsenosides: A systemic review through <i>in vivo</i> and clinical trials. J
Ginseng Res. 2021 Jan;45(1):41-47. doi: 10.1016/j.jgr.2020.09.006. Epub 2020 Oct
10. PMID: 33437155; PMCID: PMC7790892.
1283: Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain
diseases: the good, the bad, and the ugly. Oxid Med Cell Longev.
2013;2013:963520. doi: 10.1155/2013/963520. Epub 2013 Dec 5. PMID: 24381719;
PMCID: PMC3871919.
1284: Bai O, Wei Z, Lu W, Bowen R, Keegan D, Li XM. Protective effects of
atypical antipsychotic drugs on PC12 cells after serum withdrawal. J Neurosci
Res. 2002 Jul 15;69(2):278-83. doi: 10.1002/jnr.10290. PMID: 12111809.
1285: Marzullo G. Similar photoperiod-related birth seasonalities among
professional baseball players and lesbian women with an opposite seasonality
among gay men: Maternal melatonin may affect fetal sexual dimorphism. Psychiatry
Res. 2014 May 30;216(3):424-31. doi: 10.1016/j.psychres.2014.02.022. Epub 2014
Feb 22. PMID: 24612972.
1286: Zhang KE, Kari PH, Davis MR, Doss G, Baillie TA, Vyas KP. Metabolism of A
dopamine D(4)-selective antagonist in rat, monkey, and humans: formation of A
novel mercapturic acid adduct. Drug Metab Dispos. 2000 Jun;28(6):633-42. PMID:
10820134.
1287: Korkut Celikates B, Kilic V, Atli-Eklioglu O, Baysal M, Aydogan-Kılıc G,
Ucarcan S, Ilgin S. Effects of quetiapine administration on sperm quality and
testicular histology. Drug Chem Toxicol. 2022 Sep;45(5):2379-2387. doi:
10.1080/01480545.2021.1946558. Epub 2021 Jul 7. PMID: 34229556.
1288: de Carvalho MD, De Mesquita JF. Structural modeling and in silico analysis
of human superoxide dismutase 2. PLoS One. 2013 Jun 13;8(6):e65558. doi:
10.1371/journal.pone.0065558. PMID: 23785434; PMCID: PMC3681941.
1289: Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye
R. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic
review. Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi:
10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. PMID: 25957927.
1290: Wyatt RJ, Karoum F, Masserano J. Effects of antipsychotics, vitamin E, and
MK-801 on dopamine dynamics in the rat brain following discontinuation of
cocaine. Psychiatry Res. 1998 Sep 21;80(3):213-25. doi:
10.1016/s0165-1781(98)00080-8. PMID: 9796937.
1291: Pérez-Neri I, Montes S, Boll MC, Ramírez-Bermúdez J, Ríos C. Liquid
chromatographic-fluorimetric method for the estimation of nitric oxide
biosynthesis in the central nervous system. J Chromatogr B Analyt Technol Biomed
Life Sci. 2004 Jul 5;806(2):133-9. doi: 10.1016/j.jchromb.2004.03.043. PMID:
15171922.
1292: Górny M, Bilska-Wilkosz A, Iciek M, Rogóż Z, Lorenc-Koci E. Treatment with
aripiprazole and N-acetylcysteine affects anaerobic cysteine metabolism in the
hippocampus and reverses schizophrenia-like behavior in the neurodevelopmental
rat model of schizophrenia. FEBS J. 2023 Aug 30. doi: 10.1111/febs.16944. Epub
ahead of print. PMID: 37646112.
1293: Brott DA, Goodman MJ, Hermann RP, Merz M, Calvo R, Poorkhalkali N, Kiazand
A. Are laboratory parameter (biomarker) values similar to the healthy volunteer
reference range in all patient populations? Drug Des Devel Ther. 2018 Sep
6;12:2757-2773. doi: 10.2147/DDDT.S173671. PMID: 30233139; PMCID: PMC6132491.
1294: Klamer D, Pålsson E, Revesz A, Engel JA, Svensson L. Habituation of
acoustic startle is disrupted by psychotomimetic drugs: differential dependence
on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology
(Berl). 2004 Nov;176(3-4):440-50. doi: 10.1007/s00213-004-1901-z. Epub 2004 Jun
2. PMID: 15173930.
1295: Nishimura Y, Kanda Y, Sone H, Aoyama H. Oxidative Stress as a Common Key
Event in Developmental Neurotoxicity. Oxid Med Cell Longev. 2021 Jul
19;2021:6685204. doi: 10.1155/2021/6685204. PMID: 34336113; PMCID: PMC8315852.
1296: Rassart E, Desmarais F, Najyb O, Bergeron KF, Mounier C. Apolipoprotein D.
Gene. 2020 Sep 25;756:144874. doi: 10.1016/j.gene.2020.144874. Epub 2020 Jun 15.
PMID: 32554047; PMCID: PMC8011330.
1297: Long Y, Wang Y, Shen Y, Huang J, Li Y, Wu R, Zhao J. Minocycline and
antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS
via regulating the MAPKs/ JAK-STAT signaling pathway. BMC Psychiatry. 2023 Jul
18;23(1):514. doi: 10.1186/s12888-023-05014-1. PMID: 37464316; PMCID:
PMC10354898.
1298: Kosten L, Chowdhury GMI, Mingote S, Staelens S, Rothman DL, Behar KL,
Rayport S. Glutaminase activity in GLS1 Het mouse brain compared to putative
pharmacological inhibition by ebselen using ex vivo MRS. Neurochem Int. 2019
Oct;129:104508. doi: 10.1016/j.neuint.2019.104508. Epub 2019 Jul 19. PMID:
31326460; PMCID: PMC6941670.
1299: Guo X, Tang P, Hou C, Li R. Mendelian randomization investigation
highlights different roles of selenium status in mental disorders. Prog
Neuropsychopharmacol Biol Psychiatry. 2023 Mar 2;122:110694. doi:
10.1016/j.pnpbp.2022.110694. Epub 2022 Dec 12. PMID: 36521586.
1300: Paul BD, Snyder SH. Therapeutic Applications of Cysteamine and Cystamine
in Neurodegenerative and Neuropsychiatric Diseases. Front Neurol. 2019 Dec
12;10:1315. doi: 10.3389/fneur.2019.01315. PMID: 31920936; PMCID: PMC6920251.
1301: Moreira EG, Boll KM, Correia DG, Soares JF, Rigobello C, Maes M. Why
Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1? Curr
Neuropharmacol. 2019;17(11):1004-1020. doi: 10.2174/1570159X17666181227164947.
PMID: 30592255; PMCID: PMC7052826.
1302: Biglan KM, Holloway RG. A review of pramipexole and its clinical utility
in Parkinson's disease. Expert Opin Pharmacother. 2002 Feb;3(2):197-210. doi:
10.1517/14656566.3.2.197. PMID: 11829733.
1303: Fond G, Lançon C, Korchia T, Auquier P, Boyer L. The Role of Inflammation
in the Treatment of Schizophrenia. Front Psychiatry. 2020 Mar 18;11:160. doi:
10.3389/fpsyt.2020.00160. PMID: 32256401; PMCID: PMC7093323.
1304: Rafiq H, Farhan M, Rafi H, Rehman S, Arshad M, Shakeel S. Inhibition of
drug induced Parkinsonism by chronic supplementation of quercetin in
haloperidol-treated wistars. Pak J Pharm Sci. 2022 Nov;35(6):1655-1662. PMID:
36789825.
1305: Howland RH. Melatonin, Liraglutide, and Naltrexone/Bupropion for the
Treatment of Obesity and Medication-Related Weight Gain. J Psychosoc Nurs Ment
Health Serv. 2015 Jun;53(6):19-22. doi: 10.3928/02793695-20150526-02. PMID:
26091546.
1306: Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S. The Role of Vitamin D in
Brain Health: A Mini Literature Review. Cureus. 2018 Jul 10;10(7):e2960. doi:
10.7759/cureus.2960. PMID: 30214848; PMCID: PMC6132681.
1307: Shireen E. Experimental treatment of antipsychotic-induced movement
disorders. J Exp Pharmacol. 2016 Aug 8;8:1-10. doi: 10.2147/JEP.S63553. PMID:
27540314; PMCID: PMC4982503.
1308: Grosso C, Valentão P, Ferreres F, Andrade PB. The use of flavonoids in
central nervous system disorders. Curr Med Chem. 2013;20(37):4694-719. doi:
10.2174/09298673113209990155. PMID: 23834189.
1309: Herrmann AP, Lunardi P, Pilz LK, Tramontina AC, Linck VM, Okunji CO,
Gonçalves CA, Elisabetsky E. Effects of the putative antipsychotic alstonine on
glutamate uptake in acute hippocampal slices. Neurochem Int. 2012
Dec;61(7):1144-50. doi: 10.1016/j.neuint.2012.08.006. Epub 2012 Aug 25. PMID:
22940693.
1310: Kim J. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of
Sulforaphane in Alzheimer's Disease. Int J Mol Sci. 2021 Mar 13;22(6):2929. doi:
10.3390/ijms22062929. PMID: 33805772; PMCID: PMC7999245.
1311: Kato T, Mizoguchi Y, Monji A, Horikawa H, Suzuki SO, Seki Y, Iwaki T,
Hashioka S, Kanba S. Inhibitory effects of aripiprazole on interferon-gammainduced microglial activation via intracellular Ca2+ regulation in vitro. J
Neurochem. 2008 Jul;106(2):815-25. doi: 10.1111/j.1471-4159.2008.05435.x. Epub
2008 Apr 19. PMID: 18429930.
1312: Issy AC, Pedrazzi JF, Yoneyama BH, Del-Bel EA. Critical role of nitric
oxide in the modulation of prepulse inhibition in Swiss mice. Psychopharmacology
(Berl). 2014 Feb;231(4):663-72. doi: 10.1007/s00213-013-3277-4. Epub 2013 Oct 8.
PMID: 24101156.
1313: Yun AJ, Bazar KA, Lee PY. Pineal attrition, loss of cognitive plasticity,
and onset of puberty during the teen years: is it a modern maladaptation exposed
by evolutionary displacement? Med Hypotheses. 2004;63(6):939-50. doi:
10.1016/j.mehy.2004.07.027. PMID: 15504560.
1314: Patel HP, Chaudhari PS, Gandhi PA, Desai BV, Desai DT, Dedhiya PP, Vyas
BA, Maulvi FA. Nose to brain delivery of tailored clozapine nanosuspension
stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate:
Optimization and in vivo pharmacokinetic studies. Int J Pharm. 2021 May
1;600:120474. doi: 10.1016/j.ijpharm.2021.120474. Epub 2021 Mar 15. PMID:
33737093.
1315: Pires PC, Paiva-Santos AC, Veiga F. Liposome-Derived Nanosystems for the
Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes,
Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability.
Pharmaceuticals (Basel). 2023 Oct 8;16(10):1424. doi: 10.3390/ph16101424. PMID:
37895895; PMCID: PMC10610493.
1316: Cortes-Torres AG, López-Castillo GN, Marín-Torres JL, Portillo-Reyes R,
Luna F, Baca BE, Sandoval-Ramírez J, Carrasco-Carballo A. <i>Cymbopogon
citratus</i> Essential Oil: Extraction, GC-MS, Phytochemical Analysis,
Antioxidant Activity, and In Silico Molecular Docking for Protein Targets
Related to CNS. Curr Issues Mol Biol. 2023 Jun 16;45(6):5164-5179. doi:
10.3390/cimb45060328. PMID: 37367077; PMCID: PMC10297282.
1317: Shao X, Yan C, Sun D, Fu C, Tian C, Duan L, Zhu G. Association Between
Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese
Han Population. Neuropsychiatr Dis Treat. 2020 Oct 6;16:2297-2305. doi:
10.2147/NDT.S272278. PMID: 33116528; PMCID: PMC7547781.
1318: Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry:
review of effectiveness and safety. Br J Psychiatry. 2006 Feb;188:109-21. doi:
10.1192/bjp.188.2.109. PMID: 16449696.
1319: Yanik M, Vural H, Tutkun H, Zoroğlu SS, Savaş HA, Herken H, Koçyiğit A,
Keleş H, Akyol O. The role of the arginine-nitric oxide pathway in the
pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci.
2004 Feb;254(1):43-7. doi: 10.1007/s00406-004-0453-x. PMID: 14991378.
1320: Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, Moreira
EG, Maes M. The role of high-density lipoprotein cholesterol, apolipoprotein A
and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci
Biobehav Rev. 2021 Jun;125:244-263. doi: 10.1016/j.neubiorev.2021.02.037. Epub
2021 Feb 28. PMID: 33657433.
1321: Diamond BJ, Bailey MR. Ginkgo biloba: indications, mechanisms, and safety.
Psychiatr Clin North Am. 2013 Mar;36(1):73-83. doi: 10.1016/j.psc.2012.12.006.
PMID: 23538078.
1322: Muchová L, Kráslová I, Lenícek M, Vítek L. Gilbertův syndrom--mýty a
realita [Gilbert's syndrome--myths and reality]. Cas Lek Cesk.
2004;143(6):375-80. Czech. PMID: 15309863.
1323: Lamanna-Rama N, Romero-Miguel D, Desco M, Soto-Montenegro ML. An Update on
the Exploratory Use of Curcumin in Neuropsychiatric Disorders. Antioxidants
(Basel). 2022 Feb 10;11(2):353. doi: 10.3390/antiox11020353. PMID: 35204235;
PMCID: PMC8868558.
1324: Socea LI, Barbuceanu SF, Pahontu EM, Dumitru AC, Nitulescu GM, Sfetea RC,
Apostol TV. Acylhydrazones and Their Biological Activity: A Review. Molecules.
2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719. PMID: 36557851; PMCID:
PMC9783609.
1325: Dehghani A, Pourjafari F, Koohkan F, Haghpanh T, Pourjafari F, Sheibani V,
Afarinesh MR. L-carnitine attenuates acoustic startle reflex dysfunction in
adult male rats exposed to mancozeb. Toxicol Ind Health. 2023 Feb;39(2):115-126.
doi: 10.1177/07482337231151739. Epub 2023 Jan 17. PMID: 36650049.
1326: Apweiler M, Streyczek J, Saliba SW, Ditrich J, Muñoz E, Fiebich BL. AntiInflammatory and Anti-Oxidative Effects of AM404 in IL-1β-Stimulated SK-N-SH
Neuroblastoma Cells. Front Pharmacol. 2021 Nov 17;12:789074. doi:
10.3389/fphar.2021.789074. PMID: 34867421; PMCID: PMC8635764.
1327: Li P, Wang Y, Liu X, Zhou Z, Wang J, Zhou H, Zheng L, Yang L. Atypical
antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.
BMC Pharmacol Toxicol. 2019 Feb 12;20(1):10. doi: 10.1186/s40360-019-0287-9.
PMID: 30755277; PMCID: PMC6373048.
1328: Morales-Medina JC, Mejorada A, Romero-Curiel A, Aguilar-Alonso P, LeónChávez BA, Gamboa C, Quirion R, Flores G. Neonatal administration of N-omeganitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness
to locomotor activity by D-amphetamine in postpubertal rats. Neuropharmacology.
2008 Dec;55(8):1313-20. doi: 10.1016/j.neuropharm.2008.08.019. Epub 2008 Aug 26.
PMID: 18790702.
1329: Fejgin K, Pålsson E, Wass C, Finnerty N, Lowry J, Klamer D. Prefrontal
GABA(B) receptor activation attenuates phencyclidine-induced impairments of
prepulse inhibition: involvement of nitric oxide. Neuropsychopharmacology. 2009
Jun;34(7):1673-84. doi: 10.1038/npp.2008.225. Epub 2009 Jan 14. PMID: 19145229.
1330: Fukuyama K, Hasegawa T, Okada M. Cystine/Glutamate Antiporter and
Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical
L-Glutamatergic Transmission. Int J Mol Sci. 2018 Nov 19;19(11):3645. doi:
10.3390/ijms19113645. PMID: 30463253; PMCID: PMC6274792.
1331: Gorelick DA. Pharmacological Treatment of Cannabis-Related Disorders: A
Narrative Review. Curr Pharm Des. 2016;22(42):6409-6419. doi:
10.2174/1381612822666160822150822. PMID: 27549375.
1332: Hajszan T, Leranth C. Bisphenol A interferes with synaptic remodeling.
Front Neuroendocrinol. 2010 Oct;31(4):519-30. doi: 10.1016/j.yfrne.2010.06.004.
Epub 2010 Jul 6. PMID: 20609373; PMCID: PMC2964437.
1333: Hellerstedt WL, McGovern PM, Fontaine P, Oberg CN, Cordes JE. Prenatal
environmental exposures and child health: Minnesota's role in the National
Children's Study. Minn Med. 2008 Sep;91(9):40-3. PMID: 18990917.
1334: Zoroğlu SS, Yürekli M, Meram I, Söğüt S, Tutkun H, Yetkin O, Sivasli E,
Savaş HA, Yanik M, Herken H, Akyol O. Pathophysiological role of nitric oxide
and adrenomedullin in autism. Cell Biochem Funct. 2003 Mar;21(1):55-60. doi:
10.1002/cbf.989. PMID: 12579522.
1335: Becker E, Hummel T, Piel E, Pauli E, Kobal G, Hautzinger M. Olfactory
event-related potentials in psychosis-prone subjects. Int J Psychophysiol. 1993
Jul;15(1):51-8. doi: 10.1016/0167-8760(93)90095-7. PMID: 8407434.
1336: Wabaidur SM, Alothman ZA, Naushad M. Determination of dopamine in
pharmaceutical formulation using enhanced luminescence from europium complex.
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Jul;93:331-4. doi:
10.1016/j.saa.2012.03.031. Epub 2012 Mar 17. PMID: 22484841.
1337: Ayorech Z, Tracy DK, Baumeister D, Giaroli G. Taking the fuel out of the
fire: evidence for the use of anti-inflammatory agents in the treatment of
bipolar disorders. J Affect Disord. 2015 Mar 15;174:467-78. doi:
10.1016/j.jad.2014.12.015. Epub 2014 Dec 12. PMID: 25553408.
1338: Cieślik P, Siekierzycka A, Radulska A, Płoska A, Burnat G, Brański P,
Kalinowski L, Wierońska JM. Nitric Oxide-Dependent Mechanisms Underlying MK-801or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies. Int J
Mol Sci. 2021 Nov 13;22(22):12282. doi: 10.3390/ijms222212282. PMID: 34830164;
PMCID: PMC8624219.
1339: Tran TV, Park SJ, Shin EJ, Tran HQ, Jeong JH, Jang CG, Lee YJ, Nah SY,
Nabeshima T, Kim HC. Blockade of platelet-activating factor receptor attenuates
abnormal behaviors induced by phencyclidine in mice through down-regulation of
NF-κB. Brain Res Bull. 2018 Mar;137:71-78. doi:
10.1016/j.brainresbull.2017.11.004. Epub 2017 Nov 7. PMID: 29122692.
1340: Fournier M, Ferrari C, Baumann PS, Polari A, Monin A, Bellier-Teichmann T,
Wulff J, Pappan KL, Cuenod M, Conus P, Do KQ. Impaired metabolic reactivity to
oxidative stress in early psychosis patients. Schizophr Bull. 2014
Sep;40(5):973-83. doi: 10.1093/schbul/sbu053. Epub 2014 Mar 31. PMID: 24687046;
PMCID: PMC4133680.
1341: Csernansky JG, Martin MV, Czeisler B, Meltzer MA,
Neuroprotective effects of olanzapine in a rat model of
injury. Pharmacol Biochem Behav. 2006 Feb;83(2):208-13.
10.1016/j.pbb.2006.01.009. Epub 2006 Mar 9. Erratum in:
2006 Jul;84(3):543. PMID: 16524622.
Ali Z, Dong H.
neurodevelopmental
doi:
Pharmacol Biochem Behav.
1342: Neis VB, Rosa PB, Moretti M, Rodrigues ALS. Involvement of Heme
Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases. Curr Pharm Des.
2018;24(20):2283-2302. doi: 10.2174/1381612824666180717160623. PMID: 30019638.
1343: Assies J, Mocking RJ, Lok A, Ruhé HG, Pouwer F, Schene AH. Effects of
oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and
cardiovascular disease comorbidity. Acta Psychiatr Scand. 2014
Sep;130(3):163-80. doi: 10.1111/acps.12265. Epub 2014 Mar 21. PMID: 24649967;
PMCID: PMC4171779.
1344: Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity in rats:
Involvement of tumour necrosis factor alpha, NF-κβ and caspase-3. Toxicol Rep.
2014 Nov 20;1:1213-1223. doi: 10.1016/j.toxrep.2014.11.012. PMID: 28962331;
PMCID: PMC5598316.
1345: Kovacic P, Somanathan R. Redox processes in neurodegenerative disease
involving reactive oxygen species. Curr Neuropharmacol. 2012 Dec;10(4):289-302.
doi: 10.2174/157015912804143487. PMID: 23730253; PMCID: PMC3520039.
1346: Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways
of disease. Exp Mol Pathol. 2007 Aug;83(1):84-92. doi:
10.1016/j.yexmp.2006.09.008. Epub 2007 Jan 18. PMID: 17239370.
1347: Seol IW, Kuo NY, Kim KM. Effects of dopaminergic drugs on the mast cell
degranulation and nitric oxide generation in RAW 264.7 cells. Arch Pharm Res.
2004 Jan;27(1):94-8. doi: 10.1007/BF02980053. PMID: 14969346.
1348: Panchal SK, Brown L. Potential Benefits of Anthocyanins in Chronic
Disorders of the Central Nervous System. Molecules. 2022 Dec 22;28(1):80. doi:
10.3390/molecules28010080. PMID: 36615279; PMCID: PMC9822395.
1349: Ostrowska K. Coumarin-piperazine derivatives as biologically active
compounds. Saudi Pharm J. 2020 Feb;28(2):220-232. doi:
10.1016/j.jsps.2019.11.025. Epub 2019 Dec 7. PMID: 32042262; PMCID: PMC7000312.
1350: Avan R, Sahebnasagh A, Hashemi J, Monajati M, Faramarzi F, Henney NC,
Montecucco F, Jamialahmadi T, Sahebkar A. Update on Statin Treatment in Patients
with Neuropsychiatric Disorders. Life (Basel). 2021 Dec 8;11(12):1365. doi:
10.3390/life11121365. PMID: 34947895; PMCID: PMC8703562.
1351: Wen S, Cheng M, Wang H, Yue J, Wang H, Li G, Zheng L, Zhong Z, Peng F.
Serum uric acid levels and the clinical characteristics of depression. Clin
Biochem. 2012 Jan;45(1-2):49-53. doi: 10.1016/j.clinbiochem.2011.10.010. Epub
2011 Oct 20. PMID: 22040815.
1352: Marchitti SA, Orlicky DJ, Vasiliou V. Expression and initial
characterization of human ALDH3B1. Biochem Biophys Res Commun. 2007 May
11;356(3):792-8. doi: 10.1016/j.bbrc.2007.03.046. Epub 2007 Mar 15. PMID:
17382292; PMCID: PMC1899873.
1353: Das UN. Is angiotensin-II an endogenous pro-inflammatory molecule? Med Sci
Monit. 2005 May;11(5):RA155-162. Epub 2005 Apr 28. PMID: 15874906.
1354: Shafabakhsh R, Mirzaei H, Asemi Z. Melatonin: A promising agent targeting
leukemia. J Cell Biochem. 2020 Apr;121(4):2730-2738. doi: 10.1002/jcb.29495.
Epub 2019 Nov 11. PMID: 31713261.
1355: Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL.
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by
NADPH-oxidase. Science. 2007 Dec 7;318(5856):1645-7. doi:
10.1126/science.1148045. PMID: 18063801.
1356: Wass C, Archer T, Pålsson E, Fejgin K, Alexandersson A, Klamer D, Engel
JA, Svensson L. Phencyclidine affects memory in a nitric oxide-dependent manner:
working and reference memory. Behav Brain Res. 2006 Nov 1;174(1):49-55. doi:
10.1016/j.bbr.2006.07.003. Epub 2006 Aug 28. PMID: 16935357.
1357: Naidu PS, Kulkarni SK. Quercetin, a bioflavonoid, reverses haloperidolinduced catalepsy. Methods Find Exp Clin Pharmacol. 2004 Jun;26(5):323-6. doi:
10.1358/mf.2004.26.5.831321. PMID: 15319809.
1358: Saini R, Azam Z, Sapra L, Srivastava RK. Neuronal Nitric Oxide Synthase
(nNOS) in Neutrophils: An Insight. Rev Physiol Biochem Pharmacol.
2021;180:49-83. doi: 10.1007/112_2021_61. PMID: 34115206.
1359: Hans D, Rengel A, Hans J, Bassett D, Hood S. N-Acetylcysteine as a novel
rapidly acting anti-suicidal agent: A pilot naturalistic study in the emergency
setting. PLoS One. 2022 Jan 28;17(1):e0263149. doi:
10.1371/journal.pone.0263149. PMID: 35089954; PMCID: PMC8797247.
1360: Nakao A, Matsunaga Y, Hayashida K, Takahashi N. Role of Oxidative Stress
and Ca²⁺ Signaling in Psychiatric Disorders. Front Cell Dev Biol.
2021 Feb 11;9:615569. doi: 10.3389/fcell.2021.615569. PMID: 33644051; PMCID:
PMC7905097.
1361: Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R,
Martínez-Orgado J. Cannabidiol for neurodegenerative disorders: important new
clinical applications for this phytocannabinoid? Br J Clin Pharmacol. 2013
Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. PMID: 22625422; PMCID:
PMC3579248.
1362: Dokuyucu R, Kokacya H, Inanir S, Copoglu US, Erbas O. Antipsychotic-like
effect of minocycline in a rat model. Int J Clin Exp Med. 2014 Oct
15;7(10):3354-61. PMID: 25419368; PMCID: PMC4238471.
1363: Raza MU, Tufan T, Wang Y, Hill C, Zhu MY. DNA Damage in Major Psychiatric
Diseases. Neurotox Res. 2016 Aug;30(2):251-67. doi: 10.1007/s12640-016-9621-9.
Epub 2016 Apr 28. PMID: 27126805; PMCID: PMC4947450.
1364: Marazziti D, Diep PT, Carter S, Carbone MG. Oxytocin: An Old Hormone, a
Novel Psychotropic Drug and its Possible Use in Treating Psychiatric Disorders.
Curr Med Chem. 2022;29(35):5615-5687. doi: 10.2174/0929867329666220727120646.
PMID: 35894453.
1365: Abboud M, Rizk R, AlAnouti F, Papandreou D, Haidar S, Mahboub N. The
Health Effects of Vitamin D and Probiotic Co-Supplementation: A Systematic
Review of Randomized Controlled Trials. Nutrients. 2020 Dec 30;13(1):111. doi:
10.3390/nu13010111. PMID: 33396898; PMCID: PMC7824176.
1366: Theodoropoulou S, Gialouris AG. [Lipids and mental disorders: Evidence,
uncertainties and perspectives]. Psychiatriki. 2019 Apr-Jun;30(2):129-141.
Greek, Modern. doi: 10.22365/jpsych.2019.302.129. PMID: 31425141.
1367: Koca TT. Clinical Significance of Serum Bilirubin in Behçet's Disease. J
Transl Int Med. 2018 Dec 31;6(4):185-188. doi: 10.2478/jtim-2018-0034. PMID:
30637206; PMCID: PMC6326032.
1368: Huang WJ, Lee HJ, Chen HL, Fan PC, Ku YL, Chiou LC. Hispidulin, a
constituent of Clerodendrum inerme that remitted motor tics, alleviated
methamphetamine-induced hyperlocomotion without motor impairment in mice. J
Ethnopharmacol. 2015 May 26;166:18-22. doi: 10.1016/j.jep.2015.03.001. Epub 2015
Mar 9. PMID: 25764963.
1369: Morris G, Walder K, Berk M, Carvalho AF, Marx W, Bortolasci CC, Yung AR,
Puri BK, Maes M. Intertwined associations between oxidative and nitrosative
stress and endocannabinoid system pathways: Relevance for neuropsychiatric
disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 2;114:110481.
doi: 10.1016/j.pnpbp.2021.110481. Epub 2021 Nov 24. PMID: 34826557.
1370: McNeill RV, Kehrwald C, Brum M, Knopf K, Brunkhorst-Kanaan N, Etyemez S,
Koreny C, Bittner RA, Freudenberg F, Herterich S, Reif A, Kittel-Schneider S.
Uncovering associations between mental illness diagnosis, nitric oxide synthase
gene variation, and peripheral nitric oxide concentration. Brain Behav Immun.
2022 Mar;101:275-283. doi: 10.1016/j.bbi.2022.01.006. Epub 2022 Jan 15. PMID:
35041938.
1371: Lotter J, Möller M, Dean O, Berk M, Harvey BH. Studies on Haloperidol and
Adjunctive α-Mangostin or Raw <i>Garcinia mangostana</i> Linn Pericarp on BioBehavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male
Rats. Front Psychiatry. 2020 Mar 31;11:121. doi: 10.3389/fpsyt.2020.00121. PMID:
32296347; PMCID: PMC7136492.
1372: Sahab Negah S, Forouzanfar F. Oxidative stress is a new avenue for
treatment of neuropsychiatric disorders: hype of hope? Curr Mol Med. 2023 Sep 4.
doi: 10.2174/1566524023666230904150907. Epub ahead of print. PMID: 37670697.
1373: Jung WH, Borgwardt S, Fusar-Poli P, Kwon JS. Gray matter volumetric
abnormalities associated with the onset of psychosis. Front Psychiatry. 2012 Dec
3;3:101. doi: 10.3389/fpsyt.2012.00101. PMID: 23227013; PMCID: PMC3512053.
1374: Reyes-Madrigal F, León-Ortiz P, Mao X, Mora-Durán R, Shungu DC, de la
Fuente-Sandoval C. Striatal Glutathione in First-episode Psychosis Patients
Measured In Vivo with Proton Magnetic Resonance Spectroscopy. Arch Med Res. 2019
May;50(4):207-213. doi: 10.1016/j.arcmed.2019.08.003. Epub 2019 Sep 26. PMID:
31499481; PMCID: PMC10624128.
1375: Jimoh IJ, Sebe B, Balicza P, Fedor M, Pataky I, Rudas G, Gal A, InczedyFarkas G, Nemeth G, Molnar MJ. Wernicke-Korsakoff syndrome associated with mtDNA
disease. Ther Adv Neurol Disord. 2020 Jul 30;13:1756286420938972. doi:
10.1177/1756286420938972. PMID: 32821290; PMCID: PMC7412926.
1376: Fejgin K, Pålsson E, Wass C, Svensson L, Klamer D. Nitric oxide signaling
in the medial prefrontal cortex is involved in the biochemical and behavioral
effects of phencyclidine. Neuropsychopharmacology. 2008 Jul;33(8):1874-83. doi:
10.1038/sj.npp.1301587. Epub 2007 Sep 26. PMID: 17895915.
1377: Dietrich-Muszalska A, Kontek B, Rabe-Jabłońska J. Quetiapine, olanzapine
and haloperidol affect human plasma lipid peroxidation in vitro.
Neuropsychobiology. 2011;63(4):197-201. doi: 10.1159/000321623. Epub 2011 Mar
22. PMID: 21422766.
1378: Efthymiou D, Zekakos DX, Papatriantafyllou E, Ziagkas E, Petrelis AN,
Vassilopoulou E. Gait Alterations in the Prediction of Metabolic Syndrome in
Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles. Front
Psychiatry. 2022 Jan 27;13:756600. doi: 10.3389/fpsyt.2022.756600. PMID:
35153872; PMCID: PMC8829465.
1379: Shefa U, Kim D, Kim MS, Jeong NY, Jung J. Roles of Gasotransmitters in
Synaptic Plasticity and Neuropsychiatric Conditions. Neural Plast. 2018 May
6;2018:1824713. doi: 10.1155/2018/1824713. PMID: 29853837; PMCID: PMC5960547.
1380: Gürbüz Özgür B, Aksu H, Yılmaz M, Karakoç Demirkaya S. The probable role
of adrenomedullin and nitric oxide in childhood attention deficit hyperactivity
disorder. Nord J Psychiatry. 2017 Oct;71(7):521-524. doi:
10.1080/08039488.2017.1343382. Epub 2017 Jul 2. PMID: 28670953.
1381: Deslauriers J, Lefrançois M, Larouche A, Sarret P, Grignon S.
Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in
SH-SY5Y neuroblastoma cells. Synapse. 2011 Apr;65(4):321-31. doi:
10.1002/syn.20851. Epub 2010 Sep 24. PMID: 20730801.
1382: Falcão AS, Silva RF, Pancadas S, Fernandes A, Brito MA, Brites D.
Apoptosis and impairment of neurite network by short exposure of immature rat
cortical neurons to unconjugated bilirubin increase with cell differentiation
and are additionally enhanced by an inflammatory stimulus. J Neurosci Res. 2007
May 1;85(6):1229-39. doi: 10.1002/jnr.21227. PMID: 17342778.
1383: Eguiagaray JG, Egea J, Bravo-Cordero JJ, García AG. Neurotransmisores,
señales de calcio y comunicación neuronal [Neurotransmitters, calcium signalling
and neuronal communication]. Neurocirugia (Astur). 2004 Apr;15(2):109-18.
Spanish. doi: 10.1016/s1130-1473(04)70489-3. PMID: 15159788.
1384: Baykal S, Nalbantoğlu A. An Examination of the Relationship Between
Exposure to Bisphenol A and Attention-Deficit/Hyperactivity Disorder in Children
and Adolescents. Clin Neuropharmacol. 2023 Nov-Dec 01;46(6):214-219. doi:
10.1097/WNF.0000000000000574. Epub 2023 Oct 16. PMID: 37962308.
1385: Ngoupaye GT, Pahaye DB, Ngondi J, Moto FCO, Bum EN. Gladiolus dalenii
lyophilisate reverses scopolamine-induced amnesia and reduces oxidative stress
in rat brain. Biomed Pharmacother. 2017 Jul;91:350-357. doi:
10.1016/j.biopha.2017.04.061. Epub 2017 May 2. PMID: 28463798.
1386: Kleppisch T, Feil R. cGMP signalling in the mammalian brain: role in
synaptic plasticity and behaviour. Handb Exp Pharmacol. 2009;(191):549-79. doi:
10.1007/978-3-540-68964-5_24. PMID: 19089345.
1387: Moon E, Lavin P, Storch KF, Linnaranta O. Effects of antipsychotics on
circadian rhythms in humans: a systematic review and meta-analysis. Prog
Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110162. doi:
10.1016/j.pnpbp.2020.110162. Epub 2020 Nov 2. PMID: 33152385.
1388: Coleshill MJ, Aung E, Carland JE, Faasse K, Stocker S, Day RO. Rebranding
Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
Ther Innov Regul Sci. 2021 Jan;55(1):138-141. doi: 10.1007/s43441-020-00198-0.
Epub 2020 Jul 13. PMID: 32661926.
1389: Fullerton JM, Tiwari Y, Agahi G, Heath A, Berk M, Mitchell PB, Schofield
PR. Assessing oxidative pathway genes as risk factors for bipolar disorder.
Bipolar Disord. 2010 Aug;12(5):550-6. doi: 10.1111/j.1399-5618.2010.00834.x.
PMID: 20712757.
1390: Mohan S, Gupta D. Crosstalk of toll-like receptors signaling and Nrf2
pathway for regulation of inflammation. Biomed Pharmacother. 2018
Dec;108:1866-1878. doi: 10.1016/j.biopha.2018.10.019. Epub 2018 Oct 23. PMID:
30372892.
1391: Górski KM, Klimczyk J, Mokros Ł, Witusik A, Pietras T. Effect of
haloperidol and amisulpride on the production of malondialdehyde in reaction to
free radical attack on deoxyrybosis. Pol Merkur Lekarski. 2021 Dec
16;49(294):426-429. PMID: 34919086.
1392: Weber M, Chang WL, Durbin JP, Park PE, Luedtke RR, Mach RH, Swerdlow NR.
Using prepulse inhibition to detect functional D3 receptor antagonism: effects
of WC10 and WC44. Pharmacol Biochem Behav. 2009 Aug;93(2):141-7. doi:
10.1016/j.pbb.2009.04.022. Epub 2009 May 6. PMID: 19426754; PMCID: PMC2720754.
1393: Kelle I, Eriman H, Erdinc M, Uyar E. Risperidone and ethyl pyruvate have
protective effects against ketamine-induced cognitive impairments in mice. Eur
Rev Med Pharmacol Sci. 2022 Mar;26(5):1708-1716. doi:
10.26355/eurrev_202203_28240. PMID: 35302220.
1394: Esnafoglu E, İrende İ. Decreased plasma agmatine levels in autistic
subjects. J Neural Transm (Vienna). 2018 Apr;125(4):735-740. doi:
10.1007/s00702-017-1836-2. Epub 2018 Jan 4. PMID: 29302750.
1395: Czekus C, Steullet P, Orero López A, Bozic I, Rusterholz T, Bandarabadi M,
Do KQ, Gutierrez Herrera C. Alterations in TRN-anterodorsal thalamocortical
circuits affect sleep architecture and homeostatic processes in oxidative stress
vulnerable Gclm^-/- mice. Mol Psychiatry. 2022 Nov;27(11):4394-4406.
doi: 10.1038/s41380-022-01700-w. Epub 2022 Jul 28. PMID: 35902628; PMCID:
PMC9734061.
1396: Zheng W, Xiang YQ, Ng CH, Ungvari GS, Chiu HF, Xiang YT. Extract of Ginkgo
biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials.
Pharmacopsychiatry. 2016 May;49(3):107-11. doi: 10.1055/s-0042-102884. Epub 2016
Mar 15. PMID: 26979525.
1397: Brekk OR, Makridakis M, Mavroeidi P, Vlahou A, Xilouri M, Stefanis L.
Impairment of chaperone-mediated autophagy affects neuronal homeostasis through
altered expression of DJ-1 and CRMP-2 proteins. Mol Cell Neurosci. 2019
Mar;95:1-12. doi: 10.1016/j.mcn.2018.12.006. Epub 2018 Dec 15. PMID: 30562574.
1398: Yao JK, Dougherty GG, Reddy RD, Matson WR, Kaddurah-Daouk R, Keshavan MS.
Associations between purine metabolites and monoamine neurotransmitters in
first-episode psychosis. Front Cell Neurosci. 2013 Jun 11;7:90. doi:
10.3389/fncel.2013.00090. PMID: 23781173; PMCID: PMC3678099.
1399: Kurup RK, Kurup PA. Schizoid neurochemical pathology-induced membrane
Na(+)-K+ ATPase inhibition in relation to neurological disorders. Int J
Neurosci. 2003 Dec;113(12):1705-17. doi: 10.1080/00207450390245153. PMID:
14602543.
1400: Sahu R, Mehan S, Kumar S, Prajapati A, Alshammari A, Alharbi M, Assiri MA,
Narula AS. Effect of alpha-mangostin in the prevention of behavioural and
neurochemical defects in methylmercury-induced neurotoxicity in experimental
rats. Toxicol Rep. 2022 Apr 22;9:977-998. doi: 10.1016/j.toxrep.2022.04.023.
PMID: 35783250; PMCID: PMC9247835.
1401: Chen HH, Stoker A, Markou A. The glutamatergic compounds sarcosine and
N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic
glutamate 5 receptor knockout mice. Psychopharmacology (Berl). 2010
May;209(4):343-50. doi: 10.1007/s00213-010-1802-2. Epub 2010 Mar 10. PMID:
20217053; PMCID: PMC2855017.
1402: Akpinar A, Yaman GB, Demirdas A, Onal S. Possible role of adrenomedullin
and nitric oxide in major depression. Prog Neuropsychopharmacol Biol Psychiatry.
2013 Oct 1;46:120-5. doi: 10.1016/j.pnpbp.2013.07.003. Epub 2013 Jul 16. PMID:
23867466.
1403: Antoni FA. The Case for Clinical Trials with Novel GABAergic Drugs in
Diabetes Mellitus and Obesity. Life (Basel). 2022 Feb 21;12(2):322. doi:
10.3390/life12020322. PMID: 35207609; PMCID: PMC8876029.
1404: Zmorzyński S, Świderska-Kołacz G, Koczkodaj D, Filip AA. Significance of
Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in
Hematopoietic Cancers and Solid Tumors. Biomed Res Int. 2015;2015:853573. doi:
10.1155/2015/853573. Epub 2015 Nov 23. PMID: 26682223; PMCID: PMC4670853.
1405: Massaoudi Y, Anissi J, Lefter R, Lobiuc A, Sendide K, Ciobica A, Hassouni
ME. Protective Effects of Two Halophilic Crude Extracts from <i>Pseudomonas
zhaodongensis</i> and <i>Bacillus stratosphericus</i> against Memory Deficits
and Anxiety- and Depression-Like Behaviors in Methionine-Induced Schizophrenia
in Mice Focusing on Oxidative Stress Status. Evid Based Complement Alternat Med.
2020 Nov 24;2020:8852418. doi: 10.1155/2020/8852418. PMID: 33299461; PMCID:
PMC7707988.
1406: Monteiro J, Assis-de-Lemos G, de-Souza-Ferreira E, Marques AM, Neves GA,
Silveira MS, Galina A. Energization by multiple substrates and calcium challenge
reveal dysfunctions in brain mitochondria in a model related to acute psychosis.
J Bioenerg Biomembr. 2020 Feb;52(1):1-15. doi: 10.1007/s10863-019-09816-5. Epub
2019 Dec 18. PMID: 31853754.
1407: Thomson DM, Mitchell EJ, Openshaw RL, Pratt JA, Morris BJ. Mice lacking
melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced
social interaction. J Psychopharmacol. 2021 Oct;35(10):1265-1276. doi:
10.1177/02698811211032439. Epub 2021 Jul 24. PMID: 34304635; PMCID: PMC8521347.
1408: Xiao R, Li S, Cao Q, Wang X, Yan Q, Tu X, Zhu Y, Zhu F. Human endogenous
retrovirus W env increases nitric oxide production and enhances the migration
ability of microglia by regulating the expression of inducible nitric oxide
synthase. Virol Sin. 2017 Jun;32(3):216-225. doi: 10.1007/s12250-017-3997-4.
Epub 2017 Jun 23. PMID: 28656540; PMCID: PMC6598877.
1409: Howlett AC, Blume LC, Dalton GD. CB(1) cannabinoid receptors and their
associated proteins. Curr Med Chem. 2010;17(14):1382-93. doi:
10.2174/092986710790980023. PMID: 20166926; PMCID: PMC3179980.
1410: Saha I, Chatterji U, Chaudhuri-Sengupta S, Nag TC, Nag D, Banerjee S,
Maiti BR. Ultrastructural and hormonal changes in the pineal-testicular axis
following arecoline administration in rats. J Exp Zool A Ecol Genet Physiol.
2007 Apr 1;307(4):187-98. doi: 10.1002/jez.354. PMID: 17436329.
1411: Albert U, De Cori D, Aguglia A, Barbaro F, Bogetto F, Maina G. Increased
uric acid levels in bipolar disorder subjects during different phases of
illness. J Affect Disord. 2015 Mar 1;173:170-5. doi: 10.1016/j.jad.2014.11.005.
Epub 2014 Nov 15. PMID: 25462413.
1412: Gourgiotis I, Kampouri NG, Koulouri V, Lempesis IG, Prasinou MD,
Georgiadou G, Pitsikas N. Nitric oxide modulates apomorphine-induced recognition
memory deficits in rats. Pharmacol Biochem Behav. 2012 Oct;102(4):507-14. doi:
10.1016/j.pbb.2012.06.013. Epub 2012 Jun 23. PMID: 22735830.
1413: Xia W, Veljkovic E, Koshibu K, Peitsch MC, Hoeng J. Neurobehavioral
effects of selected tobacco constituents in rodents following subchronic
administration. Eur J Pharmacol. 2019 Dec 15;865:172809. doi:
10.1016/j.ejphar.2019.172809. Epub 2019 Nov 15. PMID: 31738931.
1414: Subramaniam M, Ng C, Chong SA, Mahendran R, Lambert T, Pek E, Huak CY.
Metabolic differences between Asian and Caucasian patients on clozapine
treatment. Hum Psychopharmacol. 2007 Jun;22(4):217-22. doi: 10.1002/hup.842.
PMID: 17431927.
1415: Ferreira RCM, de Almeida DL, Duarte IDG, Aguiar DC, Moreira FA, Romero
TRL. The antipsychotic aripiprazole induces peripheral antinociceptive effects
through PI3Kγ/NO/cGMP/K_ATP pathway activation. Eur J Pain. 2022
Apr;26(4):825-834. doi: 10.1002/ejp.1910. Epub 2022 Feb 1. PMID: 35044019.
1416: Su JM, Tan YL, Zhou DF. [Relationship between tardive dyskinesia and the
polymorphism of superoxide dismutase val9Ala and efficacy of Chaihu Taoren
Capsules on it]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Aug;27(8):700-3.
Chinese. PMID: 17879532.
1417: Cohrs S, Pohlmann K, Guan Z, Jordan W, Meier A, Huether G, Rüther E,
Rodenbeck A. Quetiapine reduces nocturnal urinary cortisol excretion in healthy
subjects. Psychopharmacology (Berl). 2004 Jul;174(3):414-20. doi:
10.1007/s00213-003-1766-6. Epub 2004 Jan 20. PMID: 14735295.
1418: Postolache TT, Medoff DR, Brown CH, Fang LJ, Upadhyaya SK, Lowry CA,
Miller M, Kreyenbuhl JA. Lipophilic vs. hydrophilic statins and psychiatric
hospitalizations and emergency room visits in US Veterans with schizophrenia and
bipolar disorder. Pteridines. 2021 Jan;32(1):48-69. doi:
10.1515/pteridines-2020-0028. Epub 2021 Sep 23. PMID: 34887622; PMCID:
PMC8654264.
1419: Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP. Cystamine
prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal
cortex. J Neurochem. 2008 Nov;107(4):941-51. doi:
10.1111/j.1471-4159.2008.05665.x. Epub 2008 Sep 11. PMID: 18786174.
1420: Pierre JM. Extrapyramidal symptoms with atypical antipsychotics :
incidence, prevention and management. Drug Saf. 2005;28(3):191-208. doi:
10.2165/00002018-200528030-00002. PMID: 15733025.
1421: Dhikav V, Anand KS. Is hippocampal atrophy a future drug target? Med
Hypotheses. 2007;68(6):1300-6. doi: 10.1016/j.mehy.2006.09.040. Epub 2006 Nov
13. PMID: 17098374.
1422: Uzelac TN, Nikolić-Kokić AL, Spasić SD, Mačvanin MT, Nikolić MR, Mandić
LM, Jovanović VB. Opposite clozapine and ziprasidone effects on the reactivity
of plasma albumin SH-group are the consequence of their different binding
properties dependent on protein fatty acids content. Chem Biol Interact. 2019
Sep 25;311:108787. doi: 10.1016/j.cbi.2019.108787. Epub 2019 Aug 7. PMID:
31400341.
1423: Firth J, Teasdale SB, Allott K, Siskind D, Marx W, Cotter J, Veronese N,
Schuch F, Smith L, Solmi M, Carvalho AF, Vancampfort D, Berk M, Stubbs B, Sarris
J. The efficacy and safety of nutrient supplements in the treatment of mental
disorders: a meta-review of meta-analyses of randomized controlled trials. World
Psychiatry. 2019 Oct;18(3):308-324. doi: 10.1002/wps.20672. PMID: 31496103;
PMCID: PMC6732706.
1424: Tendilla-Beltrán H, Meneses-Prado S, Vázquez-Roque RA, Tapia-Rodríguez M,
Vázquez-Hernández AJ, Coatl-Cuaya H, Martín-Hernández D, MacDowell KS, GarcésRamírez L, Leza JC, Flores G. Risperidone Ameliorates Prefrontal Cortex Neural
Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats
with Neonatal Ventral Hippocampus Lesion. J Neurosci. 2019 Oct
23;39(43):8584-8599. doi: 10.1523/JNEUROSCI.1249-19.2019. Epub 2019 Sep 13.
PMID: 31519825; PMCID: PMC6807277.
1425: Wood PL, Woltjer RL. Serine ether glycerophospholipids: Decrements in the
frontal cortex associated with mild cognitive impairment and Alzheimer's
disease. Front Aging Neurosci. 2022 Aug 8;14:981868. doi:
10.3389/fnagi.2022.981868. PMID: 36004004; PMCID: PMC9393623.
1426: Tsaluchidu S, Cocchi M, Tonello L, Puri BK. Fatty acids and oxidative
stress in psychiatric disorders. BMC Psychiatry. 2008 Apr 17;8 Suppl 1(Suppl
1):S5. doi: 10.1186/1471-244X-8-S1-S5. PMID: 18433515; PMCID: PMC2330073.
1427: Kumar GP, Khanum F. Neuroprotective potential of phytochemicals.
Pharmacogn Rev. 2012 Jul;6(12):81-90. doi: 10.4103/0973-7847.99898. PMID:
23055633; PMCID: PMC3459459.
1428: Xuan Y, Yan G, Wu R, Huang Q, Li X, Xu H. The cuprizone-induced changes in
(1)H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of
quetiapine. Neurochem Int. 2015 Nov;90:185-92. doi:
10.1016/j.neuint.2015.08.015. Epub 2015 Sep 2. PMID: 26340869.
1429: Brzózka MM, Havemann-Reinecke U, Wichert SP, Falkai P, Rossner MJ.
Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by
Chronic Lithium Treatment. Schizophr Bull. 2016 Jul;42 Suppl 1(Suppl 1):S22-33.
doi: 10.1093/schbul/sbv194. Epub 2015 Dec 28. PMID: 26714764; PMCID: PMC4960433.
1430: Heynen JP, McHugh RR, Boora NS, Simcock G, Kildea S, Austin MP, Laplante
DP, King S, Montina T, Metz GAS. Urinary ¹H NMR Metabolomic Analysis
of Prenatal Maternal Stress Due to a Natural Disaster Reveals Metabolic Risk
Factors for Non-Communicable Diseases: The QF2011 Queensland Flood Study.
Metabolites. 2023 Apr 21;13(4):579. doi: 10.3390/metabo13040579. PMID: 37110237;
PMCID: PMC10145263.
1431: Rodkin S, Nwosu C, Sannikov A, Tyurin A, Chulkov VS, Raevskaya M, Ermakov
A, Kirichenko E, Gasanov M. The Role of Gasotransmitter-Dependent Signaling
Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and
Neurodegenerative Diseases and Mental Disorders. Int J Mol Sci. 2023 Mar
23;24(7):6014. doi: 10.3390/ijms24076014. PMID: 37046987; PMCID: PMC10094524.
1432: Yoo S, Kim MY, Cho JY. Syk and Src-targeted anti-inflammatory activity of
aripiprazole, an atypical antipsychotic. Biochem Pharmacol. 2018 Feb;148:1-12.
doi: 10.1016/j.bcp.2017.12.006. Epub 2017 Dec 12. PMID: 29241811.
1433: Allan L, Leith JL, Papakosta M, Morrow JA, Irving NG, McFerran BW, Clark
AG. Development of a novel high-throughput assay for the investigation of
GlyT-1b neurotransmitter transporter function. Comb Chem High Throughput Screen.
2006 Jan;9(1):9-14. doi: 10.2174/138620706775213886. PMID: 16454681.
1434: Salum C, Guimarães FS, Brandão ML, Del Bel EA. Dopamine and nitric oxide
interaction on the modulation of prepulse inhibition of the acoustic startle
response in the Wistar rat. Psychopharmacology (Berl). 2006 Apr;185(2):133-41.
doi: 10.1007/s00213-005-0277-z. Epub 2006 Jan 10. PMID: 16402193.
1435: Hettiarachchi P, Johnson MA. Characterization of D3 Autoreceptor Function
in Whole Zebrafish Brain with Fast-Scan Cyclic Voltammetry. ACS Chem Neurosci.
2022 Oct 5;13(19):2863-2873. doi: 10.1021/acschemneuro.2c00280. Epub 2022 Sep
13. PMID: 36099546; PMCID: PMC10105970.
1436: Baghayeri M, Nodehi M, Veisi H, Tehrani MB, Maleki B, Mehmandost M. The
role of pramipexole functionalized MWCNTs to the fabrication of Pd nanoparticles
modified GCE for electrochemical detection of dopamine. Daru. 2019
Dec;27(2):593-603. doi: 10.1007/s40199-019-00287-y. Epub 2019 Jul 17. PMID:
31317442; PMCID: PMC6895371.
1437: Gholampour H, Moezi L, Shafaroodi H. Aripiprazole prevents renal
ischemia/reperfusion injury in rats, probably through nitric oxide involvement.
Eur J Pharmacol. 2017 Oct 15;813:17-23. doi: 10.1016/j.ejphar.2017.07.032. Epub
2017 Jul 19. PMID: 28734929.
1438: Zeng J, Zhang W, Lu X, Zhou H, Huang J, Xu Z, Liao H, Liang J, Liang M, Ye
C, Sun T, Hu Y, She Q, Chen H, Guo Q, Yan L, Wu R, Li Z. The association of SOD
and HsCRP with the efficacy of sulforaphane in schizophrenia patients with
residual negative symptoms. Eur Arch Psychiatry Clin Neurosci. 2023 Sep 20. doi:
10.1007/s00406-023-01679-7. Epub ahead of print. PMID: 37728803.
1439: Smythies J. The biochemical basis of synaptic plasticity and
neurocomputation: a new theory. Proc Biol Sci. 1997 Apr 22;264(1381):575-9. doi:
10.1098/rspb.1997.0082. PMID: 9149426; PMCID: PMC1688402.
1440: Ehrenreich H, Bartels C, Sargin D, Stawicki S, Krampe H. Recombinant human
erythropoietin in the treatment of human brain disease: focus on cognition. J
Ren Nutr. 2008 Jan;18(1):146-53. doi: 10.1053/j.jrn.2007.10.029. PMID: 18089462.
1441: Curpan AS, Luca AC, Ciobica A. Potential Novel Therapies for
Neurodevelopmental Diseases Targeting Oxidative Stress. Oxid Med Cell Longev.
2021 Jul 22;2021:6640206. doi: 10.1155/2021/6640206. PMID: 34336109; PMCID:
PMC8321748.
1442: Jeon P, Limongi R, Ford SD, Branco C, Mackinley M, Gupta M, Powe L,
Théberge J, Palaniyappan L. Glutathione as a Molecular Marker of Functional
Impairment in Patients with At-Risk Mental State: 7-Tesla ¹H-MRS
Study. Brain Sci. 2021 Jul 17;11(7):941. doi: 10.3390/brainsci11070941. PMID:
34356175; PMCID: PMC8307096.
1443: Iovino M, Messana T, Tortora A, Giusti C, Lisco G, Giagulli VA,
Guastamacchia E, De Pergola G, Triggiani V. Oxytocin Signaling Pathway: From
Cell Biology to Clinical Implications. Endocr Metab Immune Disord Drug Targets.
2021;21(1):91-110. doi: 10.2174/1871530320666200520093730. PMID: 32433011.
1444: Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, Cuenod
M, Do KQ. Redox dysregulation affects the ventral but not dorsal hippocampus:
impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J
Neurosci. 2010 Feb 17;30(7):2547-58. doi: 10.1523/JNEUROSCI.3857-09.2010. PMID:
20164340; PMCID: PMC6634545.
1445: Khaled Y, Abdelhamid AA, Al-Mazroey H, Almannai AK, Fetais S, Al-Srami AS,
Ahmed S, Al-Hajri N, Mustafa A, Chivese T, Djouhri L. Higher serum uric acid is
associated with poorer cognitive performance in healthy middle-aged people: a
cross-sectional study. Intern Emerg Med. 2023 Sep;18(6):1701-1709. doi:
10.1007/s11739-023-03337-1. Epub 2023 Jun 17. PMID: 37330420; PMCID:
PMC10504193.
1446: Moon E, Kim K, Partonen T, Linnaranta O. Role of Melatonin in the
Management of Sleep and Circadian Disorders in the Context of Psychiatric
Illness. Curr Psychiatry Rep. 2022 Nov;24(11):623-634. doi:
10.1007/s11920-022-01369-6. Epub 2022 Oct 13. PMID: 36227449; PMCID: PMC9633504.
1447: Ruiz-Perera LM, Greiner JFW, Kaltschmidt C, Kaltschmidt B. A Matter of
Choice: Inhibition of c-Rel Shifts Neuronal to Oligodendroglial Fate in Human
Stem Cells. Cells. 2020 Apr 22;9(4):1037. doi: 10.3390/cells9041037. PMID:
32331232; PMCID: PMC7226153.
1448: Qing H, Xu H, Wei Z, Gibson K, Li XM. The ability of atypical
antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced
apoptosis. Eur J Neurosci. 2003 Apr;17(8):1563-70. doi:
10.1046/j.1460-9568.2003.02590.x. PMID: 12752374.
1449: Liang Y, Yu H, Ke X, Eyles D, Sun R, Wang Z, Huang S, Lin L, McGrath JJ,
Lu J, Guo X, Yao P. Vitamin D deficiency worsens maternal diabetes induced
neurodevelopmental disorder by potentiating hyperglycemia-mediated epigenetic
changes. Ann N Y Acad Sci. 2021 May;1491(1):74-88. doi: 10.1111/nyas.14535. Epub
2020 Dec 10. PMID: 33305416.
1450: Díaz-Marsá M, Macdowell KS, Guemes I, Rubio V, Carrasco JL, Leza JC.
Activation of the cholinergic anti-inflammatory system in peripheral blood
mononuclear cells from patients with borderline personality disorder. J
Psychiatr Res. 2012 Dec;46(12):1610-7. doi: 10.1016/j.jpsychires.2012.09.009.
Epub 2012 Oct 17. PMID: 23083519.
1451: Wass C, Archer T, Pålsson E, Fejgin K, Klamer D, Engel JA, Svensson L.
Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent
mechanisms. Behav Brain Res. 2006 Jul 15;171(1):147-53. doi:
10.1016/j.bbr.2006.03.036. Epub 2006 May 4. PMID: 16677724.
1452: Turner BJ, Rembach A, Spark R, Lopes EC, Cheema SS. Opposing effects of
low and high-dose clozapine on survival of transgenic amyotrophic lateral
sclerosis mice. J Neurosci Res. 2003 Nov 15;74(4):605-13. doi:
10.1002/jnr.10796. PMID: 14598305.
1453: Nordholm D, Jensen MA, Glenthøj LB, Kristensen TD, Wenneberg C, Garde AH,
Nordentoft M. Sleep disturbances and the association with attenuated psychotic
symptoms in individuals at ultra high-risk of psychosis. J Psychiatr Res. 2023
Feb;158:143-149. doi: 10.1016/j.jpsychires.2022.12.041. Epub 2022 Dec 23. PMID:
36584492.
1454: Thakkar D, Kate AS. 1-(Benzo[b]thiophen-4-yl)piperazine Ring Induced
Bioactivation of Brexpiprazole in Liver Microsomes: Identification and
Characterization of Reactive Conjugates Using Ultra-High-Performance Liquid
Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. Eur J Drug Metab
Pharmacokinet. 2020 Jun;45(3):393-403. doi: 10.1007/s13318-020-00606-8. PMID:
32002811.
1455: Tavakkoli A, Abnous K, Vahdati Hassani F, Hosseinzadeh H, BirnerGruenberger R, Mehri S. Alteration of protein profile in cerebral cortex of rats
exposed to bisphenol a: a proteomics study. Neurotoxicology. 2020 May;78:1-10.
doi: 10.1016/j.neuro.2020.01.013. Epub 2020 Feb 1. PMID: 32017977.
1456: Patel M, Mundada V, Sawant K. Enhanced intestinal absorption of asenapine
maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of
transport mechanism, permeability across Caco-2 cell line and in vivo
pharmacokinetic studies. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):144-153.
doi: 10.1080/21691401.2018.1546186. PMID: 30669881.
1457: Zheng W, Li X, Zhang T, Wang J. Biological mechanisms and clinical
efficacy of sulforaphane for mental disorders. Gen Psychiatr. 2022 Apr
5;35(2):e100700. doi: 10.1136/gpsych-2021-100700. PMID: 35492261; PMCID:
PMC8987744.
1458: Froestl W, Muhs A, Pfeifer A. Cognitive enhancers (nootropics). Part 2:
drugs interacting with enzymes. J Alzheimers Dis. 2013;33(3):547-658. doi:
10.3233/JAD-2012-121537. PMID: 23042218.
1459: Froestl W, Pfeifer A, Muhs A. Cognitive enhancers (nootropics). Part 3:
drugs interacting with targets other than receptors or enzymes. diseasemodifying drugs. J Alzheimers Dis. 2013;34(1):1-114. doi: 10.3233/JAD-121729.
PMID: 23186990.
1460: Neustadt J, Pieczenik SR. Medication-induced mitochondrial damage and
disease. Mol Nutr Food Res. 2008 Jul;52(7):780-8. doi: 10.1002/mnfr.200700075.
PMID: 18626887.
1461: Trivedi MS, Deth RC. Role of a redox-based methylation switch in mRNA life
cycle (pre- and post-transcriptional maturation) and protein turnover:
implications in neurological disorders. Front Neurosci. 2012 Jun 26;6:92. doi:
10.3389/fnins.2012.00092. PMID: 22740813; PMCID: PMC3382963.
1462: Machado MS, Rosa RM, Dantas AS, Reolon GK, Appelt HR, Braga AL, Henriques
JA, Roesler R. An organic selenium compound attenuates apomorphine-induced
stereotypy in mice. Neurosci Lett. 2006 Dec 27;410(3):198-202. doi:
10.1016/j.neulet.2006.09.079. Epub 2006 Oct 18. PMID: 17052842.
1463: Hussain G, Rasul A, Anwar H, Aziz N, Razzaq A, Wei W, Ali M, Li J, Li X.
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative
Disorders. Int J Biol Sci. 2018 Mar 9;14(3):341-357. doi: 10.7150/ijbs.23247.
PMID: 29559851; PMCID: PMC5859479.
1464: Morris G, Carvalho AF, Anderson G, Galecki P, Maes M. The Many
Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be
Associated with the Pathophysiology of Neuro-Immune Disorders. Curr Pharm Des.
2016;22(8):963-77. doi: 10.2174/1381612822666151215102420. PMID: 26667000.
1465: Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health
and disease: from molecular mechanisms to therapeutic opportunities. Antioxid
Redox Signal. 2010 Jan;12(1):125-69. doi: 10.1089/ars.2009.2668. Erratum in:
Antioxid Redox Signal. 2010 Feb;12(2):321. Khanna, Savita [removed];Kulkarni,
Shrinivas K [removed]; Maher, Pamela [removed]; Mancuso, Cesare [removed];
Rapoport, Stanley I [removed]; Smith, Mark [removed]; Thomas, Bobby [removed];
Yagami, Tatsurou [removed]. PMID: 19624272.
1466: Lum PT, Sekar M, Gan SH, Pandy V, Bonam SR. Protective effect of
mangiferin on memory impairment: A systematic review. Saudi J Biol Sci. 2021
Jan;28(1):917-927. doi: 10.1016/j.sjbs.2020.11.037. Epub 2020 Nov 13. PMID:
33424383; PMCID: PMC7783829.
1467: Gałecki P, Talarowska M, Anderson G, Berk M, Maes M. Mechanisms underlying
neurocognitive dysfunctions in recurrent major depression. Med Sci Monit. 2015
May 27;21:1535-47. doi: 10.12659/MSM.893176. PMID: 26017336; PMCID: PMC4459569.
1468: Zhou X, Chen Q, Hu X, Mao S, Kong Y. Pyrroloquinoline quinone prevents
MK-801-induced stereotypical behavior and cognitive deficits in mice. Behav
Brain Res. 2014 Jan 1;258:153-9. doi: 10.1016/j.bbr.2013.10.025. Epub 2013 Oct
20. PMID: 24149067.
1469: Ubbenhorst A, Striebich S, Lang F, Lang UE. Exploring the relationship
between vitamin D and basic personality traits. Psychopharmacology (Berl). 2011
Jun;215(4):733-7. doi: 10.1007/s00213-011-2175-x. Epub 2011 Jan 29. PMID:
21274699.
1470: Caldiroli A, Capuzzi E, Barkin JL, Grassi S, Esposito CM, Auxilia AM,
Russo S, Tagliabue I, Carnevali GS, Mucci F, Invernizzi E, Clerici M, Buoli M.
Is there an association between inflammatory/anti-oxidant markers and the
presence of psychotic symptoms or severity of illness in mood and psychotic
disorders? A multi-centric study on a drug-free sample. Brain Behav Immun
Health. 2022 Mar 19;22:100453. doi: 10.1016/j.bbih.2022.100453. PMID: 35403068;
PMCID: PMC8990055.
1471: Ikawa T, Sato M, Oh-Hashi K, Furuta K, Hirata Y. Oxindole-curcumin hybrid
compound enhances the transcription of γ-glutamylcysteine ligase. Eur J
Pharmacol. 2021 Apr 5;896:173898. doi: 10.1016/j.ejphar.2021.173898. Epub 2021
Jan 26. PMID: 33508284.
1472: Karagöz YS, Doğan Ö, Elgün S, Öztop DB, Kılıç BG. Ubiquinone Levels as a
Marker of Antioxidant System in Children with Attention Deficit Hyperactivity
Disorder. J Mol Neurosci. 2021 Oct;71(10):2173-2178. doi:
10.1007/s12031-020-01763-w. Epub 2020 Nov 27. PMID: 33245486.
1473: Abdel-Wahab BA, Metwally ME, El-khawanki MM, Hashim AM. Protective effect
of captopril against clozapine-induced myocarditis in rats: role of oxidative
stress, proinflammatory cytokines and DNA damage. Chem Biol Interact. 2014 Jun
5;216:43-52. doi: 10.1016/j.cbi.2014.03.012. Epub 2014 Apr 5. PMID: 24709159.
1474: Sun GY, Simonyi A, Fritsche KL, Chuang DY, Hannink M, Gu Z, Greenlief CM,
Yao JK, Lee JC, Beversdorf DQ. Docosahexaenoic acid (DHA): An essential nutrient
and a nutraceutical for brain health and diseases. Prostaglandins Leukot Essent
Fatty Acids. 2018 Sep;136:3-13. doi: 10.1016/j.plefa.2017.03.006. Epub 2017 Mar
10. PMID: 28314621; PMCID: PMC9087135.
1475: Morén C, Treder N, Martínez-Pinteño A, Rodríguez N, Arbelo N, Madero S,
Gómez M, Mas S, Gassó P, Parellada E. Systematic Review of the Therapeutic Role
of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in
Schizophrenia. Antioxidants (Basel). 2022 Nov 17;11(11):2275. doi:
10.3390/antiox11112275. PMID: 36421461; PMCID: PMC9686909.
1476: Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavón N, Pisani A,
Bernardi G, Moratalla R, Calabresi P. Distinct roles of D1 and D5 dopamine
receptors in motor activity and striatal synaptic plasticity. J Neurosci. 2003
Sep 17;23(24):8506-12. doi: 10.1523/JNEUROSCI.23-24-08506.2003. PMID: 13679419;
PMCID: PMC6740372.
1477: Romero-Miguel D, Casquero-Veiga M, Fernández J, Lamanna-Rama N, GómezRangel V, Gálvez-Robleño C, Santa-Marta C, Villar CJ, Lombó F, Abalo R, Desco M,
Soto-Montenegro ML. Maternal Supplementation with N-Acetylcysteine Modulates the
Microbiota-Gut-Brain Axis in Offspring of the Poly I:C Rat Model of
Schizophrenia. Antioxidants (Basel). 2023 Apr 20;12(4):970. doi:
10.3390/antiox12040970. PMID: 37107344; PMCID: PMC10136134.
1478: Avitan I, Halperin Y, Saha T, Bloch N, Atrahimovich D, Polis B, Samson AO,
Braitbard O. Towards a Consensus on Alzheimer's Disease Comorbidity? J Clin Med.
2021 Sep 24;10(19):4360. doi: 10.3390/jcm10194360. PMID: 34640387; PMCID:
PMC8509357.
1479: Froestl W, Muhs A, Pfeifer A. Cognitive enhancers (nootropics). Part 1:
drugs interacting with receptors. J Alzheimers Dis. 2012;32(4):793-887. doi:
10.3233/JAD-2012-121186. PMID: 22886028.
1480: Deslauriers J, Desmarais C, Sarret P, Grignon S. α-Lipoic acid interaction
with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling
pathway induced by antipsychotics: potential relevance for the treatment of
schizophrenia. J Mol Neurosci. 2013 May;50(1):134-45. doi:
10.1007/s12031-012-9884-4. Epub 2012 Sep 14. PMID: 22975849.
1481: Carta MG, Hardoy MC, Dell'Osso L, Carpiniello B. La terapia della
discinesia tardiva, una revisione sistematica della letteratura [Tardive
dyskinesia: review of the literature]. Clin Ter. 2004 Apr;155(4):127-33.
Italian. PMID: 15354761.
1482: Wolfschlag M, Håkansson A. Increased risk for developing gambling disorder
under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide
register study in Sweden. PLoS One. 2021 Jun 1;16(6):e0252516. doi:
10.1371/journal.pone.0252516. PMID: 34061895; PMCID: PMC8168838.
1483: Klamer D, Zhang J, Engel JA, Svensson L. Selective interaction of nitric
oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor
binding studies in the rat. Behav Brain Res. 2005 Apr 15;159(1):95-103. doi:
10.1016/j.bbr.2004.10.006. PMID: 15795002.
1484: Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. Antipsychotic
Potential and Safety Profile of TPGS-Based Mucoadhesive Aripiprazole
Nanoemulsion: Development and Optimization for Nose-To-Brain Delivery. J Pharm
Sci. 2021 Apr;110(4):1761-1778. doi: 10.1016/j.xphs.2021.01.021. Epub 2021 Jan
27. PMID: 33515583.
1485: Yang N, Yu L, Deng Y, Han Q, Wang J, Yu L, Zhai Z, Li W. Identification
and characterization of proteins that are differentially expressed in adipose
tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative
proteomics. J Proteomics. 2020 Feb 10;212:103570. doi:
10.1016/j.jprot.2019.103570. Epub 2019 Nov 9. PMID: 31706944.
1486: Valles SL, Singh SK, Campos-Campos J, Colmena C, Campo-Palacio I, AlvarezGamez K, Caballero O, Jorda A. Functions of Astrocytes under Normal Conditions
and after a Brain Disease. Int J Mol Sci. 2023 May 8;24(9):8434. doi:
10.3390/ijms24098434. PMID: 37176144; PMCID: PMC10179527.
1487: Montes P, Ruiz-Sanchez E, Rojas C, Rojas P. Ginkgo biloba Extract 761: A
Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders. CNS
Neurol Disord Drug Targets. 2015;14(1):132-49. doi:
10.2174/1871527314666150202151440. PMID: 25642989.
1488: Walton NM, Shin R, Tajinda K, Heusner CL, Kogan JH, Miyake S, Chen Q,
Tamura K, Matsumoto M. Adult neurogenesis transiently generates oxidative
stress. PLoS One. 2012;7(4):e35264. doi: 10.1371/journal.pone.0035264. Epub 2012
Apr 30. PMID: 22558133; PMCID: PMC3340368.
1489: Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune Influencers
in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic
Pathway. Biomedicines. 2021 Jun 25;9(7):734. doi: 10.3390/biomedicines9070734.
PMID: 34202246; PMCID: PMC8301407.
1490: Emran TB, Islam F, Nath N, Sutradhar H, Das R, Mitra S, Alshahrani MM,
Alhasaniah AH, Sharma R. Naringin and Naringenin Polyphenols in Neurological
Diseases: Understandings from a Therapeutic Viewpoint. Life (Basel). 2022 Dec
29;13(1):99. doi: 10.3390/life13010099. PMID: 36676048; PMCID: PMC9867091.
1491: Mattson MP, Culmsee C, Yu Z, Camandola S. Roles of nuclear factor kappaB
in neuronal survival and plasticity. J Neurochem. 2000 Feb;74(2):443-56. doi:
10.1046/j.1471-4159.2000.740443.x. PMID: 10646495.
1492: Sedlak TW, Nucifora LG, Koga M, Shaffer LS, Higgs C, Tanaka T, Wang AM,
Coughlin JM, Barker PB, Fahey JW, Sawa A. Sulforaphane Augments Glutathione and
Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study. Mol
Neuropsychiatry. 2018 May;3(4):214-222. doi: 10.1159/000487639. Epub 2018 Apr
17. PMID: 29888232; PMCID: PMC5981770.
1493: Jankowska A, Wesolowska A, Pawlowski M, Chlon-Rzepa G. Multi-TargetDirected Ligands Affecting Serotonergic Neurotransmission for Alzheimer's
Disease Therapy: Advances in Chemical and Biological Research. Curr Med Chem.
2018;25(17):2045-2067. doi: 10.2174/0929867324666170529122802. PMID: 28554324.
1494: Grover S, Kumar P, Singh K, Vikram V, Budhiraja RD. Possible beneficial
effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist
against a rat model of oral dyskinesia. Pharmacol Biochem Behav. 2013
Oct;111:17-23. doi: 10.1016/j.pbb.2013.08.001. Epub 2013 Aug 12. PMID: 23948071.
1495: Kaya MC, Bez Y, Selek S, Fatih Karababa I, Bulut M, Savaş HA, Celik H,
Herken H. No effect of antidepressant treatment on elevated serum ceruloplasmin
level in patients with first-episode depression: a longitudinal study. Arch Med
Res. 2012 May;43(4):294-7. doi: 10.1016/j.arcmed.2012.05.006. Epub 2012 Jun 13.
PMID: 22704847.
1496: Cruz TS, Faria PA, Santana DP, Ferreira JC, Oliveira V, Nascimento OR,
Cerchiaro G, Curti C, Nantes IL, Rodrigues T. On the mechanisms of
phenothiazine-induced mitochondrial permeability transition: Thiol oxidation,
strict Ca2+ dependence, and cyt c release. Biochem Pharmacol. 2010 Oct
15;80(8):1284-95. doi: 10.1016/j.bcp.2010.06.052. Epub 2010 Jul 7. PMID:
20619250.
1497: Grant WB, Strange RC, Garland CF. Sunshine is good medicine. The health
benefits of ultraviolet-B induced vitamin D production. J Cosmet Dermatol. 2003
Apr;2(2):86-98. doi: 10.1111/j.1473-2130.2004.00041.x. PMID: 17156062.
1498: El Midaoui A, Ghzaiel I, Vervandier-Fasseur D, Ksila M, Zarrouk A, Nury T,
Khallouki F, El Hessni A, Ibrahimi SO, Latruffe N, Couture R, Kharoubi O, Brahmi
F, Hammami S, Masmoudi-Kouki O, Hammami M, Ghrairi T, Vejux A, Lizard G. Saffron
(<i>Crocus sativus</i> L.): A Source of Nutrients for Health and for the
Treatment of Neuropsychiatric and Age-Related Diseases. Nutrients. 2022 Jan
29;14(3):597. doi: 10.3390/nu14030597. PMID: 35276955; PMCID: PMC8839854.
1499: Thilakaratne RA, Malig BJ, Basu R. Examining the relationship between
ambient carbon monoxide, nitrogen dioxide, and mental health-related emergency
department visits in California, USA. Sci Total Environ. 2020 Dec 1;746:140915.
doi: 10.1016/j.scitotenv.2020.140915. Epub 2020 Jul 18. PMID: 32745847.
1500: Scumpia PO, Kelly-Scumpia K, Stevens BR. Alpha-lipoic acid effects on
brain glial functions accompanying double-stranded RNA antiviral and
inflammatory signaling. Neurochem Int. 2014 Jan;64:55-63. doi:
10.1016/j.neuint.2013.11.006. Epub 2013 Nov 20. PMID: 24269587.
1501: Zheng LT, Hwang J, Ock J, Lee MG, Lee WH, Suk K. The antipsychotic
spiperone attenuates inflammatory response in cultured microglia via the
reduction of proinflammatory cytokine expression and nitric oxide production. J
Neurochem. 2008 Dec;107(5):1225-35. doi: 10.1111/j.1471-4159.2008.05675.x. Epub
2008 Sep 11. PMID: 18786164.
1502: Kundakovic M, Gudsnuk K, Herbstman JB, Tang D, Perera FP, Champagne FA.
DNA methylation of BDNF as a biomarker of early-life adversity. Proc Natl Acad
Sci U S A. 2015 Jun 2;112(22):6807-13. doi: 10.1073/pnas.1408355111. Epub 2014
Nov 10. PMID: 25385582; PMCID: PMC4460453.
1503: Zhao SS, Qian Y, Mackie SL, Wen C, Mao Y. Genetically predicted serum
urate levels have no causal role on depression or other psychiatric disorders.
Clin Rheumatol. 2021 Sep;40(9):3729-3733. doi: 10.1007/s10067-021-05718-3. Epub
2021 Mar 30. PMID: 33786690.
1504: Koike S, Toriumi K, Kasahara S, Kibune Y, Ishida YI, Dan T, Miyata T, Arai
M, Ogasawara Y. Accumulation of Carbonyl Proteins in the Brain of Mouse Model
for Methylglyoxal Detoxification Deficits. Antioxidants (Basel). 2021 Apr
8;10(4):574. doi: 10.3390/antiox10040574. PMID: 33917901; PMCID: PMC8068291.
1505: Zhang F, Han L, Wang J, Shu M, Liu K, Zhang Y, Hsiao C, Tian Q, He Q.
Clozapine Induced Developmental and Cardiac Toxicity on Zebrafish Embryos by
Elevating Oxidative Stress. Cardiovasc Toxicol. 2021 May;21(5):399-409. doi:
10.1007/s12012-021-09632-7. Epub 2021 Jan 24. PMID: 33486714.
1506: Ozyurt B, Ozyurt H, Akpolat N, Erdogan H, Sarsilmaz M. Oxidative stress in
prefrontal cortex of rat exposed to MK-801 and protective effects of CAPE. Prog
Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):832-8. doi:
10.1016/j.pnpbp.2007.01.029. Epub 2007 Feb 12. PMID: 17374554.
1507: Liu Y, Lan N, Ren J, Wu Y, Wang ST, Huang XF, Yu Y. Orientin improves
depression-like behavior and BDNF in chronic stressed mice. Mol Nutr Food Res.
2015 Jun;59(6):1130-42. doi: 10.1002/mnfr.201400753. Epub 2015 Apr 29. Erratum
in: Mol Nutr Food Res. 2015 Jul;59(7):1411. PMID: 25788013.
1508: da Silva A, Silveira BKS, Hermsdorff HHM, da Silva W, Bressan J. Effect of
omega-3 fatty acid supplementation on telomere length and telomerase activity: A
systematic review of clinical trials. Prostaglandins Leukot Essent Fatty Acids.
2022 Jun;181:102451. doi: 10.1016/j.plefa.2022.102451. Epub 2022 May 21. PMID:
35661999.
1509: Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol.
Prog Neurobiol. 2001 Jan;63(1):29-60. doi: 10.1016/s0301-0082(00)00025-3. PMID:
11040417.
1510: Aouti S, Padavattan S, Padmanabhan B. Structure-based discovery of an
antipsychotic drug, paliperidone, as a modulator of human superoxide dismutase
1: a potential therapeutic target in amyotrophic lateral sclerosis. Acta
Crystallogr D Struct Biol. 2023 Jun 1;79(Pt 6):531-544. doi:
10.1107/S2059798323003649. Epub 2023 May 19. PMID: 37204819.
1511: Beppe GJ, Kenko Djoumessie LB, Keugong Wado E, Ngatanko Abaïssou HH,
Nkwingwa BK, Damo Kamda JL, Nhouma RR, Foyet HS. Aqueous Root Bark Extract of
<i>Daniellia oliveri</i> (Hutch. & Dalz.) (Fabaceae) Protects Neurons against
Diazepam-Induced Amnesia in Mice. Evid Based Complement Alternat Med. 2020 Jul
21;2020:7815348. doi: 10.1155/2020/7815348. PMID: 32774429; PMCID: PMC7391112.
1512: Asghari M, Shaghaghi Z, Farzipour S, Ghasemi A, Hosseinimehr SJ.
Radioprotective effect of olanzapine as an anti-psychotic drug against
genotoxicity and apoptosis induced by ionizing radiation on human lymphocytes.
Mol Biol Rep. 2019 Dec;46(6):5909-5917. doi: 10.1007/s11033-019-05024-x. Epub
2019 Aug 12. PMID: 31407246.
1513: Sorce S, Krause KH, Jaquet V. Targeting NOX enzymes in the central nervous
system: therapeutic opportunities. Cell Mol Life Sci. 2012 Jul;69(14):2387-407.
doi: 10.1007/s00018-012-1014-5. Epub 2012 May 30. PMID: 22643836.
1514: Yao JK, Reddy RD. Metabolic investigation in psychiatric disorders. Mol
Neurobiol. 2005;31(1-3):193-203. doi: 10.1385/MN:31:1-3:193. PMID: 15953821.
1515: Vicente-Sánchez A, Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J. HINT1
protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate
NMDA receptor activity. Mol Brain. 2013 Oct 5;6:42. doi: 10.1186/1756-6606-6-42.
PMID: 24093505; PMCID: PMC3851374.
1516: Wyckhuys T, Verhaeghe J, Wyffels L, Langlois X, Schmidt M, Stroobants S,
Staelens S. N-acetylcysteine- and MK-801-induced changes in glutamate levels do
not affect in vivo binding of metabotropic glutamate 5 receptor radioligand
11C-ABP688 in rat brain. J Nucl Med. 2013 Nov;54(11):1954-61. doi:
10.2967/jnumed.113.121608. Epub 2013 Sep 19. PMID: 24050937.
1517: Yang CP, Wang YY, Lin SY, Hong YJ, Liao KY, Hsieh SK, Pan PH, Chen CJ,
Chen WY. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium
Mobilization in Female Rats. Int J Mol Sci. 2019 Feb 1;20(3):640. doi:
10.3390/ijms20030640. PMID: 30717287; PMCID: PMC6387243.
1518: Schipper HM, Song W, Tavitian A, Cressatti M. The sinister face of heme
oxygenase-1 in brain aging and disease. Prog Neurobiol. 2019 Jan;172:40-70. doi:
10.1016/j.pneurobio.2018.06.008. Epub 2018 Jul 29. PMID: 30009872.
1519: Blandino G, Fiorani M, Canonico B, De Matteis R, Guidarelli A, Montanari
M, Buffi G, Coppo L, Arnér ESJ, Cantoni O. Clozapine suppresses NADPH oxidase
activation, counteracts cytosolic H₂O₂, and triggers early
onset mitochondrial dysfunction during adipogenesis of human liposarcoma
SW872 cells. Redox Biol. 2023 Nov;67:102915. doi: 10.1016/j.redox.2023.102915.
Epub 2023 Oct 12. PMID: 37866162; PMCID: PMC10623370.
1520: Rudzki L, Stone TW, Maes M, Misiak B, Samochowiec J, Szulc A. Gut
microbiota-derived vitamins - underrated powers of a multipotent ally in
psychiatric health and disease. Prog Neuropsychopharmacol Biol Psychiatry. 2021
Apr 20;107:110240. doi: 10.1016/j.pnpbp.2020.110240. Epub 2021 Jan 9. PMID:
33428888.
1521: Nagashima S, Ito N, Kobayashi R, Shiiba I, Shimura H, Fukuda T, Hagihara
H, Miyakawa T, Inatome R, Yanagi S. Forebrain-specific deficiency of the GTPase
CRAG/Centaurin-γ3 leads to immature dentate gyri and hyperactivity in mice. J
Biol Chem. 2021 Jan-Jun;296:100620. doi: 10.1016/j.jbc.2021.100620. Epub 2021
Mar 31. PMID: 33811862; PMCID: PMC8099661.
1522: Domith I, Duarte-Silva AT, Garcia CG, Calaza KDC, Paes-de-Carvalho R,
Cossenza M. Chlorogenic acids inhibit glutamate dehydrogenase and decrease
intracellular ATP levels in cultures of chick embryo retina cells. Biochem
Pharmacol. 2018 Sep;155:393-402. doi: 10.1016/j.bcp.2018.07.023. Epub 2018 Jul
20. PMID: 30031809.
1523: Rosin C, Colombo S, Calver AA, Bates TE, Skaper SD. Dopamine D2 and D3
receptor agonists limit oligodendrocyte injury caused by glutamate oxidative
stress and oxygen/glucose deprivation. Glia. 2005 Dec;52(4):336-43. doi:
10.1002/glia.20250. PMID: 16078234.
1524: Elsaid S, Kloiber S, Le Foll B. Effects of cannabidiol (CBD) in
neuropsychiatric disorders: A review of pre-clinical and clinical findings. Prog
Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub
2019 Aug 28. PMID: 31601406.
1525: Yuan L, Wu J, Liu J, Li G, Liang D. Intermittent Hypoxia-Induced
Parvalbumin-Immunoreactive Interneurons Loss and Neurobehavioral Impairment is
Mediated by NADPH-Oxidase-2. Neurochem Res. 2015 Jun;40(6):1232-42. doi:
10.1007/s11064-015-1586-1. Epub 2015 Apr 25. PMID: 25911467.
1526: Bridges R, Lutgen V, Lobner D, Baker DA. Thinking outside the cleft to
understand synaptic activity: contribution of the cystine-glutamate antiporter
(System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev.
2012 Jul;64(3):780-802. doi: 10.1124/pr.110.003889. PMID: 22759795; PMCID:
PMC3400835.
1527: Nair V, Arjuman A, Dorababu P, Gopalakrishna HN, Chakradhar Rao U, Mohan
L. Effect of NR-ANX-C (a polyherbal formulation) on haloperidol induced
catalepsy in albino mice. Indian J Med Res. 2007 Nov;126(5):480-4. PMID:
18160755.
1528: Goyal R, Longo LD. Metabolic Profiles in Ovine Carotid Arteries with
Developmental Maturation and Long-Term Hypoxia. PLoS One. 2015 Jun
25;10(6):e0130739. doi: 10.1371/journal.pone.0130739. PMID: 26110419; PMCID:
PMC4482414.
1529: Aitken RJ. Male reproductive ageing: a radical road to ruin. Hum Reprod.
2023 Oct 3;38(10):1861-1871. doi: 10.1093/humrep/dead157. PMID: 37568254; PMCID:
PMC10546083.
1530: Magliaro BC, Saldanha CJ. Clozapine protects PC-12 cells from death due to
oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism
involving inhibition of extracellular signal-regulated kinase phosphorylation.
Brain Res. 2009 Aug 4;1283:14-24. doi: 10.1016/j.brainres.2009.05.063. Epub 2009
Jun 6. PMID: 19501068; PMCID: PMC2881214.
1531: Tsai HP, Hou PH, Mao FC, Chang CC, Yang WC, Wu CF, Liao HJ, Lin TC, Chou
LS, Hsiao LW, Chang GR. Risperidone Exacerbates Glucose Intolerance,
Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. Int J Mol
Sci. 2021 Jan 2;22(1):409. doi: 10.3390/ijms22010409. PMID: 33401717; PMCID:
PMC7795724.
1532: Sathyasaikumar KV, Pérez de la Cruz V, Pineda B, Vázquez Cervantes GI,
Ramírez Ortega D, Donley DW, Severson PL, West BL, Giorgini F, Fox JH, Schwarcz
R. Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging
the Dogma. Antioxidants (Basel). 2022 Feb 4;11(2):315. doi:
10.3390/antiox11020315. PMID: 35204197; PMCID: PMC8868204.
1533: Ozyurt B, Sarsilmaz M, Akpolat N, Ozyurt H, Akyol O, Herken H, Kus I. The
protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity
in prefrontal cortex of rat. Neurochem Int. 2007 Jan;50(1):196-202. doi:
10.1016/j.neuint.2006.08.002. Epub 2006 Sep 12. PMID: 16971021.
1534: Aydın EP, Genç A, Dalkıran M, Uyar ET, Deniz İ, Özer ÖA, Karamustafalıoğlu
KO. Thioredoxin is not a marker for treatment-resistance depression but
associated with cognitive function: An rTMS study. Prog Neuropsychopharmacol
Biol Psychiatry. 2018 Jan 3;80(Pt C):322-328. doi: 10.1016/j.pnpbp.2017.04.025.
Epub 2017 Apr 23. PMID: 28442424.
1535: Panossian A, Wikman G. Pharmacology of Schisandra chinensis Bail.: an
overview of Russian research and uses in medicine. J Ethnopharmacol. 2008 Jul
23;118(2):183-212. doi: 10.1016/j.jep.2008.04.020. Epub 2008 Apr 24. PMID:
18515024.
1536: Toledano A, Alvarez MI, Toledano-Díaz A. Diversity and variability of the
effects of nicotine on different cortical regions of the brain - therapeutic and
toxicological implications. Cent Nerv Syst Agents Med Chem. 2010 Sep
1;10(3):180-206. doi: 10.2174/1871524911006030180. PMID: 20528766.
1537: Tapia-Rojas C, Lindsay CB, Montecinos-Oliva C, Arrazola MS, Retamales RM,
Bunout D, Hirsch S, Inestrosa NC. Is L-methionine a trigger factor for
Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau
phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in
wild-type mice. Mol Neurodegener. 2015 Nov 21;10:62. doi:
10.1186/s13024-015-0057-0. PMID: 26590557; PMCID: PMC4654847.
1538: Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-term cannabidiol
treatment prevents the development of social recognition memory deficits in
Alzheimer's disease transgenic mice. J Alzheimers Dis. 2014;42(4):1383-96. doi:
10.3233/JAD-140921. PMID: 25024347.
1539: Díaz-Caneja CM, Pina-Camacho L, Rodríguez-Quiroga A, Fraguas D, Parellada
M, Arango C. Predictors of outcome in early-onset psychosis: a systematic
review. NPJ Schizophr. 2015 Mar 4;1:14005. doi: 10.1038/npjschz.2014.5. PMID:
27336027; PMCID: PMC4849440.
1540: Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical
findings and structural-functional synergies with cell membrane phospholipids.
Altern Med Rev. 2007 Sep;12(3):207-27. PMID: 18072818.
1541: Cunha AS, Matheus FC, Moretti M, Sampaio TB, Poli A, Santos DB, Colle D,
Cunha MP, Blum-Silva CH, Sandjo LP, Reginatto FH, Rodrigues AL, Farina M,
Prediger RD. Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role
of oxidative stress, nitric oxide and glutamate NMDA receptors. Behav Brain Res.
2016 Oct 1;312:64-76. doi: 10.1016/j.bbr.2016.06.014. Epub 2016 Jun 13. PMID:
27306571.
1542: Caddye E, Pineau J, Reyniers J, Ronen I, Colasanti A. Lactate: A
Theranostic Biomarker for Metabolic Psychiatry? Antioxidants (Basel). 2023 Aug
22;12(9):1656. doi: 10.3390/antiox12091656. PMID: 37759960; PMCID: PMC10526106.
1543: Abdel-Wahab BA, Salem SY, Mohammed HM, Mohammed NA, Hetta HF. The role of
vimentin, Connexin-43 proteins, and oxidative stress in the protective effect of
propranolol against clozapine-induced myocarditis and apoptosis in rats. Eur J
Pharmacol. 2021 Jan 5;890:173645. doi: 10.1016/j.ejphar.2020.173645. Epub 2020
Oct 22. PMID: 33098837.
1544: Izzo E, Sanna PP, Koob GF. Impairment of dopaminergic system function
after chronic treatment with corticotropin-releasing factor. Pharmacol Biochem
Behav. 2005 Aug;81(4):701-8. doi: 10.1016/j.pbb.2005.04.017. PMID: 16005056.
1545: Arora D, Mudgal J, Nampoothiri M, Mallik SB, Kinra M, Hall S, AnoopkumarDukie S, Grant GD, Rao CM. Interplay between adenosine receptor antagonist and
cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
Metab Brain Dis. 2018 Aug;33(4):1045-1051. doi: 10.1007/s11011-018-0201-y. Epub
2018 Mar 7. PMID: 29516413.
1546: Miniksar DY, Cansız MA, Göçmen AY, Kılıç M, Miniksar ÖH. The Effect of
Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in
Children and Adolescents with Attention Deficit and Hyperactivity Disorder. Clin
Psychopharmacol Neurosci. 2023 Feb 28;21(1):88-98. doi:
10.9758/cpn.2023.21.1.88. PMID: 36700315; PMCID: PMC9889889.
1547: Miller BJ, Murray L, Beckmann MM, Kent T, Macfarlane B. Dietary
supplements for preventing postnatal depression. Cochrane Database Syst Rev.
2013 Oct 24;2013(10):CD009104. doi: 10.1002/14651858.CD009104.pub2. PMID:
24158923; PMCID: PMC10166593.
1548: Chang GR, Liu HY, Yang WC, Wang CM, Wu CF, Lin JW, Lin WL, Wang YC, Lin
TC, Liao HJ, Hou PH, Chan CH, Lin CF. Clozapine Worsens Glucose Intolerance,
Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and
Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese
Mice. Int J Mol Sci. 2021 Jun 22;22(13):6680. doi: 10.3390/ijms22136680. PMID:
34206460; PMCID: PMC8268139.
1549: de Oliveira EG, de Lima DA, da Silva Júnior JC, de Souza Barbosa MV, de
Andrade Silva SC, de Santana JH, Dos Santos Junior OH, Lira EC, Lagranha CJ,
Duarte FS, Gomes DA. (R)-ketamine attenuates neurodevelopmental disease-related
phenotypes in a mouse model of maternal immune activation. Eur Arch Psychiatry
Clin Neurosci. 2023 Oct;273(7):1501-1512. doi: 10.1007/s00406-023-01629-3. Epub
2023 May 30. PMID: 37249625.
1550: Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, Prce I,
Wilson AA, Rusjan PM, Sailasuta N, Mizrahi R. Interaction between TSPO-a
neuroimmune marker-and redox status in clinical high risk for psychosis: a PETMRS study. Neuropsychopharmacology. 2018 Jul;43(8):1700-1705. doi:
10.1038/s41386-018-0061-5. Epub 2018 Apr 13. PMID: 29748630; PMCID: PMC6006145.
1551: Al-Bloushi S, Safer AM, Afzal M, Mousa SA. Green tea modulates reserpine
toxicity in animal models. J Toxicol Sci. 2009 Feb;34(1):77-87. doi:
10.2131/jts.34.77. PMID: 19182437.
1552: Abruzzo PM, Panisi C, Marini M. The Alteration of Chloride
Homeostasis/GABAergic Signaling in Brain Disorders: Could Oxidative Stress Play
a Role? Antioxidants (Basel). 2021 Aug 21;10(8):1316. doi:
10.3390/antiox10081316. PMID: 34439564; PMCID: PMC8389245.
1553: Wang S, Yu Y, Feng Y, Zou F, Zhang X, Huang J, Zhang Y, Zheng X, Huang XF,
Zhu Y, Liu Y. Protective effect of the orientin on noise-induced cognitive
impairments in mice. Behav Brain Res. 2016 Jan 1;296:290-300. doi:
10.1016/j.bbr.2015.09.024. Epub 2015 Sep 21. PMID: 26392065.
1554: Kim DY, Park JS, Leem YH, Park JE, Kim HS. The Potent PDE10A Inhibitor
MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced
Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models. J
Neuroimmune Pharmacol. 2021 Jun;16(2):470-482. doi: 10.1007/s11481-020-09943-6.
Epub 2020 Jul 15. PMID: 32671618.
1555: Baandrup L, Ebdrup BH, Rasmussen JØ, Lindschou J, Gluud C, Glenthøj BY.
Pharmacological interventions for benzodiazepine discontinuation in chronic
benzodiazepine users. Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD011481.
doi: 10.1002/14651858.CD011481.pub2. PMID: 29543325; PMCID: PMC6513394.
1556: Lu Z, Pu C, Zhang Y, Sun Y, Liao Y, Kang Z, Feng X, Yue W. Oxidative
Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian
Randomization Study. Antioxidants (Basel). 2022 Jul 18;11(7):1386. doi:
10.3390/antiox11071386. PMID: 35883877; PMCID: PMC9312055.
1557: Wozniak J, DiSalvo M, Farrell A, Vaudreuil C, Uchida M, Ceranoglu TA,
Joshi G, Cook E, Faraone SV, Biederman J. Findings from a pilot open-label trial
of N-acetylcysteine for the treatment of pediatric mania and hypomania. BMC
Psychiatry. 2022 May 3;22(1):314. doi: 10.1186/s12888-022-03943-x. PMID:
35505312; PMCID: PMC9066881.
1558: Altar CA, Vawter MP, Ginsberg SD. Target identification for CNS diseases
by transcriptional profiling. Neuropsychopharmacology. 2009 Jan;34(1):18-54.
doi: 10.1038/npp.2008.172. Epub 2008 Oct 15. PMID: 18923405; PMCID: PMC2675576.
1559: Howarth C, Sutherland B, Choi HB, Martin C, Lind BL, Khennouf L, LeDue JM,
Pakan JM, Ko RW, Ellis-Davies G, Lauritzen M, Sibson NR, Buchan AM, MacVicar BA.
A Critical Role for Astrocytes in Hypercapnic Vasodilation in Brain. J Neurosci.
2017 Mar 1;37(9):2403-2414. doi: 10.1523/JNEUROSCI.0005-16.2016. Epub 2017 Jan
30. Erratum in: J Neurosci. 2017 May 3;37(18):4860. PMID: 28137973; PMCID:
PMC5354350.
1560: Tran TV, Shin EJ, Nguyen LTT, Lee Y, Kim DJ, Jeong JH, Jang CG, Nah SY,
Toriumi K, Nabeshima T, Yamada K, Kim HC. Protein Kinase Cδ Gene Depletion
Protects Against Methamphetamine-Induced Impairments in Recognition Memory and
ERK_1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene.
Mol Neurobiol. 2018 May;55(5):4136-4159. doi: 10.1007/s12035-017-0638-8. Epub
2017 Jun 9. PMID: 28597397.
1561: Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira
A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L,
Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH,
Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade
JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A,
Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo
AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR,
Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM,
Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno
AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P,
Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J,
Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG,
Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF,
Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M,
Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O,
Freitas G, Jardim A, Vasconcelos R, Horta LG, Rosa RS, Kranz LF, Nugem RC,
Siqueira MS, Bordin R, Kniess R, Lacerda JT, Guedes J, Machado I, Almeida S,
Zilhão A, Alves H, Ribeiro Ó, Amaral AP, Santos A, Monteiro J, Rocha MªC, Cruz
R, Amaral AP, Lourenço M, Rocha MªC, Cruz R, Antunes S, Mendonça V, Andrade I,
Osório N, Valado A, Caseiro A, Gabriel A, Martins AC, Mendes F, Cabral L,
Ferreira M, Gonçalves A, Luz TD, Luz L, Martins R, Morgado A, Vale-Dias ML,
Porta-Nova R, Fleig TC, Reuter ÉM, Froemming MB, Guerreiro SL, Carvalho LL,
Guedelha D, Coelho P, Pereira A, Calha A, Cordeiro R, Gonçalves A, Certo A,
Galvão A, Mata MªA, Welter A, Pereira E, Ribeiro S, Kretzer M, Jiménez-Díaz JF,
Jiménez-Rodríguez C, Hernández-Martínez FJ, Rodríguez-De-Vera BDC, MarquesRodrigues A, Coelho P, Bernardes T, Pereira A, Sousa P, Filho JG, Nazario N,
Kretzer M, Amaral O, Garrido A, Veiga N, Nunes C, Pedro AR, Pereira C, Almeia A,
Fernandes HM, Vasconcelos C, Sousa N, Reis VM, Monteiro MJ, Mendes R, Pinto IC,
Pires T, Gama J, Preto V, Silva N, Magalhães C, Martins M, Duarte M, Paúl C,
Martín I, Pinheiro AA, Xavier S, Azevedo J, Bento E, Marques C, Marques M,
Macedo A, Pereira AT, Almeida JP, Almeida A, Alves J, Sousa N, Saavedra F,
Mendes R, Maia AS, Oliveira MT, Sousa AR, Ferreira PP, Lopes LS, Santiago EC,
Monteiro S, Jesus Â, Colaço A, Carvalho A, Silva RP, Cruz A, Ferreira A, Marques
C, Figueiredo JP, Paixão S, Ferreira A, Lopes C, Moreira F, Figueiredo JP,
Ferreira A, Ribeiro D, Moreira F, Figueiredo JP, Paixão S, Fernandes T, Amado D,
Leal J, Azevedo M, Ramalho S, Mangas C, Ribeiro J, Gonçalves R, Nunes AF, Tuna
AR, Martins CR, Forte HD, Costa C, Tenedório JA, Santana P, Andrade JA, Pinto
JL, Campofiorito C, Nunes S, Carmo A, Kaliniczenco A, Alves B, Mendes F, Jesus
C, Fonseca F, Gehrke F, Albuquerque C, Batista R, Cunha M, Madureira A, Ribeiro
O, Martins R, Madeira T, Peixoto-Plácido C, Santos N, Santos O, Bergland A, Bye
A, Lopes C, Alarcão V, Goulão B, Mendonça N, Nicola P, Clara JG, Gomes J,
Querido A, Tomás C, Carvalho D, Cordeiro M, Rosa MC, Marques A, Brandão D,
Ribeiro Ó, Araújo L, Paúl C, Minghelli B, Richaud S, Mendes AL, Marta-Simões J,
Trindade IA, Ferreira C, Carvalho T, Cunha M, Pinto-Gouveia J, Fernandes MC,
Rosa RS, Nugem RC, Kranz LF, Siqueira MS, Bordin R, Martins AC, Medeiros A,
Pimentel R, Fernandes A, Mendonça C, Andrade I, Andrade S, Menezes RL, Bravo R,
Miranda M, Ugartemendia L, Tena JMª, Pérez-Caballero FL, Fuentes-Broto L,
Rodríguez AB, Carmen B, Carneiro MA, Domingues JN, Paixão S, Figueiredo J,
Nascimento VB, Jesus C, Mendes F, Gehrke F, Alves B, Azzalis L, Fonseca F,
Martins AR, Nunes A, Jorge A, Veiga N, Amorim A, Silva A, Martinho L, Monteiro
L, Silva R, Coelho C, Amaral O, Coelho I, Pereira C, Correia A, Rodrigues D,
Marante N, Silva P, Carvalho S, Araujo AR, Ribeiro M, Coutinho P, Ventura S,
Roque F, Calvo C, Reses M, Conde J, Ferreira A, Figueiredo J, Silva D, Seiça L,
Soares R, Mourão R, Kraus T, Abreu AC, Padilha JM, Alves JM, Sousa P, Oliveira
M, Sousa J, Novais S, Mendes F, Pinto J, Cruz J, Marques A, Duarte H, Dixe MDA,
Sousa P, Cruz I, Bastos F, Pereira F, Carvalho FL, Oliveira TT, Raposo VR,
Rainho C, Ribeiro JC, Barroso I, Rodrigues V, Neves C, Oliveira TC, Oliveira B,
Morais MªC, Baylina P, Rodrigues R, Azeredo Z, Vicente C, Dias H, Sim-Sim M,
Parreira P, Salgueiro-Oliveira A, Castilho A, Melo R, Graveto J, Gomes J,
Vaquinhas M, Carvalho C, Mónico L, Brito N, Sarroeira C, Amendoeira J, Cunha F,
Cândido A, Fernandes P, Silva HR, Silva E, Barroso I, Lapa L, Antunes C,
Gonçalves A, Galvão A, Gomes MªJ, Escanciano SR, Freitas M, Parreira P, Marôco
J, Fernandes AR, Cabral C, Alves S, Sousa P, Ferreira A, Príncipe F, Seppänen
UM, Ferreira M, Carvalhais M, Silva M, Ferreira M, Silva J, Neves J, Costa D,
Santos B, Duarte S, Marques S, Ramalho S, Mendes I, Louro C, Menino E, Dixe M,
Dias SS, Cordeiro M, Tomás C, Querido A, Carvalho D, Gomes J, Valim FC, Costa
JO, Bernardes LG, Prebianchi H, Rosa MC, Gonçalves N, Martins MM, Kurcgant P,
Vieira A, Bento S, Deodato S, Rabiais I, Reis L, Torres A, Soares S, Ferreira M,
Graça P, Leitão C, Abreu R, Bellém F, Almeida A, Ribeiro-Varandas E, Tavares A,
Frade JG, Henriques C, Menino E, Louro C, Jordão C, Neco S, Morais C, Ferreira
P, Silva CR, Brito A, Silva A, Duarte H, Dixe MDA, Sousa P, Postolache G,
Oliveira R, Moreira I, Pedro L, Vicente S, Domingos S, Postolache O, Silva D,
Filho JG, Nazario N, Kretzer M, Schneider D, Marques FM, Parreira P, Carvalho C,
Mónico LM, Pinto C, Vicente S, Breda SJ, Gomes JH, Melo R, Parreira P, Salgueiro
A, Graveto J, Vaquinhas M, Castilho A, Jesus Â, Duarte N, Lopes JC, Nunes H,
Cruz A, Salgueiro-Oliveira A, Parreira P, Basto ML, Braga LM, Ferreira A, Araújo
B, Alves JM, Ferreira M, Carvalhais M, Silva M, Novais S, Sousa AS, Ferrito C,
Ferreira PL, Rodrigues A, Ferreira M, Oliveira I, Ferreira M, Neves J, Costa D,
Duarte S, Silva J, Santos B, Martins C, Macedo AP, Araújo O, Augusto C, Braga F,
Gomes L, Silva MA, Rosário R, Pimenta L, Carreira D, Teles P, Barros T, Tomás C,
Querido A, Carvalho D, Gomes J, Cordeiro M, Carvalho D, Querido A, Tomás C,
Gomes J, Cordeiro M, Jácome C, Marques A, Capelas S, Hall A, Alves D, Lousada M,
Loureiro MªH, Camarneiro A, Silva M, Mendes A, Pedreiro A, G.Silva A, Coelho ES,
Melo F, Ribeiro F, Torres R, Costa R, Pinho T, Jácome C, Marques A, Cruz B,
Seabra D, Carreiras D, Ventura M, Cruz X, Brooks D, Marques A, Pinto MR,
Parreira P, Lima-Basto M, Neves M, Mónico LM, Bizarro C, Cunha M, Galhardo A,
Margarida C, Amorim AP, Silva E, Cruz S, Padilha JM, Valente J, Guerrero JT,
Caballero FP, Santos RB, Gonzalez EP, Monago FM, Ugalde LU, Vélez MM, Tena MJ,
Guerrero JT, Bravo R, Pérez-Caballero FL, Becerra IA, Agudelo MªE, Acedo G, Bajo
R, Malheiro I, Gaspar F, Barros L, Furtado G, Uba-Chupel M, Marques M, Rama L,
Braga M, Ferreira JP, Teixeira AMª, Cruz J, Barbosa T, Simões Â, Coelho L,
Rodrigues A, Jiménez-Díaz JF, Martinez-Hernandez F, Rodriguez-De-Vera B,
Ferreira P, Rodrigues A, Ramalho A, Petrica J, Mendes P, Serrano J, Santo I,
Rosado A, Mendonça P, Freitas K, Ferreira D, Brito A, Fernandes R, Gomes S,
Moreira F, Pinho C, Oliveira R, Oliveira AI, Mendonça P, Casimiro AP, Martins P,
Silva I, Evangelista D, Leitão C, Velosa F, Carecho N, Coelho L, Menino E, Dixe
A, Catarino H, Soares F, Gama E, Gordo C, Moreira E, Midões C, Santos M, Machado
S, Oliveira VP, Santos M, Querido A, Dixe A, Marques R, Charepe Z, Antunes A,
Santos S, Rosa MC, Rosa MC, Marques SF, Minghelli B, CaroMinghelli E, Luís MªJ,
Brandão T, Mendes P, Marinho D, Petrica J, Monteiro D, Paulo R, Serrano J, Santo
I, Monteiro L, Ramalho F, Santos-Rocha R, Morgado S, Bento T, Sousa G, Freitas
O, Silva I, Freitas G, Morna C, Vasconcelos R, Azevedo T, Soares S, Pisco J,
Ferreira PP, Olszewer EO, Oliveira MT, Sousa AR, Maia AS, Oliveira ST, Santos E,
Oliveira AI, Maia C, Moreira F, Santos J, Mendes MF, Oliveira RF, Pinho C,
Barreira E, Pereira A, Vaz JA, Novo A, Silva LD, Maia B, Ferreira E, Pires F,
Andrade R, Camarinha L, Silva LD, Maia B, Ferreira E, Pires F, Andrade R,
Camarinha L, César AF, Poço M, Ventura D, Loura R, Gomes P, Gomes C, Silva C,
Melo E, Lindo J, Domingos J, Mendes Z, Poeta S, Carvalho T, Tomás C, Catarino H,
Dixe MªA, Ramalho A, Rosado A, Mendes P, Paulo R, Garcia I, Petrica J, Rodrigues
S, Meneses R, Afonso C, Faria L, Seixas A, Cordeiro M, Granjo P, Gomes JC, Souza
NR, Furtado GE, Rocha SV, Silva P, Carvalho J, Morais MA, Santos S, Lebre P,
Antunes A, Calha A, Xavier A, Cunha M, Pinto-Gouveia J, Alencar L, Cunha M,
Madureira A, Cardoso I, Galhardo A, Daniel F, Rodrigues V, Luz L, Luz T, Ramos
MR, Medeiros DC, Carmo BM, Seabra A, Padez C, Silva MC, Rodrigues A, Coelho P,
Coelho A, Caminha M, Matheus F, Mendes E, Correia J, Kretzer M, HernandezMartinez FJ, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Jimenez-Rodriguez C, ArmasGonzalez Y, Rodrigues C, Pedroso R, Apolinário-Hagen J, Vehreschild V, Veloso M,
Magalhães C, Cabral I, Ferraz M, Nave F, Costa E, Matos F, Pacheco J, Dias A,
Pereira C, Duarte J, Cunha M, Silva D, Mónico LM, Alferes VR, Brêda MªSJ,
Carvalho C, Parreira PM, Morais MªC, Ferreira P, Pimenta R, Boavida J, Pinto IC,
Pires T, Silva C, Ribeiro M, Viega-Branco M, Pereira F, Pereira AMª, Almeida FM,
Estevez GL, Ribeiro S, Kretzer MR, João PV, Nogueira P, Novais S, Pereira A,
Carneiro L, Mota M, Cruz R, Santiago L, Fontes-Ribeiro C, Furtado G, Rocha SV,
Coutinho AP, Neto JS, Vasconcelos LR, Souza NR, Dantas E, Dinis A, Carvalho S,
Castilho P, Pinto-Gouveia J, Sarreira-Santos A, Figueiredo A, Medeiros-Garcia L,
Seabra P, Rodrigues R, Morais MªC, Fernandes PO, Santiago C, Figueiredo MªH,
Basto ML, Guimarães T, Coelho A, Graça A, Silva AM, Fonseca AR, Vale-Dias L,
Minas B, Franco-Borges G, Simões C, Santos S, Serra A, Matos M, Jesus L, Tavares
AS, Almeida A, Leitão C, Varandas E, Abreu R, Bellém F, Trindade IA, Ferreira C,
Pinto-Gouveia J, Marta-Simões J, Amaral O, Miranda C, Guimarães P, Gonçalves R,
Veiga N, Pereira C, Fleig TC, San-Martin EA, Goulart CL, Schneiders PB, Miranda
NF, Carvalho LL, Silva AG, Topa J, Nogueira C, Neves S, Ventura R, Nazaré C,
Brandão D, Freitas A, Ribeiro Ó, Paúl C, Mercê C, Branco M, Almeida P,
Nascimento D, Pereira J, Catela D, Rafael H, Reis AC, Mendes A, Valente AR,
Lousada M, Sousa D, Baltazar AL, Loureiro MªH, Oliveira A, Aparício J, Marques
A, Marques A, Oliveira A, Neves J, Ayoub R, Sousa L, Marques-Vieira C, Severino
S, José H, Cadorio I, Lousada M, Cunha M, Andrade D, Galhardo A, Couto M, Mendes
F, Domingues C, Schukg S, Abrantes AM, Gonçalves AC, Sales T, Teixo R, Silva R,
Estrela J, Laranjo M, Casalta-Lopes J, Rocha C, Simões PC, Sarmento-Ribeiro AB,
Botelho MªF, Rosa MS, Fonseca V, Colaço D, Neves V, Jesus C, Hesse C, Rocha C,
Osório N, Valado A, Caseiro A, Gabriel A, Svensson L, Mendes F, Siba WA, Pereira
C, Tomaz J, Carvalho T, Pinto-Gouveia J, Cunha M, Duarte D, Lopes NV, FonsecaPinto R, Duarte D, Lopes NV, Fonseca-Pinto R, Martins AC, Brandão P, Martins L,
Cardoso M, Morais N, Cruz J, Alves N, Faria P, Mateus A, Morouço P, Alves N,
Ferreira N, Mateus A, Faria P, Morouço P, Malheiro I, Gaspar F, Barros L,
Parreira P, Cardoso A, Mónico L, Carvalho C, Lopes A, Salgueiro-Oliveira A,
Seixas A, Soares V, Dias T, Vardasca R, Gabriel J, Rodrigues S, Paredes H, Reis
A, Marinho S, Filipe V, Lains J, Barroso J, Da Motta C, Carvalho CB, PintoGouveia J, Peixoto E, Gomes AA, Costa V, Couto D, Marques DR, Leitão JA, Tavares
J, Azevedo MH, Silva CF, Freitas J, Parreira P, Marôco J, Garcia-Gordillo MA,
Collado-Mateo D, Chen G, Iezzi A, Sala JA, Parraça JA, Gusi N, Sousa J, Marques
M, Jardim J, Pereira A, Simões S, Cunha M, Sardo P, Guedes J, Lindo J, Machado
P, Melo E, Carvalho CB, Benevides J, Sousa M, Cabral J, Da Motta C, Pereira AT,
Xavier S, Azevedo J, Bento E, Marques C, Carvalho R, Marques M, Macedo A, Silva
AM, Alves J, Gomes AA, Marques DR, Azevedo MªH, Silva C, Mendes A, Lee HD,
Spolaôr N, Oliva JT, Chung WF, Fonseca-Pinto R, Bairros K, Silva CD, Souza CA,
Schroeder SS, Araújo E, Monteiro H, Costa R, Dias SS, Torgal J, Henriques CG,
Santos L, Caceiro EF, Ramalho SA, Oliveira R, Afreixo V, Santos J, Mota P, Cruz
A, Pimentel F, Marques R, Dixe MªA, Querido A, Sousa P, Benevides J, Da Motta C,
Sousa M, Caldeira SN, Carvalho CB, Querido A, Tomás C, Carvalho D, Gomes J,
Cordeiro M, Costa JO, Valim FC, Ribeiro LC, Charepe Z, Querido A, Figueiredo
MªH, Aquino PS, Ribeiro SG, Pinheiro AB, Lessa PA, Oliveira MF, Brito LS, Pinto
ÍN, Furtado AS, Castro RB, Aquino CQ, Martins ES, Pinheiro AB, Aquino PS,
Oliveira LL, Pinheiro PC, Sousa CR, Freitas VA, Silva TM, Lima AS, Aquino CQ,
Andrade KV, Oliveira CA, Vidal EF, Ganho-Ávila A, Moura-Ramos M, Gonçalves Ó,
Almeida J, Silva A, Brito I, Amado J, Rodrigo A, Santos S, Gomes F, Rosa MC,
Marques SF, Luís S, Cavalheiro L, Ferreira P, Gonçalves R, Lopes RS, Cavalheiro
L, Ferreira P, Gonçalves R, Fiorin BH, Santos MS, Oliveira ES, Moreira RL,
Oliveira EA, Filho BL, Palmeira L, Garcia T, Pinto-Gouveia J, Cunha M, Cardoso
S, Palmeira L, Cunha M, Pinto-Gouveia J, Marta-Simões J, Mendes AL, Trindade IA,
Oliveira S, Ferreira C, Mendes AL, Marta-Simões J, Trindade IA, Ferreira C, Nave
F, Campos M, Gaudêncio I, Martins F, Ferreira L, Lopes N, Fonseca-Pinto R,
Rodrigues R, Azeredo Z, Vicente C, Silva J, Sousa P, Marques R, Mendes I,
Rodrigues R, Azeredo Z, Vicente C, Vardasca R, Marques AR, Seixas A, Carvalho R,
Gabriel J, Ferreira PP, Oliveira MT, Sousa AR, Maia AS, Oliveira ST, Costa PO,
Silva MM, Arreguy-Sena C, Alvarenga-Martins N, Pinto PF, Oliveira DC, Parreira
PD, Gomes AT, Braga LM, Araújo O, Lage I, Cabrita J, Teixeira L, Marques R, Dixe
MªA, Querido A, Sousa P, Silva S, Cordeiro E, Pimentel J, Ferro-Lebres V, Souza
JA, Tavares M, Dixe MªA, Sousa P, Passadouro R, Peralta T, Ferreira C, Lourenço
G, Serrano J, Petrica J, Paulo R, Honório S, Mendes P, Simões A, Carvalho L,
Pereira A, Silva S, Sousa P, Padilha JM, Figueiredo D, Valente C, Marques A,
Ribas P, Sousa J, Brandão F, Sousa C, Martins M, Sousa P, Marques R, Mendes F,
Fernandes R, Martins E, Magalhães C, Araújo P, Grande C, Mata MªA, Vieitez JG,
Bianchini B, Nazario N, Filho JG, Kretzer M, Costa T, Almeida A, Baffour G,
Almeida A, Costa T, Baffour G, Azeredo Z, Laranjeira C, Guerra M, Barbeiro AP,
Ferreira R, Lopes S, Nunes L, Mendes A, Martins J, Schneider D, Kretzer M,
Magajewski F, Soares C, Marques A, Batista M, Castuera RJ, Mesquita H, Faustino
A, Santos J, Honório S, Vizzotto BP, Frigo L, Pivetta HF, Sardo D, Martins C,
Abreu W, Figueiredo MªC, Batista M, Jimenez-Castuera R, Petrica J, Serrano J,
Honório S, Paulo R, Mendes P, Sousa P, Marques R, Faustino A, Silveira P,
Serrano J, Paulo R, Mendes P, Honório S, Oliveira C, Bastos F, Cruz I, Rodriguez
CK, Kretzer MR, Nazário NO, Cruz P, Vaz DC, Ruben RB, Avelelas F, Silva S,
Campos MªJ, Almeida M, Gonçalves L, Antunes L, Sardo P, Guedes J, Simões J,
Machado P, Melo E, Cardoso S, Santos O, Nunes C, Loureiro I, Santos F, Alves G,
Soar C, Marsi TO, Silva E, Pedrosa D, Leça A, Silva D, Galvão A, Gomes M,
Fernandes P, Noné A, Combadão J, Ramalhete C, Figueiredo P, Caeiro P, Fontana
KC, Lacerda JT, Machado PO, Borges R, Barbosa F, Sá D, Brunhoso G, Aparício G,
Carvalho A, Garcia AP, Fernandes PO, Santos A, Veiga N, Brás C, Carvalho I,
Batalha J, Glória M, Bexiga F, Coelho I, Amaral O, Pereira C, Pinho C, Paraíso
N, Oliveira AI, Lima CF, Dias AP, Silva P, Espada M, Marques M, Pereira A,
Pereira AMª, Veiga-Branco Mª, Pereira F, Ribeiro M, Lima V, Oliveira AI, Pinho
C, Cruz G, Oliveira RF, Barreiros L, Moreira F, Camarneiro A, Loureiro MªH,
Silva M, Duarte C, Jesus Â, Cruz A, Mota M, Novais S, Nogueira P, Pereira A,
Carneiro L, João PV, Lima TM, Salgueiro-Oliveira A, Vaquinhas M, Parreira P,
Melo R, Graveto J, Castilho A, Gomes JH, Medina MS, Blanco VG, Santos O, Lopes
E, Virgolino A, Dinis A, Ambrósio S, Almeida I, Marques T, Heitor MªJ, GarciaGordillo MA, Collado-Mateo D, Olivares PR, Parraça JA, Sala JA, Castilho A,
Graveto J, Parreira P, Oliveira A, Gomes JH, Melo R, Vaquinhas M, Cheio M, Cruz
A, Pereira OR, Pinto S, Oliveira A, Manso MC, Sousa C, Vinha AF, Machado MªM,
Vieira M, Fernandes B, Tomás T, Quirino D, Desouzart G, Matos R, Bordini M,
Mouroço P, Matos AR, Serapioni M, Guimarães T, Fonseca V, Costa A, Ribeiro J,
Lobato J, Martin IZ, Björklund A, Tavares AI, Ferreira P, Passadouro R, Morgado
S, Tavares N, Valente J, Martins AC, Araújo P, Fernandes R, Mendes F, Magalhães
C, Martins E, Mendes P, Paulo R, Faustino A, Mesquita H, Honório S, Batista M,
Lacerda JT, Ortiga AB, Calvo MªC, Natal S, Pereira M, Ferreira M, Prata AR,
Nelas P, Duarte J, Carneiro J, Oliveira AI, Pinho C, Couto C, Oliveira RF,
Moreira F, Maia AS, Oliveira MT, Sousa AR, Ferreira PP, Souza GM, Almada LF,
Conceição MA, Santiago EC, Rodrigues S, Domingues G, Ferreira I, Faria L, Seixas
A, Costa AR, Jesus Â, Cardoso A, Meireles A, Colaço A, Cruz A, Vieira VL, Vincha
KR, Cervato-Mancuso AMª, Faria M, Reis C, Cova MP, Ascenso RT, Almeida HA,
Oliveira EG, Santana M, Pereira R, Oliveira EG, Almeida HA, Ascenso RT, Jesus R,
Tapadas R, Tim-Tim C, Cezanne C, Lagoa M, Dias SS, Torgal J, Lopes J, Almeida H,
Amado S, Carrão L, Cunha M, Saboga-Nunes L, Albuquerque C, Ribeiro O, Oliveira
S, Morais MªC, Martins E, Mendes F, Fernandes R, Magalhães C, Araújo P, Pedro
AR, Amaral O, Escoval A, Assunção V, Luís H, Luís L, Apolinário-Hagen J,
Vehreschild V, Fotschl U, Lirk G, Martins AC, Andrade I, Mendes F, Mendonça V,
Antunes S, Andrade I, Osório N, Valado A, Caseiro A, Gabriel A, Martins AC,
Mendes F, Silva PA, Mónico LM, Parreira PM, Carvalho C, Carvalho C, Parreira PM,
Mónico LM, Ruivo J, Silva V, Sousa P, Padilha JM, Ferraz V, Aparício G, Duarte
J, Vasconcelos C, Almeida A, Neves J, Correia T, Amorim H, Mendes R, SabogaNunes L, Cunha M, Albuquerque C, Pereira ES, Santos LS, Reis AS, Silva HR, Rombo
J, Fernandes JC, Fernandes P, Ribeiro J, Mangas C, Freire A, Silva S, Francisco
I, Oliveira A, Catarino H, Dixe MªA, Louro MªC, Lopes S, Dixe A, Dixe MªA,
Menino E, Catarino H, Soares F, Oliveira AP, Gordo S, Kraus T, Tomás C, Queirós
P, Rodrigues T, Sousa P, Frade JG, Lobão C, Moura CB, Dreyer LC, Meneghetti V,
Cabral PP, Pinto F, Sousa P, Esteves MªR, Galvão S, Tytgat I, Andrade I, Osório
N, Valado A, Caseiro A, Gabriel A, Martins AC, Mendes F, Casas-Novas M, Bernardo
H, Andrade I, Sousa G, Sousa AP, Rocha C, Belo P, Osório N, Valado A, Caseiro A,
Gabriel A, Martins AC, Mendes F, Martins F, Pulido-Fuentes M, Barroso I, Cabral
G, Monteiro MJ, Rainho C, Prado A, Carvalho YM, Campos M, Moreira L, Ferreira J,
Teixeira A, Rama L, Campos M, Moreira L, Ferreira J, Teixeira A, Rama L.
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria,
Portugal. 6-7 May 2016. BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200.
doi: 10.1186/s12913-016-1423-5. PMID: 27409075; PMCID: PMC4943498.